RESULT_COUNT: 1254,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
ALXN,ALXN:UW,BBG000G32HL2,What's in the Cards for Amgen (AMGN) this Earnings Season?,2017-10-20 17:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RKiVsbKWKYU/whats-in-the-cards-for-amgen-amgn-this-earnings-season-cm862668,Biotech major Amgen Inc AMGN will report third quarter 2017 results on Oct 25 after the market closes Amgen delivered a positive earnings surprise of 5 83 in the last quarter Amgen shares are up 25 9 so far this year This compares favorably with the 12 1 increase registered by
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : October 19, 2017",2017-10-19 12:16:33 +0000,http://finance.yahoo.com/r/f6ca9ea2-9660-3f8e-8c81-f7a883e30f87/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-alxn-us-october-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alexion Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Exelixis Soars on Priority Review, FDA Panel Supports Spark Drug",2017-10-18 13:54:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w-fiC1HGtqE/biotech-stock-roundup-exelixis-soars-on-priority-review-fda-panel-supports-spark-drug-cm861198,With biotech sector earnings season round the corner there were not too many updates this week Important news this week include priority review for Exelixis s EXEL label expansion plans for Cabometyx and a positive FDA panel outcome for Spark Therapeutics s ONCE Luxturna Recap of
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-10-18 12:03:47 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120347169.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,"Notable Tuesday Option Activity: ACN, NVDA, ALXN",2017-10-17 18:49:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ph-SN3lVIPI/notable-tuesday-option-activity-acn-nvda-alxn-cm860879,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Accenture plc Symbol ACN where a total of 18 116 contracts have traded so far representing approximately 1 8 million underlying shares That amounts to about 79 5 of ACN s
ALXN,ALXN:UW,BBG000G32HL2,"With An ROE Of 6.11%, Has Alexion Pharmaceuticals Inc’s (ALXN) Management Done A Good Job?",2017-10-16 23:17:40 +0000,https://finance.yahoo.com/news/roe-6-11-alexion-pharmaceuticals-231740520.html?.tsrc=rss,"Alexion Pharmaceuticals Inc (NASDAQ:ALXN) generated a below-average return on equity of 6.11% in the past 12 months, while its industry returned 15.86%. An investor may attribute an inferior ROE toRead More..."
ALXN,ALXN:UW,BBG000G32HL2,"Seeking Alpha Editors' Picks Daily - October 11, 2017",2017-10-16 16:16:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JXoJF0LR8rk/seeking-alpha-editors-picks-daily-october-11-2017-cm860191,By SA Editor Jason Kirsch BySA Editor Jason Kirsch We often hear from readers that our Editors Picks are well selected but also hard to find So we re testing a daily write up of our previous day s Editors Picks as a way to highlight our editors favorite articles We often hear
ALXN,ALXN:UW,BBG000G32HL2,"Rhenman & Partners Asset Management AB Buys Arena Pharmaceuticals Inc, Vertex ...",2017-10-14 19:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dI2fm6sZbJ4/rhenman-partners-asset-management-ab-buys-arena-pharmaceuticals-inc-vertex-cm859858,Rhenman Partners Asset Management AB New Purchases ARNA BSX LOXO MYOK JUNO NVO DERM RARX NLNK AGIO Added Positions VRTX ADMS PTLA GKOS AGN HZNP ABMD ESRX ITCI ANTM Reduced Positions PFE NVCR GILD BIIB HCA LLY MRK INCY
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alexion Pharmaceuticals, Inc. – (ALXN)",2017-10-14 02:50:00 +0000,https://finance.yahoo.com/news/alexion-investigation-initiated-former-louisiana-025000604.html?.tsrc=rss,"Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Alexion Pharmaceuticals, Inc."
ALXN,ALXN:UW,BBG000G32HL2,Is It Too Late To Buy Facebook?,2017-10-13 16:01:21 +0000,http://finance.yahoo.com/r/b42e262c-6876-3c8e-bde3-b6f153e508d7/is-it-too-late-to-buy-facebook?src=A00220&yptr=yahoo&.tsrc=rss,The Big Cap 20 has its share of extended stocks. But there are a handful that are still basing.
ALXN,ALXN:UW,BBG000G32HL2,S&P 500 Analyst Moves: ALXN,2017-10-12 17:13:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A6OfumhQB8Q/sp-500-analyst-moves-alxn-cm858931,The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Alexion Pharmaceuticals ALXN is now the 54 analyst pick moving up by 1 spot This rank is formed by averaging the analyst opinions for each component from
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Trying To Close In On Key Technical Measure,2017-10-11 07:00:00 +0000,http://finance.yahoo.com/r/4d306636-38f1-36b4-a04c-7368b8027e0b/alexion-pharmaceuticals-trying-to-close-in-on-key-technical-measure?src=A00220&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion to Report Third Quarter 2017 Results on Thursday, October 26, 2017",2017-10-10 14:00:00 +0000,https://finance.yahoo.com/news/alexion-report-third-quarter-2017-140000195.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that the Company will report its financial results for the third quarter 2017 on Thursday, October 26, 2017 before the US financial markets open."
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-10-09 12:03:40 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120340040.html?.tsrc=rss,"This could indicate that investors who seek to profit from falling equity prices are not currently targeting ALXN.  Over the last one-month, outflows of investor capital in ETFs holding ALXN totaled $6.54 billion."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alexion Pharmaceuticals, Inc. - (ALXN)",2017-10-07 02:50:00 +0000,https://finance.yahoo.com/news/alexion-investigation-initiated-former-louisiana-025000406.html?.tsrc=rss,"NEW ORLEANS, Oct. 6, 2017 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (""KSF""), announces that KSF has commenced an investigation into Alexion Pharmaceuticals, Inc. (ALXN).  Since late 2016, the Company has been the subject of investigations by numerous legal and regulatory authorities and significant litigation relating to its use of a myriad of unethical and possibly illegal sales and promotion campaigns by its salespeople in connection with its flagship drug, Soliris."
ALXN,ALXN:UW,BBG000G32HL2,Analysts Predict 10% Upside For The Holdings of QQQ,2017-10-05 14:51:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IkcwWJDXYL4/analysts-predict-10-upside-for-the-holdings-of-qqq-cm855643,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
ALXN,ALXN:UW,BBG000G32HL2,How Strensiq Could Boost Alexion’s Long-Term Growth,2017-10-05 11:39:58 +0000,http://finance.yahoo.com/r/6af6c304-55f8-3936-a98b-f16aeea99d7d/how-strensiq-could-boost-alexions-long-term-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Alexion Pharmaceuticals’ (ALXN) Strensiq generated revenues of ~$83 million, which was ~84% higher YoY and ~12% higher QoQ."
ALXN,ALXN:UW,BBG000G32HL2,Gauging Alexion’s 2018 Growth with Soliris,2017-10-04 14:39:45 +0000,http://finance.yahoo.com/r/85a86302-18d7-3b30-9351-074bcfab2f8b/gauging-alexions-2018-growth-with-soliris?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Alexion Pharmaceuticals’ (ALXN) Soliris generated revenues of ~$814 million, which represented a ~16% YoY rise and a ~4% QoQ rise."
ALXN,ALXN:UW,BBG000G32HL2,How Is Alexion Pharmaceuticals Positioned after 1H17?,2017-10-04 13:11:01 +0000,http://finance.yahoo.com/r/d6158f2d-f22b-30d2-a20e-35b7076953fd/how-is-alexion-pharmaceuticals-positioned-after-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Alexion Pharmaceuticals (ALXN) generated revenues of ~$912 million, which was ~21% higher YoY (year-over-year) and ~5% higher QoQ."
ALXN,ALXN:UW,BBG000G32HL2,Alexion on the Street: Analyst Recommendations in October,2017-10-04 11:44:26 +0000,http://finance.yahoo.com/r/c49592e2-16f8-37d0-b1b5-43caa49a7a02/alexion-on-the-street-analyst-recommendations-in-october?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In August 2017, the EC (European Commission) approved the label expansion of Alexion Pharmaceuticals' (ALXN) Soliris."
ALXN,ALXN:UW,BBG000G32HL2,"The Zacks Analyst Blog Highlights: Flexion Therapeutics, Alexion Pharmaceuticals, PTC Therapeutics, Johnson & Johnson and TESARO",2017-10-03 13:52:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T2OqzRFWOvs/the-zacks-analyst-blog-highlights-flexion-therapeutics-alexion-pharmaceuticals-ptc-therapeutics-johnson-johnson-and-tesaro-cm854479,For Immediate Release Chicago IL October 03 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
ALXN,ALXN:UW,BBG000G32HL2,"The Zacks Analyst Blog Highlights: Flexion Therapeutics, Alexion Pharmaceuticals, PTC Therapeutics, Johnson & Johnson and TESARO",2017-10-03 12:14:12 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-flexion-121412027.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Flexion Therapeutics, Alexion Pharmaceuticals, PTC Therapeutics, Johnson & Johnson and TESARO"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : October 2, 2017",2017-10-02 15:14:12 +0000,http://finance.yahoo.com/r/68ef9378-2139-3445-811f-275a95469c45/alexion-pharmaceuticals-inc-value-analysis-nasdaqalxn-october-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Alexion Pharmaceuticals, Inc. a score of 69. Our analysis is based on comparing Alexion Pharmaceuticals, Inc. with the following peers – Celgene Corporation, Ionis Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., Gilead Sciences, Inc., Vertex Pharmaceuticals Incorporated, Intrexon Corporation, Biogen Inc., QIAGEN NV, Ultragenyx Pharmaceutical, Inc. and Agios Pharmaceuticals, ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,3 Biotech and Pharma Stocks with Key FDA Catalysts this October,2017-10-02 13:11:01 +0000,https://finance.yahoo.com/news/3-biotech-pharma-stocks-key-131101168.html?.tsrc=rss,Here is a look at three biotech and pharma stocks including Flexion (FLXN) that have an important regulatory event lined up this month.
ALXN,ALXN:UW,BBG000G32HL2,"Roivant Makes $116 Million Investment In Arbutus, Backing Battle With Moderna",2017-10-02 12:20:00 +0000,http://finance.yahoo.com/r/a6a227e2-4138-3a8c-b82a-ce5cba509c92/roivant-makes-116-million-investment-in-arbutus-backing-battle-with-moderna?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Roivant and Moderna, two of the most highly-funded private biotech companies, appear to engaged in a proxy war over medical technology and headed for a showdown."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alexion Pharmaceuticals, Inc. – (ALXN)",2017-09-30 02:50:00 +0000,https://finance.yahoo.com/news/alexion-investigation-initiated-former-louisiana-025000158.html?.tsrc=rss,"Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Alexion Pharmaceuticals, Inc."
ALXN,ALXN:UW,BBG000G32HL2,When Should You Sell Alexion Pharmaceuticals Inc (ALXN)?,2017-09-29 13:22:13 +0000,https://finance.yahoo.com/news/sell-alexion-pharmaceuticals-inc-alxn-132213106.html?.tsrc=rss,"Alexion Pharmaceuticals Inc (NASDAQ:ALXN) trades with a trailing P/E of 59.4x, which is higher than the industry average of 33.7x. While ALXN might seem like a stock to avoid orRead More..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : September 29, 2017",2017-09-29 12:15:48 +0000,http://finance.yahoo.com/r/87e1c45e-43f8-3aa1-bc12-8c02f8beae64/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-alxn-us-september-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alexion Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,Biotech Stocks Facing FDA Decision In October,2017-09-29 07:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nmihicMyCXk/biotech-stocks-facing-fda-decision-in-october-20170929-00332,Biotech Stocks Facing FDA Decision In October
ALXN,ALXN:UW,BBG000G32HL2,Clovis Oncology Scores Relative Strength Rating Upgrade,2017-09-28 14:44:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ExXVg4f2oQA/clovis-oncology-scores-relative-strength-rating-upgrade-cm852533,Clovis Oncology CLVS saw a positive improvement to its Relative Strength RS Rating on Thursday with an upgrade from 88 to 92 ibd display video id 449419 width 50 float left autostart true IBD s unique RS Rating identifies market leadership by showing how
ALXN,ALXN:UW,BBG000G32HL2,"Notable Wednesday Option Activity: ALXN, MON, CME",2017-09-27 19:54:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SltksuA6-N8/notable-wednesday-option-activity-alxn-mon-cme-cm852086,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Alexion Pharmaceuticals Inc Symbol ALXN where a total volume of 11 483 contracts has been traded thus far today a contract volume which is representative of approximately 1
ALXN,ALXN:UW,BBG000G32HL2,Intercept (ICPT) Provides Safety Guidelines For Ocaliva,2017-09-27 16:00:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/93712jrIyZE/intercept-icpt-provides-safety-guidelines-for-ocaliva-cm851900,Intercept Pharmaceuticals Inc ICPT provided a statement on the recent safety and dosing issues for lead drug Ocaliva Ocaliva was approved in the United States in May 2016 and subsequently in the European Union and Canada for the treatment of patients with primary biliary cholangitis
ALXN,ALXN:UW,BBG000G32HL2,4 'Strong Buy' Stocks From Best-Performing Analysts,2017-09-27 15:07:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EGQm1kVbsW8/4-strong-buy-stocks-from-best-performing-analysts-cm851788,Which stocks have the most bullish sentiment from the best analysts on Wall Street? These are the analysts with the highest success rate and average return. It follows that the smartest way to outperform the market is to follow only the advice from these top analysts who consistently get it right.  We turned to the
ALXN,ALXN:UW,BBG000G32HL2,Acceleron Pharma Reaches 80-Plus Relative Strength Rating Benchmark,2017-09-27 14:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xj7b6r-WRPM/acceleron-pharma-reaches-80-plus-relative-strength-rating-benchmark-cm851895,Acceleron Pharma XLRN saw a positive improvement to its Relative Strength RS Rating on Wednesday rising from 77 to 81 ibd display video id 449419 width 50 float left autostart true IBD s proprietary rating tracks market leadership with a 1 worst to 99
ALXN,ALXN:UW,BBG000G32HL2,Stocks Flashing Renewed Technical Strength: Innoviva,2017-09-27 14:57:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xmHlGvhHS0Q/stocks-flashing-renewed-technical-strength-innoviva-cm851883,When considering what names to put on your watch list look for stocks with an 80 or higher RS Rating Innoviva INVA just cleared that benchmark with an upgrade from 77 to 81 ibd display video id 449423 width 50 float left autostart true IBD s proprietary RS
ALXN,ALXN:UW,BBG000G32HL2,Stocks To Watch: Prothena Sees Relative Strength Rating Jump To 81,2017-09-27 14:56:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ucZemWcA9k4/stocks-to-watch-prothena-sees-relative-strength-rating-jump-to-81-cm851877,One important metric to look for in a stock is an 80 or higher Relative Strength Rating Prothena PRTA now clears that threshold with a jump from 78 to 81 Wednesday ibd display video id 449419 width 50 float left autostart true IBD s proprietary RS Rating
ALXN,ALXN:UW,BBG000G32HL2,Stocks Showing Market Leadership: Sarepta Therapeutics Earns 91 RS Rating,2017-09-27 14:56:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o6gKLKDVRVA/stocks-showing-market-leadership-sarepta-therapeutics-earns-91-rs-rating-cm851869,Sarepta Therapeutics SRPT had its Relative Strength RS Rating upgraded from 87 to 91 Wednesday ibd display video id 449433 width 50 float left autostart true IBD s unique RS Rating measures technical performance by showing how a stock s price action over the
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-09-27 12:04:28 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120428553.html?.tsrc=rss,"This could indicate that investors who seek to profit from falling equity prices are not currently targeting ALXN.  Over the last one-month, outflows of investor capital in ETFs holding ALXN totaled $9.08 billion."
ALXN,ALXN:UW,BBG000G32HL2,Acceleron Pharma Reaches 80-Plus Relative Strength Rating Benchmark,2017-09-27 07:00:00 +0000,http://finance.yahoo.com/r/3fb34c9f-68cf-3bb4-ab3f-d69df8e9cc87/acceleron-pharma-reaches-80-plus-relative-strength-rating-benchmark?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Acceleron Pharma shows improving technical performance.
ALXN,ALXN:UW,BBG000G32HL2,Stocks Showing Market Leadership: Sarepta Therapeutics Earns 91 RS Rating,2017-09-27 07:00:00 +0000,http://finance.yahoo.com/r/f208b781-1549-3880-ab1c-6238b7e693cf/stocks-showing-market-leadership-sarepta-therapeutics-earns-91-rs-rating?src=A00220&yptr=yahoo&.tsrc=rss,"Sarepta Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating."
ALXN,ALXN:UW,BBG000G32HL2,Stocks Flashing Renewed Technical Strength: Innoviva,2017-09-27 07:00:00 +0000,http://finance.yahoo.com/r/4fded98e-5403-3b86-8586-cb5d810a390b/stocks-flashing-renewed-technical-strength-innoviva?src=A00220&yptr=yahoo&.tsrc=rss,"Innoviva shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81."
ALXN,ALXN:UW,BBG000G32HL2,"Robbins Arroyo LLP: Alexion Pharmaceuticals, Inc. (ALXN) Misled Shareholders According to a Recently Filed Lawsuit",2017-09-26 18:56:00 +0000,https://finance.yahoo.com/news/robbins-arroyo-llp-alexion-pharmaceuticals-185600494.html?.tsrc=rss,"Shareholder rights law firm Robbins Arroyo LLP announces that a shareholder derivative lawsuit was filed on behalf of Alexion Pharmaceuticals, Inc. . The complaint is brought against certain of Alexion's officers and directors for alleged breaches of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, waste of corporate assets, and violations of the Securities Exchange Act of ..."
ALXN,ALXN:UW,BBG000G32HL2,Infinity/ Bristol-Myers Adds TNBC Patients to Clinical Deal,2017-09-26 16:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8FRxrYNAo-g/infinity-bristol-myers-adds-tnbc-patients-to-clinical-deal-cm851181,Infinity Pharmaceuticals Inc INFI announced that it has expanded its existing clinical collaboration with Bristol Myers Squibb BMY for evaluating IPI 549 in combination with 160 latter s checkpoint inhibitor Opdivo The collaboration will include patients with triple negative breast
ALXN,ALXN:UW,BBG000G32HL2,Acceleron Pharma Trying To Close In On Key Technical Measure,2017-09-26 14:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fQCHZu6bTPo/acceleron-pharma-trying-to-close-in-on-key-technical-measure-cm851113,Acceleron Pharma XLRN had its Relative Strength RS Rating upgraded from 67 to 77 Tuesday a welcome improvement but still below the 80 or higher score you prefer to see ibd display video id 449419 width 50 float left autostart true IBD s unique RS
ALXN,ALXN:UW,BBG000G32HL2,Acorda Therapeutics Getting Closer To Key Technical Measure,2017-09-26 14:57:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5V-QSgc-zpU/acorda-therapeutics-getting-closer-to-key-technical-measure-cm851105,Acorda Therapeutics ACOR saw a welcome improvement to its Relative Strength RS Rating on Tuesday rising from 67 to 78 ibd display video id 449433 width 50 float left autostart true IBD s unique rating measures market leadership with a 1 worst to 99
ALXN,ALXN:UW,BBG000G32HL2,"Global Blood Therapeutic Clears Technical Benchmark, Hitting 80-Plus RS Rating",2017-09-26 14:55:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-b79O5RoKjM/global-blood-therapeutic-clears-technical-benchmark-hitting-80-plus-rs-rating-cm851071,The Relative Strength RS Rating for Global Blood Therapeutic GBT climbed into a new percentile Tuesday with an increase from 78 to 82 ibd display video id 449433 width 50 float left autostart true IBD s unique rating tracks market leadership with a 1
ALXN,ALXN:UW,BBG000G32HL2,Infinity/ Bristol-Myers Adds TNBC Patients to Clinical Deal,2017-09-26 14:24:02 +0000,https://finance.yahoo.com/news/infinity-bristol-myers-adds-tnbc-142402318.html?.tsrc=rss,Infinity (INFI) expanded its existing clinical collaboration with Bristol-Myers Squibb for evaluating IPI-549 in combination with Opdivo to include patients with triple negative breast cancer.
ALXN,ALXN:UW,BBG000G32HL2,3 Biotech Stocks With Major Catalysts in October,2017-09-26 13:52:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jrCSOvFQb3s/3-biotech-stocks-with-major-catalysts-in-october-cm850928,Every month brings plenty of catalysts for several biotech stocks October is no exception There are quite a few regulatory decisions and clinical results expected to be announced next month Three biotechs in particular could enjoy boosts to their stocks if all goes well Here are
ALXN,ALXN:UW,BBG000G32HL2,3 Biotech Stocks With Major Catalysts in October,2017-09-26 13:32:00 +0000,http://finance.yahoo.com/r/8565200c-db91-3665-a6ed-d3a832666fe5/3-biotech-stocks-with-major-catalysts-in-october.aspx?yptr=yahoo&.tsrc=rss,These biotechs are hoping that October brings blue skies for their promising pipeline candidates.
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-09-26 12:04:22 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120422289.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,Acorda Therapeutics Getting Closer To Key Technical Measure,2017-09-26 07:00:00 +0000,http://finance.yahoo.com/r/1a84de45-b9ae-39ea-8707-4a3f7d8596e1/acorda-therapeutics-getting-closer-to-key-technical-measure?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Acorda Therapeutics shows improving technical performance. Will it continue?
ALXN,ALXN:UW,BBG000G32HL2,Abbvie/Bristol-Myers Inks Deal to Develop Therapeutic Cancer,2017-09-25 16:51:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uykP3mWgkS0/abbviebristol-myers-inks-deal-to-develop-therapeutic-cancer-cm850446,AbbVie ABBV and Bristol Myers Squibb Company BMY entered into a deal to evaluate the combination of AbbVie s investigational antibody drug conjugate ABBV 399 and Bristol Myers Squibb s immune oncology drug Opdivo nivolumab in c Met overexpressing non small cell lung cancer
ALXN,ALXN:UW,BBG000G32HL2,Abbvie/Bristol-Myers Inks Deal to Develop Therapeutic Cancer,2017-09-25 14:49:02 +0000,https://finance.yahoo.com/news/abbvie-bristol-myers-inks-deal-144902944.html?.tsrc=rss,AbbVie (ABBV) and Bristol-Myers Squibb entered into a deal to evaluate the combination of ABBV-399 and Opdivo (nivolumab) in c-Met overexpressing non-small cell lung cancer.
ALXN,ALXN:UW,BBG000G32HL2,"Ardsley Advisory Partners Buys Alexion Pharmaceuticals Inc, New Residential Investment Corp, ...",2017-09-22 17:35:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lm-UCFqay7g/ardsley-advisory-partners-buys-alexion-pharmaceuticals-inc-new-residential-investment-corp-cm849757,Ardsley Advisory Partners New Purchases NSM URI MKTX VIAV GDDY ABCO X QTNA CY DY Added Positions ALXN NRZ XBI SSNI PE CELG HASI MSFT BABA FTAI Reduced Positions SHPG BMRN BIOS EXAS MU JAZZ PEGI VSLR LLY OXFD Sold Out
ALXN,ALXN:UW,BBG000G32HL2,The Medicines Co. Continues to Focus on Pipeline Development,2017-09-22 16:35:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yJ7vXYibVuM/the-medicines-co-continues-to-focus-on-pipeline-development-cm849632,We issued an updated report on The Medicines Company MDCO on Sep 21 Notably the Medicines Co has undertaken a restructuring program to boost shareholder value In fact the company is exploring options for optimizing capital structure and liquidity position by divesting certain non
ALXN,ALXN:UW,BBG000G32HL2,Bayer (BAYRY) Focuses on Pipeline Development & Acquisitions,2017-09-22 15:40:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2S9d3AxmXVY/bayer-bayry-focuses-on-pipeline-development-acquisitions-cm849578,We issued an updated report on Bayer Aktiengesellschaft BAYRY on Sep 21 Notably Bayer is a life science company with core competencies in the areas of health care and agriculture The company reports results under five divisions Pharmaceuticals Consumer Health Crop Science Animal
ALXN,ALXN:UW,BBG000G32HL2,"Werner Enterprises, Cott, Akari Therapeutics, and Alexion highlighted as Zacks Bull and Bear of the Day",2017-09-22 14:41:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ECK-njNMrsA/werner-enterprises-cott-akari-therapeutics-and-alexion-highlighted-as-zacks-bull-and-bear-of-the-day-cm849548,For Immediate Release Chicago IL September 22 2017 Zacks Equity Research Werner Enterprises Nasdaq 160 WERN Free Report as the Bull of the Day Cott Corporation NYSE 160 COT Free Report as the Bear of the Day In addition Zacks Equity Research provides analysis
ALXN,ALXN:UW,BBG000G32HL2,The Medicines Co. Continues to Focus on Pipeline Development,2017-09-22 14:41:02 +0000,https://finance.yahoo.com/news/medicines-co-continues-focus-pipeline-144102091.html?.tsrc=rss,The Medicines Co.&apos;s (MDCO) divestment of non-core assets should allow the company to focus on key assets and brings in a non-dilutive source of funds as well.
ALXN,ALXN:UW,BBG000G32HL2,Dr. Reddy's Laboratories (RDY) Surges: Stock Moves 5.7% Higher,2017-09-22 14:40:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qcfo1_o-yho/dr-reddys-laboratories-rdy-surges-stock-moves-57-higher-cm849542,Dr Reddy s Laboratories Limited RDY was a big mover last session as the company saw its shares rise nearly 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now
ALXN,ALXN:UW,BBG000G32HL2,Dr. Reddy&apos;s Laboratories (RDY) Surges: Stock Moves 5.7% Higher,2017-09-22 12:32:12 +0000,https://finance.yahoo.com/news/dr-reddy-apos-laboratories-rdy-123212413.html?.tsrc=rss,"Dr. Reddy&apos;s Laboratories (RDY) was a big mover last session, as the company saw its shares rise nearly 6% on the day amid huge volumes."
ALXN,ALXN:UW,BBG000G32HL2,"Werner Enterprises, Cott, Akari Therapeutics, and Alexion highlighted as Zacks Bull and Bear of the Day",2017-09-22 12:25:12 +0000,https://finance.yahoo.com/news/werner-enterprises-cott-akari-therapeutics-122512584.html?.tsrc=rss,"Werner Enterprises, Cott, Akari Therapeutics, and Alexion highlighted as Zacks Bull and Bear of the Day"
ALXN,ALXN:UW,BBG000G32HL2,Akari Therapeutics (AKTX) Stock is Skyrocketing Over 60% Today: Here's Why,2017-09-21 20:38:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tHM2WzkB9P4/akari-therapeutics-aktx-stock-is-skyrocketing-over-60-today-heres-why-cm849252,On Thursday shares of biopharmaceutical company Akari Therapeutics AKTX are skyrocketing up over 60 in midday trading the stock was up 90 in premarket trading after it announced it would advance its lead drug candidate In a press release Akari said that after an End of Phase 2
ALXN,ALXN:UW,BBG000G32HL2,"Alnylam/Sanofi's RNAi Drug Meets Endpoint in Study, Stock Up",2017-09-21 17:36:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rYtUU_ZPQQE/alnylamsanofis-rnai-drug-meets-endpoint-in-study-stock-up-cm849108,Shares of Alnylam Pharmaceuticals Inc ALNY soared by more than 50 after the company and its partner Sanofi SNY announced that a pivotal phase III study on its pipeline candidate patisiran met its primary as well as all secondary endpoints Alnylam s shares have outperformed the industry
ALXN,ALXN:UW,BBG000G32HL2,Karyopharm's Liposarcoma Candidate Superior in Phase II Study,2017-09-21 16:36:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ee9Po8nfkH8/karyopharms-liposarcoma-candidate-superior-in-phase-ii-study-cm849055,Karyopharm Therapeutics Inc KPTI announced positive data from a phase II portion of phase II III SEAL study demonstrating superiority of its liposarcoma candidate selinexor in improving progression free survival PFS when compared to a placebo The company s oral Selective Inhibitor
ALXN,ALXN:UW,BBG000G32HL2,"Alnylam/Sanofi&apos;s RNAi Drug Meets Endpoint in Study, Stock Up",2017-09-21 15:01:03 +0000,https://finance.yahoo.com/news/alnylam-sanofi-apos-rnai-drug-150103739.html?.tsrc=rss,Alnylam (ALNY) and partner Sanofi RNAi therapeutic patisiran met its primary efficacy endpoint and all secondary endpoints in the phase III APOLLO study.
ALXN,ALXN:UW,BBG000G32HL2,Karyopharm&apos;s Liposarcoma Candidate Superior in Phase II Study,2017-09-21 14:55:02 +0000,https://finance.yahoo.com/news/karyopharm-apos-liposarcoma-candidate-superior-145502113.html?.tsrc=rss,Karyopharm&apos;s (KPTI) selinexor reduced the risk of progression or death in previously treated patients with advanced dedifferentiated liposarcoma.
ALXN,ALXN:UW,BBG000G32HL2,Alnylam Pharmaceuticals (ALNY) Soars: Stock Adds 51.7% in Session,2017-09-21 14:40:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ESZU7XcS_3U/alnylam-pharmaceuticals-alny-soars-stock-adds-517-in-session-cm848917,Alnylam Pharmaceuticals Inc ALNY was a big mover last session as the company saw its shares rise nearly 52 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading
ALXN,ALXN:UW,BBG000G32HL2,Alnylam Pharmaceuticals (ALNY) Soars: Stock Adds 51.7% in Session,2017-09-21 12:56:12 +0000,https://finance.yahoo.com/news/alnylam-pharmaceuticals-alny-soars-stock-125612727.html?.tsrc=rss,"Alnylam Pharmaceuticals (ALNY) saw a big move last session, as its shares jumped nearly 52% on the day, amid huge volumes."
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-09-21 12:03:44 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120423235.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,ProQR's Genetic Disorder Candidate Gets Orphan Drug Status,2017-09-20 20:37:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ufAsVIjX_l8/proqrs-genetic-disorder-candidate-gets-orphan-drug-status-cm848640,ProQR Therapeutics N V PRQR announced that the FDA has granted orphan drug designation to its genetic disorder candidate QR 313 for the treatment of dystrophic epidermolysis bullosa DEB ProQR s share price has increased 2 1 so far this year underperforming the industry s rise
ALXN,ALXN:UW,BBG000G32HL2,Novartis Poised to Grow on Oncology Portfolio & Biosimilars,2017-09-20 20:36:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e7rgUjmdywM/novartis-poised-to-grow-on-oncology-portfolio-biosimilars-cm848634,We issued an updated report on Novartis AG NVS on Sep 19 Novartis has a strong portfolio of oncology drugs like Afinitor Exjade Jakavi Zykadia Tasigna Jadenu and an improved formulation of Exjade In February 2016 the company received a boost with the FDA approving Afinitor for
ALXN,ALXN:UW,BBG000G32HL2,Novartis Poised to Grow on Oncology Portfolio & Biosimilars,2017-09-20 18:32:06 +0000,https://finance.yahoo.com/news/novartis-poised-grow-oncology-portfolio-183206549.html?.tsrc=rss,"Novartis expects the next growth phase to begin in 2018 driven by Cosentyx Entresto, Kisqali and Kymriah."
ALXN,ALXN:UW,BBG000G32HL2,ProQR&apos;s Genetic Disorder Candidate Gets Orphan Drug Status,2017-09-20 18:10:06 +0000,https://finance.yahoo.com/news/proqr-apos-genetic-disorder-candidate-181006564.html?.tsrc=rss,"ProQR Therapeutics (PRQR) announced that its investigational dystrophic epidermolysis bullosa candidate, QR-313, was granted orphan drug designation by the FDA."
ALXN,ALXN:UW,BBG000G32HL2,Teva/Nuvelution to Speed Up Development of Austedo in US,2017-09-20 16:41:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z8aYMDPKwaA/tevanuvelution-to-speed-up-development-of-austedo-in-us-cm848460,Teva Pharmaceutical Industries Ltd TEVA announced a partnership deal with Nuvelution Pharma Inc to accelerate development of Austedo deutetrabenazine tablets for the treatment of tics associated with Tourette syndrome TS in pediatric patients in the United States Per the
ALXN,ALXN:UW,BBG000G32HL2,Epizyme (EPZM) Looks Good: Stock Adds 7.8% in Session,2017-09-20 14:41:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ppFEfKpnnWA/epizyme-epzm-looks-good-stock-adds-78-in-session-cm848314,Epizyme Inc EPZM was a big mover last session as the company saw its shares rise nearly 8 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above the
ALXN,ALXN:UW,BBG000G32HL2,Teva/Nuvelution to Speed Up Development of Austedo in US,2017-09-20 14:36:02 +0000,https://finance.yahoo.com/news/teva-nuvelution-speed-development-austedo-143602797.html?.tsrc=rss,Teva Pharma (TEVA) and Nuvelution inked a deal to accelerate the development of Austedo (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome.
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-09-20 12:04:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120437295.html?.tsrc=rss,"This could indicate that investors who seek to profit from falling equity prices are not currently targeting ALXN.  Over the last one-month, outflows of investor capital in ETFs holding ALXN totaled $1.42 billion."
ALXN,ALXN:UW,BBG000G32HL2,Pluristem's Ischemia Candidate Gets Fast Track Designation,2017-09-19 15:38:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h7c0t8Vl2ps/pluristems-ischemia-candidate-gets-fast-track-designation-cm847815,Pluristem Therapeutics Inc PSTI announced that the FDA has granted Fast Track designation to a phase III study evaluating its critical limb ischemia CLI candidate PLacental eXpanded PLX PAD cells The candidate is being evaluated in patients who are not eligible for
ALXN,ALXN:UW,BBG000G32HL2,Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia,2017-09-19 15:38:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/opQpcEckhpQ/alkermes-aristada-shows-better-results-to-treat-schizophrenia-cm847812,Alkermes plc ALKS announced positive top line results from a phase IV study of Aristada aripiprazole lauroxil extended release injectable suspension for the treatment of schizophrenia The study showed that patients who switched to ARISTADA 441 mg 662 mg or 882 mg monthly or 882 mg every
ALXN,ALXN:UW,BBG000G32HL2,Alkermes&apos; ARISTADA Shows Better Results to Treat Schizophrenia,2017-09-19 14:37:02 +0000,https://finance.yahoo.com/news/alkermes-apos-aristada-shows-better-143702283.html?.tsrc=rss,Alkermes (ALKS) announced encouraging results from a phase IV study of ARISTADA for the treatment of schizophrenia.
ALXN,ALXN:UW,BBG000G32HL2,Pluristem&apos;s Ischemia Candidate Gets Fast Track Designation,2017-09-19 14:35:02 +0000,https://finance.yahoo.com/news/pluristem-apos-ischemia-candidate-gets-143502762.html?.tsrc=rss,Pluristem Therapeutics&apos; (PSTI) phase III study of PLX-PAD cells in patients with critical limb ischemia granted Fast Track designation by the FDA.
ALXN,ALXN:UW,BBG000G32HL2,Clovis Oncology (CLVS) in Focus: Stock Moves 10.5% Higher,2017-09-19 12:51:12 +0000,https://finance.yahoo.com/news/clovis-oncology-clvs-focus-stock-125112535.html?.tsrc=rss,"Clovis Oncology (CLVS) was a big mover last session, as the company saw its shares rise nearly 11% on the day amid huge volumes."
ALXN,ALXN:UW,BBG000G32HL2,Axovant Sciences Ltd. (AXON) Jumps: Stock Rises 7.2%,2017-09-19 12:35:12 +0000,https://finance.yahoo.com/news/axovant-sciences-ltd-axon-jumps-123512940.html?.tsrc=rss,"Axovant Sciences Ltd. (AXON) was a big mover last session, as the company saw its shares rise over 7% on the day."
ALXN,ALXN:UW,BBG000G32HL2,Apple Leads 7 Top Stocks Holding In Buy Range,2017-09-19 11:01:21 +0000,http://finance.yahoo.com/r/352304b8-fbd3-38e1-8748-2b15e4a79c56/apple-microsoft-lead-7-top-stocks-holding-in-buy-range-sp-500-futures?src=A00220&yptr=yahoo&.tsrc=rss,"With the market grinding higher, some breakouts struggle. But Apple, Microsoft, Biogen, Alexion Pharmaceuticals, Wynn Resorts and Electronic Arts are holding in buy zones after breaking out several days or weeks ago."
ALXN,ALXN:UW,BBG000G32HL2,RBC Capital's Marc Harris breaks down his best biotech pi...,2017-09-18 18:16:00 +0000,https://finance.yahoo.com/video/rbc-capitals-marc-harris-breaks-181600703.html?.tsrc=rss,"Marc Harris, RBC Capital, discusses the run in the biotech sector and gives his stock picks."
ALXN,ALXN:UW,BBG000G32HL2,J&J's (JNJ) Psoriasis Drug Guselkumab Gets CHMP Nod in EU,2017-09-18 16:41:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LWfnBaT_V3Q/jjs-jnj-psoriasis-drug-guselkumab-gets-chmp-nod-in-eu-cm847197,Johnson amp Johnson JNJ announced that the European Medicines Agency s EMA Committee for Medicinal Products for Human Use CHMP has granted a positive opinion recommending approval of its pipeline candidate guselkumab for the treatment of moderate to severe plaque psoriasis in the EU
ALXN,ALXN:UW,BBG000G32HL2,Glaxo's Triple Therapy COPD Inhaler Gets CHMP Nod in the EU,2017-09-18 16:40:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qv95kHKxPGg/glaxos-triple-therapy-copd-inhaler-gets-chmp-nod-in-the-eu-cm847176,GlaxoSmithKline plc GSK and partner Innoviva Inc INVA announced that the European Medicines Agency s EMA Committee for Medicinal Products for Human Use CHMP has granted a positive opinion recommending approval of its once daily single inhaler triple therapy in the EU So far this
ALXN,ALXN:UW,BBG000G32HL2,Synthetic Biologics (SYN) in Focus: Stock Moves 7.7% Higher,2017-09-18 14:41:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UbdjCl76JiY/synthetic-biologics-syn-in-focus-stock-moves-77-higher-cm847020,Synthetic Biologics Inc SYN was a big mover last session as the company saw its shares rise nearly 8 on Friday The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 47 5
ALXN,ALXN:UW,BBG000G32HL2,Abeona Therapeutics (ABEO) Surges: Stock Moves 22.9% Higher,2017-09-18 14:41:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NdOsyd-kKfo/abeona-therapeutics-abeo-surges-stock-moves-229-higher-cm847011,Abeona Therapeutics Inc ABEO was a big mover last session as the company saw its shares rise nearly 23 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 102 4
ALXN,ALXN:UW,BBG000G32HL2,"Keryx Biopharmaceuticals, Inc. (KERX) Catches Eye: Stock Jumps 5.9%",2017-09-18 14:40:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vvpKapMSGeI/keryx-biopharmaceuticals-inc-kerx-catches-eye-stock-jumps-59-cm847007,Keryx Biopharmaceuticals Inc KERX was a big mover last session as the company saw its shares rise nearly 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This stock which remained volatile and traded within the range of 6 5 7
ALXN,ALXN:UW,BBG000G32HL2,Glaxo&apos;s Triple Therapy COPD Inhaler Gets CHMP Nod in the EU,2017-09-18 14:23:02 +0000,https://finance.yahoo.com/news/glaxo-apos-triple-therapy-copd-142302010.html?.tsrc=rss,Glaxo&apos;s (GSK) single inhaler triple therapy for the treatment of COPD in patients who are already being treated with a ICS/LAMA combination received a positive opinion from the CHMP in the EU.
ALXN,ALXN:UW,BBG000G32HL2,Why Alexion Pharmaceuticals (ALXN) Could Beat Earnings Estimates Again,2017-09-18 12:48:12 +0000,https://finance.yahoo.com/news/why-alexion-pharmaceuticals-alxn-could-124812667.html?.tsrc=rss,"Alexion Pharmaceuticals (ALXN) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat."
ALXN,ALXN:UW,BBG000G32HL2,Intercept Pharmaceuticals (ICPT) in Focus: Stock Moves 8.6% Higher,2017-09-18 12:43:12 +0000,https://finance.yahoo.com/news/intercept-pharmaceuticals-icpt-focus-stock-124312926.html?.tsrc=rss,"Intercept Pharmaceuticals, Inc. (ICPT) was a big mover last session, as the company saw its shares rise nearly 9% on the day."
ALXN,ALXN:UW,BBG000G32HL2,"Keryx Biopharmaceuticals, Inc. (KERX) Catches Eye: Stock Jumps 5.9%",2017-09-18 12:39:12 +0000,https://finance.yahoo.com/news/keryx-biopharmaceuticals-inc-kerx-catches-123912281.html?.tsrc=rss,"Keryx Biopharmaceuticals, Inc. (KERX) was a big mover last session, as the company saw its shares rise nearly 6% on the day"
ALXN,ALXN:UW,BBG000G32HL2,Abeona Therapeutics (ABEO) Surges: Stock Moves 22.9% Higher,2017-09-18 12:35:12 +0000,https://finance.yahoo.com/news/abeona-therapeutics-abeo-surges-stock-123512213.html?.tsrc=rss,"Abeona Therapeutics (ABEO) shares rose nearly 23% in the last trading session, amid huge volumes."
ALXN,ALXN:UW,BBG000G32HL2,Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study,2017-09-15 16:39:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6yNdIVuxcig/pfizer-xtandi-succeeds-in-early-stage-prostate-cancer-study-cm846359,Pfizer Inc PFE and its Japanese partner Astellas announced that their prostate cancer drug Xtandi met the primary endpoint in a late stage study which can expand the label of the drug to include early stage patients Top line data from the phase III PROSPER study showed that treatment
ALXN,ALXN:UW,BBG000G32HL2,"IBB, BIIB, REGN, ALXN: ETF Inflow Alert",2017-09-15 16:38:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jp7jqBjHZBY/ibb-biib-regn-alxn-etf-inflow-alert-cm846357,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 448 1 million dollar inflow that s a 4 8 increase week over week
ALXN,ALXN:UW,BBG000G32HL2,Strength Seen in Halozyme Therapeutics (HALO): Stock Soars 21.2%,2017-09-15 14:40:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XqtZLNJiz-o/strength-seen-in-halozyme-therapeutics-halo-stock-soars-212-cm846234,Halozyme Therapeutics Inc HALO was a big mover last session as the company saw its shares rise more than 21 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now
ALXN,ALXN:UW,BBG000G32HL2,4 Biotech Stocks That Show Promise on Sustainable Growth,2017-09-14 23:35:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DUmN8t894cM/4-biotech-stocks-that-show-promise-on-sustainable-growth-cm846030,Within the Medical sector biotech stocks have performed well in the first half of the year despite challenges like rising competition pipeline setbacks slowdown in growth of mature products and generic competition for certain key drugs The sector recovered from the pricing controversy of
ALXN,ALXN:UW,BBG000G32HL2,RBC Launches Biotech Sector Coverage Amid 'An Innovation Revolution',2017-09-14 20:52:00 +0000,http://finance.yahoo.com/r/0f7f86bb-fddc-3516-921a-b7d578b017c8/rbc-launches-biotech-sector-coverage-amid-an-innovation-revolution-1505422378?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"RBC Capital Markets just launched coverage of the biotech sector, covered by Brian Abrahams, Kennen MacKay, and Matthew Eckler, and they spoke with Barrons.com about the industry, which they say is seeing a number of exciting innovations as we enter a new era of personalized medicine.  Of course, biotech has been on a wild ride in recent years, but after being shunned by a number of investors previously, the sector is seeing new life in 2017, with the Nasdaq Biotechnology Index (NBI) up more than 25% this year, and SPDR S&P Biotech ETF (XBI) up more than 40%."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Adds Paul A. Friedman, M.D. to Its Board of Directors",2017-09-14 20:30:00 +0000,https://finance.yahoo.com/news/alexion-adds-paul-friedman-m-203000137.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that Paul A. Friedman, M.D. has been appointed to serve on the Company’s Board of Directors, succeeding R. Douglas Norby, who has retired as a Director following 18 years of service to the Company."
ALXN,ALXN:UW,BBG000G32HL2,Glaxo's Shingles Candidate Gets Positive FDA Committee Vote,2017-09-14 17:38:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PTYsiVXTvO8/glaxos-shingles-candidate-gets-positive-fda-committee-vote-cm845841,GlaxoSmithKline plc GSK recently announced that an FDA advisory panel has unanimously voted recommending approval for its shingles vaccine candidate Shingrix in older patients Glaxo said the FDA s Vaccines and Related Biological Products Advisory Committee were impressed by
ALXN,ALXN:UW,BBG000G32HL2,Glaxo&apos;s Shingles Candidate Gets Positive FDA Committee Vote,2017-09-14 15:25:03 +0000,https://finance.yahoo.com/news/glaxo-apos-shingles-candidate-gets-152503006.html?.tsrc=rss,"Glaxo (GSK) declared that an FDA advisory panel has unanimously voted recommending approval for its shingles vaccine candidate, Shingrix, in older patients."
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Reports Interim Results for Soliris Study,2017-09-14 15:05:03 +0000,https://finance.yahoo.com/news/alexion-alxn-reports-interim-results-150503912.html?.tsrc=rss,Alexion (ALXN) announced results from an interim analysis of an ongoing phase III REGAIN study of Soliris. The study showed sustained treatment benefits of Soliris treatment for patients with refractory generalized myasthenia gravis.
ALXN,ALXN:UW,BBG000G32HL2,"FDA Panel Nod For GSK's Shingles Vaccine, FOLD Beyond Essence, FENC Is Red Hot",2017-09-14 03:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/09APhjRftng/fda-panel-nod-for-gsks-shingles-vaccine-fold-beyond-essence-fenc-is-red-hot-20170914-00117,"FDA Panel Nod For GSK's Shingles Vaccine, FOLD Beyond Essence, FENC Is Red Hot"
ALXN,ALXN:UW,BBG000G32HL2,Roche (RHHBY) Announces Data on Respiratory Drug Esbriet,2017-09-13 22:08:10 +0000,https://finance.yahoo.com/news/roche-rhhby-announces-data-respiratory-220810160.html?.tsrc=rss,Roche Holdings AG (RHHBY) announced results from a six-month study combining idiopathic pulmonary fibrosis (IPF) drug Esbriet (pirfenidone) and Ofev.
ALXN,ALXN:UW,BBG000G32HL2,"Alexion to Restructure Operations, to Lower Headcount by 20%",2017-09-13 22:02:10 +0000,https://finance.yahoo.com/news/alexion-restructure-operations-lower-headcount-220210972.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. (ALXN) announced that it will undertake a restructuring plan to re-align the global organization and cut workforce."
ALXN,ALXN:UW,BBG000G32HL2,Interim Analysis from Phase 3 Open-Label Extension Study Shows Sustained Benefits of Soliris® (Eculizumab) Treatment for Patients with Refractory Generalized Myasthenia Gravis,2017-09-13 22:00:00 +0000,https://finance.yahoo.com/news/interim-analysis-phase-3-open-220000857.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. announced today results from an interim analysis of an ongoing Phase 3 open-label extension study of the pivotal, placebo-controlled REGAIN study of Soliris® for the treatment of patients with refractory generalized myasthenia gravis who are anti-acetylcholine receptor antibody-positive."
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Alexion to Cut Jobs, Streamline Operations, Kura Up on Cancer Data",2017-09-13 12:33:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-alexion-cut-123312574.html?.tsrc=rss,Key highlights include Alexion&apos;s (ALXN) restructuring plans and promising data from Kura Oncology on its lead pipeline candidate.
ALXN,ALXN:UW,BBG000G32HL2,"[$$] Alexion to Cut Workforce by 20%, Shift Headquarters to Boston",2017-09-13 04:35:56 +0000,http://finance.yahoo.com/r/558fffbf-e0f4-3ab0-92ed-45c6d6330c50/alexion-to-cut-workforce-by-20-move-headquarters-to-boston-1505220820?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals is cutting its workforce by 20%, moving its headquarters to Boston and closing offices and manufacturing sites as it works to cut its overhead and move on from a sales-practices ..."
ALXN,ALXN:UW,BBG000G32HL2,"Astellas, KMPH, SRNE To Face FDA, ALXN Trims Workforce, ALDX Soars On Trial Data",2017-09-13 02:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6BZdXJm6LWE/astellas-kmph-srne-to-face-fda-alxn-trims-workforce-aldx-soars-on-trial-data-20170913-00068,"Astellas, KMPH, SRNE To Face FDA, ALXN Trims Workforce, ALDX Soars On Trial Data"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Could Target Sage, Ra Pharma: Analyst",2017-09-12 20:56:00 +0000,http://finance.yahoo.com/r/76c874bf-c213-3e63-ade1-76aade89a5e9/alexion-could-target-sage-ra-pharma-analyst.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,BMO Capital Markets analyst M. Ian Somaiya says Alexion could view Sage Therapeutics and Ra Pharmaceuticals as potential acquisition targets. Somaiya pointed to Sage's diverse pipeline and Ra's diversified ...
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals is moving its headquarters to Boston,2017-09-12 20:25:22 +0000,https://finance.yahoo.com/news/alexion-pharmaceuticals-inc-moving-headquarters-130922905.html?.tsrc=rss,"Alexion Pharmaceuticals Inc. is relocating its headquarters from New Haven, Connecticut, to Boston and cutting 20 percent of its global workforce, the company said Tuesday. About 400 jobs will move to ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Will Trim Workforce By 20% To Invest In Research,2017-09-12 20:09:55 +0000,http://finance.yahoo.com/r/37739cef-2d20-30df-a262-78fc336ed9e4/alexion-will-trim-workforce-by-20-to-invest-in-research?src=A00220&yptr=yahoo&.tsrc=rss,"Alexion will cut its workforce by 20% to reinvest in research, just six months after hiring a new chief executive."
ALXN,ALXN:UW,BBG000G32HL2,AstraZeneca's Asthma Candidate Shows Promising Results,2017-09-12 17:37:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DetlelqRf_g/astrazenecas-asthma-candidate-shows-promising-results-cm844474,AstraZeneca Plc AZN announced a subgroup analysis from SIROCCO and CALIMA phase III studies The studies evaluated the efficacy and safety of a regular subcutaneous administration of benralizumab fixed 30mg dose for up to 56 weeks in exacerbation prone adult and adolescent patients between
ALXN,ALXN:UW,BBG000G32HL2,"Achillion's HCV Partnership with J&J Terminated, Stock Falls",2017-09-12 17:35:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j4bCaOMpoBg/achillions-hcv-partnership-with-jj-terminated-stock-falls-cm844461,Achillion Pharmaceuticals Inc ACHN announced that it has received a notice for the termination of the global license and collaboration agreement for developing hepatitis C treatments from its partner Janssen a subsidiary of Johnson amp Johnson JNJ We remind investors that the
ALXN,ALXN:UW,BBG000G32HL2,"[$$] Alexion to Cut Workforce by 20%, Move Headquarters to Boston",2017-09-12 17:05:28 +0000,http://finance.yahoo.com/r/558fffbf-e0f4-3ab0-92ed-45c6d6330c50/alexion-to-cut-workforce-by-20-move-headquarters-to-boston-1505220820?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals is cutting its workforce by 20%, moving its headquarters to Boston and closing offices and manufacturing sites as it works to cut its overhead and move on from a sales-practices ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion to close Lexington facility as part of Boston HQ move,2017-09-12 16:55:07 +0000,http://finance.yahoo.com/r/87f914d1-9e74-35e8-84f0-f69fd2edc610/alexion-to-close-lexington-facility-as-part-of.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals announced Tuesday that it plans to slash headcount and relocate its headquarters from Connecticut to Boston by mid-2018 — a shakeup that will also see the drugmaker close a sizable research and development outpost in Lexington.  A spokesperson for Alexion (ALXN) said that employees at the 81,000 square-foot facility in Lexington will move to the new headquarters in the Seaport District, which is currently under construction.  The spokesperson did not say how many employees are currently located in Lexington."
ALXN,ALXN:UW,BBG000G32HL2,Pfizer Lung Cancer Drug's Overall Survival Data Unfavorable,2017-09-12 16:39:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L4bkJOC_IbU/pfizer-lung-cancer-drugs-overall-survival-data-unfavorable-cm844436,Pfizer Inc PFE announced final overall survival data from a phase III study PROFILE 1014 evaluating its cancer drug Xalkori for first line treatment of ALK positive non small cell lung cancer NSCLC Xalkori is currently approved for the treatment of ALK or ROS1 positive locally
ALXN,ALXN:UW,BBG000G32HL2,Rare disease drugmaker Alexion to move headquarters to Boston,2017-09-12 16:34:11 +0000,http://finance.yahoo.com/r/433e3ef9-124c-33c1-93e7-76b20b73ff97/rare-disease-drugmaker-alexion-to-move.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals said Tuesday that it plans to move its headquarters from New Haven, Connecticut to Boston's Seaport District by mid-2018, becoming the latest big drugmaker to make Massachusetts home.  Alexion (ALXN) said that 400 positions would be located in the new headquarters at 121 Seaport Blvd., with around 450 employees remaining in New Haven."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma to lay off 20 pct of workforce,2017-09-12 15:37:35 +0000,https://finance.yahoo.com/news/us-drugmaker-alexion-lay-off-131252495.html?.tsrc=rss,"Alexion Pharmaceuticals Inc  said on Tuesday it would lay off about 20 percent of its  workforce and sharpen its focus on its core rare disease drugs  business, as it looks to restore investor confidence.  Alexion has been roiled in recent months by a sales  practices scandal related to Soliris, its pricey rare disease  treatment, as well as an exodus of top management."
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ALXN, PAYX",2017-09-12 15:35:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVo05WkUxN8/nasdaq-100-movers-alxn-payx-cm844302,In early trading on Tuesday shares of Paychex PAYX topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 2 Year to date Paychex has lost about 3 7 of its value And the worst performing Nasdaq 100 component thus far on the day is
ALXN,ALXN:UW,BBG000G32HL2,AstraZeneca&apos;s Asthma Candidate Shows Promising Results,2017-09-12 15:25:03 +0000,https://finance.yahoo.com/news/astrazeneca-apos-asthma-candidate-shows-152503322.html?.tsrc=rss,"AstraZeneca&apos;s asthma candidate, benralizumab, showed promising results in patients who experience more frequent exacerbations despite being on standard-of-care medicines."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Slashes 20% of Its Workforce So It Could Boost Profits,2017-09-12 13:35:00 +0000,http://finance.yahoo.com/r/dab7d4c4-20ff-3754-8d07-c0ba1ffa9300/alexion-pharmaceuticals-to-cut-20-of-global-workforce.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The resulting financial flexibility will allow Alexion to reinvest $100 million per year in R&D.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. moving headquarters to Boston.,2017-09-12 13:09:17 +0000,http://finance.yahoo.com/r/23a5c060-16a0-38de-bbba-2aa1a956bf2d/alexion-pharmaceuticals-inc-moving-headquarters-130922905.html?.tsrc=rss,"NEW HAVEN, Conn. (AP) — Alexion Pharmaceuticals Inc. has announced that it is relocating its headquarters from New Haven, Connecticut to Boston."
ALXN,ALXN:UW,BBG000G32HL2,Alexion to fire 20% of global workforce in restructuring,2017-09-12 12:27:14 +0000,http://finance.yahoo.com/r/6ffb24fd-05f9-376c-9bbc-b5c2a705f93e/Story.aspx?guid=80C58BC6-6561-4086-A8C3-F0D6CE8AF294&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals Inc. said early Tuesday that it plans to fire 20% of its global workforce as part of a restructuring effort. Alexion expects pre-tax savings of about $270 million in GAAP and about ...
ALXN,ALXN:UW,BBG000G32HL2,Drugmaker Alexion to cut 20 pct of jobs,2017-09-12 12:26:12 +0000,https://finance.yahoo.com/news/drugmaker-alexion-cut-20-pct-122612954.html?.tsrc=rss,"U.S. drugmaker Alexion Pharmaceuticals Inc said on Tuesday it would lay off about 20 percent of its global workforce in an effort to cut spending. The company had about 3,100 full-time employees worldwide ..."
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-09-12 12:05:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120542764.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,Alexion Announces Restructuring to Advance Corporate Strategy,2017-09-12 12:00:00 +0000,https://finance.yahoo.com/news/alexion-announces-restructuring-advance-corporate-120000823.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced an operational plan to re-align the global organization with its refocused corporate strategy. The plan is expected to deliver approximately $270 million in GAAP and approximately $250 million in non-GAAP pre-tax savings annually by 2019."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma To Reduce Global Workforce By Approx. 20% - Quick Facts,2017-09-12 08:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ZLrMnzASZc/alexion-pharma-to-reduce-global-workforce-by-approx-20---quick-facts-20170912-00591,Alexion Pharma To Reduce Global Workforce By Approx. 20% - Quick Facts
ALXN,ALXN:UW,BBG000G32HL2,"AstraZeneca's Lung Cancer Study Data Promising, Shares Spike",2017-09-11 21:36:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qX3ftwWGQYY/astrazenecas-lung-cancer-study-data-promising-shares-spike-cm844029,AstraZeneca plc AZN announced data from a late stage study on Imfinzi which showed that the new cancer drug led to superior progression free survival to standard of care in lung cancer patients Shares of AstraZeneca inched up more than 1 on Friday as well as in pre market trading on
ALXN,ALXN:UW,BBG000G32HL2,"Alexion to Host Call to Discuss Restructuring to Advance Corporate Strategy at 8:30 a.m. on September 12, 2017",2017-09-11 20:15:00 +0000,https://finance.yahoo.com/news/alexion-host-call-discuss-restructuring-201500193.html?.tsrc=rss,"Alexion Pharmaceuticals today announced that the Company will issue a press release on its restructuring to advance its corporate strategy on Tuesday, September 12, 2017 at 8:00 a.m."
ALXN,ALXN:UW,BBG000G32HL2,Regeneron/Sanofi's Dupixent Asthma Study Meets Endpoints,2017-09-11 19:34:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jOIxmlXRpzY/regeneronsanofis-dupixent-asthma-study-meets-endpoints-cm843960,Regeneron Pharmaceuticals Inc REGN and partner Sanofi SNY announced that Dupixent dupilumab met its two primary endpoints in a phase III study conducted on patients with uncontrolled persistent asthma Data from the LIBERTY ASTHMA QUEST study showed that Dupixent when added to
ALXN,ALXN:UW,BBG000G32HL2,"AstraZeneca&apos;s Lung Cancer Study Data Promising, Shares Spike",2017-09-11 19:17:07 +0000,https://finance.yahoo.com/news/astrazeneca-apos-lung-cancer-study-191707671.html?.tsrc=rss,"AstraZeneca, (AZN) releases data from a late-stage study on Imfinzi which showed that the new cancer drug led to superior progression-free survival to standard of care in lung cancer patients."
ALXN,ALXN:UW,BBG000G32HL2,Regeneron/Sanofi&apos;s Dupixent Asthma Study Meets Endpoints,2017-09-11 18:15:06 +0000,https://finance.yahoo.com/news/regeneron-sanofi-apos-dupixent-asthma-181506428.html?.tsrc=rss,"Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi&apos;s (SNY) Dupixent (dupilumab) met two primary endpoints in phase III study."
ALXN,ALXN:UW,BBG000G32HL2,5 Top-Ranked Biotech Stocks to Buy Right Now,2017-09-11 15:41:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mxrvHm0Xspo/5-top-ranked-biotech-stocks-to-buy-right-now-cm843699,Biotech stocks are back in favor thanks to two recent major developments that led to a rally in the sector The first catalyst was Gilead Sciences GILD announcement that it will be acquiring immunotherapy focused company Kite Pharma KITE while the FDA approval of the first gene therapy in
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-09-11 14:10:05 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-141005562.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,5 Top-Ranked Biotech Stocks to Buy Right Now,2017-09-11 13:33:01 +0000,https://finance.yahoo.com/news/5-top-ranked-biotech-stocks-133301388.html?.tsrc=rss,"If you are looking to invest in the biotech sector, here is a peek at 5 buy-ranked biotech stocks including Regeneron Pharmaceuticals (REGN)."
ALXN,ALXN:UW,BBG000G32HL2,Your Easy Guide To Credit Suisse's New Top Stocks List,2017-09-11 13:21:07 +0000,https://finance.yahoo.com/news/easy-guide-credit-suisses-top-132107848.html?.tsrc=rss,"For traders looking for stock ideas, it doesn’t get much better than having a team of sector experts pick the number one stock in each of roughly 50 market subsectors. However, that’s exactly what Credit ..."
ALXN,ALXN:UW,BBG000G32HL2,4 Biotech Stocks to Improve Your Portfolio’s Health,2017-09-08 22:53:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v0JK55zhpU8/4-biotech-stocks-to-improve-your-portfolios-health-cm843236,InvestorPlace Stock Market News Stock Advice amp Trading Tips The pharmaceuticals and biotech industry has been blessed with good health so far this year The sector has recovered from the pricing controversy of 2016 and defied uncertainties surrounding President Trump s
ALXN,ALXN:UW,BBG000G32HL2,Why The Biotech &apos;Catch-Up Rally&apos; Could Add Another 15%-20%,2017-09-08 20:32:23 +0000,http://finance.yahoo.com/r/3d487276-a862-3de8-ba40-1e7247ff72d7/why-the-biotech-catch-up-rally-could-add-another-15-20?src=A00220&yptr=yahoo&.tsrc=rss,"A rally in the biotech sector could tack on another 15%-20% with Celgene, Alexion and Regeneron leading the charge, an analyst says."
ALXN,ALXN:UW,BBG000G32HL2,"Lilly to Cut 3,500 Jobs to Invest in New Drugs and Growth",2017-09-08 15:55:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4ELjzSz_DaM/lilly-to-cut-3500-jobs-to-invest-in-new-drugs-and-growth-cm842928,Eli Lilly amp Company LLY announced plans on Thursday to reduce its global workforce by approximately 3 500 positions These initiatives are expected to amass annualized savings of approximately 500 million beginning 2018 The drug giant plans to invest the savings in new drugs and
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-09-08 14:24:18 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-142418558.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,"Lilly to Cut 3,500 Jobs to Invest in New Drugs and Growth",2017-09-08 13:54:01 +0000,https://finance.yahoo.com/news/lilly-cut-3-500-jobs-135401853.html?.tsrc=rss,"Lilly (LLY) plans to reduce its global workforce by approximately 3,500 positions, which should save $500 million. Lilly plans to invest the savings in new drugs and overall growth of the company."
ALXN,ALXN:UW,BBG000G32HL2,AstraZeneca's COPD Candidate Duaklir Reports Positive Data,2017-09-07 16:56:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yGtpx29ePsw/astrazenecas-copd-candidate-duaklir-reports-positive-data-cm842421,AstraZeneca Plc AZN announced positive top line results from the phase III AMPLIFY study for Duaklir aclidinium bromide formoterol 400µg 12µg twice daily The candidate is being evaluated for the treatment of chronic obstructive pulmonary disease COPD The study met its primary endpoint
ALXN,ALXN:UW,BBG000G32HL2,Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan,2017-09-07 15:58:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iRa9UBr0-KY/aerie-initiates-phase-iii-study-for-ophthalmic-drug-roclatan-cm842311,Aerie Pharmaceuticals Inc AERI announced the initiation of phase III study Mercury 3 in Europe for its pipeline candidate Roclatan 0 02 0 005 Roclatan is a once daily quadruple action fixed dose combination of Rhopressa and Pfizer s PFE Xalatan iis being evaluated to lower
ALXN,ALXN:UW,BBG000G32HL2,Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan,2017-09-07 13:41:01 +0000,https://finance.yahoo.com/news/aerie-initiates-phase-iii-study-134101098.html?.tsrc=rss,"Aerie Pharmaceuticals, (AERI) announced that it has commenced phase III study -Mercury 3 in Europe for its pipeline candidate Roclatan 0.02%/0.005%."
ALXN,ALXN:UW,BBG000G32HL2,ProQR's QRX-421 Gets Orphan Drug Designation from FDA and EMA,2017-09-07 00:49:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3iq1RbT8zDo/proqrs-qrx-421-gets-orphan-drug-designation-from-fda-and-ema-cm842003,ProQR Therapeutics N V PRQR announced that its pipeline candidate QRX 421 has received orphan drug designation ODD from the FDA and European Medicines Agency EMA for Usher syndrome In fact QRX 421 is the third candidate in the company s ophthalmology pipeline and the fourth drug in
ALXN,ALXN:UW,BBG000G32HL2,VIVUS Gives Rights to Alvogen in Korea for Anti-Obesity Drug,2017-09-06 23:50:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lLGPq54_hL8/vivus-gives-rights-to-alvogen-in-korea-for-anti-obesity-drug-cm841971,VIVUS Inc VVUS signed an agreement with global privately owned pharmaceutical company Alvogen giving rights to the latter to market anti obesity drug Qsymia in Korea for the treatment of chronic weight management or weight related conditions VIVUS shares have underperformed the
ALXN,ALXN:UW,BBG000G32HL2,ProQR&apos;s QRX-421 Gets Orphan Drug Designation from FDA and EMA,2017-09-06 22:14:10 +0000,https://finance.yahoo.com/news/proqr-apos-qrx-421-gets-221410064.html?.tsrc=rss,"ProQR Therapeutics&apos;s (PRQR) pipeline candidate, QRX-421, has received orphan drug designation from the FDA and European Medicines Agency."
ALXN,ALXN:UW,BBG000G32HL2,Nasdaq 100 Biotechnology: Beyond Pure Tech; Still Pure Innovation,2017-09-06 15:12:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7XYkrK6D_uI/nasdaq-100-biotechnology-beyond-pure-tech-still-pure-innovation-cm841662,"Shutterstock photo    While the pure technology sector is the engine of innovation for much of what we consider the highest technology advancements of our age, there is a host of other industries represented in the Nasdaq-100 that are trailblazing. These companies that lie outside the pure tech sphere are some of"
ALXN,ALXN:UW,BBG000G32HL2,Cellect Biotechnology (APOP) Soars: Stock Adds 10.2% in Session,2017-09-06 13:53:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UYU1vQYL9_g/cellect-biotechnology-apop-soars-stock-adds-102-in-session-cm841545,Cellect Biotechnology Ltd APOP was a big mover last session as the company saw its shares rise more than 10 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 55
ALXN,ALXN:UW,BBG000G32HL2,Cellect Biotechnology (APOP) Soars: Stock Adds 10.2% in Session,2017-09-06 12:36:12 +0000,https://finance.yahoo.com/news/cellect-biotechnology-apop-soars-stock-123612928.html?.tsrc=rss,"Cellect Biotechnology Ltd. (APOP) was a big mover last session, as the company saw its shares rise more than 10% on the day."
ALXN,ALXN:UW,BBG000G32HL2,Behind Bioverativ’s Analyst Recommendations This September,2017-09-06 11:37:49 +0000,http://finance.yahoo.com/r/06c943b4-ba2f-31ed-8397-34d58f7e0de5/behind-bioverativs-analyst-recommendations-this-september?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 12 analysts tracking Bioverativ (BIVV), three recommend a “strong buy” for the stock, while one recommends a “buy,” and seven recommend a ""hold."""
ALXN,ALXN:UW,BBG000G32HL2,4 Biotech Stocks to Improve Your Portfolio's Health,2017-09-05 20:52:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xK-Nz0BrpNg/4-biotech-stocks-to-improve-your-portfolios-health-cm841215,The pharmaceuticals and biotech industry has been blessed with good health so far this year The sector has recovered from the pricing controversy of 2016 and defied uncertainties surrounding President Trump s proposed healthcare policy The NYSE ARCA Pharmaceutical Index has risen almost 9
ALXN,ALXN:UW,BBG000G32HL2,Insider Bets Paying Off At ALXN As New 52-Week High Reached,2017-09-05 18:50:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kub5nYoZjzg/insider-bets-paying-off-at-alxn-as-new-52-week-high-reached-cm841155,In trading on Tuesday shares of Alexion Pharmaceuticals Inc Symbol ALXN touched a new 52 week high of 149 34 share That s a 55 27 rise or 53 16 per share from the 52 week low of 96 18 set back on 05 26 2017 That means at today s intraday high any investor who purchased ALXN stock
ALXN,ALXN:UW,BBG000G32HL2,Sarepta: Time to Buy?,2017-09-05 16:31:00 +0000,http://finance.yahoo.com/r/8b68ff46-cd26-37a4-b0b6-8361070015a7/sarepta-time-to-buy-1504629099?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"What could drive shares of Sarepta Therapeutics (SRPT) higher?  Back in July, my colleague Andrew Bary noted thatExondys 51, the company’s controversial drug for Duchenne muscular dystrophy (DMD), is gaining traction, which could push the stock price higher.  Credit Suisse analyst Alethia Young and her team say the company could release top-line data from an early stage study of its experimental drug SRP-4053 before releasing the full data later this year."
ALXN,ALXN:UW,BBG000G32HL2,"The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Activision Blizzard, Intuit, Alexion Pharmaceuticals and Gilead Sciences",2017-09-05 15:53:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZD9s7ZD2XD8/the-zacks-analyst-blog-highlights-regeneron-pharmaceuticals-activision-blizzard-intuit-alexion-pharmaceuticals-and-gilead-sciences-cm841005,For Immediate Release Chicago IL September 5 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
ALXN,ALXN:UW,BBG000G32HL2,Alexion: Quite a Comeback,2017-09-05 15:50:00 +0000,http://finance.yahoo.com/r/76e782ab-6a7d-3e0d-abae-bfafcc337361/alexion-quite-a-comeback-1504626651?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"J.P. Morgan analyst Anupam Rama and his team are rethinking their stance on Alexion Pharmaceuticals (ALXN).  Today, Rama has reversed course, resuming a bullish stance on Alexion, restoring his previous Overweight rating and lifting his price target from $163 a share to $175 a share.  On the 2Q earnings call, Alexion prudently set low expectations for the 2H17 earnings and we believe Street focus is shifting to 2H17 / 1H18 clinical catalysts as key drivers over the next 6-12 months."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma Stock A Buy After A Pair Of 'De-Risking' Events In 2017,2017-09-05 15:00:26 +0000,https://finance.yahoo.com/news/alexion-pharma-stock-buy-pair-150026661.html?.tsrc=rss,"Following two key de-risking event, namely the second-quarter strategic update and hiring of an industry veteran as the chief financial officer, JP Morgan upgraded shares of Alexion Pharmaceuticals, Inc. ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at Upcoming Investor Conferences,2017-09-05 14:00:00 +0000,https://finance.yahoo.com/news/alexion-present-upcoming-investor-conferences-140000706.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that management will present at two upcoming investor conferences:"
ALXN,ALXN:UW,BBG000G32HL2,"The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Activision Blizzard, Intuit, Alexion Pharmaceuticals and Gilead Sciences",2017-09-05 13:56:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-regeneron-135601399.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Activision Blizzard, Intuit, Alexion Pharmaceuticals and Gilead Sciences"
ALXN,ALXN:UW,BBG000G32HL2,Biotech Stocks Back in Favor: Will the Rally Continue?,2017-09-05 13:52:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I7MKDiXq3RQ/biotech-stocks-back-in-favor-will-the-rally-continue-cm840879,The biotech sector got a shot in the arm last week thanks to two major developments that led to a rally in the sector The first catalyst was Gilead Sciences GILD decision to acquire immunotherapy focused company Kite Pharma KITE and the second was the FDA approval of the first gene therapy
ALXN,ALXN:UW,BBG000G32HL2,Morning Movers: U.S. Steel Jumps on Merrill Upgrade; United Technologies Drops on Rockwell Collins Acquisition,2017-09-05 13:49:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xKlPCER8NMo/morning-movers-us-steel-jumps-on-merrill-upgrade-united-technologies-drops-on-rockwell-collins-acquisition-cm840890,Welcome back from a long Labor Day weekend The market isn t providing much in the way of a welcome today as stocks look set to open lower as North Korea tensions ratchet up Welcome back from a long Labor Day weekend The market isn t providing much in the way of a welcome today as stocks
ALXN,ALXN:UW,BBG000G32HL2,AMAG's Filing for Feraheme's Label Expansion Accepted by FDA,2017-09-01 23:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9f0pkxpKumQ/amags-filing-for-ferahemes-label-expansion-accepted-by-fda-cm840532,AMAG Pharmaceuticals Inc AMAG announced that the FDA accepted its submission for the label expansion of Feraheme ferumoxytol The label will include treatment of all adults with iron deficiency anemia IDA who have an intolerance or unsatisfactory response to oral iron Notably the FDA
ALXN,ALXN:UW,BBG000G32HL2,Amgen Gets EU Nod to Expand Hyperparathyroidism Drug Label,2017-09-01 17:51:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W4SKhsccWS0/amgen-gets-eu-nod-to-expand-hyperparathyroidism-drug-label-cm840389,Amgen Inc AMGN announced that the European Commission has approved the marketing application for a pediatric formulation granules in capsule for opening of Mimpara for the treatment of secondary hyperparathyroidism sHPT With this approval the drug s label has been expanded to include
ALXN,ALXN:UW,BBG000G32HL2,Sell In May And Go Away? Doing So With These Stocks Was A Mistake,2017-09-01 16:09:02 +0000,https://finance.yahoo.com/news/sell-may-away-doing-stocks-160902558.html?.tsrc=rss,"Investors who took the advice of the popular slogan ""sell in May and go away"" may now be wishing they can go back in time and hold on to their positions, especially those that belonged to a small ..."
ALXN,ALXN:UW,BBG000G32HL2,5 Winning Stocks to Beat September Blues,2017-09-01 11:35:11 +0000,https://finance.yahoo.com/news/5-winning-stocks-beat-september-113511336.html?.tsrc=rss,Investing in stocks that have traditionally given consistent returns during the weakest month of the year seems judicious.
ALXN,ALXN:UW,BBG000G32HL2,Roche's (RHHBY) Actemra Gets FDA Nod for Label Expansion,2017-08-31 16:53:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DWTvY0Adp6c/roches-rhhby-actemra-gets-fda-nod-for-label-expansion-cm839821,Roche Holding AG s RHHBY member Genentech announced that the FDA has approved a label expansion for Actemra tocilizumab 160 Actemra is now approved for the treatment of chimeric antigen receptor CAR T cell induced severe or life threatening cytokine release syndrome CRS in
ALXN,ALXN:UW,BBG000G32HL2,Teva Austedo Gets FDA Nod for Label Expansion in Dyskinesia,2017-08-31 15:15:03 +0000,https://finance.yahoo.com/news/teva-austedo-gets-fda-nod-151503074.html?.tsrc=rss,Teva Pharmaceutical (TEVA) announced that the FDA has approved the label expansion of Austedo to include tardive dyskinesia in adults. Shares are up since announcement.
ALXN,ALXN:UW,BBG000G32HL2,How The Parts Add Up: QQQ Headed For $158,2017-08-31 13:52:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0tkq2PrHDIE/how-the-parts-add-up-qqq-headed-for-158-cm839556,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
ALXN,ALXN:UW,BBG000G32HL2,BioMarin's Pegvaliase BLA Granted Priority Review by the FDA,2017-08-30 16:52:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5joWee5MWTw/biomarins-pegvaliase-bla-granted-priority-review-by-the-fda-cm839195,BioMarin Pharmaceutical Inc BMRN announced that the Biologics License Application BLA for pegvaliase has been accepted by the FDA for priority review A decision is expected on Feb 28 2018 BioMarin is looking to get pegvaliase approved for lowering blood phenylalanine Phe levels in
ALXN,ALXN:UW,BBG000G32HL2,"XBI, EXEL, ALXN, VRTX: ETF Inflow Alert",2017-08-30 16:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7J8CNknYz9I/xbi-exel-alxn-vrtx-etf-inflow-alert-cm839245,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 334 6 million dollar inflow that s a 9 1 increase week over week in outstanding
ALXN,ALXN:UW,BBG000G32HL2,BioMarin&apos;s Pegvaliase BLA Granted Priority Review by the FDA,2017-08-30 15:10:03 +0000,https://finance.yahoo.com/news/biomarin-apos-pegvaliase-bla-granted-151003007.html?.tsrc=rss,"BioMarin Pharmaceutical (BMRN) announced that the FDA has accepted and granted priority review to the BLA for phenylketonuria candidate, Pegvaliase with a decision expected in February 2018."
ALXN,ALXN:UW,BBG000G32HL2,Juno Therapeutics (JUNO) Soars: Stock Adds 20.1% in Session,2017-08-30 14:53:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2qCfCL-0FQA/juno-therapeutics-juno-soars-stock-adds-201-in-session-cm839089,Juno Therapeutics Inc JUNO was a big mover last session as the company saw its shares rise over 20 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 54 1
ALXN,ALXN:UW,BBG000G32HL2,Novo Nordisk's Tresiba Gets Canadian Nod,2017-08-29 23:50:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdgPHZxj90E/novo-nordisks-tresiba-gets-canadian-nod-cm838896,Novo Nordisk A S NVO announced that the Canadian regulatory authority has approved its basal insulin Tresiba for the once daily treatment of adults with diabetes mellitus to improve glycemic control Notably Tresiba is expected to be launched in the Canadian market in October Tresiba
ALXN,ALXN:UW,BBG000G32HL2,Advanced Accelerator Gets Action Date for Lutathera from FDA,2017-08-29 21:46:09 +0000,https://finance.yahoo.com/news/advanced-accelerator-gets-action-date-214609549.html?.tsrc=rss,The FDA granted an action date for Lutathera after the company resubmitted the New Drug Application (NDA) for the candidate.
ALXN,ALXN:UW,BBG000G32HL2,Analysts’ Recommendations for Pfizer in August 2017,2017-08-29 20:14:52 +0000,http://finance.yahoo.com/r/804bdc72-966d-38dd-979e-557a2b4eb7c6/analysts-recommendations-for-pfizer-in-august-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 22 analysts covering Pfizer (PFE) in August 2017, one analyst recommended a “strong buy” and ten analysts recommended a “buy.” On August 26, Pfizer had a consensus 12-month target price of $37.45 ..."
ALXN,ALXN:UW,BBG000G32HL2,September Could be Kind to Biotechnology ETFs,2017-08-29 15:04:43 +0000,https://finance.yahoo.com/news/september-could-kind-biotechnology-etfs-150443283.html?.tsrc=rss,"The iShares Nasdaq Biotechnology ETF (NASDAQGM:  IBB ) , the largest biotechnology exchange traded fund by assets, is up nearly 18% and the behemoth biotech fund could add to those gains in September. ..."
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-08-29 12:03:12 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120312301.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,Traders buy calls on Alexion Pharma,2017-08-28 17:58:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tuLrQ9WY1Ws/traders-buy-calls-on-alexion-pharma-cm838118,Traders are amassing a position in Alexion Pharmaceuticals ALXN Monday So far 1 000 contracts of the Oct 100 call have changed hands against open interest of 21 contracts Today s volume has all been on the high side of the spread indicating these calls were bought to
ALXN,ALXN:UW,BBG000G32HL2,Kamada (KMDA) Gets FDA Approval for Rabies Vaccine,2017-08-28 16:34:04 +0000,https://finance.yahoo.com/news/kamada-kmda-gets-fda-approval-163404483.html?.tsrc=rss,Kamada Ltd. (KMDA) and partner Kedrion Biopharma and announced that FDA has approved Kedrab [rabies immune globulin (Human)] for post-exposure prophylaxis against rabies infection.
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-08-28 12:03:10 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120310994.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.,2017-08-25 16:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k1QgDXo3Fvg/vertexs-cystic-fibrosis-combo-gets-priority-review-in-us-cm837196,Vertex Pharmaceuticals Incorporated VRTX announced that its regulatory applications for tezacaftor ivacaftor Kalydeco combination have been accepted by the FDA and the European Medicines Agency EMA for review The regulatory applications have been filed to seek approval of Kalydeco
ALXN,ALXN:UW,BBG000G32HL2,"Paratek Pharmaceuticals, Inc. (PRTK) Catches Eye: Stock Up 27.3%",2017-08-24 14:43:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ySGTEm4eVMo/paratek-pharmaceuticals-inc-prtk-catches-eye-stock-up-273-cm836464,Paratek Pharmaceuticals Inc PRTK was a big mover last session as the company saw its shares rise over 27 on the day The move came on solid volume too with far more shares changing hands than in a normal session This stock which remained volatile and traded within the range of 18
ALXN,ALXN:UW,BBG000G32HL2,Intra-Cellular (ITCI) Soars: Stock Adds 27.7% in Session,2017-08-24 14:43:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oSr0m_3xPuo/intra-cellular-itci-soars-stock-adds-277-in-session-cm836461,Intra Cellular Therapies Inc ITCI was a big mover last session as the company saw its shares rise nearly 28 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now
ALXN,ALXN:UW,BBG000G32HL2,Array BioPharma (ARRY) Looks Good: Stock Adds 5.9% in Session,2017-08-24 14:43:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IjcpwFf9wiU/array-biopharma-arry-looks-good-stock-adds-59-in-session-cm836445,Array BioPharma Inc ARRY was a big mover last session as the company saw its shares rise nearly 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 22 3 in
ALXN,ALXN:UW,BBG000G32HL2,"Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ...",2017-08-23 22:37:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8srIcgQhMh4/orbimed-advisors-llc-buys-cigna-corp-clovis-oncology-inc-gilead-sciences-inc-sells-centene-cm836259,Orbimed Advisors Llc New Purchases CI CLVS EVHC JUNO IOVA IART CTIC NVUS ARGX VRNA Added Positions GILD MYL BIIB ALNY REGN CELG IMMU JNJ GBT NVRO Reduced Positions HCA PFE SHPG BMY AET INCY IRWD BMRN AGN BSX Sold Out CNC
ALXN,ALXN:UW,BBG000G32HL2,Immunomedics (IMMU) Catches Eye: Stock Up 5.1%,2017-08-23 12:48:12 +0000,https://finance.yahoo.com/news/immunomedics-immu-catches-eye-stock-124812565.html?.tsrc=rss,"Immunomedics (IMMU) was a big mover last session, as the company saw its shares rise over 5% on the day amid huge volumes."
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe",2017-08-23 11:56:11 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-eu-label-115611574.html?.tsrc=rss,Key highlights include regulatory approvals for companies like Alexion (ALXN) and Ironwood while Biogen is one of the companies facing an investigation into the pricing of multiple sclerosis drugs.
ALXN,ALXN:UW,BBG000G32HL2,Immunomedics' Progress in Phase II Cancer Study Encouraging,2017-08-22 16:41:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hkwhwWHIKdg/immunomedics-progress-in-phase-ii-cancer-study-encouraging-cm835421,Immunomedics Inc IMMU announced encouraging interim results from a phase II study on its antibody drug conjugate ADC labetuzumab govitecan IMMU 130 The candidate is being evaluated as a single agent in heavily pretreated patients with metastatic colorectal cancer mCRC
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy ETF Inflows: XBI, EXEL, ALXN, VRTX",2017-08-22 16:40:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9eaHHlBLeXc/noteworthy-etf-inflows-xbi-exel-alxn-vrtx-cm835446,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 37 7 million dollar inflow that s a 1 1 increase week over week in outstanding
ALXN,ALXN:UW,BBG000G32HL2,Alexion's (ALXN) Soliris' Label Expansion Approved in Europe,2017-08-22 15:42:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nE3hKj1UFVg/alexions-alxn-soliris-label-expansion-approved-in-europe-cm835286,Alexion Pharmaceuticals Inc ALXN announced that the European Commission EC approved a label expansion of lead drug Soliris The European Commission expanded the indication for Soliris to include the treatment of refractory generalized myasthenia gravis gMG in adults who
ALXN,ALXN:UW,BBG000G32HL2,Inside Incyte’s Valuation after the 2Q17 Earnings,2017-08-22 14:56:50 +0000,http://finance.yahoo.com/r/765256ce-1eba-3522-ba3b-e3043f789149/inside-incytes-valuation-after-the-2q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Incyte reported revenues of ~$326.4 million for 2Q17, compared with ~$246.3 million for 2Q16."
ALXN,ALXN:UW,BBG000G32HL2,Immunomedics&apos; Progress in Phase II Cancer Study Encouraging,2017-08-22 14:44:02 +0000,https://finance.yahoo.com/news/immunomedics-apos-progress-phase-ii-144402166.html?.tsrc=rss,"Immunomedics, Inc. (IMMU) announced encouraging interim results from a phase II study on its cancer candidate, labetuzumab govitecan. Shares were up 7% on Monday in response."
ALXN,ALXN:UW,BBG000G32HL2,4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings,2017-08-22 14:10:02 +0000,https://finance.yahoo.com/news/4-biotech-stocks-add-portfolio-141002250.html?.tsrc=rss,Here is a look at four biotech stocks including Gilead (GILD) that topped estimates in Q2 and are witnessing upward estimate revisions for the current year.
ALXN,ALXN:UW,BBG000G32HL2,Alexion&apos;s (ALXN) Soliris&apos; Label Expansion Approved in Europe,2017-08-22 14:04:02 +0000,https://finance.yahoo.com/news/alexion-apos-alxn-soliris-apos-140402843.html?.tsrc=rss,Alexion Pharmaceuticals (ALXN) announced that the European Commission (EC) approved a label expansion of lead drug Soliris which should further boost sales.
ALXN,ALXN:UW,BBG000G32HL2,Intec Pharma (NTEC) Catches Eye: Stock Adds 9.8% in Session,2017-08-22 13:41:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_UcFWMyKHXc/intec-pharma-ntec-catches-eye-stock-adds-98-in-session-cm835265,Intec Pharma Ltd NTEC was a big mover last session as its shares rose more than 9 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above the volatile price
ALXN,ALXN:UW,BBG000G32HL2,"FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed",2017-08-22 01:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4wjgdJDoGlA/fda-approves-irwds-gout-drug-its-a-thumbs-up-for-alxn-in-eu-crme-crushed-20170822-00025,"FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed"
ALXN,ALXN:UW,BBG000G32HL2,European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG),2017-08-21 13:25:00 +0000,https://finance.yahoo.com/news/european-commission-grants-indication-soliris-132500485.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. announced today that the European Commission approved the extension of the indication for Soliris® to include the treatment of refractory generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody-positive."
ALXN,ALXN:UW,BBG000G32HL2,Falling Earnings Estimates Signal Weakness Ahead for Adamas (ADMS),2017-08-21 13:02:01 +0000,https://finance.yahoo.com/news/falling-earnings-estimates-signal-weakness-130201979.html?.tsrc=rss,"One stock that you may want to consider dropping is Adamas Pharmaceuticals, Inc. (ADMS), which has witnessed a significant price decline in the past four weeks"
ALXN,ALXN:UW,BBG000G32HL2,Mirati Therapeutics (MRTX) Rises: Stock Moves 10.9% Higher,2017-08-21 12:15:12 +0000,https://finance.yahoo.com/news/mirati-therapeutics-mrtx-rises-stock-121512179.html?.tsrc=rss,"Mirati Therapeutics, Inc. (MRTX) moved big last session, as its shares rose almost 11% on the day."
ALXN,ALXN:UW,BBG000G32HL2,"Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ...",2017-08-18 19:37:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/quy__G9HnE0/orbimed-advisors-llc-buys-cigna-corp-clovis-oncology-inc-gilead-sciences-inc-sells-centene-cm834160,Orbimed Advisors Llc New Purchases CI CLVS EVHC JUNO IOVA IART CTIC NVUS ARGX VRNA Added Positions GILD MYL BIIB ALNY REGN CELG IMMU JNJ GBT NVRO Reduced Positions HCA PFE SHPG BMY AET INCY IRWD BMRN AGN BSX Sold Out CNC
ALXN,ALXN:UW,BBG000G32HL2,Horizon Pharma (HZNP) Soars: Stock Adds 10.5% in Session,2017-08-18 14:40:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6PSXWiO85n8/horizon-pharma-hznp-soars-stock-adds-105-in-session-cm833840,Horizon Pharma Public Limited Company HZNP was a big mover last session as the company saw its shares rise nearly 11 on the day The move came on solid volume too with far more shares changing hands than in a normal session This stock trading within a volatile range of 11 54 13 48 in
ALXN,ALXN:UW,BBG000G32HL2,Horizon Pharma (HZNP) Soars: Stock Adds 10.5% in Session,2017-08-18 12:48:12 +0000,https://finance.yahoo.com/news/horizon-pharma-hznp-soars-stock-124812300.html?.tsrc=rss,"Horizon Pharma Public Limited Company (HZNP) was a big mover last session, as the company saw its shares rise nearly 11% on the day amid huge volumes."
ALXN,ALXN:UW,BBG000G32HL2,Novo Nordisk's Semaglutide Shows Remarkable Results in Study,2017-08-18 00:37:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zQgyFW0AMdA/novo-nordisks-semaglutide-shows-remarkable-results-in-study-cm833671,Novo Nordisk NVO announced results from SUSTAIN 7 study which showed that people with type II diabetes who are treated with once weekly semaglutide experienced superior reduction in HbA1c and body weight compared with treatment with Eli Lilly and Co s LLY Trulicity dulaglutide 160
ALXN,ALXN:UW,BBG000G32HL2,Seattle Genetics' Adcetris Granted Priority Review by FDA,2017-08-18 00:37:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ie9rpF0p9zE/seattle-genetics-adcetris-granted-priority-review-by-fda-cm833667,Seattle Genetics Inc SGEN announced that the FDA has accepted its supplemental Biologics License Application BLA for Adcetris brentuximab vedotin in patients with cutaneous T cell lymphoma CTCL Additionally the FDA granted Priority Review for the application and has set a target
ALXN,ALXN:UW,BBG000G32HL2,Seattle Genetics&apos; Adcetris Granted Priority Review by FDA,2017-08-17 22:33:10 +0000,https://finance.yahoo.com/news/seattle-genetics-apos-adcetris-granted-223310071.html?.tsrc=rss,"Seattle Genetics, Inc.&apos;s (SGEN) supplemental Biologics License Application for Adcetris in patients with cutaneous T-cell lymphoma has been accepted by the FDA and granted priority review."
ALXN,ALXN:UW,BBG000G32HL2,Novo Nordisk&apos;s Semaglutide Shows Remarkable Results in Study,2017-08-17 22:26:10 +0000,https://finance.yahoo.com/news/novo-nordisk-apos-semaglutide-shows-222610296.html?.tsrc=rss,Novo Nordisk (NVO) pipeline candidate shows superior glucose control and weight loss in study in diabetes patients compared with Eli Lilly and Co&apos;s Trulicity (dulaglutide).
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-08-17 12:03:50 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120350123.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,Shire Files Marketing Application for Lifitegrast in Europe,2017-08-16 23:37:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f_KnvLd1ZNs/shire-files-marketing-application-for-lifitegrast-in-europe-cm833067,Shire plc SHPG announced that it has submitted a Marketing Authorization Application MAA for lifitegrast for the treatment of dry eye disease in Europe In fact the application has been validated by the UK as the Reference Member State involved in the Decentralized Procedure DCP
ALXN,ALXN:UW,BBG000G32HL2,Spectrum (SPPI) Initiates Phase II Study for Cancer Drug,2017-08-16 21:44:09 +0000,https://finance.yahoo.com/news/spectrum-sppi-initiates-phase-ii-214409818.html?.tsrc=rss,"Spectrum Pharmaceuticals, Inc. (SPPI) initiated the registrational phase III study of qapzola in patients with non-muscle invasive bladder cancer (NMIBC) as per the FDA&apos;s requirement."
ALXN,ALXN:UW,BBG000G32HL2,Shire Files Marketing Application for Lifitegrast in Europe,2017-08-16 21:18:09 +0000,https://finance.yahoo.com/news/shire-files-marketing-application-lifitegrast-211809670.html?.tsrc=rss,Shire plc (SHPG) submitted a Marketing Authorization Application (MAA) for lifitegrast for the treatment of dry eye disease in Europe.
ALXN,ALXN:UW,BBG000G32HL2,"Update in Lawsuit for Investors in NASDAQ: ALXN Shares Against Alexion Pharmaceuticals, Inc. Announced by Shareholders Foundation",2017-08-16 13:35:00 +0000,https://finance.yahoo.com/news/lawsuit-investors-nasdaq-alxn-shares-133500254.html?.tsrc=rss,"SAN DIEGO, CA / ACCESSWIRE / August 16, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for investors who purchased NASDAQ: ALXN shares against Alexion Pharmaceuticals over ..."
ALXN,ALXN:UW,BBG000G32HL2,MiMedx Group (MDXG) in Focus: Stock Moves 6.1% Higher,2017-08-16 12:48:12 +0000,https://finance.yahoo.com/news/mimedx-group-mdxg-focus-stock-124812867.html?.tsrc=rss,"MiMedx Group (MDXG) was a big mover last session, as the company saw its rise over 6% on the day amid huge volumes."
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-08-16 12:03:28 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120330036.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges",2017-08-16 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UPeOCxT4xeY/alxns-strengthening-patents-folds-fabry-drug-approved-in-oz-vbiv-surges-20170816-00044,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Receives Three New U.S. Patents for Soliris® (eculizumab), Extending Patent Protection Into 2027",2017-08-15 20:05:00 +0000,https://finance.yahoo.com/news/alexion-receives-three-u-patents-200500130.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has issued U.S. Patents No. 9,732,149; 9,718,880; and 9,725,504, which are directed to the composition of matter of eculizumab , pharmaceutical formulations of eculizumab, and methods of treating paroxysmal nocturnal hemoglobinuria with eculizumab, respectively, and which will expire in 2027."
ALXN,ALXN:UW,BBG000G32HL2,"ETFs with exposure to Alexion Pharmaceuticals, Inc. : August 15, 2017",2017-08-15 19:17:23 +0000,http://finance.yahoo.com/r/c9e23d4c-c8dc-3962-bf5d-0e0867f64961/etfs-with-exposure-to-alexion-pharmaceuticals-inc-august-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alexion Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ALXN-US. Comparing the performance and risk of Alexion Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,Regeneron vs. Alexion: Which Stock is a Better Pick Post Q2 Earnings?,2017-08-14 13:32:01 +0000,https://finance.yahoo.com/news/regeneron-vs-alexion-stock-better-133201559.html?.tsrc=rss,"Biotech companies, Regeneron (REGN) and Alexion, both topped estimates in Q2 and raised their outlook. But, which stock is better-positioned for the second half of the year?"
ALXN,ALXN:UW,BBG000G32HL2,3 'Strong Buy' Biotech Stocks You Should Watch,2017-08-14 12:55:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J21ybI75RXE/3-strong-buy-biotech-stocks-you-should-watch-cm831519,"The volatile biotech sector is rebounding with attractive stock valuations and renewed political confidence. Investors believe that President Trump is unlikely to introduce tough controls on drug prices, and could even streamline the lengthy drug-approval process by the Food & Drug Administration (FDA). We can see"
ALXN,ALXN:UW,BBG000G32HL2,Editas Medicine (EDIT) Looks Good: Stock Moves Up 11.3%,2017-08-14 12:15:12 +0000,https://finance.yahoo.com/news/editas-medicine-edit-looks-good-121512791.html?.tsrc=rss,"Editas Medicine, Inc. (EDIT) moved big moved last session, as its shares rose over 11% on the day."
ALXN,ALXN:UW,BBG000G32HL2,Edited Transcript of ALXN earnings conference call or presentation 27-Jul-17 2:00pm GMT,2017-08-13 11:01:12 +0000,https://finance.yahoo.com/news/edited-transcript-alxn-earnings-conference-232347083.html?.tsrc=rss,Q2 2017 Alexion Pharmaceuticals Inc Earnings Call
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-08-12 12:03:27 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120327353.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,Call of the week: Best stocks for a dollar bear market,2017-08-11 17:25:13 +0000,https://finance.yahoo.com/news/call-week-best-stocks-dollar-bear-market-172513884.html?.tsrc=rss,"The call of the week is a bearish one on the US dollar and has far reaching implications for many US companies.  The team of analysts, including Andrew Garthwaite, managing director and global equity strategist at Credit Suisse, point to history as a guide, noting that the dollar has tended to move in long-term cycles, with bull markets lasting 6-7 years and bear markets lasting about 9-10 years.  Credit Suisse singles out companies like Alexion (ALXN), Gilead (GILD), McDonald’s (MCD), Activision Blizzard (ATVI) and Carnival (CCL) — companies that not only have positive earnings and sales momentum, but significant European exposure."
ALXN,ALXN:UW,BBG000G32HL2,Call of the week: best stocks for a dollar bear market,2017-08-11 17:13:00 +0000,https://finance.yahoo.com/video/call-week-best-stocks-dollar-171335760.html?.tsrc=rss,Yahoo Finance's Justine Underhill explains what companies can benefit from Credit Suisse's bearish call on the US dollar.
ALXN,ALXN:UW,BBG000G32HL2,"XBI, EXEL, ALXN, CLVS: ETF Outflow Alert",2017-08-11 16:36:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hKewXWR9bgA/xbi-exel-alxn-clvs-etf-outflow-alert-cm830991,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 63 3 million dollar outflow that s a 1 8 decrease week over week from 46 500 000
ALXN,ALXN:UW,BBG000G32HL2,Implied Volatility Surging for Alexion Pharmaceuticals (ALXN) Stock Options,2017-08-11 14:39:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y82mpQutByM/implied-volatility-surging-for-alexion-pharmaceuticals-alxn-stock-options-cm830884,Investors in Alexion Pharmaceuticals Inc ALXN need to pay close attention to the stock based on moves in the options market lately That is because the August 18 th 2017 65 00 Put had some of the highest implied volatility of all equity options today What is Implied
ALXN,ALXN:UW,BBG000G32HL2,"Forget Teva (TEVA), Buy These 4 Drug Stocks Instead",2017-08-11 14:38:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hkSo-GedxMk/forget-teva-teva-buy-these-4-drug-stocks-instead-cm830870,It s not been a good quarter for Israel based generic drug maker Teva Pharmaceutical Industries Limited TEVA Teva missed on both second quarter earnings and revenues and lowered its outlook for 2017 The company s shares are down significantly following the release of disappointing
ALXN,ALXN:UW,BBG000G32HL2,"Forget Teva (TEVA), Buy These 4 Drug Stocks Instead",2017-08-11 12:42:12 +0000,https://finance.yahoo.com/news/forget-teva-teva-buy-4-124212412.html?.tsrc=rss,"With generic drugmakers like Teva (TEVA) under pressure, here is a look at four drug stocks that look well-positioned."
ALXN,ALXN:UW,BBG000G32HL2,Implied Volatility Surging for Alexion Pharmaceuticals (ALXN) Stock Options,2017-08-11 12:30:12 +0000,https://finance.yahoo.com/news/implied-volatility-surging-alexion-pharmaceuticals-123012169.html?.tsrc=rss,Investors need to pay close attention to Alexion Pharmaceuticals (ALXN) stock based on the movements in the options market lately.
ALXN,ALXN:UW,BBG000G32HL2,"Geron (GERN) Q2 Loss Narrows, Sales Miss Estimates, Stock Up",2017-08-10 16:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SXA6VBUQaDE/geron-gern-q2-loss-narrows-sales-miss-estimates-stock-up-cm830322,Geron Corporation GERN reported a loss of 4 cents per share in the second quarter of 2017 which was narrower than the Zacks Consensus Estimate of a loss of 5 cents In the year ago quarter too the company had recorded a loss of 5 cents Shares rose 4 7 in after hours trading on
ALXN,ALXN:UW,BBG000G32HL2,"Puma (PBYI) Q2 Loss Narrower than Expected, Nerlynx in Focus",2017-08-10 16:39:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Md5F_PLoFpg/puma-pbyi-q2-loss-narrower-than-expected-nerlynx-in-focus-cm830320,Puma Biotechnology Inc PBYI reported a loss of 2 10 in the second quarter of 2017 including the impact of stock based compensation expenses narrower than the Zacks Consensus Estimate of a loss of 2 82 The company had reported a loss of 2 05 Shares of Puma Biotech were down 1 9
ALXN,ALXN:UW,BBG000G32HL2,New Patients and Alexion Pharmaceuticals’ Metabolic Franchise,2017-08-10 13:06:09 +0000,http://finance.yahoo.com/r/d90db0ff-fcb5-3fee-811f-b2ef61dcab70/identification-new-patients-may-drive-growth-alexion-pharmaceuticals-metabolic-franchise?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals (ALXN) has reiterated its 2017 revenue guidance of $375.0 million–$400.0 million for its metabolic franchise.
ALXN,ALXN:UW,BBG000G32HL2,"IHS Markit Score downgrades Alexion Pharmaceuticals Inc to 60 out of 100, ranking positively in only one out of three available IHS Markit categories.",2017-08-10 12:04:14 +0000,https://finance.yahoo.com/news/ihs-markit-score-downgrades-alexion-120414823.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Expects Robust Revenue for Soliris,2017-08-10 11:36:14 +0000,http://finance.yahoo.com/r/7c2fa2f0-dc92-336d-8658-64ee11044f30/alexion-pharmaceuticals-expects-robust-revenue-performance-soliris-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals (ALXN) raised its 2017 revenue projections for Soliris from $3.025 billion–$3.1 billion to $3.075 billion–$3.125 billion.
ALXN,ALXN:UW,BBG000G32HL2,Alexion and Sema4 Partner in Rare Disease Diagnostics and Systems Biology,2017-08-10 10:30:00 +0000,https://finance.yahoo.com/news/alexion-sema4-partner-rare-disease-103000061.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. and Sema4 today announced a strategic partnership to leverage their shared experience in data science and systems biology to accelerate rare disease diagnosis and therapeutic discovery."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion,Sema4 Partner In Rare Disease Diagnostics And Systems Biology",2017-08-10 06:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ikHl45lamfc/alexionsema4-partner-in-rare-disease-diagnostics-and-systems-biology-20170810-00288,"Alexion,Sema4 Partner In Rare Disease Diagnostics And Systems Biology"
ALXN,ALXN:UW,BBG000G32HL2,Why Achillion Pharmaceuticals Is Shooting 25% Higher Today,2017-08-09 18:37:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BEEDnGOkGAI/why-achillion-pharmaceuticals-is-shooting-25-higher-today-cm829684,What happened After the company updated investors on its second quarter financials and the progress it s making in its clinical stage drug pipeline shares in Achillion Pharmaceuticals NASDAQ ACHN are soaring 24 higher at 11 45 a m EDT today So what
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals: Modest Growth Projections,2017-08-09 14:37:44 +0000,http://finance.yahoo.com/r/06fbf75d-dac7-31bd-b8ae-6a4f43b3f19d/alexion-pharmaceuticals-provided-modest-growth-projections-2h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals has raised its projection for its 2017 pricing headwind from 1.0%–2.0% to 2.0%–3.0%.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Raised 2017 Earnings Guidance,2017-08-09 13:08:24 +0000,http://finance.yahoo.com/r/e070e9bc-d65b-3f82-95dc-b1d6105c3663/alexion-pharmaceuticals-raised-non-gaap-eps-guidance-full-year-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals (ALXN) raised its 2017 non-GAAP guidance from the previously estimated $5.10–$5.30 to $5.40–$5.55.
ALXN,ALXN:UW,BBG000G32HL2,See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.,2017-08-09 12:03:49 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120349400.html?.tsrc=rss,Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Raised Its Revenue Guidance for 2017,2017-08-09 11:40:58 +0000,http://finance.yahoo.com/r/d88bdbcd-5471-3a80-8ae9-f03e147d1f2b/alexion-pharmaceuticals-raised-revenue-guidance-full-year-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In its 2Q17 earnings conference call, Alexion Pharmaceuticals (ALXN) raised its 2017 revenue guidance from $3.4 billion–$3.5 billion to $3.45 billion–$3.53 billion."
ALXN,ALXN:UW,BBG000G32HL2,"The Key Reason Alexion Pharmaceuticals, Inc. Vaulted 13% Higher in July",2017-08-08 22:35:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1dP-auzXng0/the-key-reason-alexion-pharmaceuticals-inc-vaulted-13-higher-in-july-cm829094,What happened Shares of Alexion Pharmaceuticals NASDAQ ALXN a biotech company with a keen focus on developing therapies to treat ultra rare diseases moved steadily higher by 13 during the month of July according to data from S amp P Global Market Intelligence
ALXN,ALXN:UW,BBG000G32HL2,"The Key Reason Alexion Pharmaceuticals, Inc. Vaulted 13% Higher in July",2017-08-08 20:58:00 +0000,http://finance.yahoo.com/r/abd08145-8ba9-360f-8372-0da1628d240d/the-key-reason-alexion-pharmaceuticals-inc-vaulted.aspx?yptr=yahoo&.tsrc=rss,"Surprise! It&apos;s Soliris, again."
ALXN,ALXN:UW,BBG000G32HL2,Analyst Recommendations for Alexion Pharmaceuticals in August,2017-08-08 20:52:10 +0000,http://finance.yahoo.com/r/b97624a0-157d-38fe-8fcf-50f493e9643d/analysts-recommendations-alexion-pharmaceuticals-august-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Alexion Pharmaceuticals (ALXN) reported revenues close to $912.0 million, which is a YoY (year-over-year) rise of 21.0%."
ALXN,ALXN:UW,BBG000G32HL2,"Forget Bayer, Buy These 3 Drug Stocks Instead",2017-08-08 15:44:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kJ0EzMKB4Nk/forget-bayer-buy-these-3-drug-stocks-instead-cm828781,Life science company Bayer AG BAYRY reported a mixed second quarter with earnings surpassing expectations but sales falling short While the Pharmaceuticals Animal Health and Covestro segments recorded a year over year increase in sales the Crop Science and Consumer Health divisions
ALXN,ALXN:UW,BBG000G32HL2,Dynavax Technologies (DVAX) Catches Eye: Stock Adds 11.2% in Session,2017-08-08 14:42:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xz-S22k2AwM/dynavax-technologies-dvax-catches-eye-stock-adds-112-in-session-cm828687,Dynavax Technologies Corporation DVAX 160 was a big mover last session as the company saw its shares rise over 11 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is
ALXN,ALXN:UW,BBG000G32HL2,"For Vertex Pharmaceuticals, Can One Billion-Dollar Breakthrough Beget Another?",2017-08-08 13:45:00 +0000,http://finance.yahoo.com/r/a5f3bd85-6c8b-335d-ae3f-adf1fe0e288f/vertex-pharmaceuticals-and-the-price-of-inspiration?utm_source=yahoo&utm_medium=partner&utm_campaign=yahoofeed&partner=yahoomag&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals' new $200,000-a-year cystic fibrosis drug could help 90% of patients breathe. It's an amazing--and amazingly profitable--innovation. But will that windfall spur the 28-year-old startup to do it again?"
ALXN,ALXN:UW,BBG000G32HL2,"Forget Bayer, Buy These 3 Drug Stocks Instead",2017-08-08 13:25:01 +0000,https://finance.yahoo.com/news/forget-bayer-buy-3-drug-132501277.html?.tsrc=rss,"With Bayer (BAYRY) reporting mixed results in the second quarter and lowering its outlook, here is a look at 3 drug stocks which look well positioned."
ALXN,ALXN:UW,BBG000G32HL2,Featured Company News - US Oncology Research and Epizyme Establish Collaboration to Identify Non-Hodgkin Lymphoma Patients with EZH2 Mutations,2017-08-03 11:40:00 +0000,https://finance.yahoo.com/news/featured-company-news-us-oncology-114000794.html?.tsrc=rss,"Research Desk Line-up: Alexion Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 3, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Epizyme, ..."
ALXN,ALXN:UW,BBG000G32HL2,New Strong Buy Stocks for August 2nd,2017-08-02 16:01:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p9q5pjAUoso/new-strong-buy-stocks-for-august-2nd-cm825884,Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today Aerie Pharmaceuticals Inc AERI This clinical stage pharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings gaining 2 5 over the last 30 days Aerie Pharmaceuticals
ALXN,ALXN:UW,BBG000G32HL2,New Strong Buy Stocks for August 2nd,2017-08-02 13:23:01 +0000,https://finance.yahoo.com/news/strong-buy-stocks-august-2nd-132301843.html?.tsrc=rss,New Strong Buy Stocks for August 2nd
ALXN,ALXN:UW,BBG000G32HL2,Stephanie Link: here&apos;s what to buy at record highs,2017-08-01 16:30:45 +0000,https://finance.yahoo.com/news/stephanie-apos-buy-record-highs-163045832.html?.tsrc=rss,&quot;Halftime Report&quot; trader Stephanie Link gives her &quot;buy&quot; list.
ALXN,ALXN:UW,BBG000G32HL2,Stephanie Link: here's what to buy at record highs,2017-08-01 16:30:45 +0000,http://finance.yahoo.com/r/4e913611-c01d-36da-b7f0-48f68a180b04/104624233?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104624233&yptr=yahoo&.tsrc=rss,"""Halftime Report"" trader Stephanie Link gives her ""buy"" list."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017",2017-08-01 15:07:18 +0000,http://finance.yahoo.com/r/701705b6-5e9a-3b30-b1a1-b0e9a9cacf99/alexion-pharmaceuticals-inc-alxn-us-earnings-analysis-q2-2017-by-the-numbers-august-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Alexion Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Alexion Pharmaceuticals, Inc. – Celgene Corporation, Gilead Sciences, Inc., Vertex Pharmaceuticals Incorporated, Biogen Inc., QIAGEN NV and Ultragenyx Pharmaceutical, Inc. (CELG-US, GILD-US, VRTX-US, BIIB-US, QGEN-US and RARE-US) that ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,3 ETFs to Watch Out for on Biotech Earnings,2017-08-01 06:53:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0LkkR150B0M/3-etfs-to-watch-out-for-on-biotech-earnings-cm824658,The earnings season is off to a flying start with almost 75 of the companies having surpassed expectations The performance has been quite impressive for Biotech companies with major players beating market estimates President Donald Trump s failure to implement the healthcare bill was a
ALXN,ALXN:UW,BBG000G32HL2,3 ETFs to Watch Out for on Biotech Earnings,2017-08-01 04:26:04 +0000,https://finance.yahoo.com/news/3-etfs-watch-biotech-earnings-042604658.html?.tsrc=rss,Major players in the biotech space reported their second quarter 2017 results.
ALXN,ALXN:UW,BBG000G32HL2,Alexion tops Street 2Q forecasts,2017-07-28 05:24:20 +0000,https://finance.yahoo.com/news/alexion-tops-street-2q-forecasts-104502206.html?.tsrc=rss,"On a per-share basis, the New Haven, Connecticut-based company said it had profit of 73 cents. Earnings, adjusted for one-time gains and costs, were $1.56 per share. The results beat Wall Street expectations. ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Tops Q2 Earnings & Revenues, Ups 2017 View",2017-07-27 17:03:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u18ba8GNAfo/alexion-alxn-tops-q2-earnings-revenues-ups-2017-view-cm822597,Alexion Pharmaceuticals Inc s ALXN posted second quarter 2017 adjusted earnings including after tax impact of stock based compensation expense of 1 31 per share higher than the year ago earnings of 93 cents as well as the Zacks Consensus Estimate of 1 08 Strong product revenues drove
ALXN,ALXN:UW,BBG000G32HL2,Alexion: Thank You For Your Patience?,2017-07-27 16:22:00 +0000,http://finance.yahoo.com/r/cce3f34b-af5f-3a9c-838d-58347c085d9b/alexion-thank-you-for-your-patience-1501172532?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Alexion Pharmaceuticals (ALXN) are rising today after the biotech company beat earnings forecasts and raised its guidance.  Leerink analyst Geoffrey Porges and Bradley Canino call today's report ""the most important"" of the large-cap biotech stocks: This morning Alexion announced Q2 revenue of $912mm, which was a 7% beat against consensus of $849mm and an 8% beat vs. our estimate of $846mm (which implied sequentially lower revenue given management’s conservative commentary last quarter and the attrition of patients on Soliris to clinical trials).  Shares of Alexion Pharmaceuticals have gained 2% to $133.72 at 12:18 p.m. today, but had been up as much as 8.6% earlier today."
ALXN,ALXN:UW,BBG000G32HL2,​Alexion cuts ties with two Cambridge biotechs in reorganization,2017-07-27 15:20:14 +0000,http://finance.yahoo.com/r/6ed3b1fc-e660-3c65-8819-d087be536d65/alexion-cuts-ties-with-two-cambridge-biotechs-in.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals said Thursday that it’s scrapping a handful of drug development programs as part of a reorganization, including its partnership deals with a pair of Cambridge biotechs.  Moderna : Alexion’s 2014 deal with Moderna, one of the state’s largest privately-held biotechs, covered treatments that use messenger RNA, or mRNA — molecules that recruit the body's own cells to create proteins to fight rare diseases.  Under that agreement, Alexion paid Moderna $100 million upfront in exchange for the option to partner on up to 10 products."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Tops Q2 Earnings & Revenues, Ups 2017 View",2017-07-27 15:03:03 +0000,https://finance.yahoo.com/news/alexion-alxn-tops-q2-earnings-150303168.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. (ALXN) exceeded both earnings and revenue estimates in Q2 and also raised its 2017 guidance."
ALXN,ALXN:UW,BBG000G32HL2,"AstraZeneca Beats, But Stock Dives On Drug Failure; 4 More Report",2017-07-27 14:27:26 +0000,http://finance.yahoo.com/r/fbf729ae-b2bc-30e8-b2c0-0076ed74d9bd/astrazeneca-beats-but-stock-dives-on-mystic-failure-3-more-drug-giants-report?src=A00220&yptr=yahoo&.tsrc=rss,"AstraZeneca topped profit views, but shares crashed on an immuno-oncology setback. Roche also beat."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Tops Q2 Earnings, Sales; Shares Up",2017-07-27 14:04:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6vGO6WPhhv4/alexion-alxn-tops-q2-earnings-sales-shares-up-cm822444,Alexion Pharmaceuticals Inc ALXN focuses on the development and commercialization of life transforming drugs for treating patients suffering from ultra rare disorders Soliris approved for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome is the key product of this
ALXN,ALXN:UW,BBG000G32HL2,Alexion posts higher Q2 earnings on strong Soliris sales,2017-07-27 13:46:39 +0000,https://finance.yahoo.com/news/alexion-posts-higher-q2-earnings-134639803.html?.tsrc=rss,"Alexion Pharmaceuticals Inc  posted a better than expected second-quarter profit on  Thursday and raised its full-year forecast on strong sales of  its expensive rare disease treatment Soliris.  Shares of Alexion - which have been roiled by a scandal  related to its sales practices for Soliris as well as management  resignations - rose around 6 percent in before the bell trading.  Alexion said it had net income of $165 million, or 73 cents  a share, in the quarter, up from $120 million, or 54 cents a  share, last year."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Spikes on Q2 Earnings Blowout Providing Positive Signs for Rest of Sector -Biotech Movers,2017-07-27 13:29:00 +0000,http://finance.yahoo.com/r/1f09459a-64f6-36b6-8189-0192129fdf2b/biotech-movers-alexion-spikes-on-38-rise-in-second-quarter-earnings.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals, United Therapeutics and Gilead Sciences were among the biotech stock movers in premarket trading on July 27."
ALXN,ALXN:UW,BBG000G32HL2,"Investor Network: Alexion Pharmaceuticals, Inc. to Host Earnings Call",2017-07-27 12:40:00 +0000,https://finance.yahoo.com/news/investor-network-alexion-pharmaceuticals-inc-124000426.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 27, 2017 at 10:00 ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Tops Q2 Earnings, Sales; Shares Up",2017-07-27 12:34:12 +0000,https://finance.yahoo.com/news/alexion-alxn-tops-q2-earnings-123412119.html?.tsrc=rss,Alexion surpassed earnings and sales expectations in the second quarter of 2017.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Reports Second Quarter 2017 Results,2017-07-27 10:30:00 +0000,https://finance.yahoo.com/news/alexion-reports-second-quarter-2017-103000914.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced financial results for the second quarter of 2017. Total revenues in the quarter were $912 million, a 21 percent increase compared to the same period in 2016."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharma Lifts FY17 Adj. Earnings View, Above Market Estimates",2017-07-27 07:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6610yUpBxMg/alexion-pharma-lifts-fy17-adj-earnings-view-above-market-estimates-20170727-00684,"Alexion Pharma Lifts FY17 Adj. Earnings View, Above Market Estimates"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. Reports 38% Rise In Q2 Profit,2017-07-27 06:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kpCNK3n0iRs/alexion-pharmaceuticals-inc-reports-38-rise-in-q2-profit-20170727-00496,Alexion Pharmaceuticals Inc. Reports 38% Rise In Q2 Profit
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. Reports 38% Rise In Q2 Profit,2017-07-27 06:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sXs0KpfwOME/alexion-pharmaceuticals-inc-reports-38%25-rise-in-q2-profit-20170727-00496,Alexion Pharmaceuticals Inc. Reports 38% Rise In Q2 Profit
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy Wednesday Option Activity: HBI, EA, ALXN",2017-07-26 19:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Slqyj15eRA/noteworthy-wednesday-option-activity-hbi-ea-alxn-cm821947,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in HanesBrands Inc Symbol HBI where a total volume of 25 211 contracts has been traded thus far today a contract volume which is representative of approximately 2 5
ALXN,ALXN:UW,BBG000G32HL2,"XBI, CLVS, EXEL, ALXN: ETF Outflow Alert",2017-07-26 15:57:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QwxLkjjKPJc/xbi-clvs-exel-alxn-etf-outflow-alert-cm821649,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 112 8 million dollar outflow that s a 2 8 decrease week over week from 50 050 000
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stocks Jul27 Q2 Earnings Roster: BMY, CELG & ALXN",2017-07-26 15:03:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gcMbigB7vzo/biotech-stocks-jul27-q2-earnings-roster-bmy-celg-alxn-cm821738,The second quarter earnings season is off to a strong start As of July 25 approximately 128 S amp P 500 companies or 36 1 of the index s total membership have reported results 160 A deep look into the results show that earnings for the companies reported so far are up 7 year over year
ALXN,ALXN:UW,BBG000G32HL2,Why Alexion Pharmaceuticals (ALXN) Might Surprise This Earnings Season,2017-07-26 13:59:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NcDKasXEKtY/why-alexion-pharmaceuticals-alxn-might-surprise-this-earnings-season-cm821581,Investors are always looking for stocks that are poised to beat at earnings season and Alexion Pharmaceuticals Inc ALXN may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Alexion Pharmaceuticals
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stocks Jul27 Q2 Earnings Roster: BMY, CELG & ALXN",2017-07-26 13:37:01 +0000,https://finance.yahoo.com/news/biotech-stocks-jul27-q2-earnings-133701059.html?.tsrc=rss,"Bristol-Myers Squibb Company (BMY), Celgene (CELG) and Alexion Pharma (ALXN) are set to report second-quarter results on Jul 27."
ALXN,ALXN:UW,BBG000G32HL2,Why Alexion Pharmaceuticals (ALXN) Might Surprise This Earnings Season,2017-07-26 12:55:12 +0000,https://finance.yahoo.com/news/why-alexion-pharmaceuticals-alxn-might-125512224.html?.tsrc=rss,Alexion Pharmaceuticals (ALXN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ALXN,ALXN:UW,BBG000G32HL2,Amgen Topples After Increased Forecast Still Lags Some Views,2017-07-25 21:02:13 +0000,http://finance.yahoo.com/r/d3eba095-bcec-3563-bb8c-91b0ead3ee2e/amgen-tops-q2-sales-profits-expectations?src=A00220&yptr=yahoo&.tsrc=rss,"Amgen beat second-quarter expectations, but its 2017 earnings guidance still lagged some views."
ALXN,ALXN:UW,BBG000G32HL2,Can Intercept (ICPT) Beat Estimates this Earnings Season?,2017-07-25 16:08:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nd1RV9KvWW4/can-intercept-icpt-beat-estimates-this-earnings-season-cm821036,Intercept Pharmaceuticals Inc ICPT is scheduled to report second quarter 2017 results on Jul 31 In the last reported quarter the company beat expectations by 15 4 Let s see how things are shaping up for this announcement Intercept s share price movement in the year so far
ALXN,ALXN:UW,BBG000G32HL2,What's in the Cards for Exelixis (EXEL) in Q2 Earnings?,2017-07-24 17:09:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tPDyd3kQAmk/whats-in-the-cards-for-exelixis-exel-in-q2-earnings-cm820318,Exelixis Inc EXEL is scheduled to report second quarter 2017 results on Aug 2 after the market closes Exelixis track record is outstanding The company has surpassed expectations in all the four trailing quarters with an average positive earnings surprise of 512 1
ALXN,ALXN:UW,BBG000G32HL2,Is Celgene (CELG) Poised For a Beat This Earnings Season?,2017-07-24 16:09:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xNhWO-IuSHA/is-celgene-celg-poised-for-a-beat-this-earnings-season-cm820167,Celgene Corporation CELG is scheduled to report second quarter 2017 results on Jul 27 before the opening bell Last quarter the company beat expectations by 4 08 Celgene has outperformed the Zacksclassified industry in the year so far The stock has gained 19 during this
ALXN,ALXN:UW,BBG000G32HL2,Biogen Earnings Preview: Analysis,2017-07-24 16:07:00 +0000,http://finance.yahoo.com/r/99a4bfb0-9025-3519-98ec-0e9f84c65026/biogen-earnings-preview-analysis?partner=YahooSA&yptr=yahoo&.tsrc=rss,Revenue and earnings probably declined in the latest quarter
ALXN,ALXN:UW,BBG000G32HL2,"Biotechs On A Hot Streak, And Could Be &apos;Cooking With Gas&apos;",2017-07-21 20:14:03 +0000,http://finance.yahoo.com/r/a8195dfd-eb98-3013-9614-baa8c81e7481/biotechs-on-a-hot-streak-and-could-be-cooking-with-gas?src=A00220&yptr=yahoo&.tsrc=rss,IBD&apos;s 439-company Biotech industry group is now ranked fourth out of 197. How far can the rally go?
ALXN,ALXN:UW,BBG000G32HL2,Are Options Traders Betting on a Big Move in Alexion Pharmaceuticals (ALXN) Stock?,2017-07-21 16:13:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Dw35SjtEhg/are-options-traders-betting-on-a-big-move-in-alexion-pharmaceuticals-alxn-stock-cm819367,Investors in Alexion Pharmaceuticals Inc ALXN need to pay close attention to the stock based on moves in the options market lately That is because the August 18 2017 65Put had some of the highest implied volatility of all equity options today What is Implied Volatility
ALXN,ALXN:UW,BBG000G32HL2,Are Options Traders Betting on a Big Move in Alexion Pharmaceuticals (ALXN) Stock?,2017-07-21 13:42:01 +0000,https://finance.yahoo.com/news/options-traders-betting-big-move-134201280.html?.tsrc=rss,"Investors in Alexion Pharmaceuticals, Inc. (ALXN) need to pay close attention to the stock based on moves in the options market lately."
ALXN,ALXN:UW,BBG000G32HL2,S&P 500 Analyst Moves: ALXN,2017-07-20 17:05:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q1ULTYJRSPs/sp-500-analyst-moves-alxn-cm818798,The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Alexion Pharmaceuticals ALXN is now the 120 analyst pick moving up by 2 spots This rank is formed by averaging the analyst opinions for each component
ALXN,ALXN:UW,BBG000G32HL2,Is a Beat in Store for Alexion (ALXN) this Earnings Season?,2017-07-20 17:03:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XFqLvluNQmc/is-a-beat-in-store-for-alexion-alxn-this-earnings-season-cm818766,Alexion Pharmaceuticals Inc ALXN is scheduled to report second quarter 2017 results on Jul 160 27 before the opening bell In the last reported quarter Alexion s earnings surpassed Zacks Consensus Estimate Alexion s track record is excellent as the company has consistently
ALXN,ALXN:UW,BBG000G32HL2,Is a Beat in Store for Alexion (ALXN) this Earnings Season?,2017-07-20 15:31:03 +0000,https://finance.yahoo.com/news/beat-store-alexion-alxn-earnings-153103207.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc.&apos;s (ALXN) drugs like Soliris and Strensiq have been performing well. Let&apos;s see if these lead the company to an earnings beat."
ALXN,ALXN:UW,BBG000G32HL2,Is Gilead (GILD) Poised for a Beat This Earnings Season?,2017-07-20 14:08:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dj8ghdNt3vo/is-gilead-gild-poised-for-a-beat-this-earnings-season-cm818541,Gilead Sciences Inc GILD is scheduled to report second quarter 2017 results on Jul 26 after the market closes Last quarter the company beat expectations by 0 92 Gilead Sciences Inc Price and EPS Surprise Gilead Sciences Inc Price and EPS
ALXN,ALXN:UW,BBG000G32HL2,"Robbins Arroyo LLP Is Investigating the Officers and Directors of Alexion Pharmaceuticals, Inc. (ALXN) on Behalf of Shareholders",2017-07-19 18:08:00 +0000,https://finance.yahoo.com/news/robbins-arroyo-llp-investigating-officers-180800477.html?.tsrc=rss,"Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Alexion Pharmaceuticals, Inc. breached their fiduciary duties to shareholders."
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs",2017-07-19 14:06:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vPIIyQZEiWc/biotech-stock-roundup-vertex-boosted-by-cf-data-fda-nod-for-gilead-puma-drugs-cm818047,Key highlights this week include impressive data from Vertex s VRTX cystic fibrosis CF pipeline while companies like Gilead GILD and Puma PBYI got FDA approval for their hepatitis C virus HCV and breast cancer treatments respectively 160 Recap of the Week s Most Important
ALXN,ALXN:UW,BBG000G32HL2,Wall Street’s 5 Hottest Biotech Stocks Right Now,2017-07-17 23:45:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pr9S-b3dxaE/wall-streets-5-hottest-biotech-stocks-right-now-cm817217,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech stocks recently experienced their best week since the start of 2017 The biotechnology sector spiked following news that President Donald Trump plans to address drug prices with an executive order rather than
ALXN,ALXN:UW,BBG000G32HL2,"Alexion May Report A Weak Quarter, But The Stock's Still A Buy: Instinet",2017-07-17 19:41:00 +0000,http://finance.yahoo.com/r/62d0877f-b2a2-3f8d-b226-edaeedc1cf7e/alexion-may-report-a-weak-quarter-but-the-stocks-still-a-buy-instinet-1500320487?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Instinet's Christopher Marai and his team have a preview of Alexion Pharmaceuticals' (ALXN) upcoming earnings report, and while they expect EPS and revenue to come in a bit shy of the Street's expectations, ..."
ALXN,ALXN:UW,BBG000G32HL2,[$$] Biotechs in Focus Ahead of Earnings,2017-07-17 15:15:00 +0000,http://finance.yahoo.com/r/622b6d9d-e661-32f7-87f9-7dae41ef33e0/biotechs-in-focus-ahead-of-earnings-1500304501?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  Heading into the quarter, Biogen and Alexion Pharmaceuticals are in focus in our coverage universe.  Key products of focus for the quarter include Regeneron’s (REGN) newly launched Dupixent, Biogen/Ionis Pharmaceuticals’ (IONS) Spinraza now in its second full quarter and Alexion’s (ALXN) Soliris."
ALXN,ALXN:UW,BBG000G32HL2,"XBI, CLVS, EXEL, ALXN: Large Inflows Detected at ETF",2017-07-13 16:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n377MjGb2Vs/xbi-clvs-exel-alxn-large-inflows-detected-at-etf-cm815708,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 196 6 million dollar inflow that s a 5 4 increase week over week in outstanding
ALXN,ALXN:UW,BBG000G32HL2,Biotech 2Q17: It's Mostly all Gravy,2017-07-13 13:46:00 +0000,http://finance.yahoo.com/r/fc9f4171-9d0c-316f-9b64-af53d2daab53/biotech-2q17-its-mostly-all-gravy-1499953599?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"There's still a big question mark around healthcare policy, but drug pricing concerns have abated and investor sentiment appears to be improving. Exchange-traded funds tracking biotechnology stocks are ..."
ALXN,ALXN:UW,BBG000G32HL2,Cramer's lightning round: Companies that do this are too desperate for me,2017-07-11 22:50:30 +0000,http://finance.yahoo.com/r/cdd1d68d-2a2d-302c-aee0-3905b78707ae/104579630?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104579630&yptr=yahoo&.tsrc=rss,"Jim Cramer rattles off his take on callers' favorite stocks at lightning speed, including this telecom name."
ALXN,ALXN:UW,BBG000G32HL2,Cramer&apos;s lightning round: Companies that do this are too desperate for me,2017-07-11 22:50:30 +0000,https://finance.yahoo.com/news/cramer-apos-lightning-round-companies-225030330.html?.tsrc=rss,"Jim Cramer rattles off his take on callers&apos; favorite stocks at lightning speed, including this telecom name."
ALXN,ALXN:UW,BBG000G32HL2,Spiros Segalas Commentary on Alexion Pharmaceuticals,2017-07-11 16:44:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J9_bmp4WRb0/spiros-segalas-commentary-on-alexion-pharmaceuticals-cm814565,NASDAQ ALXN Spiros Segalas Trades Portfolio Premium Members This article first appeared on GuruFocus This article first appeared
ALXN,ALXN:UW,BBG000G32HL2,5 Top Multibagger Biotech Stocks to Buy in the 2nd Half,2017-07-11 15:51:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YuwPUF1jU7Q/5-top-multibagger-biotech-stocks-to-buy-in-the-2nd-half-cm814468,After a dreadful 2016 biotech stocks have sprung back to life this year as possibilities of a draconian crackdown on drug prices ease out The unveiling of a health care refurbish plan by Senate Republicans in the meanwhile has reinstated investors confidence in the Republicans ability
ALXN,ALXN:UW,BBG000G32HL2,"Alexion to Report Second Quarter 2017 Results and Strategic Update on Thursday, July 27, 2017",2017-07-11 14:00:00 +0000,https://finance.yahoo.com/news/alexion-report-second-quarter-2017-140000434.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that the Company will report its financial results for the second quarter 2017 on Thursday, July 27, 2017 before the US financial markets open."
ALXN,ALXN:UW,BBG000G32HL2,What Analysts Recommend for BioMarin Pharmaceuticals,2017-07-10 13:07:54 +0000,http://finance.yahoo.com/r/cf02b496-4085-3899-b066-ca212cbdc160/what-analysts-recommend-for-biomarin-pharmaceuticals?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"A total of 20 analysts were analyzing BioMarin Pharmaceuticals in July 2017. Six analysts recommended a “strong buy,” while nine analysts suggested a “buy.”"
ALXN,ALXN:UW,BBG000G32HL2,3 Stocks With Huge Business Advantages,2017-07-09 12:34:00 +0000,http://finance.yahoo.com/r/6a666c24-0b14-3318-ae0c-f7bc58222296/3-stocks-with-huge-business-advantages.aspx?yptr=yahoo&.tsrc=rss,These companies are running circles around their competitors.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Investigation Believed to Have 'Minimal Impact',2017-07-07 20:35:00 +0000,http://finance.yahoo.com/r/be7a3050-ecaf-3166-a771-df327f4739f8/alexion-investigation-believed-to-have-quot-minimal-impact-quot.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Investors shouldn't ruffle their feathers. At least, not yet."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals: Nothing to See Here?,2017-07-07 15:58:00 +0000,http://finance.yahoo.com/r/a4450d62-5311-3a0b-ba77-d44df4f4329b/alexion-pharmaceuticals-nothing-to-see-here-1499443119?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yesterday, Bloomberg reported that the U.S. Department of Health and Human Services was also investigating  Alexion Pharmaceuticals (ALXN) sales practices, helping to send shares down 3.2% on the day.  Alexion's sales practices have been a huge concern, and resulted not only in an investigation, but the replacement of nearly the entire C-suite as well.  Morgan Stanley's Matthew Harrison and team explain why: Alexion clarified that this is related to a previously disclosed Massachusetts U.S. Attorney’s Office investigation into drug assistance programs in which multiple pharmaceutical companies are involved...While any investigation is concerning, the details suggest relatively modest risk...Given most investors fear a significant new investigation around Soliris sales practices, the details of this investigation appear more moderate, esp."
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Movers: Alexion, Arena, Novavax",2017-07-07 13:40:00 +0000,http://finance.yahoo.com/r/7d13ac06-006b-3d10-9fb0-cf19294ea6df/biotech-movers-alexion-arena-novavax.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Alexion, Arena and Novavax were among the biotech stock movers ahead of the market open on Friday, July 7."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Reportedly Being Investigated by HHS, Shares Slip",2017-07-07 13:06:01 +0000,https://finance.yahoo.com/news/alexion-reportedly-being-investigated-hhs-130601552.html?.tsrc=rss,"Shares of Alexion Pharmaceuticals, Inc. (ALXN) were down more than 3% on Thursday after a Bloomberg report stated that it is under investigation by the U.S. Department of Health and Human Services&apos; (HHS) Office of Inspector General (OIG)."
ALXN,ALXN:UW,BBG000G32HL2,The Market In 5 Minutes,2017-07-07 13:05:09 +0000,https://finance.yahoo.com/news/market-5-minutes-130509991.html?.tsrc=rss,"IN THE NEWS Benzinga Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) shares plunged nearly 5 percent Thursday on news that it was under investigation by the U.S. Department of Health and Human Services’ ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma Stock Dives On Report It&apos;s Under Federal Scrutiny,2017-07-06 21:51:47 +0000,http://finance.yahoo.com/r/7e206972-6858-34f0-a0eb-1b4a979506ed/alexion-pharma-stock-dives-on-report-its-under-federal-scrutiny?src=A00220&yptr=yahoo&.tsrc=rss,Alexion stock toppled Thursday after Health and Human Services confirmed it has an open and ongoing investigation into the rare disease biotech.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals reportedly under investigation by HHS,2017-07-06 21:37:20 +0000,https://finance.yahoo.com/news/alexion-pharmaceuticals-reportedly-under-investigation-213720602.html?.tsrc=rss,"The Department of Health and Human Services&apos; Inspector General is investigating Alexion Pharmaceuticals, Bloomberg reports."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals reportedly under investigation by HHS,2017-07-06 21:37:20 +0000,http://finance.yahoo.com/r/a6828c4d-fb0a-3a11-8865-1370b1bdbaa8/104571461?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104571461&yptr=yahoo&.tsrc=rss,"The Department of Health and Human Services' Inspector General is investigating Alexion Pharmaceuticals, Bloomberg reports."
ALXN,ALXN:UW,BBG000G32HL2,Alexion stock drops 3.6% on Bloomberg report that it's under investigation,2017-07-06 19:56:34 +0000,http://finance.yahoo.com/r/34613204-9fa9-3328-b888-ae4265aa093b/Story.aspx?guid=081FEA4D-6B7C-4A96-8501-021AD5C5721E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals Inc. shares dropped 3.5% to $120.62 in heavy Thursday afternoon trade after Bloomberg reported that the company is under investigation by the Department of Health and Human Services' ...
ALXN,ALXN:UW,BBG000G32HL2,Alexion shares down amid HHS investigation,2017-07-06 19:44:00 +0000,https://finance.yahoo.com/video/alexion-shares-down-amid-hhs-194400684.html?.tsrc=rss,CNBC's Meg Tirrell reports that Alexion Pharmaceuticals is being investigated by US Department of Health and Human Services Inspector General.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Says U.S. Health Inspector General Is Part of DOJ Probe,2017-07-06 19:05:35 +0000,http://finance.yahoo.com/r/e28cff53-1c51-3ea6-8522-4cf47aeccd32/alexion-under-investigation-by-u-s-office-of-inspector-general?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&trackingId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals Inc. is under investigation by the U.S. Department of Health and Human Services’ Office of Inspector General, related to a probe of the drugmaker’s support for charities that aid ..."
ALXN,ALXN:UW,BBG000G32HL2,3 Hot Biotech Stocks Ready for the Sector’s Next Breakout,2017-07-06 15:50:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qmh4wSz1ycA/3-hot-biotech-stocks-ready-for-the-sectors-next-breakout-cm812546,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech stocks and pharmaceutical stocks have been in the political crosshairs for more than a year The threat of government controls left the group attractively valued into 2017 but the potential for headline risks has
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy ETF Outflows: XBI, CLVS, EXEL, ALXN",2017-07-05 16:45:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pDZmOw0HFkE/noteworthy-etf-outflows-xbi-clvs-exel-alxn-cm811897,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 155 9 million dollar outflow that s a 4 2 decrease week over week from 48 000 000
ALXN,ALXN:UW,BBG000G32HL2,Alexion Reaches Funding Agreement with NICE and NHS England for Strensiq® (asfotase alfa) for Patients with Pediatric-onset Hypophosphatasia (HPP),2017-07-05 08:00:00 +0000,https://finance.yahoo.com/news/alexion-reaches-funding-agreement-nice-080000804.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that it has reached a national funding agreement with the National Institute for Health and Care Excellence and the National Health Service England based on a Managed Access Agreement , which provides access to Strensiq® for patients in England with pediatric-onset hypophosphatasia , regardless of their current age."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Reaches Funding Agreement With NICE, NHS For Strensiq - Quick Facts",2017-07-05 04:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TwzyxqGhY28/alexion-reaches-funding-agreement-with-nice-nhs-for-strensiq--quick-facts-20170705-00112,"Alexion Reaches Funding Agreement With NICE, NHS For Strensiq - Quick Facts"
ALXN,ALXN:UW,BBG000G32HL2,3 Reasons Why Gilead Sciences Shouldn't Buy Vertex Pharmaceuticals,2017-07-03 15:45:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pXLFFlUxL1E/3-reasons-why-gilead-sciences-shouldnt-buy-vertex-pharmaceuticals-cm811188,The idea of a 160 marriage between Gilead Sciences NASDAQ GILD and Vertex Pharmaceuticals NASDAQ VRTX has been repeatedly floated by analysts for the better part of the last two years After all a deal to buy Vertex would easily fall within Gilead s price range and
ALXN,ALXN:UW,BBG000G32HL2,3 Best-Performing Stocks in June,2017-07-03 14:47:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z3qgs2BQpj0/3-best-performing-stocks-in-june-cm811117,June was a quiet month for the S amp P 500 The famous index ended the month down less than 1 from where it started However not every company from the index had muted returns In fact three stocks Signet Jewelers Limited NYSE SIG Alexion Pharmaceuticals
ALXN,ALXN:UW,BBG000G32HL2,3 Best-Performing Stocks in June,2017-07-03 13:02:00 +0000,http://finance.yahoo.com/r/b00d27f7-a159-3a48-beb5-45c353c8849f/3-best-performing-stocks-in-june.aspx?yptr=yahoo&.tsrc=rss,"Here&apos;s why Signet Jewelers Limited, Alexion Pharmaceuticals, and Acuity Brands all posted gains of 20% or more during the month."
ALXN,ALXN:UW,BBG000G32HL2,Biogen: Insiders Are Buying. Should You Be Too?,2017-06-30 18:30:00 +0000,http://finance.yahoo.com/r/90c2bb1f-4863-3941-8e9f-da5b474eda9e/biogen-insiders-are-buying-should-you-be-too-1498847436?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"As former Fidelity Investments star Peter Lynch once observed, “Insiders might sell their shares for any number of reasons, but they buy them for only one: They think the price will rise.” Keeping that thought in mind, the biotechnology analysts at Cowen -- Phil Nadeau, Eric Schmidt and Joseph Thome -- analyzed the Form 4 SEC filings and open market transactions by insiders for the 10 largest biotechnology companies over the past decade and gauged the stock’s performance over the one-, three-, six- and 12-month period following the transactions.  What did they find?"
ALXN,ALXN:UW,BBG000G32HL2,Analysts Anticipate QQQ Will Reach $151,2017-06-30 14:39:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/noaESHpFRDQ/analysts-anticipate-qqq-will-reach-151-cm810451,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
ALXN,ALXN:UW,BBG000G32HL2,2 Fastest Growing Biotech Stocks,2017-06-28 21:04:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UG9yk_buRn4/2-fastest-growing-biotech-stocks-cm809607,Even though biotech has been sky rocketing over the last five years the industry s eye popping growth spurt isn t showing any signs of slowing down In fact EvaluatePharma estimates that global prescription drug sales will rise at an astounding compound annual growth rate or CAGR
ALXN,ALXN:UW,BBG000G32HL2,2 Fastest Growing Biotech Stocks,2017-06-28 19:44:00 +0000,http://finance.yahoo.com/r/cad7a982-1e33-37a0-9e6a-b887c86853c3/3-fastest-growing-pharma-stocks.aspx?yptr=yahoo&.tsrc=rss,"Celgene and Alexion Pharmaceuticals are biotech&apos;s brightest stars, but can they continue to outshine their peers?"
ALXN,ALXN:UW,BBG000G32HL2,Where to find value in health-care stocks ahead of Senate...,2017-06-28 16:39:00 +0000,https://finance.yahoo.com/video/where-value-health-care-stocks-163900033.html?.tsrc=rss,CNBC's Landon Dowdy reports on the health care sector moves ahead of the Senate health-care bill vote. The “Fast Money Halftime Report” traders weigh in.
ALXN,ALXN:UW,BBG000G32HL2,Here's Why Ra Pharmaceuticals Inc. Tumbled as Much as 32% Today,2017-06-27 21:51:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vEeVX2bLX44/heres-why-ra-pharmaceuticals-inc-tumbled-as-much-as-32-today-cm809083,What happened Shares of Ra Pharmaceuticals NASDAQ RARX a clinical stage drug developer with a keen focus on developing therapies to treat rare diseases tumbled as much as 32 on Tuesday after announcing its initial data for its phase 2 trials involving experimental
ALXN,ALXN:UW,BBG000G32HL2,Here&apos;s Why Ra Pharmaceuticals Inc. Tumbled as Much as 32% Today,2017-06-27 20:24:00 +0000,http://finance.yahoo.com/r/65dc7762-e2bc-35bf-97a3-956e67079bc4/heres-why-ra-pharmaceuticals-inc-tumbled-as-much-a.aspx?yptr=yahoo&.tsrc=rss,Investors find fault in Ra&apos;s phase 2 initial data for its lead drug.
ALXN,ALXN:UW,BBG000G32HL2,SPDR S&P Biotech ETF Experiences Big Inflow,2017-06-27 16:51:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MZr0g5PMcjY/spdr-sp-biotech-etf-experiences-big-inflow-cm808861,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 264 2 million dollar inflow that s a 7 4 increase week over week in outstanding
ALXN,ALXN:UW,BBG000G32HL2,3 Top Stocks on Sale This Summer,2017-06-26 12:51:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HaAmPn9jFkQ/3-top-stocks-on-sale-this-summer-cm807926,Believe it or not the bull market rally recently logged its eighth birthday Since bottoming out in March 2009 the broad market indexes have catapulted to new all time highs Over the trailing one year period the broad based S amp P 500 has galloped higher by more than
ALXN,ALXN:UW,BBG000G32HL2,3 Top Stocks on Sale This Summer,2017-06-26 11:26:00 +0000,http://finance.yahoo.com/r/b9b56f95-089e-31a4-8d6d-2cb5fcd9f9d2/3-top-stocks-on-sale-this-summer.aspx?yptr=yahoo&.tsrc=rss,It could be time for long-term investors to go shopping.
ALXN,ALXN:UW,BBG000G32HL2,"Top Stock Reports for Oracle, Allergan & Abbott",2017-06-23 19:49:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z0besSxmumY/top-stock-reports-for-oracle-allergan-abbott-cm807616,Friday June 23 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 12 major stocks including Oracle ORCL Allergan AGN and Abbott ABT These research reports have been hand picked from
ALXN,ALXN:UW,BBG000G32HL2,Alexion Receives Positive CHMP Opinion for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG) in the European Union,2017-06-23 12:00:00 +0000,https://finance.yahoo.com/news/alexion-receives-positive-chmp-opinion-120000732.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion to extend the current therapeutic indication for Soliris® to include the treatment of refractory generalized myasthenia gravis in patients who are anti-acetylcholine receptor antibody-positive."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma: CHMP Issues Positive Opinion For Soliris - Quick Facts,2017-06-23 08:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wNPF2MQ-Dtg/alexion-pharma-chmp-issues-positive-opinion-for-soliris--quick-facts-20170623-00296,Alexion Pharma: CHMP Issues Positive Opinion For Soliris - Quick Facts
ALXN,ALXN:UW,BBG000G32HL2,Bullish Two Hundred Day Moving Average Cross - ALXN,2017-06-21 22:20:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NPjlMPAczJ4/bullish-two-hundred-day-moving-average-cross-alxn-cm806560,In trading on Wednesday shares of Alexion Pharmaceuticals Inc Symbol ALXN crossed above their 200 day moving average of 123 03 changing hands as high as 123 72 per share Alexion Pharmaceuticals Inc shares are currently trading up about 3 8 on the day The chart below shows the one
ALXN,ALXN:UW,BBG000G32HL2,Biotech Insider Just Loaded Up $234 Million Worth the Stock,2017-06-21 18:18:00 +0000,http://finance.yahoo.com/r/802c9107-6c62-3b57-b542-150ec4c98676/biotech-insider-just-loaded-up-234-million-worth-the-stock.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Massive biotech bet!
ALXN,ALXN:UW,BBG000G32HL2,Here are the biotech stocks the traders are buying,2017-06-21 16:05:00 +0000,https://finance.yahoo.com/video/biotech-stocks-traders-buying-160500556.html?.tsrc=rss,The “Fast Money Halftime Report” traders discuss what stocks they're trading as shares pop in the Nasdaq and S&P Biotech stocks.
ALXN,ALXN:UW,BBG000G32HL2,Amgen: In Defense of A Pipeline,2017-06-21 14:35:00 +0000,http://finance.yahoo.com/r/b0c77884-5a47-3ae4-8b7a-cfad798fb9ad/amgen-in-defense-of-a-pipeline-1498055757?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Critics complain that Amgen’s pipeline is bereft of exciting possibilities.  Meanwhile, Amgen’s genetics-based R&D approach hasn’t delivered any homeruns yet, what with sputtering sales of its cholesterol drug Repatha and safety issues surrounding the experimental osteoporosis drug romosozumab."
ALXN,ALXN:UW,BBG000G32HL2,Today's Research Reports on Stocks to Watch: Regeneron Pharmaceuticals and Alexion Pharmaceuticals,2017-06-21 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000497.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 21, 2017 / Regeneron's shares were down and then way up in yesterday's trading session. Shares dropped after Novartis released clinical trial data on an experimental drug ..."
ALXN,ALXN:UW,BBG000G32HL2,Food & pharma in the trader blitz,2017-06-21 11:57:00 +0000,https://finance.yahoo.com/video/food-pharma-trader-blitz-115700981.html?.tsrc=rss,The &quot;Halftime Report&quot; traders take investors through some of the day's biggest movers.
ALXN,ALXN:UW,BBG000G32HL2,UPDATE: Alexion Pharma: Its CEO Really Likes Its Stock!,2017-06-20 17:03:00 +0000,http://finance.yahoo.com/r/07802cf6-9e03-3cee-9d5d-f1e548191db9/alexion-pharma-ceo-buys-1-1b-in-stock-1497976799?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"For weeks, the news surrounding Alexion Pharmaceuticals (ALXN) has been all about the departures and arrivals in its executive suite.  Today, the shares are up more than 3% on news that CEO Ludwig Hantson has recently purchased more than $1.1 million of the drug maker’s stock.  A Form 4 filing with the SE showed that Hantson bought 10,000 shares of Alexion stock on June 14, a direct stock purchase that lifted his stake in the drug maker to 38,725 shares."
ALXN,ALXN:UW,BBG000G32HL2,Story Stocks from Briefing.com,2017-06-20 14:05:06 +0000,https://finance.yahoo.com/news/story-stocks-briefing-com-175403381.html?.tsrc=rss,Story Stocks from Briefing.com
ALXN,ALXN:UW,BBG000G32HL2,"Morning Movers: Tesla Rises, Chipotle Slumps, Lennar Jumps",2017-06-20 13:09:00 +0000,http://finance.yahoo.com/r/80a03bbc-b951-3994-8dc3-b75f8bd963d9/morning-movers-tesla-rises-chipotle-slumps-lennar-jumps-1497964155?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a slightly lower open this morning after yesterday's big rally. S&P 500 futures have fallen 0.1%, while Dow Jones Industrial Average futures have dipped 2 points. Nasdaq Composite futures ..."
ALXN,ALXN:UW,BBG000G32HL2,"Monday 6/19 Insider Buying Report: ALXN, AKAM",2017-06-19 16:21:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ATqVXUhu7nQ/monday-619-insider-buying-report-alxn-akam-cm805088,As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy they expect to make money So let s look at two noteworthy recent insider buys On Thursday Alexion Pharmaceuticals ALXN s Director made a 77 53M purchase of ALXN
ALXN,ALXN:UW,BBG000G32HL2,"Biogen: ""The Underperformance Stops Here""",2017-06-19 15:11:00 +0000,http://finance.yahoo.com/r/05671a65-d2e2-3e72-886c-753d7d8245b3/biogen-the-underperformance-stops-here-1497885096?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It was more than three months ago when UBS warned investors to exit Biogen (BIIB), initiating coverage on the drug maker at a Sell and predicting the shares would fall to $260 a share.  Analyst Carter Gould’s prediction came to bear.  As of Friday’s close, Biogen’s share price had fallen to just under $252, a more than 14% decline since he set his sell rating on March 8."
ALXN,ALXN:UW,BBG000G32HL2,Weekly Top Insider Buys Highlight for the Week of June 16,2017-06-18 18:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WKQeNwjjMBU/weekly-top-insider-buys-highlight-for-the-week-of-june-16-cm804825,The largest Insider Buys this week were for Alexion Pharmaceuticals Inc ALXN Coty Inc COTY Macy s Inc M and Range Resources Corp RRC The largest Insider Buys this week were for Alexion Pharmaceuticals Inc ALXN Coty Inc COTY Macy s Inc M and
ALXN,ALXN:UW,BBG000G32HL2,"Baker Bros. Advisors Lp Buys Incyte Corp, AveXis Inc, La Jolla Pharmaceutical Co, Sells AbbVie ...",2017-06-17 19:18:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nJ8GTrEIjno/baker-bros-advisors-lp-buys-incyte-corp-avexis-inc-la-jolla-pharmaceutical-co-sells-abbvie-cm804758,Baker Bros Advisors Lp New Purchases ANAB JNCE TNXP BPMX WINT Added Positions INCY AVXS LJPC ASND AQXP HRTX BCRX CBAY DERM SGMO Reduced Positions ARRY EXEL ZGNX VSAR AGLE CRBP JUNO NTRA PRTO Sold Out ABBV DSCI ADHD ENTA
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : June 16, 2017",2017-06-16 20:40:02 +0000,http://finance.yahoo.com/r/dc902b87-994a-3256-a1aa-a6aa5728983e/alexion-pharmaceuticals-inc-value-analysis-nasdaqalxn-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Alexion Pharmaceuticals, Inc. a score of 72. Our analysis is based on comparing Alexion Pharmaceuticals, Inc. with the following peers – Celgene Corporation, Ionis Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., Gilead Sciences, Inc., Vertex Pharmaceuticals Incorporated, Intrexon Corporation, Biogen Inc., QIAGEN NV, Ultragenyx Pharmaceutical, Inc. and Agios Pharmaceuticals, ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Has a Savior Complex,2017-06-15 18:00:18 +0000,http://finance.yahoo.com/r/e60daf67-fe0e-30f7-b8ad-4dfe2fc7fe84/alexion-s-new-cfo-paul-clancy-can-t-fix-all-problems?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Paul Clancy can't do much to end its over-reliance on its biggest drug.
ALXN,ALXN:UW,BBG000G32HL2,"Company News for June 15, 2017",2017-06-15 16:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hJG8KQRRnA4/company-news-for-june-15-2017-cm803866,160 160 160 Shares of H amp R Block Inc HRB surged 8 after reporting fiscal fourth quarter adjusted earnings of 3 76 per share beating the Zacks Consensus Estimate of 3 51 160 160 160 Alexion Pharmaceuticals Inc s ALXN 160 shares soared 9 3 after the
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug",2017-06-15 14:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/48Ck4WkI57Y/biotech-stock-roundup-management-changes-at-biogen-alexion-gild-files-hiv-drug-cm803727,Biogen BIIB and Alexion ALXN were both in the headlines this week with the companies announcing management changes while Biogen s shares were down on the news Alexion s shares soared Meanwhile Gilead GILD continues to work on strengthening its HIV franchise with the company now seeking
ALXN,ALXN:UW,BBG000G32HL2,"Company News for June 15, 2017",2017-06-15 14:07:02 +0000,https://finance.yahoo.com/news/company-news-june-15-2017-140702620.html?.tsrc=rss,"Companies in the News are: HRB,ALXN,UPS,NAME"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : June 15, 2017",2017-06-15 12:13:14 +0000,http://finance.yahoo.com/r/3471a662-4cff-3026-8456-6fbcbfb02659/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-alxn-us-june-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alexion Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,Why Alexion's Gain In the C-Suite Doesn't Bode Well For Biogen Takeout Prospects,2017-06-15 12:02:00 +0000,http://finance.yahoo.com/r/a82be746-82c1-37ba-b128-6f560a31e3ac/cfo-departure-signals-biogen-isn-t-about-to-be-sold.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Paul Clancy's move to another biotech firm could mean that there's nothing imminent in terms of Biogen being bought out, says Mizuho analyst Salim Syed."
ALXN,ALXN:UW,BBG000G32HL2,Today's Research Reports on Stocks to Watch: Epizyme and Alexion Pharmaceuticals,2017-06-15 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000106.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 15, 2017 / Epizyme's shares exploded in Wednesday trading after releasing positive efficacy data results from its phase II clinical trial of Tazemetostat. Alexion Pharmaceuticals ..."
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion’s Housecleaning Should Continue to Pay Off,2017-06-15 04:20:34 +0000,http://finance.yahoo.com/r/a7c8c267-313b-3493-bd54-10073b091f22/alexions-housecleaning-should-continue-to-pay-off-1497456928?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Beleaguered drugmaker Alexion Pharmaceuticals is showing signs of getting its act together.
ALXN,ALXN:UW,BBG000G32HL2,What Happened in the Stock Market Today,2017-06-14 22:07:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZwQwkmTYVt8/what-happened-in-the-stock-market-today-cm803548,Stocks had a mixed day on Wednesday with the Dow Jones Industrial Average DJINDICES DJI rising to a record close and the S amp P 500 SNPINDEX GSPC losing ground Today s stock market Index Percentage Change Point
ALXN,ALXN:UW,BBG000G32HL2,"Gainers & Losers Of June 14: OMER, EPZM, ALXN, SBBP, GBT...",2017-06-14 21:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0TN-bpW7JaQ/gainers--losers-of-june-14-omer-epzm-alxn-sbbp-gbt-20170614-01310,"Gainers & Losers Of June 14: OMER, EPZM, ALXN, SBBP, GBT..."
ALXN,ALXN:UW,BBG000G32HL2,The Hot Stock: Alexion Pharmaceuticals Jumps 9.3%,2017-06-14 21:46:00 +0000,http://finance.yahoo.com/r/7be35edb-7b12-3601-ae16-0804aae7315a/the-hot-stock-alexion-pharmaceuticals-jumps-9-3-1497476801?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals (ALXN) soared to the top of the S&P 500 today after it poached Biogen's (BIIB) CFO. Alexion Pharmaceuticals gained 9.3% to $118.00 today, while the S&P 500 dipped 0.1% to 2,437.92. ..."
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy Wednesday Option Activity: STRP, ALXN, SCCO",2017-06-14 21:08:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kd_11HbniBk/noteworthy-wednesday-option-activity-strp-alxn-scco-cm803539,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Straight Path Communications Inc Symbol STRP where a total of 740 contracts have traded so far representing approximately 74 000 underlying shares That amounts to about 45 7
ALXN,ALXN:UW,BBG000G32HL2,What Happened in the Stock Market Today,2017-06-14 21:02:18 +0000,http://finance.yahoo.com/r/93ac6a41-7f38-3660-8d2e-e6b302537977/what-happened-in-the-stock-market-today-24.aspx?yptr=yahoo&.tsrc=rss,Shares of H&R Block and Alexion Pharmaceuticals climbed on a mixed day for the market.
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 6,194.89 down -25.48 points",2017-06-14 20:48:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KkTBYZ5dMw4/market-close-report-nasdaq-composite-index-closes-at-619489-down-2548-points-cm803544,Wednesday s session closes with the NASDAQ Composite Index at 6 194 89 The total shares traded for the NASDAQ was over 1 95 billion Declining stocks led advancers by 1 39 to 1 ratio There were 1212 advancers and 1689 decliners for the day On the NASDAQ Stock Exchange 43 stocks reached a 52
ALXN,ALXN:UW,BBG000G32HL2,Is Defecting CFO A Glutton For Punishment By Moving To Alexion?,2017-06-14 20:16:17 +0000,http://finance.yahoo.com/r/9922fe85-159f-343e-8398-6dc740bdcab0/alexion-gets-a-new-finance-chief-from-rival-biogen-shares-rise?src=A00220&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals&apos; newest executive must have an appetite for punishment, by defecting from Biogen, an analyst suggested Wednesday"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Stock Soars After It Poaches Biogen CFO,2017-06-14 20:16:00 +0000,http://finance.yahoo.com/r/8a41a6a3-168f-323b-a460-88c40e4bff8d/alexion-soars-after-biogen-cfo-joins-company-alxn-biib?partner=YahooSA&yptr=yahoo&.tsrc=rss,Alexion shares climbed more than 9% amid news that it had poached Biogen CFO Paul Clancy.
ALXN,ALXN:UW,BBG000G32HL2,"Wednesday Sector Leaders: Healthcare, Utilities",2017-06-14 20:07:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G0k8Zl_cF6s/wednesday-sector-leaders-healthcare-utilities-cm803481,In afternoon trading on Wednesday Healthcare stocks are the best performing sector up 0 8 Within that group Alexion Pharmaceuticals Inc Symbol ALXN and Vertex Pharmaceuticals Inc Symbol VRTX are two of the day s stand outs showing a gain of 8 7 and 2 5 respectively
ALXN,ALXN:UW,BBG000G32HL2,"Advanced Micro Devices, Inc. (AMD) Stock Doesn’t Stack Up",2017-06-14 18:07:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jhuKhlMlwZM/advanced-micro-devices-inc-amd-stock-doesnt-stack-up-cm803467,InvestorPlace Stock Market News Stock Advice amp Trading Tips In February I advised against buying Advanced Micro Devices Inc NASDAQ AMD I noted that AMD stock seemed overvalued and too hot and instead recommended Intel Corporation NASDAQ INTC
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion Even Stronger After Adding Biogen CFO,2017-06-14 18:02:00 +0000,http://finance.yahoo.com/r/09bbad32-62fa-3044-b8e9-17d3b55e03e3/alexion-even-stronger-after-adding-biogen-cfo-1497463351?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When news broke late Tuesday that Biogen’s much respected chief financial officer Paul Clancy was leaving the company, investors quickly sold the biotech giant’s stock.  Clancy’s departure, though a loss for Biogen (ticker:ticker:NasdaqGS:BIIB), is a big gain for Alexion Pharmaceuticals (ALXN).  The same veteran executive who helped lead Biogen through a turnaround will assume the CFO post at Alexion on July 31, replacing Dave Anderson, who plans to leave come August."
ALXN,ALXN:UW,BBG000G32HL2,Alexion's New CFO Continues To Shore Up Investor Concerns,2017-06-14 17:37:04 +0000,https://finance.yahoo.com/news/alexions-cfo-continues-shore-investor-173704735.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) announced Tuesday that Paul Clancy has been appointed to replace Dave Anderson as CFO, effective July 31. Anderson will remain as a senior advisor through ..."
ALXN,ALXN:UW,BBG000G32HL2,One of Stephanie Link's picks jumps 10 percent,2017-06-14 17:31:00 +0000,https://finance.yahoo.com/video/one-stephanie-links-picks-jumps-173100515.html?.tsrc=rss,Big moves in today's Halftime blitz - Alexion jumps big.
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pops, Biogen Falls on Executive Shuffle; Epizyme Recovers As Investors Digest Phase 2 Data",2017-06-14 16:22:00 +0000,http://finance.yahoo.com/r/ba2a0bf1-25c9-35ee-b612-3ed19c375493/biotech-movers-epizyme-alexion-xbiotech.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Epizyme, Alexion Pharmaceuticals and XBiotech were among the biotech stock movers premarket trading on June 14."
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion's Housecleaning Should Continue to Pay Off,2017-06-14 16:15:31 +0000,http://finance.yahoo.com/r/a7c8c267-313b-3493-bd54-10073b091f22/alexions-housecleaning-should-continue-to-pay-off-1497456928?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Beleaguered drugmaker Alexion Pharmaceuticals is showing signs of getting its act together.
ALXN,ALXN:UW,BBG000G32HL2,Omeros (OMER) Lead Candidate Gets Breakthrough Designation,2017-06-14 16:09:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/njW-XW47lg4/omeros-omer-lead-candidate-gets-breakthrough-designation-cm803314,Omeros Corporation OMER announced that the FDA granted breakthrough therapy designation to pipeline candidate OMS721 The candidate will be used to treat Immunoglobulin A IgA nephropathy OMS721 is Omeros lead human monoclonal antibody targeting mannan binding lectin associated
ALXN,ALXN:UW,BBG000G32HL2,"Biogen Loses Top Executive Again, CFO Clancy to Join Alexion",2017-06-14 16:08:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HXG_C03QQGI/biogen-loses-top-executive-again-cfo-clancy-to-join-alexion-cm803299,Biogen Inc s BIIB chief financial officer CFO for the last 10 years Paul Clancy is joining Alexion Pharmaceuticals Inc ALXN next month Shares of Alexion were up 3 7 in after hours trading on Tuesday while Biogen s shares declined 1 3 This year Biogen s shares have declined 9 9
ALXN,ALXN:UW,BBG000G32HL2,"S&P 500 Movers: RIG, HRB",2017-06-14 16:08:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1aiwswt6E1A/sp-500-movers-rig-hrb-cm803324,In early trading on Wednesday shares of H amp R Block topped the list of the day s best performing components of the S amp P 500 index trading up 10 2 Year to date H amp R Block registers a 29 3 gain And the worst performing S amp P 500 component thus far on the day is
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: BIIB, ALXN",2017-06-14 16:08:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6bndhbihqqU/nasdaq-100-movers-biib-alxn-cm803320,In early trading on Wednesday shares of Alexion Pharmaceuticals topped the list of the day s best performing components of the Nasdaq 100 index trading up 7 2 Year to date Alexion Pharmaceuticals has lost about 5 4 of its value And the worst performing Nasdaq 100 component thus far
ALXN,ALXN:UW,BBG000G32HL2,"3 Stocks to Watch on Wednesday: Ford Motor Company (F), Alexion Pharmaceuticals, Inc. (ALXN) and H & R Block Inc (HRB)",2017-06-14 16:06:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tY-3JMZtj7I/3-stocks-to-watch-on-wednesday-ford-motor-company-f-alexion-pharmaceuticals-inc-alxn-and-h-r-block-inc-hrb-cm803370,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S markets bounced back on Tuesday thanks to tech stocks recovery from 160 a dismal Monday Friday slide The 160 S amp P 500 Index 160 was 0 5 better the 160 Dow Jones Industrial Average
ALXN,ALXN:UW,BBG000G32HL2,"Biogen Loses Top Executive Again, CFO Clancy to Join Alexion",2017-06-14 14:31:02 +0000,https://finance.yahoo.com/news/biogen-loses-top-executive-again-143102983.html?.tsrc=rss,"Biogen Inc.&apos;s (BIIB) chief financial officer (CFO) for the last 10 years, Paul Clancy, is joining Alexion Pharmaceuticals, Inc. (ALXN) next month."
ALXN,ALXN:UW,BBG000G32HL2,"Stocks Flatten Ahead Of Fed, But Dow Etches New High",2017-06-14 13:47:11 +0000,http://finance.yahoo.com/r/caf64c84-327d-31f0-818c-c9aab6fb67ee/stock-futures-up-ahead-of-fed-but-will-this-ibd-50-stock-trip-a-sell-signal?src=A00220&yptr=yahoo&.tsrc=rss,Stocks saw narrow opening gains quickly fade to flat trade Wednesday as investors waited on an afternoon rate announcement from the Federal Reserve.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Adds New CFO From Biogen,2017-06-14 13:15:28 +0000,https://finance.yahoo.com/news/alexion-pharmaceuticals-adds-cfo-biogen-131528115.html?.tsrc=rss,Shares of Alexion Pharmaceuticals saw a handy gain early on Wednesday after the company announced that there would be changes in its leadership.
ALXN,ALXN:UW,BBG000G32HL2,Morning Movers: Alexion Climbs on Biogen Hire; H&R Block Jumps,2017-06-14 12:31:00 +0000,http://finance.yahoo.com/r/c774a429-b20d-3a9d-81a2-d772720f16d8/morning-movers-alexion-climbs-on-biogen-hire-h-r-block-jumps-1497443482?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open this morning ahead of the Fed's announcement on interest rates this afternoon. S&P 500 futures have advanced 0.1%, while Dow Jones Industrial Average futures have risen ..."
ALXN,ALXN:UW,BBG000G32HL2,"3 Stocks to Watch on Wednesday: Ford Motor Company (F), Alexion Pharmaceuticals, Inc. (ALXN) and H & R Block Inc (HRB)",2017-06-14 12:03:54 +0000,https://finance.yahoo.com/news/3-stocks-watch-wednesday-ford-120354186.html?.tsrc=rss,"Ford Motor Company (NYSE:F), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and H & R Block Inc (NYSE:HRB) are all in the spotlight Wednesday morning.  F shares are trying to keep up a slow recovery amid news that Ford has made some inroads on the electric vehicle front — in Germany.  Germany’s Deutsche Post DHL Group — better known under its simpler delivery brand, DHL — has signed Ford up as a components supplier as it builds out its line of StreetScooter electric delivery vans."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma. To Present At William Blair Conference; Webcast At 12:20 PM ET,2017-06-14 11:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rEq_C5Be61w/alexion-pharma-to-present-at-william-blair-conference-webcast-at-1220-pm-et-20170614-00794,Alexion Pharma. To Present At William Blair Conference; Webcast At 12:20 PM ET
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. (ALXN) Is Up Sharply After New CFO Named,2017-06-14 09:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nb8EQphfCyI/alexion-pharmaceuticals-inc-alxn-is-up-sharply-after-new-cfo-named-20170614-00650,Alexion Pharmaceuticals Inc. (ALXN) Is Up Sharply After New CFO Named
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma Appoints Biogen Executive Paul Clancy As CFO,2017-06-13 23:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4NySnA0IseE/alexion-pharma-appoints-biogen-executive-paul-clancy-as-cfo-20170613-01392,Alexion Pharma Appoints Biogen Executive Paul Clancy As CFO
ALXN,ALXN:UW,BBG000G32HL2,Biogen CFO Bolts to Alexion,2017-06-13 22:05:00 +0000,http://finance.yahoo.com/r/a3a5cef0-c131-3613-b49d-0afea82fe621/biogen-cfo-bolts-to-alexion.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Chief accounting officer Greg Covino will serve as Biogen's interim principal financial officer while the firm searches for a new finance chief.
ALXN,ALXN:UW,BBG000G32HL2,Alexion names Biogen's Paul Clancy as CFO,2017-06-13 21:46:55 +0000,https://finance.yahoo.com/news/alexion-names-biogens-paul-clancy-204706819.html?.tsrc=rss,"Alexion Pharmaceuticals Inc on Tuesday named Biogen Inc's Chief Financial Officer Paul Clancy as its finance head, effective July 31. Clancy will succeed Dave Anderson, who will remain with Alexion until ..."
ALXN,ALXN:UW,BBG000G32HL2,Biogen exodus continues as CFO set to join Alexion,2017-06-13 21:05:09 +0000,http://finance.yahoo.com/r/5ca5a7ba-ff68-3722-871c-1d7e1ad762df/biogen-exodus-continues-as-cfo-set-to-join-alexion.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Biogen, one of the state's largest drugmakers, has seen its leadership ranks dwindle in recent years, fueling speculation about a potential takeover.  Biogen (BIIB) said in a release Tuesday afternoon that chief financial officer Paul Clancy will leave ""to join another biopharmaceutical company."" Moments later, New Haven, Connecticut-based Alexion Pharmaceuticals (ALXN) announced that Clancy had accepted a job as its CFO.  Earlier this year, Adriana Karaboutis left her post as executive vice president of technology, business solutions and corporate affairs."
ALXN,ALXN:UW,BBG000G32HL2,Alexion hires Biogen executive to serve as its CFO,2017-06-13 20:45:33 +0000,http://finance.yahoo.com/r/46eee632-df8c-30b5-9181-4cf94c345dbd/Story.aspx?guid=5A8B9180-2A94-4E6E-AC06-CF221B400CA3&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Shares of Alexion Pharmaceuticals Inc. rose more than 2% late Tuesday after the company announced the hiring of the former Biogen Inc. chief financial officer as its CFO. Paul J. Clancy will join Alexion ...
ALXN,ALXN:UW,BBG000G32HL2,Alexion Names Paul Clancy Chief Financial Officer,2017-06-13 20:30:00 +0000,https://finance.yahoo.com/news/alexion-names-paul-clancy-chief-203000284.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that Paul J. Clancy, a seasoned financial executive with 30 years of experience, will join the company on July 10, 2017 and will assume the role of Chief Financial Officer effective July 31, 2017."
ALXN,ALXN:UW,BBG000G32HL2,9 Biotech Stats That Will Blow You Away,2017-06-12 14:31:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-8a3oNDm2oY/9-biotech-stats-that-will-blow-you-away-cm801994,In many ways the biotech industry could be described as Wall Street s roulette wheel The odds are certainly against your succeeding with many drug developers losing money and looking to simply get their first drug approved However for those that do succeed the returns can be
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy ETF Outflows: PBE, QGEN, IONS, ALXN",2017-06-09 16:27:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FY_BpqekmeM/noteworthy-etf-outflows-pbe-qgen-ions-alxn-cm801241,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the PowerShares Dynamic Biotechnology amp Genome Portfolio Symbol PBE where we have detected an approximate 69 7 million dollar outflow that s a 23 4
ALXN,ALXN:UW,BBG000G32HL2,5 Top Stocks for June,2017-06-07 14:19:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e8L41bJaOsI/5-top-stocks-for-june-cm799910,Sell in May and go away is an adage 160 that we Fools refuse to follow If you feel the same way then you re probably on the hunt for a 160 few great stocks to buy Here s why you should consider FactSet Research Systems NYSE FDS Chipotle Mexican Grill NYSE
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion: A High Risk but Very High Reward Stock,2017-06-07 09:52:00 +0000,http://finance.yahoo.com/r/ea73ff38-bfe6-393b-8479-08d6488f741c/alexion-a-high-risk-but-very-high-reward-stock-1496829138?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It’s been a tough year for Alexion Pharmaceuticals.  After enduring two major management shake-ups in the past seven months, and a flurry of other negative headlines, among them an internal investigation into the sales practices used to sell its lead drug, Soliris, Alexion (ALXN) is in “show-me” mode.  The new CEO, Ludwig Hantson, hired in March, must show he can clean up the mess left by the former regime to help allay investor concerns."
ALXN,ALXN:UW,BBG000G32HL2,3 Stocks With Vertex Pharmaceuticals-Like Return Potential,2017-06-03 14:31:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ebVQOhrzjrA/3-stocks-with-vertex-pharmaceuticals-like-return-potential-cm798352,Over the past decade Vertex 160 Pharmaceuticals NASDAQ VRTX stock has tripled in value thanks in large part to the success of its core cystic fibrosis drug franchise With this biotech s shares now trading at a sky high forward price to earnings ratio of 41 however it
ALXN,ALXN:UW,BBG000G32HL2,3 Stocks With Vertex Pharmaceuticals-Like Return Potential,2017-06-03 13:01:00 +0000,http://finance.yahoo.com/r/de0cd226-5b5b-3e13-8404-d73d2c84d410/3-stocks-with-vertex-pharmaceuticals-like-return-p.aspx?yptr=yahoo&.tsrc=rss,These three biotechs may be ready for a Vertex-like run higher.
ALXN,ALXN:UW,BBG000G32HL2,Alexion stock rises 1.4% after naming new executives,2017-06-02 14:33:05 +0000,http://finance.yahoo.com/r/0c039f81-1f3b-39cf-a47a-254ce6362229/Story.aspx?guid=626FCE30-B40B-450B-8C43-4FAE540EE698&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals Inc. shares rose 1.4% to $101.57 in morning trade Friday, after the company announced several new executives will start June 5. The news follows a massive managerial shake-up at ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Announces Additions to Executive Leadership Team,2017-06-01 20:10:00 +0000,https://finance.yahoo.com/news/alexion-announces-additions-executive-leadership-201000818.html?.tsrc=rss,"Alexion Pharmaceuticals Inc. today announced key additions to its executive leadership team effective June 5, 2017. Reporting to Chief Executive Officer, Ludwig Hantson will be: John Orloff, M.D., Executive Vice President, Head of Research & Development, Anne-Marie Law, Executive Vice President, Chief Human Resources Officer, and Indrani Lall Franchini, J.D., Executive Vice President, Chief Compliance ..."
ALXN,ALXN:UW,BBG000G32HL2,Small-Cap Action Is Improving,2017-06-01 15:12:00 +0000,http://finance.yahoo.com/r/e603f1c8-400d-3e10-a0ea-4487eea2d8d8/small-cap-action-improving?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,But I don't have a lot of confidence in this market beyond the intraday action.
ALXN,ALXN:UW,BBG000G32HL2,Why Is Alexion (ALXN) Down 23% Since the Last Earnings Report?,2017-06-01 12:33:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XkNtt2K7Iyc/why-is-alexion-alxn-down-23-since-the-last-earnings-report-cm797240,It has been about a month since the last earnings report for Alexion Pharmaceuticals Inc ALXN Shares have lost about 23 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a
ALXN,ALXN:UW,BBG000G32HL2,Analysts’ Views on Alexion Pharmaceuticals and Its Peers,2017-06-01 11:37:57 +0000,http://finance.yahoo.com/r/e1db19d2-3c1c-38ec-bbff-b2549505a088/analysts-views-alexion-pharmaceuticals-peers?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 21 analysts analyzing Alexion Pharmaceuticals, six analysts recommended a “strong buy” and 11 analysts recommended a “buy.”"
ALXN,ALXN:UW,BBG000G32HL2,"Healthcare Companies’ Analyst Ratings: May 22–26, 2017",2017-06-01 11:37:45 +0000,http://finance.yahoo.com/r/eda3f014-a922-32ec-b698-a2562fe1f97b/healthcare-companies-analyst-ratings-changes-22-26-may-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals' (ALXN) mean target price of $159.50 per share implies a 63.3% gain from its current level.
ALXN,ALXN:UW,BBG000G32HL2,Why Is Alexion (ALXN) Down 23% Since the Last Earnings Report?,2017-06-01 10:37:10 +0000,https://finance.yahoo.com/news/why-alexion-alxn-down-23-103710537.html?.tsrc=rss,Alexion (ALXN) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
ALXN,ALXN:UW,BBG000G32HL2,Strensiq: Key Growth Driver for Alexion Pharmaceuticals in 2017,2017-05-31 21:05:43 +0000,http://finance.yahoo.com/r/40093d4c-3f56-3009-825c-eb25018f04e5/strensiq-may-become-key-growth-driver-alexion-pharmaceuticals-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Alexion Pharmaceuticals’ (ALXN) Strensiq generated revenue of ~$74 million, which reflects ~4% quarter-over-quarter and ~124% YoY growth."
ALXN,ALXN:UW,BBG000G32HL2,Soliris Is Expected to Continue Generating High Revenue,2017-05-31 19:35:48 +0000,http://finance.yahoo.com/r/ab788cb5-ee61-34ab-bf1e-c8fae872c92c/soliris-expected-continue-generating-high-revenue?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Alexion Pharmaceuticals’ (ALXN) Soliris generated revenue of ~$783 million, which is ~18% YoY (year-over-year) growth."
ALXN,ALXN:UW,BBG000G32HL2,What to Expect from Alexion Pharmaceuticals in 2017,2017-05-31 17:38:35 +0000,http://finance.yahoo.com/r/218e06d1-8cb8-3658-9d3d-3edafa970c0e/expect-alexion-pharmaceuticals-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Alexion Pharmaceuticals reported net product sales of ~$869 million, which is ~24% YoY growth. In 1Q17, it reported non-GAAP EPS of $1.38."
ALXN,ALXN:UW,BBG000G32HL2,"Top Losers in the Healthcare Sector: May 22–26, 2017",2017-05-31 16:01:33 +0000,http://finance.yahoo.com/r/547c1ea6-b28f-3436-b92c-632256284434/top-losers-in-the-healthcare-sector-may-22-26-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"During the week ended May 26, 2017, Alexion Pharmaceuticals (ALXN) saw the biggest loss in the healthcare sector. ALXN's stock price witnessed a steep fall of ~14.2%."
ALXN,ALXN:UW,BBG000G32HL2,Biotech Stocks Feel the Pain: Time to Buy?,2017-05-31 13:54:00 +0000,http://finance.yahoo.com/r/d9995da1-ed8e-3abb-b571-bffa9e552d8a/biotech-stocks-feel-the-pain-time-to-buy-1496238865?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Biotechnology stocks suffered as investors struggled to make sense of changes hitting the health care industry.  Alexion Pharmaceuticals (ALXN) is going through a major management shake-up.  California is making noise with a universal single-payer system proposal.
ALXN,ALXN:UW,BBG000G32HL2,"Analyst: With This Much Pessimism Priced In, Alexion Begins To Look Attractive",2017-05-30 18:51:59 +0000,https://finance.yahoo.com/news/analyst-much-pessimism-priced-alexion-185159251.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) shares are down 23.5 percent in the past month as investors have grown concerned about the growth outlook for Solaris and the implications of the company's ..."
ALXN,ALXN:UW,BBG000G32HL2,"Lifshitz & Miller LLP Announces Investigation of Akari Therapeutics, Plc, Alexion Pharmaceuticals, Inc., Amgen Inc., Cel-Sci Corp., Dick's Sporting Goods, Inc., Eco Science Solutions, Inc., Intra-Cellular Therapies, Inc. and Twilio Inc.",2017-05-30 17:43:00 +0000,https://finance.yahoo.com/news/lifshitz-miller-llp-announces-investigation-174300638.html?.tsrc=rss,"NEW YORK, May 30, 2017 /PRNewswire/ -- Akari Therapeutics, Plc (AKTX) Lifshitz & Miller announces investigation on behalf of AKTX investors concerning whether AKTX issued false information about AKTX's ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma: Negative Market Sentiment Creates Buying Opportunity,2017-05-30 14:44:00 +0000,http://finance.yahoo.com/r/ea421391-8d2f-3a27-ac4b-c1060a3fe9bd/alexion-pharma-negative-market-sentiment-creates-buying-opportunity.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,I think the market is obsessing over the Alexion negatives and not looking at the real potential for positive catalysts ahead.
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at Upcoming Investor Conferences,2017-05-30 14:00:00 +0000,https://finance.yahoo.com/news/alexion-present-upcoming-investor-conferences-140000393.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that management will present at two upcoming investor conferences:"
ALXN,ALXN:UW,BBG000G32HL2,How The Pieces Add Up: EQAL Targets $31,2017-05-30 13:32:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6jMaJpIvGBI/how-the-pieces-add-up-eqal-targets-31-cm796001,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
ALXN,ALXN:UW,BBG000G32HL2,"The Good, the Bad and the Ugly; Explaining the Inexplicable: Doug Kass' Views",2017-05-29 05:00:00 +0000,http://finance.yahoo.com/r/03020eda-a09f-3ebd-91f9-6b7fdc15b511/the-good-the-bad-and-the-ugly-explaining-the-inexplicable-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Doug Kass shares his thoughts on trying to explain that which cannot be explained, and also discusses what was good (and bad and ugly) this week."
ALXN,ALXN:UW,BBG000G32HL2,"After Hours Most Active for May 25, 2017 :  HPE, KO, OZRK, JNPR, MSFT, XOM, DFS, ALXN, BMY, CTSH, JD, CMCSA",2017-05-25 21:00:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5s4Yx8Fxtu4/after-hours-most-active-for-may-25-2017-hpe-ko-ozrk-jnpr-msft-xom-dfs-alxn-bmy-ctsh-jd-cmcsa-cm794882,The NASDAQ 100 After Hours Indicator is up 2 57 to 5 780 94 The total After hours volume is currently 39 306 456 shares traded The following are the most active stocks for the after hours session Hewlett Packard Enterprise Company HPE is 0 0112 at 18 85 with 5 301
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,205.26.",2017-05-25 20:48:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ajoAkAY8DXs/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-620526-cm794881,Thursday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 6 205 26 up 42 24 for the day The index had a previous high 6169 87009 on 05 16 2017 The total shares traded for the NASDAQ was over 1 98 billion Thursday s session closes with the
ALXN,ALXN:UW,BBG000G32HL2,2 Key Reasons Morgan Stanley Upgraded Alexion Pharmaceuticals,2017-05-25 14:38:47 +0000,https://finance.yahoo.com/news/2-key-reasons-morgan-stanley-143847049.html?.tsrc=rss,"Analysts at Morgan Stanley upgraded Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Thursday despite the stock's 17-percent loss year to date and two management shake-ups in the past six months alone. Morgan ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals: Time to Buy?,2017-05-25 13:52:00 +0000,http://finance.yahoo.com/r/a69b8161-4451-3982-891b-c404e7b6f1b8/alexion-pharmaceuticals-time-to-buy-1495720362?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Alexion Pharmaceuticals (ALXN) have been hammered the past two days after its new CEO cleaned house. But has it fallen too far? Investors, it seems, worry that the decision to replace much of ..."
ALXN,ALXN:UW,BBG000G32HL2,The Market In 5 Minutes,2017-05-25 13:00:20 +0000,https://finance.yahoo.com/news/market-5-minutes-130020410.html?.tsrc=rss,IN THE NEWS BENZINGA Bank investors hoping financial deregulation will open the door for a new golden era of banking in the near future will likely have to be patient and keep expectations in check: Link ...
ALXN,ALXN:UW,BBG000G32HL2,"Analysts' Actions -- Kellogg, Kraft Heinz, Altria, PayPal and More",2017-05-25 11:36:00 +0000,https://finance.yahoo.com/news/analysts-actions-kellogg-kraft-heinz-113600018.html?.tsrc=rss,"Here are Thursday's top research calls, including new coverage for Kellogg, Kraft Heinz and Altria, and a downgrade for PayPal."
ALXN,ALXN:UW,BBG000G32HL2,"Company News for May 24, 2017",2017-05-24 16:36:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nDttGzrTMKo/company-news-for-may-24-2017-cm793992,160 160 160 Shares of Agilent Technologies Inc A advanced 4 6 after the company reported fiscal second quarter earnings of 0 58 per share beating the Zacks Consensus Estimate by 0 10 160 160 160 Nokia Corporation s NOK shares gained 5 3 following the news that Apple
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ALXN, INTU",2017-05-24 16:34:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_pBWHpvKrMk/nasdaq-100-movers-alxn-intu-cm793968,In early trading on Wednesday shares of Intuit INTU topped the list of the day s best performing components of the Nasdaq 100 index trading up 7 8 Year to date Intuit registers a 21 4 gain And the worst performing Nasdaq 100 component thus far on the day is Alexion
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals: Waiting For the Next Shoe?,2017-05-24 14:55:00 +0000,http://finance.yahoo.com/r/939169aa-faf1-3eea-ae7e-361ec6fe4057/alexion-pharmaceuticals-waiting-for-the-next-shoe-1495637704?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals (ALXN) was the second-worst performing stock in the S&P 500 after the biotech company made massive changes to its executive suite, changes which caused its shares to tumble 9.3%.  The pressure hasn't let up today either, as Alexion's stock has dropped another 3% this morning.  Why is Alexion getting still getting beaten up?"
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data",2017-05-24 14:19:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H8cVVhDN_4U/biotech-stock-roundup-fda-nod-for-regeneron-ra-drug-amgen-hit-by-study-data-cm793761,Major news in the biotech sector include FDA approval for Regeneron s REGN rheumatoid arthritis RA treatment Kevzara as well as data from companies like Amgen AMGN and Celgene CELG 160 Recap of the Week s Most Important Stories Regeneron Sanofi RA Drug Gets FDA Nod
ALXN,ALXN:UW,BBG000G32HL2,Back to 2400 Already?,2017-05-24 14:17:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/59_Y_6cHUjY/back-to-2400-already-cm793659,Artificial Intelligence is the hottest topic in the entire technology sector In fact the latest data from the IDC projects that worldwide adoption of artificial intelligence will drive global revenues to a shocking 47 billion in 2020 So it s no wonder investors are asking how they can cash
ALXN,ALXN:UW,BBG000G32HL2,"Company News for May 24, 2017",2017-05-24 14:10:02 +0000,https://finance.yahoo.com/news/company-news-may-24-2017-141002763.html?.tsrc=rss,"Companies in the News are: A,NOK,AAPL,ALXN,BG,GLEN"
ALXN,ALXN:UW,BBG000G32HL2,"Trader's Daily Notebook: As Long Weekend Nears, Volume Will Stay Low",2017-05-24 11:00:00 +0000,http://finance.yahoo.com/r/24446fd4-b4b6-3968-b0b9-66a11bf81baf/traders-daily-notebook-long-weekend-nears-volume-will-stay-low?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"If you want to stay active, you'll have to do more homework."
ALXN,ALXN:UW,BBG000G32HL2,When the Patient Is a Gold Mine: The Trouble With Rare-Disease Drugs,2017-05-24 08:00:15 +0000,https://finance.yahoo.com/news/patient-gold-mine-trouble-rare-080015824.html?.tsrc=rss,"With a flagship treatment that helps fewer than 11,000 people, how is Alexion making so much money?"
ALXN,ALXN:UW,BBG000G32HL2,"Why Herbalife, Alexion Pharmaceuticals, and Brown-Forman Slumped Today",2017-05-23 22:13:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uVl8ilkdwpA/why-herbalife-alexion-pharmaceuticals-and-brown-forman-slumped-today-cm793582,Tuesday was another solid day for stocks and a rising Dow S amp P 500 and Nasdaq Composite all helped sustain positive sentiment toward the prospects for the economy especially in the U S market Gains for the major benchmarks weren t all that substantial but they
ALXN,ALXN:UW,BBG000G32HL2,Alexion Shares Drop Amid Executive Changes,2017-05-23 21:50:00 +0000,http://finance.yahoo.com/r/69472d64-6565-37cd-9bcf-c0ed7380eec8/alexion-shares-drop-amid-executive-changes.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The biopharmaceutical firm on Tuesday announced changes, including the planned departure of its chief financial officer."
ALXN,ALXN:UW,BBG000G32HL2,"Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE...",2017-05-23 21:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t5IyzUfbJZ8/gainers--losers-of-may-23-glyc-pbyi-sgmo-cers-agle-20170523-01429,"Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE..."
ALXN,ALXN:UW,BBG000G32HL2,Biotech And Pharma Industry And Stock News,2017-05-23 21:11:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
ALXN,ALXN:UW,BBG000G32HL2,"Why Herbalife, Alexion Pharmaceuticals, and Brown-Forman Slumped Today",2017-05-23 21:00:58 +0000,http://finance.yahoo.com/r/f4df3642-6077-35ff-9453-945c98fd6273/why-herbalife-alexion-pharmaceuticals-and-brown-fo.aspx?yptr=yahoo&.tsrc=rss,"Despite a higher market, these stocks fell. Find out why."
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 6,138.71 up 5.09 points",2017-05-23 20:48:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/45nBgg_am4U/market-close-report-nasdaq-composite-index-closes-at-613871-up-509-points-cm793575,Tuesday s session closes with the NASDAQ Composite Index at 6 138 71 The total shares traded for the NASDAQ was over 1 73 billion Tuesday s session closes with the NASDAQ Composite Index at 6 138 71 The total shares traded for the NASDAQ was over 1 73 billion Advancers stocks led declining
ALXN,ALXN:UW,BBG000G32HL2,Alexion At Nearly 4-Year Low After Announcing Exits Of 4 Execs,2017-05-23 20:24:01 +0000,http://finance.yahoo.com/r/4b11ebb1-f464-39fe-bbf5-da6280c81364/alexion-plummets-to-4-year-low-after-4-execs-announce-their-exits?src=A00220&yptr=yahoo&.tsrc=rss,Alexion stock plummeted to a four-year low Tuesday after announcing the departure of four executives.
ALXN,ALXN:UW,BBG000G32HL2,Mid-Afternoon Market Update: America's Car-Mart Rises On Earnings Beat; Alexion Shares Drop,2017-05-23 20:12:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3wA1KYIKdmo/mid-afternoon-market-update-americas-car-mart-rises-on-earnings-beat-alexion-shares-drop-cm793543,Toward the end of trading Tuesday the Dow traded up 0 22 percent to 20 941 76 while the NASDAQ declined 0 02 percent to 6 132 66 The S amp P also rose gaining 0 19 percent to 2 398 65 Leading and Lagging Sectors Utilities sector was the top gainer in the US market on Tuesday
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)",2017-05-23 19:05:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-190500297.html?.tsrc=rss,"NEW YORK, May 23, 2017 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") (NASDAQ: ALXN).  Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/alxn.  The investigation concerns whether Alexion and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934."
ALXN,ALXN:UW,BBG000G32HL2,"Health Care Sector Update for 05/23/2017: ALXN, ETRM, CERS, JNJ, NVS",2017-05-23 18:52:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lSTULCjqg3w/health-care-sector-update-for-05232017-alxn-etrm-cers-jnj-nvs-cm793514,Top Health Care StocksTop Health Care Stocks JNJ 0 20 JNJ 0 20 PFE 0 03 PFE 0 03 ABT 0 30 ABT 0 30 MRK 0 59 MRK 0 59 AMGN 0 83 AMGN 0 83 Health care stocks were putting up small gains during Tuesday trading with the NYSE Health Care Index advancing about 0 2 while shares of
ALXN,ALXN:UW,BBG000G32HL2,House Cleaning To Re-Shape Alexion?,2017-05-23 18:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BPeOceNMufc/house-cleaning-to-reshape-alexion-20170523-01352,House Cleaning To Re-Shape Alexion?
ALXN,ALXN:UW,BBG000G32HL2,Here's Why Alexion Pharma (ALXN) Stock is Sinking Today,2017-05-23 18:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FucJeURjKUg/heres-why-alexion-pharma-alxn-stock-is-sinking-today-cm793431,On Tuesday shares of Alexion Pharmaceuticals Inc ALXN are sinking down over about 8 5 in mid morning trading after the company announced a series of changes to its management team Alexion s Chief Commercial Officer Carsten Thiel will resign effective June 1 and Brian Goff has been hired
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion's Shakeup Continues as Four Executives Exit,2017-05-23 17:43:12 +0000,http://finance.yahoo.com/r/74e3eef9-7d52-31b1-a7a1-aed0d52bfa14/alexion-management-shakeup-continues-as-four-more-executives-exit-1495546681?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals Inc.’s new chief executive is reshaping the top ranks of the organization following an internal investigation into sales practices.
ALXN,ALXN:UW,BBG000G32HL2,Mid-Day Market Update: Kirkland's Drops After Weak Q1 Results; Helios and Matheson Analytics Shares Surge,2017-05-23 17:41:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CBZRe3CamGI/mid-day-market-update-kirklands-drops-after-weak-q1-results-helios-and-matheson-analytics-shares-surge-cm793485,Midway through trading Tuesday the Dow traded up 0 21 percent to 20 937 96 while the NASDAQ climbed 0 16 percent to 6 143 19 The S amp P also rose gaining 0 23 percent to 2 399 57 Leading and Lagging Sectors Utilities sector was the top gainer in the US market on Tuesday
ALXN,ALXN:UW,BBG000G32HL2,What To Make Of the Alexion Shake-up,2017-05-23 17:17:00 +0000,http://finance.yahoo.com/r/97db2e89-c707-3ef4-a3e1-4e9b9ea2b7b9/what-make-alexion-shakeup-alxn-ibb?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Alexion’s management shake-up continues as four executives, including its CFO, exit the company."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals is Now Oversold (ALXN),2017-05-23 17:14:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kTsru7PZzyY/alexion-pharmaceuticals-is-now-oversold-alxn-cm793388,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy Tuesday Option Activity: ALXN, GOOGL, MGRC",2017-05-23 17:13:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1gbKFTjlvds/noteworthy-tuesday-option-activity-alxn-googl-mgrc-cm793395,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Alexion Pharmaceuticals Inc Symbol ALXN where a total of 25 128 contracts have traded so far representing approximately 2 5 million underlying shares That amounts to about 115 5
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alexion Pharmaceuticals, Inc. - ALXN",2017-05-23 17:11:00 +0000,https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-171100875.html?.tsrc=rss,"NEW YORK, May 23, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") (NASDAQ:  ALXN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.  On May 8, 2017 Alexion's São Paulo offices were raided as part of an investigation into the Company's business practices."
ALXN,ALXN:UW,BBG000G32HL2,Alexion’s top management shake-up includes CFO who started in December,2017-05-23 16:42:55 +0000,http://finance.yahoo.com/r/1c231f7e-8e5d-331d-99e1-d5c03600a1c8/Story.aspx?guid=2738A65A-3FD1-11E7-82F3-A3969A86B432&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The company’s stock plummeted nearly 10% after news of exits by four in top management.
ALXN,ALXN:UW,BBG000G32HL2,BMO: Too Early to Tell If Alexion's Management Shakeup Bodes Well for Stock,2017-05-23 16:24:00 +0000,http://finance.yahoo.com/r/9eec2bd0-fc46-370b-9778-d5cf779aecde/bmo-too-early-to-tell-if-alexion-s-management-shakeup-bodes-well-for-stock.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The biopharmaceutical firm's CFO announced today that he will be leaving in August.
ALXN,ALXN:UW,BBG000G32HL2,Here&apos;s Why Alexion Pharma (ALXN) Stock is Sinking Today,2017-05-23 16:18:04 +0000,https://finance.yahoo.com/news/apos-why-alexion-pharma-alxn-161804175.html?.tsrc=rss,"On Tuesday, shares of Alexion Pharmaceuticals Inc. (ALXN) are sinking, down over about 8.5% in mid-morning trading after the company announced a series of changes to its executive team."
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: XLNX, MNST",2017-05-23 16:14:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N4nQbYdXK9Y/nasdaq-100-movers-xlnx-mnst-cm793313,In early trading on Tuesday shares of Monster Beverage topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 4 Year to date Monster Beverage registers a 11 6 gain And the worst performing Nasdaq 100 component thus far on the day is Xilinx
ALXN,ALXN:UW,BBG000G32HL2,Alexion stock plummets 9% after top management shake-up,2017-05-23 16:01:54 +0000,http://finance.yahoo.com/r/c995e522-bf62-3c3a-a1a4-32eeee8a6727/Story.aspx?guid=25B00913-2EDC-408F-8C1C-C9A25F65423B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals Inc. shares dropped 9.2% to $104.89 in very active morning trade Tuesday after the company announced departures of its chief commercial officer, chief financial officer and two ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion: Look Out Below!,2017-05-23 15:53:00 +0000,http://finance.yahoo.com/r/a1c0a159-c826-39f1-94d2-6c80e650e9b1/alexion-look-out-below-1495554811?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals (ALXN), which brought in a new CEO in March, announced more changes today, including the impending departure of its CFO. That Alexion needed change was a given. Alexion was forced ..."
ALXN,ALXN:UW,BBG000G32HL2,InPlay from Briefing.com,2017-05-23 14:57:07 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Movers: Cerus, Alexion, NantKwest",2017-05-23 13:29:00 +0000,http://finance.yahoo.com/r/4b7e8be8-3307-3e5f-a129-5ece72403327/biotech-movers-cerus-alexion-nantkwest.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Cerus, Alexion Pharmaceuticals and NantKwest were among the biotech movers in premarket trading on Tuesday."
ALXN,ALXN:UW,BBG000G32HL2,"Pre-Market Most Active for May 23, 2017 :  VIPS, TSU, SC, NOK, EPC, MOMO, TTWO, AEG, ERIC, QQQ, TLT, ALXN",2017-05-23 12:51:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SXppFKkK4ms/pre-market-most-active-for-may-23-2017-vips-tsu-sc-nok-epc-momo-ttwo-aeg-eric-qqq-tlt-alxn-cm793079,The NASDAQ 100 Pre Market Indicator is up 8 09 to 5 707 49 The total Pre Market volume is currently 3 675 401 shares traded The following are the most active stocks for the pre market session Vipshop Holdings Limited VIPS is 0 01 at 13 53 with 3 000 046 shares
ALXN,ALXN:UW,BBG000G32HL2,Alexion Announces Executive Leadership Changes,2017-05-23 12:00:00 +0000,https://finance.yahoo.com/news/alexion-announces-executive-leadership-changes-120000034.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced the following changes to its executive leadership team:"
ALXN,ALXN:UW,BBG000G32HL2,Stocks That Fell to 3-Year Lows in the Week of May 19,2017-05-22 16:11:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UDiaTB-pYD8/stocks-that-fell-to-3-year-lows-in-the-week-of-may-19-cm792710,Alexion Pharmaceuticals Inc ALXN Nielsen Holdings PLC NLSN Macerich Co MAC and Tractor Supply Co TSCO have declined to their three year lows Alexion Pharmaceuticals Inc ALXN Nielsen Holdings PLC NLSN Macerich Co MAC and Tractor Supply Co TSCO
ALXN,ALXN:UW,BBG000G32HL2,Stocks That Fell to 3-Year Lows in the Week of May 19,2017-05-21 21:08:56 +0000,https://finance.yahoo.com/news/stocks-fell-3-lows-week-210856405.html?.tsrc=rss,"Alexion Pharmaceuticals, Nielsen Holdings, Macerich Co. and Tractor Supply Co. have declined to their respective three-year lows"
ALXN,ALXN:UW,BBG000G32HL2,"Amgen, Gilead, Biogen Won&apos;t Lead The Biotech Boom — So Who Will?",2017-05-19 20:30:36 +0000,http://finance.yahoo.com/r/43448f46-ab61-3261-87b4-c50ada16e8c5/amgen-gilead-biogen-wont-lead-the-biotech-boom-so-who-will?src=A00220&yptr=yahoo&.tsrc=rss,"Regeneron, Vertex and Alexion look likely to catch the next wave in biotech and start a boom, an analyst says."
ALXN,ALXN:UW,BBG000G32HL2,5 Reasons Big Biotech Could Gain 25%-30%,2017-05-19 17:09:00 +0000,http://finance.yahoo.com/r/de60de58-e525-3cc6-80bf-38f0a88cd4ca/5-reasons-big-biotech-could-gain-25-30-1495213782?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Leerink analyst Geoffrey Porges sees a light at the end of the tunnel for Big Biotech.  In a note published today, he predicted that the stocks in his coverage area could shake off the doldrums, and climb 25% to 30% in the next year, if “the group captures a re-rating back to the long term average relative multiple, and our generally positive view of the near and long term revenue and earnings outlook materializes.” That coverage universe includes AbbVie (ABBV), Alexion Pharmaceuticals (ALXN), Amgen (AMGN), Biogen (BIIB), Celgene (CELG), Gilead Sciences (GILD), Regeneron (REGN) and Vertex (VRTX).  The smaller companies in the group offer the profile of earlier legions of biotech companies, whereas the mature companies in the group (GILD [MP], AMGN [MP], BIIB[MP]) face more near term downside than upside."
ALXN,ALXN:UW,BBG000G32HL2,Why Stay Bullish On Gilead,2017-05-19 16:02:00 +0000,http://finance.yahoo.com/r/482217aa-20b1-35d8-ad6b-7095e61a0a71/why-stay-bullish-on-gilead-1495209758?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"There’s no shortage of investors who have lost confidence in Gilead Sciences (GILD). Hopes of better news were shattered by its most recent earnings report. And so far, the company has not delivered a ..."
ALXN,ALXN:UW,BBG000G32HL2,"For millions of Chinese with rare diseases, some relief in sight",2017-05-18 23:00:01 +0000,https://finance.yahoo.com/news/millions-chinese-rare-diseases-relief-230001273.html?.tsrc=rss,"China is set to publish  its first national list of rare diseases, to guide policymakers  as part of a broader overhaul to improve diagnoses and speed up  drug approvals in the world's second-largest drugs market.  Rare illnesses, by definition affecting only a small group  of people, are often genetic and costly to treat or control."
ALXN,ALXN:UW,BBG000G32HL2,Cramer&apos;s lightning round: It&apos;s OK to own this stock — as long as you&apos;re diversified,2017-05-18 22:51:37 +0000,https://finance.yahoo.com/news/cramer-apos-lightning-round-apos-225137224.html?.tsrc=rss,"Jim Cramer flies through his take on caller favorite stocks, including a financial stock."
ALXN,ALXN:UW,BBG000G32HL2,Cramer's lightning round: It's OK to own this stock — as long as you're diversified,2017-05-18 22:51:37 +0000,http://finance.yahoo.com/r/196cf7e3-47dd-37ed-b1e6-069eb52a9734/104479001?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104479001&yptr=yahoo&.tsrc=rss,"Jim Cramer flies through his take on caller favorite stocks, including a financial stock."
ALXN,ALXN:UW,BBG000G32HL2,"Glancy Prongay & Murray LLP Commences Investigation on Behalf of Alexion Pharmaceuticals, Inc. Investors",2017-05-18 14:30:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-143000889.html?.tsrc=rss,"Glancy Prongay & Murray LLP announces an investigation on behalf of Alexion Pharmaceuticals, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws."
ALXN,ALXN:UW,BBG000G32HL2,Alexion's (ALXN) Strensiq Results Positive in Long-Term Study,2017-05-18 00:11:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tswRC8yPBD0/alexions-alxn-strensiq-results-positive-in-long-term-study-cm790953,Alexion Pharmaceuticals Inc ALXN announced that researchers presented encouraging data on Strensiq at the European Calcified Tissue Society ECTS Congress in Austria Alexion s shares declined 4 4 year to date compared with the Zacks classified Medical Biomedical and
ALXN,ALXN:UW,BBG000G32HL2,Alexion&apos;s (ALXN) Strensiq Results Positive in Long-Term Study,2017-05-17 21:55:09 +0000,https://finance.yahoo.com/news/alexion-apos-alxn-strensiq-results-215509190.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. (ALXN) announced that researchers presented encouraging data on Strensiq at the European Calcified Tissue Society (ECTS) Congress in Austria."
ALXN,ALXN:UW,BBG000G32HL2,Here's Why Omeros Corporation Is Surging Again Today,2017-05-17 17:13:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M6QXvuESj8w/heres-why-omeros-corporation-is-surging-again-today-cm790666,What happened The market is pushing up shares of Omeros Corporation NASDAQ OMER again today As of 10 50 a m EDT on Wednesday the stock was 11 1 higher after the company reported more encouraging data for its lead rare disease drug candidate So what Urine protein levels
ALXN,ALXN:UW,BBG000G32HL2,Here&apos;s Why Omeros Corporation Is Surging Again Today,2017-05-17 16:03:00 +0000,http://finance.yahoo.com/r/9a7965bd-efe7-3834-9c00-690ba3231f2b/heres-why-omeros-corporation-is-surging-again-toda.aspx?yptr=yahoo&.tsrc=rss,Positive trial results for Omeros Corporation&apos;s lead candidate keep rolling in.
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal",2017-05-17 13:18:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VWR-nTULKG0/biotech-stock-roundup-biogen-inks-deal-to-boost-pipeline-sangamo-soars-on-pfizer-deal-cm790465,Biogen BIIB was in the news this week not only for an agreement that will boost its pipeline but also for a favorable decision in a securities litigation Meanwhile Sangamo s SGMO shares skyrocketed on a collaboration with Pfizer 160 Recap of the Week s Most Important
ALXN,ALXN:UW,BBG000G32HL2,"Moderna Can't Escape My Intellectual Property, Says Arbutus CEO",2017-05-16 16:01:00 +0000,http://finance.yahoo.com/r/287c32a8-691e-36f1-9544-51c281b7b62b/moderna-cant-escape-my-intellectual-property-says-arbutus-ceo?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"“We have seen no evidence of a Moderna delivery system that is free of our intellectual property. Not in their publications, their presentations, or in the examples in their patent filings,” said Mark Murray, in his first interview on the subject."
ALXN,ALXN:UW,BBG000G32HL2,3 Top Healthcare Stocks to Buy Now,2017-05-16 13:17:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0MY7CFTznkI/3-top-healthcare-stocks-to-buy-now-cm789686,What industry should experience solid demand even if the economy takes a downturn What industry represents nearly one fifth of the U S economy and is growing rapidly 160 What industry should experience growing demand over the long run because of unstoppable demographic trends
ALXN,ALXN:UW,BBG000G32HL2,3 Top Healthcare Stocks to Buy Now,2017-05-16 12:04:00 +0000,http://finance.yahoo.com/r/c3ccc8c3-0413-3308-911b-47991ac2c7be/3-top-healthcare-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Here&apos;s what makes Alexion Pharmaceuticals, Edwards Lifesciences, and Mylan great healthcare stocks for the long term."
ALXN,ALXN:UW,BBG000G32HL2,Rady Children’s Institute for Genomic Medicine and Alexion Pharmaceuticals Partner to Speed the Diagnosis of Rare Genetic Disorders in Newborns,2017-05-16 10:30:00 +0000,https://finance.yahoo.com/news/rady-children-institute-genomic-medicine-103000414.html?.tsrc=rss,"The Rady Children’s Institute for Genomic Medicine and Alexion Pharmaceuticals, Inc. today announced a strategic partnership to accelerate the diagnosis of critically-ill newborns with rare genetic disorders."
ALXN,ALXN:UW,BBG000G32HL2,Long-term Data Confirm Benefits of Treatment with Strensiq® (asfotase alfa) in Adolescents and Adults with Hypophosphatasia (HPP) Through Five Years,2017-05-15 12:00:00 +0000,https://finance.yahoo.com/news/long-term-data-confirm-benefits-120000151.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. announced today that researchers presented data showing that the rapid benefits of Strensiq® achieved in adolescents and adults with hypophosphatasia within the first 6 months were sustained through 5 years of treatment.1 These are the final data from the extension phase of a randomized, open-label, dose-ranging Phase 2 trial of Strensiq and they confirm previously presented ..."
ALXN,ALXN:UW,BBG000G32HL2,Here's Why Omeros Corporation Stock Is Falling Today,2017-05-11 18:02:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mC0sJpiceMI/heres-why-omeros-corporation-stock-is-falling-today-cm788016,What happened Shares of Omeros Corporation NASDAQ OMER a rising star in the biotech industry are losing altitude after the company reported first quarter earnings today The stock was down 16 earlier this morning but just 11 4 lower than the previous day s closing price as
ALXN,ALXN:UW,BBG000G32HL2,ALXN1210 Is Expected to Boost Alexion Pharmaceuticals’ Revenue,2017-05-11 13:07:42 +0000,http://finance.yahoo.com/r/cbb7011d-7dca-3575-86a7-ad6c24514354/alxn1210-expected-boost-alexion-pharmaceuticals-revenues-future-years?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals has planned five clinical trials in 2017 to test the potential of investigational next-generation C5 antibody, ALXN1210, as a treatment option for complement-mediated diseases."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : May 11, 2017",2017-05-11 12:59:58 +0000,http://finance.yahoo.com/r/558c6b25-540d-30e5-b112-cd140b7c55a2/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-alxn-us-may-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alexion Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Has Raised Its 2017 Earnings Guidance,2017-05-11 11:36:54 +0000,http://finance.yahoo.com/r/63765969-a949-3cf1-a5a7-d74819e1fc50/alexion-pharmaceuticals-raised-eps-guidance-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"While Soliris is expected to continue to be a key revenue driver for Alexion Pharmaceuticals (ALXN) in 2017, the company anticipates an increasingly negative impact on Solaris's 2017 sales."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Global Headquarters Earns Highest LEED® Green Building Certification,2017-05-11 10:30:00 +0000,http://finance.yahoo.com/news/alexion-global-headquarters-earns-highest-103000727.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. and The Connecticut Green Building Council today announced that Alexion’s global headquarters at 100 College Street in New Haven has achieved LEED Platinum certification for Commercial Interiors."
ALXN,ALXN:UW,BBG000G32HL2,New Patient Starts Expected to Drive Soliris’s Revenue in 2017,2017-05-10 18:35:43 +0000,http://finance.yahoo.com/r/3005e36e-06dd-3752-9e70-4d775fb4447c/new-patient-starts-expected-drive-soliris-revenue-performance-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"During its 1Q17 earnings conference call, Alexion Pharmaceuticals (ALXN) reiterated that its drug Soliris’s 2017 revenue would fall in the range of $3.0 billion–$3.1 billion."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Projects Robust 2017 Revenue Performance,2017-05-10 17:05:50 +0000,http://finance.yahoo.com/r/373f71d2-d9d3-3afe-b27a-70e01be229bd/alexion-pharmaceuticals-projected-robust-revenue-performance-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals (ALXN) expects to report revenue in the range of $3.4 billion–$3.5 billion in 2017.
ALXN,ALXN:UW,BBG000G32HL2,Analysts’ Latest Recommendations for Alexion and Its Peers,2017-05-10 15:09:12 +0000,http://finance.yahoo.com/r/43cc9c5c-ea62-3470-ac73-cebc341dbb4e/analysts-recommendations-alexion-pharmaceuticals-peers-may-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Alexion Pharmaceuticals (ALXN) is focused on increasing its market share and defending its leading position in the complement inhibitor market in 2017.
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Regeneron, BioMarin Report Q1, Kite Down on Patient Death",2017-05-10 14:05:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ENZtDOEpGpw/biotech-stock-roundup-regeneron-biomarin-report-q1-kite-down-on-patient-death-cm787163,Kite Pharma s KITE announcement regarding a patient death related to its lead pipeline candidate was the big news in the biotech sector with the company s shares taking a hit Meanwhile major players like Regeneron REGN and BioMarin BMRN reported 1Q results while Regeneron posted a
ALXN,ALXN:UW,BBG000G32HL2,What Are We Waiting For?,2017-05-10 14:01:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JEG2G6zRyU0/what-are-we-waiting-for-cm786954,The market continues to run in place just below all time highs despite a number of positive developments including the solid earnings season and a good jobs report So what s the hold up Ultimately of course stocks want to see tax reform and other pro growth initiatives that were promised
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at the Bank of America Merrill Lynch 2017 Health Care Conference,2017-05-09 14:00:00 +0000,http://finance.yahoo.com/news/alexion-present-bank-america-merrill-140000737.html?.tsrc=rss,"Alexion Pharmaceuticals today announced that management will present at the Bank of America Merrill Lynch 2017 Health Care Conference in Las Vegas on Tuesday, May 16, 2017 at 10:40 a.m."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Shares Under Pressure Amid Brazilian Office Raid; Barclays Says Buy The Dip,2017-05-09 13:12:08 +0000,http://finance.yahoo.com/news/alexion-shares-under-pressure-amid-131208357.html?.tsrc=rss,"Shares of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ), a biopharmaceutical company perhaps most known for its Soliris therapy fell more than 3 percent during Monday's trading session. Investors and traders ..."
ALXN,ALXN:UW,BBG000G32HL2,"Monday Sector Laggards: Healthcare, Services",2017-05-08 20:01:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pbcrh7-nm9s/monday-sector-laggards-healthcare-services-cm786083,The worst performing sector as of midday Monday is the Healthcare sector showing a 0 7 loss Within the sector Incyte Corporation Symbol INCY and Alexion Pharmaceuticals Inc Symbol ALXN are two large stocks that are lagging showing a loss of 4 1 and 3 8 respectively Among
ALXN,ALXN:UW,BBG000G32HL2,BioMarin: Is Profitability On The Horizon?,2017-05-08 18:57:00 +0000,http://finance.yahoo.com/r/cc0a47e1-94b4-33a2-b154-c473e610724a/biomarin-is-profitability-on-the-horizon-1494269871?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When will BioMarin Pharmaceuticals (BMRN) turn a profit? The drug maker specializes in therapies for rare diseases, and already markets a handful of medications that generated revenue of $1.12 billion ..."
ALXN,ALXN:UW,BBG000G32HL2,Brazilian Police Raid Alexion Offices in Sales Probe,2017-05-08 16:00:00 +0000,http://finance.yahoo.com/r/6126d461-4954-336a-93b7-906d99023454/brazilian-police-raid-alexion-offices-in-sales-probe.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Alexion said that the officers have left and the company is cooperating with the investigation.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Raided by Brazilian Police in Sales Practices Probe,2017-05-08 14:56:40 +0000,http://finance.yahoo.com/news/alexion-raided-brazilian-police-sales-145640498.html?.tsrc=rss,"Alexion Pharmaceuticals Inc.’s Sao Paulo offices were raided by Brazilian authorities Monday as part of an investigation into the drugmaker’s sales practices, according to an emailed statement from the ..."
ALXN,ALXN:UW,BBG000G32HL2,"Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene",2017-05-05 15:29:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-azCLctmK68/zacks-investment-ideas-feature-highlights-regeneron-edwards-lifesciences-alexion-pharmaceuticals-align-technology-and-centene-cm784922,For Immediate Release Chicago IL May 05 2017 Today Zacks Investment Ideas feature highlights Features Regeneron NASDAQ REGN Free Report Edwards Lifesciences NYSE EW Free Report Alexion Pharmaceuticals NASDAQ ALXN Free Report Align Technology
ALXN,ALXN:UW,BBG000G32HL2,"Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene",2017-05-05 13:30:01 +0000,http://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-133001306.html?.tsrc=rss,"Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene"
ALXN,ALXN:UW,BBG000G32HL2,5 Healthcare Innovators I'm Still Buying,2017-05-05 05:19:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_bO1YJLVqBs/5-healthcare-innovators-im-still-buying-cm784690,Last week I launched a new long term portfolio for Zacks called Healthcare Innovators The basic idea is to ride the megatrends of the medical field to steady if not spectacular gains in this decade and the next You can read about those long term drivers in my article from April 21
ALXN,ALXN:UW,BBG000G32HL2,5 Healthcare Innovators I&apos;m Still Buying,2017-05-04 21:59:09 +0000,http://finance.yahoo.com/news/5-healthcare-innovators-apos-m-215909265.html?.tsrc=rss,5 Healthcare Innovators I&apos;m Still Buying
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017",2017-05-01 14:41:57 +0000,http://finance.yahoo.com/r/8803edcc-0d2a-3e43-8b0d-96a6f02ebcb1/alexion-pharmaceuticals-inc-alxn-us-earnings-analysis-q1-2017-by-the-numbers-may-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Alexion Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Alexion Pharmaceuticals, Inc. – Celgene Corporation, Vertex Pharmaceuticals Incorporated and Biogen Inc. (CELG-US, VRTX-US and BIIB-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,Edited Transcript of ALXN earnings conference call or presentation 27-Apr-17 2:00pm GMT,2017-04-29 01:10:54 +0000,http://finance.yahoo.com/news/edited-transcript-alxn-earnings-conference-125055619.html?.tsrc=rss,Q1 2017 Alexion Pharmaceuticals Inc Earnings Call
ALXN,ALXN:UW,BBG000G32HL2,S&P 500 Analyst Moves: ALXN,2017-04-28 17:27:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LmQJJsDFZqI/sp-500-analyst-moves-alxn-cm781310,The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Alexion Pharmaceuticals ALXN is now the 108 analyst pick moving up by 4 spots This rank is formed by averaging the analyst opinions for each component
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : April 28, 2017",2017-04-28 12:22:10 +0000,http://finance.yahoo.com/r/2dec7d97-fca2-3887-b99e-e20ef9585f2c/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-alxn-us-april-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alexion Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Rises More Than 5% After Beating Consensus,2017-04-28 01:48:00 +0000,http://finance.yahoo.com/r/4a621685-fbd1-3966-b102-3b95c9a24d54/alexion-rises-more-than-5-after-beating-consensus.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Soliris sales of $783 million in the first quarter benefited from a one-time, $29 million change in revenue recognition but still came in higher than consensus."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Beats On First-Quarter Sales; Profits Top By 15 Cents,2017-04-27 21:45:20 +0000,http://finance.yahoo.com/r/b9816a25-99a5-3ebc-9c2f-17ebd9d06c1b/alexion-crushes-wall-streets-revenue-profits-expectations?src=A00220&yptr=yahoo&.tsrc=rss,Alexion stock popped on Thursday after the top 10 biotech crushed Wall Street&apos;s expectations for first-quarter sales and adjusted profits.
ALXN,ALXN:UW,BBG000G32HL2,ALXN Makes Bullish Cross Above Critical Moving Average,2017-04-27 21:25:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fw8ix1pBhOU/alxn-makes-bullish-cross-above-critical-moving-average-cm780676,In trading on Thursday shares of Alexion Pharmaceuticals Inc Symbol ALXN crossed above their 200 day moving average of 126 12 changing hands as high as 127 94 per share Alexion Pharmaceuticals Inc shares are currently trading up about 5 2 on the day The chart below shows the one
ALXN,ALXN:UW,BBG000G32HL2,"AbbVie Flirts With Buy Point After Q1 Earnings, Sales Top",2017-04-27 20:48:42 +0000,http://finance.yahoo.com/r/16693180-f10d-3670-a61e-760fac0fa42e/abbvie-crushes-q1-sales-earnings-views?src=A00220&yptr=yahoo&.tsrc=rss,AbbVie reported better-than-expected earnings and revenue early Thursday. Shares of the drugmaker traded around a buy point.
ALXN,ALXN:UW,BBG000G32HL2,"Celgene Dips On $95 Million Lag In Psoriasis Sales, But Earnings Top",2017-04-27 20:43:49 +0000,http://finance.yahoo.com/r/06f62447-ab83-3a1d-a287-c76290c5e3fd/celgene-earnings-top-but-biotechs-sales-miss?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene reported better-than-expected first-quarter earnings, but sales were a little light, following similar results from fellow biotech giant Amgen late Wednesday."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Tops Q1 Earnings, Sales; Shares Up",2017-04-27 20:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V-lU8KisSXY/alexion-alxn-tops-q1-earnings-sales-shares-up-cm780653,Alexion Pharmaceuticals Inc ALXN focuses on the development and commercialization of life transforming drugs for treating patients suffering from ultra rare disorders Soliris approved for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome is the key product of this
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups '17 View",2017-04-27 20:27:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GH-Hby6_yvM/alexion-alxn-tops-q1-earnings-revenues-ups-17-view-cm780640,Alexion Pharmaceuticals Inc s ALXN first quarter 2017 earnings including stock based compensation expense of 1 20 per share compared with the year ago earnings of 76 cents The reported figure surpassed the Zacks Consensus Estimate of 1 05 Revenues rose 24 1 year over year to
ALXN,ALXN:UW,BBG000G32HL2,Three Biotechs Enter…One Biotech Gains,2017-04-27 19:51:00 +0000,http://finance.yahoo.com/r/0d3fa7ac-9ab1-34d3-8fa5-4554736e241d/three-biotechs-enterone-biotech-gains-1493322699?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Three biotech stocks--Alexion Pharmaceuticals (ALXN), Amgen (AMGN), and Celgene (CELG)--reported earnings since yesterday's close. But just one has seen its shares head higher after the announcement. That ..."
ALXN,ALXN:UW,BBG000G32HL2,"Thursday's ETF Movers: XBI, OIH",2017-04-27 19:26:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QqX20SNajbg/thursdays-etf-movers-xbi-oih-cm780593,In trading on Thursday the SPDR S amp P Biotech ETF XBI is outperforming other ETFs up about 1 4 on the day Components of that ETF showing particular strength include shares of Exact Sciences EXAS up about 25 9 and shares of Alexion Pharmaceuticals ALXN up about 5 8 on
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups &apos;17 View",2017-04-27 18:42:06 +0000,http://finance.yahoo.com/news/alexion-alxn-tops-q1-earnings-184206731.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc.&apos;s (ALXN) first-quarter 2017 earnings (including stock-based compensation expense) of $1.20 per share compared with the year ago earnings of 76 cents. The reported figure surpassed the Zacks Consensus Estimate of $1.05."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Tops Q1 Earnings, Sales; Shares Up",2017-04-27 18:31:06 +0000,http://finance.yahoo.com/news/alexion-alxn-tops-q1-earnings-183106236.html?.tsrc=rss,Alexion surpassed earnings and sales expectations in the first quarter of 2017.
ALXN,ALXN:UW,BBG000G32HL2,Biotech Movers: Pacific Biosciences Falls After Net Loss Spikes,2017-04-27 13:27:00 +0000,http://finance.yahoo.com/r/1d35cc9c-7fbc-370a-a235-740012dbfeb1/biotech-movers-pacific-biosciences-falls-after-net-loss-spikes.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Pacific Biosciences of California, Alexion Pharmaceuticals and Arena Pharmaceuticals were among the biotech stock movers in premarket trading on Thursday."
ALXN,ALXN:UW,BBG000G32HL2,Alexion beats Street 1Q forecasts,2017-04-27 10:52:21 +0000,http://finance.yahoo.com/news/alexion-beats-street-1q-forecasts-105221593.html?.tsrc=rss,"On a per-share basis, the New Haven, Connecticut-based company said it had net income of 75 cents. Earnings, adjusted for one-time gains and costs, came to $1.38 per share. The results beat Wall Street ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Reports First Quarter 2017 Results,2017-04-27 10:30:00 +0000,http://finance.yahoo.com/news/alexion-reports-first-quarter-2017-103000799.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced financial results for the first quarter of 2017. Total revenues in the quarter were $870 million, a 24 percent increase compared to the same period in 2016."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma Increases 2017 Earnings Guidance - Quick Facts,2017-04-27 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KS0JbaaDfdo/alexion-pharma-increases-2017-earnings-guidance--quick-facts-20170427-00567,Alexion Pharma Increases 2017 Earnings Guidance - Quick Facts
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. Reports 39% Gain In Q1 Profit,2017-04-27 06:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/msQKzlH32hY/alexion-pharmaceuticals-inc-reports-39-gain-in-q1-profit-20170427-00408,Alexion Pharmaceuticals Inc. Reports 39% Gain In Q1 Profit
ALXN,ALXN:UW,BBG000G32HL2,Stocks Give an Encore Performance,2017-04-26 14:03:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U2kk5k-Jw4U/stocks-give-an-encore-performance-cm779189,It feels like the market just now found out that we re having a good earnings season It took solid reports from the likes of Caterpillar and McDonalds among others to force the realization but better late than never As a result stocks followed up yesterday s sharp rally with an
ALXN,ALXN:UW,BBG000G32HL2,Is This Why Akari Therapetuics PLC Is Falling Today?,2017-04-24 18:04:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CBA96lDv3Qk/is-this-why-akari-therapetuics-plc-is-falling-today-cm778018,What happened Investors in Akari Therapeutics NASDAQ AKTX are likely suffering from whiplash today Shares of the rare disease focused biotech jumped by double digits in premarket trading after the company provided investors with several clinical updates related to its
ALXN,ALXN:UW,BBG000G32HL2,Is This Why Akari Therapetuics PLC Is Falling Today?,2017-04-24 16:33:00 +0000,http://finance.yahoo.com/r/91fe2c70-fcb4-3c7d-8266-7e9e9a5d179e/is-this-why-akari-therapetuics-plc-is-falling-toda.aspx?yptr=yahoo&.tsrc=rss,"After several positive clinical updates, shares of the rare-disease-focused biotech fell. Is this simply a matter of traders looking to book a profit from this red hot stock?"
ALXN,ALXN:UW,BBG000G32HL2,"Street Watches To See If $125,000 Drug Boosts Biogen&apos;s Results",2017-04-21 20:13:54 +0000,http://finance.yahoo.com/r/ecf53783-ebba-363a-bae3-da92f0670785/will-biogens-q1-spinraza-revenue-be-a-slam-dunk-or-resounding-flop?src=A00220&yptr=yahoo&.tsrc=rss,Wall Street will be keyed in Tuesday to Biogen&apos;s earnings for a first look at whether payer pushback hindered sales of Spinraza.
ALXN,ALXN:UW,BBG000G32HL2,"Friday Sector Laggards: Healthcare, Consumer Products",2017-04-21 20:03:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7hbaJsbjq4k/friday-sector-laggards-healthcare-consumer-products-cm777291,In afternoon trading on Friday Healthcare stocks are the worst performing sector showing a 0 7 loss Within the sector Alexion Pharmaceuticals Inc Symbol ALXN and Patterson Companies Inc Symbol PDCO are two of the day s laggards showing a loss of 2 4 and 1 6 respectively
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?,2017-04-21 15:07:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IR2asPpJMIQ/alexion-alxn-q1-earnings-can-the-stock-pull-a-surprise-cm776986,Alexion Pharmaceuticals Inc ALXN is scheduled to report first quarter 2017 results on Apr 27 before the opening bell In the last reported quarter Alexion delivered in line earnings Alexion posted an average positive earnings surprise of 2 82 over the four trailing quarters Let s see
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?,2017-04-21 13:19:01 +0000,http://finance.yahoo.com/news/alexion-alxn-q1-earnings-stock-131901799.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. (ALXN) is scheduled to report first quarter 2017 results on Apr 27, before the opening bell."
ALXN,ALXN:UW,BBG000G32HL2,What to expect from biotech,2017-04-20 21:53:00 +0000,http://finance.yahoo.com/video/expect-biotech-215300900.html?.tsrc=rss,CNBC's Meg Tirrell discusses what healthcare investors should expect from the biotech sector. With the &quot;Fast Money&quot; traders.
ALXN,ALXN:UW,BBG000G32HL2,Peek Under The Hood: IYH Has 11% Upside,2017-04-20 17:04:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/50ZyVNBpOCU/peek-under-the-hood-iyh-has-11-upside-cm776560,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ALXN,ALXN:UW,BBG000G32HL2,Gilead Sciences: Who's Frustrated Now?,2017-04-19 15:42:00 +0000,http://finance.yahoo.com/r/bda188a0-b14b-3d9a-9c65-d366c2bb23bc/gilead-sciences-whos-frustrated-now?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last month, I urged investors to stay away from  Gilead Sciences (GILD), arguing that it had, in effect, become a value trap (even if I didn't use those exact words.  Barclays analyst Geoff Meacham and team note that ""investors seem increasingly more frustrated"" with not only Gilead, but with Alexion Pharmaceuticals (ALXN) and Biogen (BIIB) as well."
ALXN,ALXN:UW,BBG000G32HL2,3 Beaten-Up Healthcare Stocks: Are They Bargains?,2017-04-19 15:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yKyvAmgvna4/3-beaten-up-healthcare-stocks-are-they-bargains-cm775772,The 160 S amp P 500 160 might be flirting with all time highs but that doesn t mean that every stock has benefited from the prosperity In fact several healthcare stocks like Alexion Pharmaceuticals NASDAQ ALXN Opko Health NASDAQ OPK and Novo Nordisk
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: FDA CRL Hits Incyte, Pipeline Setbacks Weigh on OncoMed",2017-04-19 14:06:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ElHVpLVTn4U/biotech-stock-roundup-fda-crl-hits-incyte-pipeline-setbacks-weigh-on-oncomed-cm775728,The FDA s complete response letter CRL for Incyte INCY and Lilly s experimental rheumatoid arthritis RA treatment was the big news in the biotech sector while OncoMed OMED continued to be hit by more pipeline setbacks Recap of the Week s Most Important Stories CRL for Incyte s
ALXN,ALXN:UW,BBG000G32HL2,3 Beaten-Up Healthcare Stocks: Are They Bargains?,2017-04-19 13:21:00 +0000,http://finance.yahoo.com/r/fe371753-556f-3a80-8ec6-2aa9d5ed0f96/3-beaten-up-healthcare-stocks-are-they-bargains.aspx?yptr=yahoo&.tsrc=rss,"The past year hasn&apos;t been kind to shareholders of Alexion Pharmaceuticals, Opko Health, and Novo Nordisk. Do their stocks hold value today, or should they be avoided?"
ALXN,ALXN:UW,BBG000G32HL2,The 7 Most Expensive Prescription Drugs in the World,2017-04-18 11:54:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IztSKJxo6yM/the-7-most-expensive-prescription-drugs-in-the-world-cm774991,Image source Getty Images Imagine buying a Ferrari 488 Spider and a Porsche 911 Carrera e very year You d spend more than the costs of those two sports cars if you had to pay the average wholesale price for the costliest prescription drugs The highest priced
ALXN,ALXN:UW,BBG000G32HL2,The 7 Most Expensive Prescription Drugs in the World,2017-04-18 10:00:00 +0000,http://finance.yahoo.com/r/409b70ac-2636-3ffb-b886-d153b840dad3/the-7-most-expensive-prescription-drugs-in-the-wor.aspx?yptr=yahoo&.tsrc=rss,"The costs of these drugs are astronomical -- from $543,000 per year to more than $1 million per year."
ALXN,ALXN:UW,BBG000G32HL2,3 Big Reasons to Be Bullish on Biotech Stocks,2017-04-17 11:42:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mcXIJ4TRgmk/3-big-reasons-to-be-bullish-on-biotech-stocks-cm774422,While the biotech sector isn t for the faint of heart we Fools think that it can be a mistake to avoid the industry altogether So why should you consider putting money to work in the space We asked that very question to a team of healthcare Fools Read on to find out what they said
ALXN,ALXN:UW,BBG000G32HL2,3 Big Reasons to Be Bullish on Biotech Stocks,2017-04-16 18:02:00 +0000,http://finance.yahoo.com/r/57fbb4f0-9895-35dd-b33b-917e033797ec/3-big-reasons-to-be-bullish-on-biotech-stocks.aspx?yptr=yahoo&.tsrc=rss,Have you shied away from investing in the biotech sector? Here are three key reasons why you may want to reconsider that decision.
ALXN,ALXN:UW,BBG000G32HL2,"Thursday Sector Leaders: Utilities, Healthcare",2017-04-13 20:55:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wrnpbpfnxpM/thursday-sector-leaders-utilities-healthcare-cm774018,The best performing sector as of midday Thursday is the Utilities sector not showing much of a loss Within the sector NextEra Energy Inc Symbol NEE and Public Service Enterprise Group Inc Symbol PEG are two of the day s stand outs showing a gain of 0 7 and 0 7 respectively
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,805.15 down -31.01 points",2017-04-13 20:48:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/318XaYDchjU/market-close-report-nasdaq-composite-index-closes-at-580515-down-3101-points-cm774048,Thursday s session closes with the NASDAQ Composite Index at 5 805 15 The total shares traded for the NASDAQ was over 1 58 billion Declining stocks led advancers by 2 2 to 1 ratio There were 904 advancers and 1987 decliners for the day On the NASDAQ Stock Exchange 16 stocks reached a 52
ALXN,ALXN:UW,BBG000G32HL2,The Hot Stock: Alexion Pharmaceuticals Climbs 3.3%,2017-04-13 20:18:00 +0000,http://finance.yahoo.com/r/881789be-222a-3d9f-964e-c66f05d98bf3/the-hot-stock-alexion-pharmaceuticals-climbs-3-3?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals (ALXN), a drug maker focused on rare diseases, ended Thursday at the top of the list of the best performing stocks in the S&P 500 index.  It’s been a rough two years for Alexion.  Since mid-2015, when the stock traded above $200, shares have tumbled on worries about the durability of its main drug Soliris, political furor over high drug prices, and the abrupt departure of two top executives amid an investigation into sales practices."
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: LILA, ALXN",2017-04-13 15:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rEBq02D84JE/nasdaq-100-movers-lila-alxn-cm773825,In early trading on Thursday shares of Alexion Pharmaceuticals topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 0 Year to date Alexion Pharmaceuticals has lost about 4 5 of its value And the worst performing Nasdaq 100 component thus far
ALXN,ALXN:UW,BBG000G32HL2,"[$$] Celgene, Biogen to Gain From Higher Prices",2017-04-12 15:25:00 +0000,http://finance.yahoo.com/r/6be67c46-3434-347a-8fd1-d7fbd3320773/celgene-biogen-to-gain-from-higher-prices-1492010746?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  Heading into earnings, we think Biogen, Alexion Pharmaceuticals and Gilead Sciences will be in focus.  Key products of focus are Spinraza (Biogen (BIIB)/Ionis Pharmaceuticals (IONS)), Soliris (Alexion (ALXN)) and Harvoni (Gilead (GILD)).  Interestingly, we think numbers look low for Gilead hepatitis C virus (HCV) and we see potential for a beat this quarter."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion to Report First Quarter 2017 Results on Thursday, April 27, 2017",2017-04-06 14:00:00 +0000,http://finance.yahoo.com/news/alexion-report-first-quarter-2017-140000334.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that the Company will report its financial results for the first quarter ended March 31, 2017 on Thursday, April 27, 2017 before the US financial markets open."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Slid 9.9% in March -- but Why?,2017-04-04 20:24:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/14LHrVaUstc/alexion-pharmaceuticals-slid-99-in-march-but-why-cm769791,What happened Shares of Alexion Pharmaceuticals NASDAQ ALXN a biotech focused on rare diseases fell 9 9 in March according to data from S amp P Global Market Intelligence The drop was much worse than the 2 5 fall in the biotech sector in general as measured by
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Slid 9.9% in March -- but Why?,2017-04-04 19:15:00 +0000,http://finance.yahoo.com/r/bd4d3f47-3445-31f4-89aa-08ad8582e656/alexion-pharmaceuticals-slid-99-in-march-but-why.aspx?yptr=yahoo&.tsrc=rss,It was a rough month for the biotech giant. Here&apos;s a review of the key headlines that may have influenced its share price.
ALXN,ALXN:UW,BBG000G32HL2,[$$] Beaten-Down Biotechs May Be Worth Buying,2017-04-04 15:05:00 +0000,http://finance.yahoo.com/r/fbd1819b-97a9-3c1e-a1f5-27590ead42ea/beaten-down-biotechs-may-be-worth-buying-1491318338?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  We also think all the biotech companies highlighted below represent interesting opportunities where sentiment is negative (Gilead Sciences, Alexion Pharmaceuticals and Alnylam Pharmaceuticals) or under significant debate (Tesaro, Gilead)."
ALXN,ALXN:UW,BBG000G32HL2,3 Top Growth Stocks Priced at a Bargain This Spring,2017-04-03 17:36:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W-OvK6X4aT0/3-top-growth-stocks-priced-at-a-bargain-this-spring-cm769135,For buy and hold investors the trading action since March 2009 has vindicated the strategy of buying high quality companies and staying put for the long term Yet quite a few high quality names have also moved lower recently giving long term investors an opportunity to potentially
ALXN,ALXN:UW,BBG000G32HL2,3 Top Growth Stocks Priced at a Bargain This Spring,2017-04-03 16:12:00 +0000,http://finance.yahoo.com/r/7df0c0bb-c384-3b4e-a6ec-9190166c611a/3-top-growth-stocks-priced-at-a-bargain-this-sprin.aspx?yptr=yahoo&.tsrc=rss,High-quality growth stocks abound for patient long-term investors.
ALXN,ALXN:UW,BBG000G32HL2,3 Top Growth Stocks Priced at a Bargain This Spring,2017-04-03 16:12:00 +0000,https://www.fool.com/investing/2017/04/03/3-top-growth-stocks-priced-at-a-bargain-this-sprin.aspx,3 Top Growth Stocks Priced at a Bargain This Spring
ALXN,ALXN:UW,BBG000G32HL2,Akari Gets Fast Track Status for Coversin Drug,2017-03-31 14:27:00 +0000,http://finance.yahoo.com/r/daf1d76f-8990-3e0d-a2ea-472c079e8aa6/akari-gets-fast-track-status-coversin-aktx?partner=YahooSA&yptr=yahoo&.tsrc=rss,Akari Therapeutics' Coversin drug got fast track designation.
ALXN,ALXN:UW,BBG000G32HL2,Which Biotechs Are Buyable As Sector Recovers In 2017?,2017-03-30 20:08:02 +0000,http://finance.yahoo.com/r/c19d435e-c5ae-321e-b275-2c2857e8deb4/which-biotechs-are-buyable-as-sector-recovers-in-2017?src=A00220A&yptr=yahoo&.tsrc=rss,"Biotech stocks have outperformed major indexes in 2017 and, on Thursday, a slew grabbed buy ratings."
ALXN,ALXN:UW,BBG000G32HL2,Which Biotechs Are Buyable As Sector Recovers In 2017?,2017-03-30 20:08:02 +0000,http://www.investors.com/news/technology/which-biotechs-are-buyable-as-sector-recovers-in-2017/?src=A00220A,Which Biotechs Are Buyable As Sector Recovers In 2017?
ALXN,ALXN:UW,BBG000G32HL2,Coverage initiated on Alexion Pharma by UBS,2017-03-30 13:23:21 +0000,http://finance.yahoo.com/q/ud?s=ALXN,Coverage initiated on Alexion Pharma by UBS
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study",2017-03-29 14:02:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kkJcVYj4Ifo/biotech-stock-roundup-regeneron-tesaro-drugs-approved-vertex-scores-big-in-study-cm767052,Key highlights this week include FDA approval of two highly awaited drugs Regeneron REGN Sanofi s Dupixent and Tesaro s TSRO Zejula Both drugs have blockbuster potential Vertex VRTX also got a boost with positive data being generated from a couple of late stage studies Recap of
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study",2017-03-29 12:15:00 +0000,http://finance.yahoo.com/r/b9b72f4a-909f-32b9-99d7-17455f911c52/biotech-stock-roundup-regeneron-tesaro-drugs-approved-vertex-scores-big-study?partner=YahooSA&yptr=yahoo&.tsrc=rss,Key highlights this week include FDA approval of two highly-awaited drugs – Regeneron REGN/Sanofi’s Dupixent and Tesaro’s TSRO Zejula. Both drugs have blockbuster potential. Vertex VRTX also got a boost ...
ALXN,ALXN:UW,BBG000G32HL2,Here's Why Omeros Corporation Stock Climbed Higher Today,2017-03-28 22:59:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-oGB014_RY/heres-why-omeros-corporation-stock-climbed-higher-today-cm766949,What happened Shares of Omeros Corporation NASDAQ OMER 160 a biotech developing a candidate for the treatment of rare blood disorders with limited treatment options rose 12 3 at 3 50 p m EDT during Tuesday s session The stock continued its climb after the company described
ALXN,ALXN:UW,BBG000G32HL2,Here's Why Omeros Corporation Stock Climbed Higher Today,2017-03-28 21:03:00 +0000,https://www.fool.com/investing/2017/03/28/heres-why-omeros-corporation-stock-climbed-higher.aspx,Here's Why Omeros Corporation Stock Climbed Higher Today
ALXN,ALXN:UW,BBG000G32HL2,Here's Why Omeros Corporation Stock Climbed Higher Today,2017-03-28 21:03:00 +0000,http://finance.yahoo.com/r/fe712602-077b-398a-a237-da0dbd189ef3/heres-why-omeros-corporation-stock-climbed-higher.aspx?yptr=yahoo&.tsrc=rss,Good news for the company's clinical-stage candidate keeps pouring in.
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion Names New CEO Following Internal Sales-Practice Probe,2017-03-27 21:29:15 +0000,https://www.wsj.com/articles/alexion-names-new-ceo-following-internal-sales-practice-probe-1490636870?mod=yahoo_hs,[$$] Alexion Names New CEO Following Internal Sales-Practice Probe
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion Names New CEO Following Internal Sales-Practice Probe,2017-03-27 21:29:15 +0000,http://finance.yahoo.com/r/970bed57-0a93-3e47-b080-1d8567ed2a50/alexion-names-new-ceo-following-internal-sales-practice-probe-1490636870?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals Inc. named new a chief executive Monday, months after the company’s top leadership abruptly stepped down amid an internal investigation into sales practices."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma names former Baxalta chief Ludwig Hantson CEO,2017-03-27 14:50:34 +0000,http://finance.yahoo.com/news/alexion-pharma-names-former-baxalta-112806655.html?.tsrc=rss,"Alexion Pharmaceuticals Inc on  Monday named former Baxalta CEO Ludwig Hantson to its top job,  as the rare-disease drug maker seeks to regain investor  confidence following the exit of top management.  Hantson's appointment comes after a challenging few months  for the U.S. biotech.  Alexion's flagship drug Soliris, which treats two rare blood  disorders, has fueled much of the company's growth, but looming  competition and the drug's slowing sales growth in recent  quarters have made investors jittery."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma names former Baxalta chief Ludwig Hantson CEO,2017-03-27 14:50:34 +0000,http://finance.yahoo.com/news/alexion-pharma-names-former-baxalta-112806655.html,Alexion Pharma names former Baxalta chief Ludwig Hantson CEO
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E",2017-03-27 12:24:54 +0000,http://biz.yahoo.com/e/170327/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO",2017-03-27 12:07:00 +0000,https://www.thestreet.com/story/14060032/1/alexion-pharma-still-recovering-from-boardroom-troubles-appoints-new-ceo.html?puc=yahoo&cm_ven=YAHOO,"Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO",2017-03-27 12:07:00 +0000,http://finance.yahoo.com/r/90fe4f91-4ae1-392f-8a2c-0352430a784e/alexion-pharma-still-recovering-from-boardroom-troubles-appoints-new-ceo.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Ludwig Hantson takes over the top Alexion job after serving as CEO of Baxalta, which he helped sell to Shire for $32 billion."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma names former Baxalta head Ludwig Hantson CEO,2017-03-27 10:43:08 +0000,http://finance.yahoo.com/news/alexion-pharma-names-former-baxalta-104308393.html,Alexion Pharma names former Baxalta head Ludwig Hantson CEO
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Appoints Ludwig Hantson, Ph.D., as Chief Executive Officer",2017-03-27 10:30:00 +0000,http://finance.yahoo.com/news/alexion-appoints-ludwig-hantson-ph-103000807.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. today announced that its Board of Directors has appointed Ludwig N. Hantson, Ph.D., as Chief Executive Officer and member of the Board of Directors, effective immediately."
ALXN,ALXN:UW,BBG000G32HL2,"6:30 am Alexion Pharma appoints Ludwig N. Hantson, Ph.D., as CEO and member of the Board of Directors, effective immediately",2017-03-27 10:30:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#alxn,"6:30 am Alexion Pharma appoints Ludwig N. Hantson, Ph.D., as CEO and member of the Board of Directors, effective immediately"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Appoints Ludwig Hantson, Ph.D., as Chief Executive Officer",2017-03-27 10:30:00 +0000,http://finance.yahoo.com/news/alexion-appoints-ludwig-hantson-ph-103000807.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. today announced that its Board of Directors has appointed Ludwig N. Hantson, Ph.D., as Chief Executive Officer and member of the Board of Directors, effective immediately."
ALXN,ALXN:UW,BBG000G32HL2,Wall Street Might Open Broadly Lower,2017-03-27 08:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iATlTlH-Bhk/wall-street-might-open-broadly-lower-20170327-00545,Wall Street Might Open Broadly Lower
ALXN,ALXN:UW,BBG000G32HL2,Alexion Names Ludwig Hantson CEO - Quick Facts,2017-03-27 06:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M_oPY0_39a0/alexion-names-ludwig-hantson-ceo--quick-facts-20170327-00215,Alexion Names Ludwig Hantson CEO - Quick Facts
ALXN,ALXN:UW,BBG000G32HL2,Omeros: Power in the Pipeline,2017-03-24 15:01:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZwzzmtTmkDg/omeros-power-in-the-pipeline-cm765189,Although 2016 could be considered more of a year to forget for Omeros NASDAQ OMER investors 2017 has the potential to be this company s best year by far The combination of solid execution on revenue growth along with the start of a pivotal phase 3 trial could see shares
ALXN,ALXN:UW,BBG000G32HL2,Omeros: Power in the Pipeline,2017-03-24 13:02:00 +0000,https://www.fool.com/investing/2017/03/24/omeros-power-in-the-pipeline.aspx,Omeros: Power in the Pipeline
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Files for Soliris' Label Expansion in Japan,2017-03-23 17:01:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DV3h0VCCvic/alexion-alxn-files-for-soliris-label-expansion-in-japan-cm764766,Alexion Pharmaceuticals Inc ALXN announced that it has submitted an application to Japan s Ministry of Labour and Welfare MHLW for the label expansion for Soliris to treat patients with refractory generalized myasthenia gravis gMG who are anti acetylcholine receptor
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Files for Soliris' Label Expansion in Japan,2017-03-23 14:16:02 +0000,http://finance.yahoo.com/news/alexion-alxn-files-soliris-label-141602567.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. (ALXN) announced that it has submitted an application to Japan's Ministry of Labour and Welfare (MHLW) for the label expansion for Soliris to treat patients with refractory generalized myasthenia gravis (gMG)."
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Files for Soliris' Label Expansion in Japan,2017-03-23 14:16:02 +0000,http://finance.yahoo.com/news/alexion-alxn-files-soliris-label-141602567.html,Alexion (ALXN) Files for Soliris' Label Expansion in Japan
ALXN,ALXN:UW,BBG000G32HL2,Health Care Sector Update for 03/23/2017: ALXN,2017-03-23 13:38:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EavEiuBizPc/health-care-sector-update-for-03232017-alxn-cm764561,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE flatPFE flat ABT flatABT flat MRK flatMRK flat AMGN 0 1 AMGN 0 1 Health care shares were mainly unchanged in pre market trade on Thursday Health care shares were mainly unchanged in pre market trade on Thursday
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Premarket Movers: Insys, Ultragenyx, Alexion",2017-03-23 13:36:00 +0000,https://www.thestreet.com/story/14056918/1/biotech-premarket-movers-insys-ultragenyx-alexion.html?puc=yahoo&cm_ven=YAHOO,"Biotech Premarket Movers: Insys, Ultragenyx, Alexion"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG),2017-03-22 20:05:00 +0000,http://au.finance.yahoo.com/news/alexion-submits-application-japan-soliris-200500871.html,"[Business Wire] - NEW HAVEN, Conn.--(BUSINESSWIRE)-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN - News) announced today that it has submitted an application to Japan’s Ministry of Labour and Welfare (MHLW) to extend the indication for Soliris® (eculizumab) as a potential treatment for patients with refractory generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive. “We look forward to working with the Japanese health authorities to bring this potentially life-transforming treatment to patients in Japan who are suffering and in urgent need of an effective therapy,” said Martin Mackay, Ph.D., Executive Vice President and Global Head of R&D at Alexion."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG),2017-03-22 20:05:00 +0000,http://finance.yahoo.com/news/alexion-submits-application-japan-soliris-200500535.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. announced today that it has submitted an application to Japan’s Ministry of Labour and Welfare to extend the indication for Soliris®  as a potential treatment for patients with refractory generalized myasthenia gravis who are anti-acetylcholine receptor antibody-positive."
ALXN,ALXN:UW,BBG000G32HL2,"Commit To Buy Alexion Pharmaceuticals At $75, Earn 5.1% Using Options",2017-03-22 17:07:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PN9HMjYpVEs/commit-to-buy-alexion-pharmaceuticals-at-75-earn-51-using-options-cm764180,Investors considering a purchase of Alexion Pharmaceuticals Inc Symbol ALXN stock but cautious about paying the going market price of 119 16 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Enters Oversold Territory (ALXN),2017-03-21 18:07:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DFkIRegm66Q/alexion-pharmaceuticals-enters-oversold-territory-alxn-cm763656,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ALXN,ALXN:UW,BBG000G32HL2,Look Under The Hood: BBH Has 12% Upside,2017-03-20 15:07:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lm6cnY1F0oc/look-under-the-hood-bbh-has-12-upside-cm762798,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Licenses Artubus Technology for Rare Diseases,2017-03-18 00:05:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e11LHetXY08/alexion-alxn-licenses-artubus-technology-for-rare-diseases-cm762482,Alexion Pharmaceuticals Inc ALXN has recently licensed Arbutus Biopharma Corporation s ABUS proprietary lipid nanoparticle LNP technology for use in one of former s rare disease programs The agreement enables Alexion to address the delivery of therapeutic application of messenger
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Licenses Artubus Technology for Rare Diseases,2017-03-17 22:01:10 +0000,http://finance.yahoo.com/news/alexion-alxn-licenses-artubus-technology-220110869.html,Alexion (ALXN) Licenses Artubus Technology for Rare Diseases
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Licenses Artubus Technology for Rare Diseases,2017-03-17 22:01:10 +0000,http://finance.yahoo.com/news/alexion-alxn-licenses-artubus-technology-220110869.html?.tsrc=rss,"Alexion Pharmaceuticals, Inc. (ALXN) has recently licensed Arbutus Biopharma proprietary LNP technology for use in rare disease programs."
ALXN,ALXN:UW,BBG000G32HL2,Close Update: Stocks Limp Into Friday's Close But Hang Onto Slim Gains For the Week,2017-03-17 21:25:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dg3G0v0XPS0/close-update-stocks-limp-into-fridays-close-but-hang-onto-slim-gains-for-the-week-cm762454,Wall Street was largely directionless on Friday with the benchmark averages hugging the flatline Continued profit taking pressure in the financial sector in the wake of the Federal Open Market Committee meeting this week was offset by gains in defensive sectors and industrial shares Shallow
ALXN,ALXN:UW,BBG000G32HL2,Midday Update: Market Indices Flat But Set to Close The Week Higher,2017-03-17 17:25:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SuUNiXRDNIw/midday-update-market-indices-flat-but-set-to-close-the-week-higher-cm762327,The benchmark averages were anchored to the flatline on Friday as steep losses in the healthcare and financial sectors were offset by strength in industrials utilities and material stocks Data on production and confidence of the U S consumer were briefly supportive but failed to generate
ALXN,ALXN:UW,BBG000G32HL2,Alexion Buys LNP Drug Delivery Tech from Arbutus,2017-03-17 15:43:00 +0000,http://www.investopedia.com/news/alexion-buys-lnp-tech-arbutus-alxn-abus/?partner=YahooSA,Alexion Buys LNP Drug Delivery Tech from Arbutus
ALXN,ALXN:UW,BBG000G32HL2,Alexion Buys LNP Drug Delivery Tech from Arbutus,2017-03-17 15:43:00 +0000,http://finance.yahoo.com/r/b6c943bc-043c-3188-a639-fe1d2c154b74/alexion-buys-lnp-tech-arbutus-alxn-abus?partner=YahooSA&yptr=yahoo&.tsrc=rss,Alexion hopes to use Arbutus' lipid nanoparticle technology for targeted drug delivery.
ALXN,ALXN:UW,BBG000G32HL2,Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates,2017-03-17 15:21:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/87f2TufHB8g/mid-morning-market-update-markets-edge-higher-tiffany-earnings-top-estimates-cm762287,Following the market opening Friday the Dow traded up 0 07 percent to 20 950 20 while the NASDAQ gained 0 01 percent to 5 901 52 The S amp P also rose gaining 0 04 percent to 2 382 30 Leading and Lagging Sectors Basic materials shares climbed 0 56 percent in trading on
ALXN,ALXN:UW,BBG000G32HL2,Futures Cautiously Higher Ahead of Production Data,2017-03-17 13:45:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/41FVKF6ZbpI/futures-cautiously-higher-ahead-of-production-data-cm762114,Stock futures are marginally higher ahead of Friday s open with Wall Street waiting for cues from this morning s series of economic data as well as the impact the day s expiration of stock index futures and options and stock futures and options will have on trading Gains in the energy
ALXN,ALXN:UW,BBG000G32HL2,Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product Candidate,2017-03-16 21:00:00 +0000,http://finance.yahoo.com/news/arbutus-licenses-lnp-delivery-technology-210000761.html?.tsrc=rss,"VANCOUVER, British Columbia and DOYLESTOWN, Pa., March 16, 2017-- Arbutus Biopharma Corporation, an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus ..."
ALXN,ALXN:UW,BBG000G32HL2,Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product Candidate,2017-03-16 21:00:00 +0000,http://finance.yahoo.com/news/arbutus-licenses-lnp-delivery-technology-210000761.html,"[GlobeNewswire] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., March 16, 2017-- Arbutus Biopharma Corporation, an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus ..."
ALXN,ALXN:UW,BBG000G32HL2,Catalyst Pharma Neuromuscular Drug Succeeds In Study,2017-03-15 19:17:00 +0000,http://finance.yahoo.com/r/e09b4639-ba24-3633-a116-80d22aad1d9f/catalyst-pharma-neuromuscular-drug-succeeds-cprx?partner=YahooSA&yptr=yahoo&.tsrc=rss,Catalyst stock hit a 52-week high after its Firdapse drug reported positive study results.
ALXN,ALXN:UW,BBG000G32HL2,Pharmaceutical company to lay off more than 200 employees,2017-03-15 10:04:52 +0000,http://finance.yahoo.com/news/pharmaceutical-company-lay-off-more-100452216.html?.tsrc=rss,A Connecticut pharmaceutical company has announced it plans to lay off more than 200 employees in the coming weeks. The New Haven Register reports (http://bit.ly/2nqZlIS ) that a spokeswoman for Alexion ...
ALXN,ALXN:UW,BBG000G32HL2,Pharmaceutical company to lay off more than 200 employees,2017-03-15 10:04:52 +0000,http://sg.finance.yahoo.com/news/pharmaceutical-company-lay-off-more-100452197.html,Pharmaceutical company to lay off more than 200 employees
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Trims Workforce, Scraps R&D Programs",2017-03-14 16:55:00 +0000,http://finance.yahoo.com/r/08dc0166-6319-30fe-9798-eba422b3c86c/alexion-trims-workforce-scraps-rd-programs-alxn?partner=YahooSA&yptr=yahoo&.tsrc=rss,Alexion has planned a restructuring to optimize its workforce and reassess its R&D programs.
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Trims Workforce, Scraps R&D Programs",2017-03-14 16:55:00 +0000,http://www.investopedia.com/news/alexion-trims-workforce-scraps-rd-programs-alxn/?partner=YahooSA,"Alexion Trims Workforce, Scraps R&D Programs"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Cuts 7% of Workforce,2017-03-14 13:42:00 +0000,https://www.thestreet.com/story/14042157/1/alexion-pharmaceuticals-cuts-7-of-workforce.html?puc=yahoo&cm_ven=YAHOO,Alexion Pharmaceuticals Cuts 7% of Workforce
ALXN,ALXN:UW,BBG000G32HL2,Why Did the Healthcare Sector Fall on March 13?,2017-03-14 11:39:11 +0000,http://marketrealist.com/2017/03/healthcare-sector-decline-march-13/?utm_source=yahoo&utm_medium=feed,Why Did the Healthcare Sector Fall on March 13?
ALXN,ALXN:UW,BBG000G32HL2,England Says No to Drugs That Cost More Than Your Car (or Home),2017-03-14 05:00:00 +0000,https://www.bloomberg.com/news/articles/2017-03-14/england-says-no-to-drugs-that-cost-more-than-your-car-or-home?cmpid=yhoo.headline,England Says No to Drugs That Cost More Than Your Car (or Home)
ALXN,ALXN:UW,BBG000G32HL2,Alexion to cut 7 pct of workforce,2017-03-13 22:17:25 +0000,http://finance.yahoo.com/news/alexion-cut-7-pct-workforce-221725460.html,Alexion to cut 7 pct of workforce
ALXN,ALXN:UW,BBG000G32HL2,Stock market holds its ground as Fed rate decision looms,2017-03-13 20:36:26 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=25ABC4EA-07CB-11E7-9134-706AC7433493&siteid=yhoof2,[at MarketWatch] - The U.S. stock market closes marginally higher after switching between small gains and losses on Monday as investors refrained from making sizable bets ahead of a Federal Reserve meeting that is widely ...
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy Monday Option Activity: ALXN, ANTM, PN",2017-03-13 17:05:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mJxGEiHAiq0/noteworthy-monday-option-activity-alxn-antm-pn-cm760052,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Alexion Pharmaceuticals Inc Symbol ALXN where a total of 25 562 contracts have traded so far representing approximately 2 6 million underlying shares That amounts to about 116 8
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: TSCO, CTRP",2017-03-13 16:07:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ky2mxc6meA8/nasdaq-100-movers-tsco-ctrp-cm759966,In early trading on Monday shares of Ctrip com International CTRP topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 6 Year to date Ctrip com International registers a 23 8 gain And the worst performing Nasdaq 100 component thus far on
ALXN,ALXN:UW,BBG000G32HL2,Alexion's sBLA for Soliris Receives FDA Acknowledgement,2017-03-11 00:14:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XC95fOoMveg/alexions-sbla-for-soliris-receives-fda-acknowledgement-cm759433,Alexion Pharmaceuticals Inc ALXN announced that the FDA on Mar 9 has accepted the supplemental Biologics License Application sBLA to expand the indication for Soliris for the potential treatment of 160 patients with refractory generalized myasthenia gravis gMG who
ALXN,ALXN:UW,BBG000G32HL2,Alexion's sBLA for Soliris Receives FDA Acknowledgement,2017-03-10 15:55:03 +0000,http://finance.yahoo.com/news/alexions-sbla-soliris-receives-fda-165504475.html,Alexion's sBLA for Soliris Receives FDA Acknowledgement
ALXN,ALXN:UW,BBG000G32HL2,"3 Big Stock Charts for Thursday: CA, Inc. (CA), Autodesk, Inc. (ADSK) and Alexion Pharmaceuticals, Inc. (ALXN)",2017-03-09 19:16:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3tbYbk45z4M/3-big-stock-charts-for-thursday-ca-inc-ca-autodesk-inc-adsk-and-alexion-pharmaceuticals-inc-alxn-cm758770,InvestorPlace Stock Market News Stock Advice amp Trading Tips We re starting to see more technical snags in the bull market that initiated after the results of the election in November All sectors are beginning to see dealers take profits or worse knock stocks out of
ALXN,ALXN:UW,BBG000G32HL2,ALXN Crosses Below Key Moving Average Level,2017-03-08 23:12:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2rBjbQ0ogTQ/alxn-crosses-below-key-moving-average-level-cm758168,In trading on Wednesday shares of Alexion Pharmaceuticals Inc Symbol ALXN crossed below their 200 day moving average of 128 28 changing hands as low as 126 17 per share Alexion Pharmaceuticals Inc shares are currently trading down about 1 4 on the day The chart below shows the one
ALXN,ALXN:UW,BBG000G32HL2,FDA Accepts sBLA Filing of Soliris® (Eculizumab) as a Potential Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG),2017-03-08 11:30:00 +0000,http://finance.yahoo.com/news/fda-accepts-sbla-filing-soliris-113000927.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has accepted for review the Company’s supplemental Biologics License Application to extend the indication for Soliris® as a potential treatment for patients with refractory generalized myasthenia gravis who are anti-acetylcholine receptor antibody-positive."
ALXN,ALXN:UW,BBG000G32HL2,Is This the Right Time to Invest in Biotech Stocks?,2017-03-07 14:16:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XB4ddS57gBw/is-this-the-right-time-to-invest-in-biotech-stocks-cm757033,The biotech industry was once a Wall Street favorite chalking up impressive gains until 2015 when the drug pricing issue started weighing on the sector However a look at the industry s year to date YTD price performance indicates that the sector is showing signs of recovery But will the
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals To Participate In Raymond James Conference At 1:05 PM ET,2017-03-07 12:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t-t2oDjjQ-0/alexion-pharmaceuticals-to-participate-in-raymond-james-conference-at-105-pm-et-20170307-01044,Alexion Pharmaceuticals To Participate In Raymond James Conference At 1:05 PM ET
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals To Participate In Cowen & Co Conference At 1:20 PM ET,2017-03-06 12:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gzst7uaI_xY/alexion-pharmaceuticals-to-participate-in-cowen--co-conference-at-120-pm-et-20170306-00952,Alexion Pharmaceuticals To Participate In Cowen & Co Conference At 1:20 PM ET
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E",2017-03-02 21:53:33 +0000,http://biz.yahoo.com/e/170302/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E"
ALXN,ALXN:UW,BBG000G32HL2,"Leonard Bell, M.D., Alexion’s Founder, Announces Plans to Retire as Chairman and Board Member",2017-03-02 21:05:00 +0000,http://finance.yahoo.com/news/leonard-bell-m-d-alexion-210500971.html,"[Business Wire] - Leonard Bell, M.D., Founder of Alexion Pharmaceuticals Inc. , has informed the Board of Directors that he will not stand for reelection as a Board member and will retire as Chairman of the Board and as a Director at the end of his term, effective as of the Annual Meeting of Shareholders scheduled for May 10, 2017."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Board Plans To Appoint David Brennan To Succeed Bell As Chairman,2017-03-02 17:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3ymegx2bYdg/alexion-board-plans-to-appoint-david-brennan-to-succeed-bell-as-chairman-20170302-01638,Alexion Board Plans To Appoint David Brennan To Succeed Bell As Chairman
ALXN,ALXN:UW,BBG000G32HL2,Regeneron Could See a Modest Rise in Net Profit Margins in 2017,2017-03-01 15:37:18 +0000,http://marketrealist.com/2017/02/regeneron-expected-witness-modest-rise-net-profit-margins-2017/?utm_source=yahoo&utm_medium=feed,Regeneron Could See a Modest Rise in Net Profit Margins in 2017
ALXN,ALXN:UW,BBG000G32HL2,Alexion Expects This to Be Big Medicine in 2017,2017-03-01 12:36:04 +0000,http://marketrealist.com/2017/02/alexion-pharmaceuticals-expects-alxn-1210-prove-potent-next-generation-c5-inhibitor/?utm_source=yahoo&utm_medium=feed,Alexion Expects This to Be Big Medicine in 2017
ALXN,ALXN:UW,BBG000G32HL2,Will Alexion’s Research Make Gains in the Inhibitor Space?,2017-02-28 15:36:43 +0000,http://marketrealist.com/2017/02/alexion-pharmaceuticals-continues-advance-research-programs-complement-inhibitor-space/?utm_source=yahoo&utm_medium=feed,Will Alexion’s Research Make Gains in the Inhibitor Space?
ALXN,ALXN:UW,BBG000G32HL2,Alnylam Pharmaceuticals Advances Its Patisiran Research Program,2017-02-28 14:09:18 +0000,http://marketrealist.com/2017/02/alnylam-pharmaceuticals-continues-advance-patisiran-research-program-2017/?utm_source=yahoo&utm_medium=feed,Alnylam Pharmaceuticals Advances Its Patisiran Research Program
ALXN,ALXN:UW,BBG000G32HL2,What Alexion Expects from Its Metabolic Disease Drugs in 2017,2017-02-28 14:07:34 +0000,http://marketrealist.com/2017/02/alexion-pharmaceuticals-expects-solid-performance-metabolic-disease-drugs-2017/?utm_source=yahoo&utm_medium=feed,What Alexion Expects from Its Metabolic Disease Drugs in 2017
ALXN,ALXN:UW,BBG000G32HL2,"Drug Stocks Q4 Earnings Lineup for Mar 1: MYL, KERX & More",2017-02-28 13:51:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G_ZaqJbYxoY/drug-stocks-q4-earnings-lineup-for-mar-1-myl-kerx-more-cm754034,With the curtains almost down on the Q4 earnings season we believe this quarter has turned out to be a good one with growth on track to be the highest in the last two years As of Feb 17 2017 411 S amp P 500 members accounting for 88 4 of the index s total market capitalization have
ALXN,ALXN:UW,BBG000G32HL2,Understanding Alexion’s Profit Margin Trend in 2017,2017-02-28 12:37:55 +0000,http://marketrealist.com/2017/02/alexion-pharmaceuticals-expected-witness-rise-profit-margins-2017/?utm_source=yahoo&utm_medium=feed,Understanding Alexion’s Profit Margin Trend in 2017
ALXN,ALXN:UW,BBG000G32HL2,Alexion’s Soliris: Gauging Patient Demand,2017-02-27 21:05:46 +0000,http://marketrealist.com/2017/02/soliris-expected-witness-rise-patient-demand-2017/?utm_source=yahoo&utm_medium=feed,Alexion’s Soliris: Gauging Patient Demand
ALXN,ALXN:UW,BBG000G32HL2,What to Expect from Alexion’s Revenue in 2017,2017-02-27 19:35:50 +0000,http://marketrealist.com/2017/02/alexion-pharmaceuticals-expected-witness-solid-revenue-growth-2017/?utm_source=yahoo&utm_medium=feed,What to Expect from Alexion’s Revenue in 2017
ALXN,ALXN:UW,BBG000G32HL2,Inside Alexion’s Latest Analyst Recommendations,2017-02-27 18:00:09 +0000,http://marketrealist.com/2017/02/analysts-recommendations-alexion-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Inside Alexion’s Latest Analyst Recommendations
ALXN,ALXN:UW,BBG000G32HL2,"IBB, REGN, ILMN, ALXN: Large Outflows Detected at ETF",2017-02-27 17:50:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xZP75Ngulx8/ibb-regn-ilmn-alxn-large-outflows-detected-at-etf-cm753678,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 217 6 million dollar outflow that s a 2 6 decrease week over week
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at Upcoming Investor Conferences,2017-02-27 15:21:00 +0000,http://finance.yahoo.com/news/alexion-present-upcoming-investor-conferences-152100046.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. today announced that management will present at two upcoming investor conferences:"
ALXN,ALXN:UW,BBG000G32HL2,Inside Vertex’s Revenue Expectations for 2017,2017-02-24 20:35:48 +0000,http://marketrealist.com/2017/02/vertex-pharmaceuticals-expected-witness-solid-revenue-growth-2017/?utm_source=yahoo&utm_medium=feed,Inside Vertex’s Revenue Expectations for 2017
ALXN,ALXN:UW,BBG000G32HL2,Vertex Expects Modest Revenue Growth in This,2017-02-24 19:06:02 +0000,http://marketrealist.com/2017/02/vertex-pharmaceuticals-expects-modest-revenue-growth-orkambi-2017/?utm_source=yahoo&utm_medium=feed,Vertex Expects Modest Revenue Growth in This
ALXN,ALXN:UW,BBG000G32HL2,ALEXION PHARMACEUTICALS INC Financials,2017-02-22 18:04:21 +0000,http://finance.yahoo.com/q/is?s=alxn,ALEXION PHARMACEUTICALS INC Financials
ALXN,ALXN:UW,BBG000G32HL2,"Drug Stocks Q4 Earnings Slated for Feb 23: BMRN, ICPT & More",2017-02-22 15:12:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KcgF6FkWn34/drug-stocks-q4-earnings-slated-for-feb-23-bmrn-icpt-more-cm751080,The fourth quarter earnings season is drawing to a close with results from 411 S amp P 500 members or 82 2 of the index s total membership already out as of Feb 22 2017 according to the latest Earnings Preview report Total earnings for these 411 index members were up 8 from the year
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising",2017-02-22 14:11:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lvmQma1GC9s/biotech-stock-roundup-alexion-reports-4q-results-celgene-ms-drug-looks-promising-cm751060,Key updates in the biotech sector include a mixed quarter from Alexion ALXN and promising data on Celgene s CELG investigational multiple sclerosis MS treatment Recap of the Week s Most Important Stories Mixed Results from Alexion Alexion s fourth quarter results were mixed
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: 2016 By the Numbers : February 21, 2017",2017-02-21 17:17:34 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-alxn-us-earnings-analysis-2016-by-the-numbers-february-21-2017/,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: 2016 By the Numbers : February 21, 2017"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Halts Rare-Disease Drug SBC-103 Program,2017-02-20 16:52:00 +0000,http://www.investopedia.com/news/alexion-shelves-raredisease-drug-sbc103-alxn/?partner=YahooSA,Alexion Halts Rare-Disease Drug SBC-103 Program
ALXN,ALXN:UW,BBG000G32HL2,"Forget Alexion, Buy these 4 Biotech Stocks Instead",2017-02-20 14:53:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wCRPpf18LR0/forget-alexion-buy-these-4-biotech-stocks-instead-cm750186,New Haven CT based Alexion Pharmaceuticals Inc s ALXN fourth quarter results were mixed with the company reporting in line earnings while revenues were just shy of expectations Alexion s guidance for 2017 also fell short of expectations Although flagship drug Soliris will continue
ALXN,ALXN:UW,BBG000G32HL2,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS",2017-02-20 13:52:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HZDGy-X13Nw/drug-stocks-q4-earnings-lineup-for-feb-21-irwd-mnta-exas-cm750167,As the Q4 earnings season enters the last leg we believe this quarter is on track to witness the highest growth momentum in the last two years As of Feb 17 2017 411 S amp P 500 members accounting for 88 4 of the index s total market capitalization have reported results according to
ALXN,ALXN:UW,BBG000G32HL2,"Forget Alexion, Buy these 4 Biotech Stocks Instead",2017-02-20 12:52:12 +0000,http://finance.yahoo.com/news/forget-alexion-buy-4-biotech-125212478.html,"Forget Alexion, Buy these 4 Biotech Stocks Instead"
ALXN,ALXN:UW,BBG000G32HL2,Tough U.K. Line on Rare-Disease Drugs Stirs Concern After Brexit,2017-02-20 06:48:10 +0000,https://www.bloomberg.com/news/articles/2017-02-20/tough-u-k-line-on-rare-disease-drugs-stirs-concern-after-brexit?cmpid=yhoo.headline,Tough U.K. Line on Rare-Disease Drugs Stirs Concern After Brexit
ALXN,ALXN:UW,BBG000G32HL2,"Barron's Picks And Pans: General Motors, Hess, Biotechs And More",2017-02-19 22:15:05 +0000,http://finance.yahoo.com/news/barrons-picks-pans-general-motors-221505378.html,"Barron's Picks And Pans: General Motors, Hess, Biotechs And More"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. (ALXN) Suffers Another Blow In The UK",2017-02-17 17:32:21 +0000,http://www.insidermonkey.com/blog/alexion-pharmaceuticals-inc-alxn-suffers-another-blow-in-the-uk-560321/,"Alexion Pharmaceuticals, Inc. (ALXN) Suffers Another Blow In The UK"
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ALXN, KHC",2017-02-17 16:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oj2Fh78ZQno/nasdaq-100-movers-alxn-khc-cm749669,In early trading on Friday shares of Kraft Heinz KHC topped the list of the day s best performing components of the Nasdaq 100 index trading up 7 5 Year to date Kraft Heinz registers a 7 5 gain And the worst performing Nasdaq 100 component thus far on the day is
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017",2017-02-17 14:37:42 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-alxn-us-earnings-analysis-q4-2016-by-the-numbers-february-17-2017/,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017"
ALXN,ALXN:UW,BBG000G32HL2,[$$] Takeover Candidate Alexion Is on the Mend,2017-02-17 12:44:00 +0000,http://www.barrons.com/articles/takeover-candidate-alexion-is-on-the-mend-1487335480?mod=yahoobarrons&ru=yahoo,[$$] Takeover Candidate Alexion Is on the Mend
ALXN,ALXN:UW,BBG000G32HL2,Edited Transcript of ALXN earnings conference call or presentation 16-Feb-17 3:00pm GMT,2017-02-17 01:57:42 +0000,http://finance.yahoo.com/news/edited-transcript-alxn-earnings-conference-015742835.html,Edited Transcript of ALXN earnings conference call or presentation 16-Feb-17 3:00pm GMT
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Misses on Q4 Earnings and Revenues,2017-02-16 22:55:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GgrWlmuqTIc/alexion-alxn-misses-on-q4-earnings-and-revenues-cm749239,Alexion Pharmaceuticals Inc ALXN focuses on the development and commercialization of life transforming drugs for treating patients suffering from ultra rare disorders Soliris approved for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome is the key product of this
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y",2017-02-16 22:54:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZD47EscK3gY/alexion-alxn-q4-earnings-in-line-sales-rise-yy-cm749218,Alexion Pharmaceuticals Inc s ALXN fourth quarter 2016 earnings including stock based compensation expense of 1 10 cents per share compared with the year ago earnings of 78 cents Earnings were in line with the Zacks Consensus Estimate of 1 10 Revenues on the other hand rose 19
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y",2017-02-16 21:19:09 +0000,http://finance.yahoo.com/news/alexion-alxn-q4-earnings-line-211909291.html,"Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion's 'Meh' 2017 Guide Soothes Worries Of Decline, But PNH Drug Key",2017-02-16 21:16:10 +0000,http://www.investors.com/news/technology/alexions-meh-2017-guide-soothes-worries-of-decline-but-pnh-drug-key/,"Alexion's 'Meh' 2017 Guide Soothes Worries Of Decline, But PNH Drug Key"
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Misses on Q4 Earnings and Revenues,2017-02-16 21:00:09 +0000,http://finance.yahoo.com/news/alexion-alxn-misses-q4-earnings-210009204.html,Alexion (ALXN) Misses on Q4 Earnings and Revenues
ALXN,ALXN:UW,BBG000G32HL2,Alexion Needs New Bets,2017-02-16 19:30:34 +0000,https://www.bloomberg.com/gadfly/articles/2017-02-16/alexion-needs-soliris-plan-b?cmpid=yhoo.headline,Alexion Needs New Bets
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma's revenue forecast allays investor fears,2017-02-16 18:49:19 +0000,http://sg.finance.yahoo.com/news/alexion-pharma-revenue-forecast-allays-184706554.html,Alexion Pharma's revenue forecast allays investor fears
ALXN,ALXN:UW,BBG000G32HL2,Alexion 4Q Earnings of $1.26 a Share Beats Street,2017-02-16 17:43:00 +0000,http://www.investopedia.com/news/alexion-4q-net-126share-beats-street-alxn/?partner=YahooSA,Alexion 4Q Earnings of $1.26 a Share Beats Street
ALXN,ALXN:UW,BBG000G32HL2,Alexion’s Kanuma Drug Denied UK Approval,2017-02-16 17:03:00 +0000,http://www.investopedia.com/news/alexions-kanuma-drug-denied-uk-approval-alxn/?partner=YahooSA,Alexion’s Kanuma Drug Denied UK Approval
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma's Bloated Blockbuster Deal Still Haunts,2017-02-16 15:38:00 +0000,https://www.thestreet.com/story/14005166/1/alexion-pharma-s-bloated-blockbuster-deal-still-haunts.html?puc=yahoo&cm_ven=YAHOO,Alexion Pharma's Bloated Blockbuster Deal Still Haunts
ALXN,ALXN:UW,BBG000G32HL2,How Alexion’s Pipeline Is Driving Earnings,2017-02-16 14:30:37 +0000,http://finance.yahoo.com/news/alexion-pipeline-driving-earnings-142737607.html,How Alexion’s Pipeline Is Driving Earnings
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals on the Recovery Trail,2017-02-16 14:23:00 +0000,http://www.investopedia.com/stock-analysis/cotd/021617/alexion-pharmaceuticals-recovery-trail-alxn-alxn.aspx?partner=YahooSA,Alexion Pharmaceuticals on the Recovery Trail
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a",2017-02-16 14:05:58 +0000,http://biz.yahoo.com/e/170216/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma revenue forecast allays fears about Soliris' future,2017-02-16 13:55:11 +0000,http://finance.yahoo.com/news/alexion-revenue-misses-forecasts-2017-120144249.html,Alexion Pharma revenue forecast allays fears about Soliris' future
ALXN,ALXN:UW,BBG000G32HL2,"Early movers: WEN, TIME, ALXN, AVP, GNC, TPX & more",2017-02-16 13:04:07 +0000,http://www.cnbc.com/id/104286464?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104286464,"Early movers: WEN, TIME, ALXN, AVP, GNC, TPX & more"
ALXN,ALXN:UW,BBG000G32HL2,Q4 2016 Alexion Pharmaceuticals Inc Earnings Release - Before Market Open,2017-02-16 12:07:02 +0000,http://biz.yahoo.com/research/earncal/20170216.html?t=alxn,Q4 2016 Alexion Pharmaceuticals Inc Earnings Release - Before Market Open
ALXN,ALXN:UW,BBG000G32HL2,Alexion tops 4Q profit forecasts,2017-02-16 11:48:41 +0000,http://sg.finance.yahoo.com/news/alexion-tops-4q-profit-forecasts-114841964.html,Alexion tops 4Q profit forecasts
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma's revenue rises 18.5 pct,2017-02-16 11:37:04 +0000,http://finance.yahoo.com/news/alexion-pharmas-revenue-rises-18-113704310.html,Alexion Pharma's revenue rises 18.5 pct
ALXN,ALXN:UW,BBG000G32HL2,Alexion Reports Fourth Quarter and Full Year 2016 Results and Provides Financial Guidance for 2017,2017-02-16 11:30:00 +0000,http://finance.yahoo.com/news/alexion-reports-fourth-quarter-full-113000151.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. today announced financial results for the fourth quarter and full year of 2016. Total revenues for the full year of 2016 were $3.084 billion, an 18 percent increase compared to 2015."
ALXN,ALXN:UW,BBG000G32HL2,5 Things You Must Know Before the Market Opens Thursday,2017-02-16 10:59:00 +0000,https://www.thestreet.com/story/14002804/1/5-things-you-must-know-before-the-market-opens-thursday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Thursday
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Q4 16 Earnings Conference Call At 10:00 AM ET,2017-02-16 09:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U-uYmUooZXc/alexion-pharmaceuticals-q4-16-earnings-conference-call-at-1000-am-et-20170216-00857,Alexion Pharmaceuticals Q4 16 Earnings Conference Call At 10:00 AM ET
ALXN,ALXN:UW,BBG000G32HL2,Alexion Expands Share Buyback; Sees FY17 Results Below View,2017-02-16 06:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mJscuG6Q7hE/alexion-expands-share-buyback-sees-fy17-results-below-view-20170216-00335,Alexion Expands Share Buyback; Sees FY17 Results Below View
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. Bottom Line Advances 20% In Q4,2017-02-16 06:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ZPUntcBFpQ/alexion-pharmaceuticals-inc-bottom-line-advances-20-in-q4-20170216-00324,Alexion Pharmaceuticals Inc. Bottom Line Advances 20% In Q4
ALXN,ALXN:UW,BBG000G32HL2,"Pre-Market Earnings Report for February 16, 2017 :  CHTR, DUK, PCG, WM, ALXN, ZTS, MGM, LH, AEE, ECA, SCG, HII",2017-02-15 21:13:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d73awPFvzIA/pre-market-earnings-report-for-february-16-2017-chtr-duk-pcg-wm-alxn-zts-mgm-lh-aee-eca-scg-hii-cm748583,The following companies are expected to report earnings prior to market open on 02 16 2017 Visit our Earnings Calendar for a full list of expected earnings releases Charter Communications Inc CHTR is reporting for the quarter ending December 31 2016
ALXN,ALXN:UW,BBG000G32HL2,5 Stocks to Watch that Report Earnings Tomorrow,2017-02-15 20:30:16 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-that-report-earnings-tomorrow-203833773.html,5 Stocks to Watch that Report Earnings Tomorrow
ALXN,ALXN:UW,BBG000G32HL2,The Top 5 Earnings Coming Out on Thursday,2017-02-15 18:50:46 +0000,http://finance.yahoo.com/news/top-5-earnings-coming-thursday-185046669.html,The Top 5 Earnings Coming Out on Thursday
ALXN,ALXN:UW,BBG000G32HL2,Goldman recommends buying underperformers ahead of their earnings,2017-02-15 15:59:01 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=46C3574A-F37D-11E6-946D-A0BDE617167E&siteid=yhoof2,Goldman recommends buying underperformers ahead of their earnings
ALXN,ALXN:UW,BBG000G32HL2,"Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More",2017-02-15 15:58:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aAFdX6KF4O4/drug-stocks-q4-earnings-slated-for-feb-16-alxn-zts-more-cm748281,The Q4 earnings season is on its last legs as results from 358 S amp P 500 members or 71 6 of the index s total membership is already out As of Feb 15 2017 358 S amp P 500 members that account for 81 2 of the index s total market capitalization have reported results according to the
ALXN,ALXN:UW,BBG000G32HL2,"Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More",2017-02-15 13:47:01 +0000,http://finance.yahoo.com/news/drug-stocks-q4-earnings-slated-134701280.html,"Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More"
ALXN,ALXN:UW,BBG000G32HL2,"Notable Tuesday Option Activity: UPS, ALXN, PEP",2017-02-14 21:19:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VvxuKWMi7GY/notable-tuesday-option-activity-ups-alxn-pep-cm747897,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in United Parcel Service Inc Symbol UPS where a total volume of 16 503 contracts has been traded thus far today a contract volume which is representative of approximately 1
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Q4 Earnings: Can the Stock Pull a Surprise?,2017-02-11 00:17:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IWb60icUy9A/alexion-alxn-q4-earnings-can-the-stock-pull-a-surprise-cm746602,Alexion Pharmaceuticals Inc ALXN is scheduled to report fourth quarter 2016 results on Feb 16 before the opening bell The company s track record has been mixed While over the last four quarters the company has beaten estimates on two occasions Alexion posted an average positive
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Q4 Earnings: Can the Stock Pull a Surprise?,2017-02-10 22:27:10 +0000,http://finance.yahoo.com/news/alexion-alxn-q4-earnings-stock-222710550.html,Alexion (ALXN) Q4 Earnings: Can the Stock Pull a Surprise?
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : February 8, 2017",2017-02-08 19:01:28 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-value-analysis-nasdaqalxn-february-8-2017/,"Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : February 8, 2017"
ALXN,ALXN:UW,BBG000G32HL2,Alexion's Expensive Bone Drug Gets Restricted By NICE,2017-02-08 17:40:00 +0000,http://www.investopedia.com/news/alexions-strensiq-gets-restricted-ok-nice-alxn/?partner=YahooSA,Alexion's Expensive Bone Drug Gets Restricted By NICE
ALXN,ALXN:UW,BBG000G32HL2,Oppenheimer: Currency FX on Rx,2017-02-08 13:26:00 +0000,http://blogs.barrons.com/focusonfunds/2017/02/07/oppenheimer-currency-fx-on-rx/?mod=yahoobarrons&ru=yahoo,Oppenheimer: Currency FX on Rx
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : February 7, 2017",2017-02-07 12:22:04 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-alxn-us-february-7-2017/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : February 7, 2017"
ALXN,ALXN:UW,BBG000G32HL2,S&P 500 Analyst Moves: ALXN,2017-02-06 18:17:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uFEucEhGM30/sp-500-analyst-moves-alxn-cm743707,The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Alexion Pharmaceuticals ALXN is now the 98 analyst pick moving up by 3 spots This rank is formed by averaging the analyst opinions for each component
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: BIIB, TSCO",2017-02-02 17:34:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/857Nhpe1nco/nasdaq-100-movers-biib-tsco-cm742329,In early trading on Thursday shares of Tractor Supply topped the list of the day s best performing components of the Nasdaq 100 index trading up 4 3 Year to date Tractor Supply has lost about 0 4 of its value And the worst performing Nasdaq 100 component thus far on the day is
ALXN,ALXN:UW,BBG000G32HL2,More Volatility Ahead for Biotechnology Sector,2017-02-01 20:42:44 +0000,http://blogs.wsj.com/moneybeat/2017/02/01/more-volatility-ahead-for-biotechnology-sector/?mod=yahoo_hs,More Volatility Ahead for Biotechnology Sector
ALXN,ALXN:UW,BBG000G32HL2,ALXN Crosses Above Key Moving Average Level,2017-01-31 23:31:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OaIupLhHnOk/alxn-crosses-above-key-moving-average-level-cm741187,In trading on Tuesday shares of Alexion Pharmaceuticals Inc Symbol ALXN crossed above their 200 day moving average of 130 36 changing hands as high as 131 07 per share Alexion Pharmaceuticals Inc shares are currently trading up about 2 on the day The chart below shows the one
ALXN,ALXN:UW,BBG000G32HL2,Blog Coverage EMA's Committee for Medicinal Products for Human Use Provides Positive Opinion for the Marketing Authorization of Amgen's ABP 501,2017-01-30 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-emas-committee-medicinal-131500662.html,"[Accesswire] - Upcoming AWS Coverage on Alexion Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / January 30, 2017 / Active Wall St. blog coverage looks at the headline from Amgen Inc. (NYSE: AMGN ) as ..."
ALXN,ALXN:UW,BBG000G32HL2,Ra Pharma deploys IPO cash in quest to overtake a rare disease rival Alexion,2017-01-27 12:00:09 +0000,http://www.bizjournals.com/boston/news/2017/01/27/ra-pharma-deploys-ipo-cash-in-quest-to-overtake-a.html?ana=yahoo,Ra Pharma deploys IPO cash in quest to overtake a rare disease rival Alexion
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Results on Thursday, February 16, 2017",2017-01-26 15:00:00 +0000,http://finance.yahoo.com/news/alexion-pharmaceuticals-report-fourth-quarter-150000234.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2016 on Thursday, February 16, 2017 before the US financial markets open."
ALXN,ALXN:UW,BBG000G32HL2,ALEXION PHARMACEUTICALS INC Financials,2017-01-25 18:04:06 +0000,http://finance.yahoo.com/q/is?s=alxn&annual,ALEXION PHARMACEUTICALS INC Financials
ALXN,ALXN:UW,BBG000G32HL2,"The Zacks Analyst Blog Highlights: ExxonMobil, Procter & Gamble, Micron, Macy's and Alexion Pharmaceuticals",2017-01-19 16:49:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QmcLQsy6PFs/the-zacks-analyst-blog-highlights-exxonmobil-procter-gamble-micron-macys-and-alexion-pharmaceuticals-cm735423,For Immediate Release Chicago IL January 19 2017 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
ALXN,ALXN:UW,BBG000G32HL2,4 Top Biotech Mutual Funds for 2017,2017-01-18 17:39:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hLjcNBqzg0c/4-top-biotech-mutual-funds-for-2017-cm734897,Biotechnology shares have welcomed this year in style marking a striking reversal from last year s dismal performance Part of the rebound in biotech can be attributed to the January effect Bargain hunting investors parked money into biotech firms which are trading at a discount to their
ALXN,ALXN:UW,BBG000G32HL2,[$$] Drugmakers alarmed by Trump pricing threat,2017-01-14 14:33:40 +0000,"http://www.ft.com/cms/s/e664a97e-d920-11e6-944b-e7eb37a6aa8e,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Before Donald Trump accused them of ""getting away with murder"", the mood among pharmaceutical executives was buoyant as they gathered in San Francisco for the industry's biggest annual gathering ..."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Alexion Pharmaceuticals, Inc. – (ALXN)",2017-01-14 03:50:00 +0000,http://finance.yahoo.com/news/alexion-96-hour-deadline-alert-035000638.html,"[Business Wire] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until January 17, 2017 to file lead plaintiff applications in a securities class action lawsuit against Alexion Pharmaceuticals, Inc."
ALXN,ALXN:UW,BBG000G32HL2,"FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) & Lead Plaintiff Deadline - January 17, 2017",2017-01-13 15:10:00 +0000,http://finance.yahoo.com/news/final-deadline-alert-bronstein-gewirtz-151000307.html,"[GlobeNewswire] - NEW YORK, Jan. 13, 2017-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. and certain of its ..."
ALXN,ALXN:UW,BBG000G32HL2,"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - ALXN",2017-01-12 22:02:00 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-220200509.html,"[PR Newswire] - NEW YORK, Jan. 12, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Alexion Pharmaceuticals, Inc. securities ..."
ALXN,ALXN:UW,BBG000G32HL2,Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again,2017-01-12 13:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zeRYgq2tqVE/deja-vu-for-drug-stocks-as-trump-slams-drug-pricing-again-cm732558,It was déjà vu for the healthcare sector with pharma and biotech stocks once again being hit by President elect Donald Trump s comments regarding drug pricing Although drug stocks had rallied following Trump s surprise win in November reflecting relief that the price controls that Hillary
ALXN,ALXN:UW,BBG000G32HL2,Trump takes aim at pharma,2017-01-12 11:58:28 +0000,http://finance.yahoo.com/video/trump-takes-aim-pharma-115828948.html,Trump takes aim at pharma
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,563.65.",2017-01-11 21:48:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v5emdqq_GBg/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-556365-cm732452,Wednesday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 5 563 65 up 11 83 for the day The index first reached the 5000 mark on 01 10 2017 The total shares traded for the NASDAQ was over 2 1 billion Wednesday s session closes with the
ALXN,ALXN:UW,BBG000G32HL2,Here Is Why Red-Hot Alexion Is Only Suitable for Risk Takers Now,2017-01-11 17:36:00 +0000,https://www.thestreet.com/story/13947215/1/here-is-why-red-hot-alexion-is-only-suitable-for-risk-takers-now.html?puc=yahoo&cm_ven=YAHOO,Here Is Why Red-Hot Alexion Is Only Suitable for Risk Takers Now
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ALXN, ISRG",2017-01-11 16:59:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vvv9N_kKwrU/nasdaq-100-movers-alxn-isrg-cm732228,In early trading on Wednesday shares of Intuitive Surgical ISRG topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 5 Year to date Intuitive Surgical registers a 8 1 gain And the worst performing Nasdaq 100 component thus far on the day
ALXN,ALXN:UW,BBG000G32HL2,"DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline - January 17, 2017",2017-01-11 15:07:00 +0000,http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-150700427.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 11, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Files for Label Expansion of Soliris in U.S., EU",2017-01-11 15:00:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lWwTJcJi6Fw/alexion-alxn-files-for-label-expansion-of-soliris-in-us-eu-cm732139,Alexion Pharmaceuticals Inc ALXN announced that it has filed regulatory applications with the FDA as well as the European Medicines Agency EMA seeking approval for a label expansion of Soliris The company is looking to get Soliris approved for the treatment of refractory
ALXN,ALXN:UW,BBG000G32HL2,JPMorgan Makes Big Changes to US Analyst Focus List for January,2017-01-11 14:35:49 +0000,http://finance.yahoo.com/news/jpmorgan-makes-big-changes-us-143549658.html,[24/7 Wall St.] - These are five top new picks that the JPMorgan team likes this month. All make good sense for growth portfolios.
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Files for Label Expansion of Soliris in U.S., EU",2017-01-11 13:47:01 +0000,http://finance.yahoo.com/news/alexion-alxn-files-label-expansion-134701831.html,"Alexion (ALXN) Files for Label Expansion of Soliris in U.S., EU"
ALXN,ALXN:UW,BBG000G32HL2,"Notable ETF Inflow Detected - IBB, REGN, ALXN, INCY",2017-01-10 17:50:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xDETBod0o8I/notable-etf-inflow-detected-ibb-regn-alxn-incy-cm731725,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 140 1 million dollar inflow that s a 1 7 increase week over week
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: EBAY, ILMN",2017-01-10 16:53:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AQPnbdr_FSA/nasdaq-100-movers-ebay-ilmn-cm731659,In early trading on Tuesday shares of Illumina ILMN topped the list of the day s best performing components of the Nasdaq 100 index trading up 15 7 Year to date Illumina registers a 27 9 gain And the worst performing Nasdaq 100 component thus far on the day is eBay
ALXN,ALXN:UW,BBG000G32HL2,Alexion Seeks Expanded Use for Soliris in US and EU,2017-01-10 15:45:00 +0000,http://www.investopedia.com/news/alexion-applies-expanded-use-soliris-alxn/?partner=YahooSA,Alexion Seeks Expanded Use for Soliris in US and EU
ALXN,ALXN:UW,BBG000G32HL2,Blog Coverage Alexion Pharma Applies for US and EU Marketing Approval of Refractory Generalized Myasthenia Gravis Medicine,2017-01-10 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-alexion-pharma-applies-131500419.html,"[Accesswire] - Upcoming AWS Coverage on Jazz Pharmaceuticals LONDON, UK / ACCESSWIRE / January 10, 2017 / Active Wall St. blog coverage looks at the headline from Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) as the ..."
ALXN,ALXN:UW,BBG000G32HL2,Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline,2017-01-09 22:30:00 +0000,http://www.forbes.com/sites/matthewherper/2017/01/09/mysterious-5-billion-biotech-firm-moderna-lays-out-drug-pipeline/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline
ALXN,ALXN:UW,BBG000G32HL2,"Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference",2017-01-09 20:55:00 +0000,https://www.thestreet.com/story/13947469/1/the-monday-sights-sounds-and-biotech-buzz-from-the-j-p-morgan-healthcare-conference.html?puc=yahoo&cm_ven=YAHOO,"Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Blood Disorder Meds Wins Orphan Drug Status,2017-01-09 20:30:00 +0000,http://www.investopedia.com/news/alexion-blood-drug-gets-orphan-drug-status-alxn/?partner=YahooSA,Alexion Blood Disorder Meds Wins Orphan Drug Status
ALXN,ALXN:UW,BBG000G32HL2,Alexion CEO: 'We're moving on' from shakeup,2017-01-09 19:32:00 +0000,http://finance.yahoo.com/video/alexion-ceo-were-moving-shakeup-193200117.html,Alexion CEO: 'We're moving on' from shakeup
ALXN,ALXN:UW,BBG000G32HL2,Bullish and Bearish Reversals in the Market,2017-01-09 18:33:00 +0000,http://realmoney.thestreet.com/articles/01/09/2017/bullish-and-bearish-reversals-market?puc=yahoo&cm_ven=YAHOO,Bullish and Bearish Reversals in the Market
ALXN,ALXN:UW,BBG000G32HL2,"Here's Why Alexion Pharmaceuticals, Inc. Stock Gave Up 36% in 2016",2017-01-09 16:51:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B5K7gT5D57c/heres-why-alexion-pharmaceuticals-inc-stock-gave-up-36-in-2016-cm731057,Image source Getty Images What happened Shares of rare disease specialist Alexion Pharmaceuticals Inc NASDAQ ALXN slid 35 9 lower last year according to data from S amp P Global Market Intelligence Disturbing clinical trial results for its lead drug Soliris put
ALXN,ALXN:UW,BBG000G32HL2,"Here's Why Alexion Pharmaceuticals, Inc. Stock Gave Up 36% in 2016",2017-01-09 15:42:25 +0000,http://www.fool.com/investing/2017/01/09/heres-why-alexion-pharmaceuticals-inc-stock-gave-u.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Here's Why Alexion Pharmaceuticals, Inc. Stock Gave Up 36% in 2016"
ALXN,ALXN:UW,BBG000G32HL2,"Lawsuit for Investors in Shares of Alexion Pharmaceuticals, Inc. (ALXN) Announced by Shareholders Foundation",2017-01-09 15:25:00 +0000,http://finance.yahoo.com/news/lawsuit-investors-shares-alexion-pharmaceuticals-152500632.html,"[Accesswire] - SAN DIEGO, CA / ACCESSWIRE / January 9, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain purchasers of NASDAQ: ALXN shares against Alexion Pharmaceuticals, Inc. over ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Blood Disorder Drug Gets Orphan Designation in U.S.,2017-01-09 14:52:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l2RcZdQ0GRw/alexion-blood-disorder-drug-gets-orphan-designation-in-us-cm731027,Alexion Pharmaceuticals Inc ALXN announced that the FDA has granted orphan drug designation ODD to ALXN1210 a longer acting anti C5 antibody that inhibits terminal complement for the treatment of patients with paroxysmal nocturnal hemoglobinuria PNH a debilitating ultra
ALXN,ALXN:UW,BBG000G32HL2,Alexion Blood Disorder Drug Gets Orphan Designation in U.S.,2017-01-09 13:15:01 +0000,http://finance.yahoo.com/news/alexion-blood-disorder-drug-gets-131501450.html,Alexion Blood Disorder Drug Gets Orphan Designation in U.S.
ALXN,ALXN:UW,BBG000G32HL2,Alexion Submits U.S. and EU Applications Seeking Approval of Soliris® (Eculizumab) as a Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG),2017-01-09 11:30:00 +0000,http://finance.yahoo.com/news/alexion-submits-u-eu-applications-113000062.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. today announced that the Company has submitted marketing applications to the U.S. Food and Drug Administration and the European Medicines Agency to extend the indication for Soliris® as a treatment for patients with refractory generalized myasthenia gravis who are anti-acetylcholine receptor antibody-positive."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals To Present At J.P.Morgan Conference; Webcast At 11:00 AM,2017-01-09 10:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y7ySH_ZeFmk/alexion-pharmaceuticals-to-present-at-jpmorgan-conference-webcast-at-1100-am-20170109-00671,Alexion Pharmaceuticals To Present At J.P.Morgan Conference; Webcast At 11:00 AM
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma Announces Regulatory Submissions To Extend Indication For Soliris,2017-01-09 06:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q0OUAvrvgjI/alexion-pharma-announces-regulatory-submissions-to-extend-indication-for-soliris-20170109-00176,Alexion Pharma Announces Regulatory Submissions To Extend Indication For Soliris
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2017-01-07 22:15:00 +0000,http://finance.yahoo.com/news/investor-notice-lundin-law-pc-221500126.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / January 7, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"DEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Alexion Pharmaceuticals, Inc. To Contact The Firm",2017-01-07 11:00:00 +0000,http://finance.yahoo.com/news/deadline-alert-brower-piven-reminds-110000794.html,"[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Alexion Pharmaceuticals, Inc."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. – (ALXN)",2017-01-07 03:50:00 +0000,http://finance.yahoo.com/news/alexion-shareholder-alert-former-louisiana-035000016.html,"[GlobeNewswire] - NEW ORLEANS, Jan. 06, 2017-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until January 17, 2017 to file lead ..."
ALXN,ALXN:UW,BBG000G32HL2,"Company News for January 06, 2017",2017-01-06 17:38:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LD_3usV98ck/company-news-for-january-06-2017-cm730424,Alexion Pharmaceuticals Inc s ALXN shares jumped 9 5 after forecasting earnings within the range of 4 50 to 4 65 per share for 2016 higher than the Zacks Consensus Estimate of 3 86 Shares of CEB Inc CEB climbed 20 9 following news that the company will be taken over
ALXN,ALXN:UW,BBG000G32HL2,"Company News for January 06, 2017",2017-01-06 15:10:03 +0000,http://finance.yahoo.com/news/company-news-january-06-2017-151003108.html,"Company News for January 06, 2017"
ALXN,ALXN:UW,BBG000G32HL2,"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline - January 17, 2017",2017-01-06 15:02:00 +0000,http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-150200076.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 6, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion: Internal Probe Shows No Revenue Inflation,2017-01-06 14:30:00 +0000,http://www.investopedia.com/news/alexion-closes-probe-wont-restate-earnings-alxn/?partner=YahooSA,Alexion: Internal Probe Shows No Revenue Inflation
ALXN,ALXN:UW,BBG000G32HL2,FDA Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH),2017-01-06 11:35:08 +0000,http://www.publicnow.com/view/12BEB77586C0422CF05AB400CF2FCBFECCF950BA,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to ALXN1210, a ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Says FDA Grants Orphan Drug Designation To ALXN1210 For Treatment Of PNH,2017-01-06 06:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C8Vcd9B94t8/alexion-says-fda-grants-orphan-drug-designation-to-alxn1210-for-treatment-of-pnh-20170106-00097,Alexion Says FDA Grants Orphan Drug Designation To ALXN1210 For Treatment Of PNH
ALXN,ALXN:UW,BBG000G32HL2,Alexion Says FDA Grants Orphan Drug Designation To ALXN1210 For Treatment Of PNH,2017-01-06 06:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8IL9guFqlek/alexion-says-fda-grants-orphan-drug-designation-to-alxn1210-for-treatment-of-pnh-20170106-00098,Alexion Says FDA Grants Orphan Drug Designation To ALXN1210 For Treatment Of PNH
ALXN,ALXN:UW,BBG000G32HL2,3 ideas to improve waiting for your trades,2017-01-05 21:51:58 +0000,http://finance.yahoo.com/tumblr/blog-3-ideas-to-improve-waiting-for-your-trades-215209047.html,3 ideas to improve waiting for your trades
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,487.94.",2017-01-05 21:48:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5XmfOQJzBUM/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-548794-cm730138,Thursday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 5 487 94 up 10 93 for the day The index first reached the 5000 mark on 12 27 2016 The total shares traded for the NASDAQ was over 1 9 billion Declining stocks led advancers by 1 44 to
ALXN,ALXN:UW,BBG000G32HL2,The Hot Stock: Alexion Rockets 9.5%,2017-01-05 21:45:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/05/the-hot-stock-alexion-rockets-9-5/?mod=yahoobarrons&ru=yahoo,The Hot Stock: Alexion Rockets 9.5%
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Admits 'Inappropriate Conduct,' But Doesn't Restate Earnings",2017-01-05 21:32:58 +0000,http://www.investors.com/news/technology/alexion-2015-report-skewed-on-inappropriate-conduct-delayed-10-q/,"Alexion Admits 'Inappropriate Conduct,' But Doesn't Restate Earnings"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion shares zoom higher as sales probe ends with no need for restatement, backs 2016 forecast",2017-01-05 19:04:36 +0000,http://www.cnbc.com/id/104201819?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104201819,"Alexion shares zoom higher as sales probe ends with no need for restatement, backs 2016 forecast"
ALXN,ALXN:UW,BBG000G32HL2,"ALXN ALERT: Rosen Law Firm Reminds Alexion Pharmaceuticals, Inc. Investors of Important January 17 Deadline in Class Action – ALXN",2017-01-05 18:48:23 +0000,http://finance.yahoo.com/news/alxn-alert-rosen-law-firm-184823539.html,"[GlobeNewswire] - NEW YORK, Jan. 05, 2017-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Alexion Pharmaceuticals, Inc. securities from February 10, 2014 through November 9, 2016, inclusive of ..."
ALXN,ALXN:UW,BBG000G32HL2,ALXN Crosses Above Key Moving Average Level,2017-01-05 18:38:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t41xMXkaxwg/alxn-crosses-above-key-moving-average-level-cm729979,In trading on Thursday shares of Alexion Pharmaceuticals Inc Symbol ALXN crossed above their 200 day moving average of 131 15 changing hands as high as 140 00 per share Alexion Pharmaceuticals Inc shares are currently trading up about 8 5 on the day The chart below shows the one
ALXN,ALXN:UW,BBG000G32HL2,"Early movers: M, KSS, ALXN, GOOGL, WBA, MYL, MA & more",2017-01-05 18:06:52 +0000,http://www.cnbc.com/id/104201088?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104201088,"Early movers: M, KSS, ALXN, GOOGL, WBA, MYL, MA & more"
ALXN,ALXN:UW,BBG000G32HL2,Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday,2017-01-05 16:40:43 +0000,http://finance.yahoo.com/news/why-5-biopharma-stocks-making-164043079.html,Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday
ALXN,ALXN:UW,BBG000G32HL2,"S&P 500 Movers: KSS, ALXN",2017-01-05 16:39:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DU3-NxvnUtg/sp-500-movers-kss-alxn-cm729834,In early trading on Thursday shares of Alexion Pharmaceuticals ALXN topped the list of the day s best performing components of the S amp P 500 index trading up 9 2 Year to date Alexion Pharmaceuticals registers a 13 4 gain And the worst performing S amp P 500 component thus far
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: WBA, ALXN",2017-01-05 16:39:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RunFlGNue0U/nasdaq-100-movers-wba-alxn-cm729831,In early trading on Thursday shares of Alexion Pharmaceuticals ALXN topped the list of the day s best performing components of the Nasdaq 100 index trading up 8 3 Year to date Alexion Pharmaceuticals registers a 12 5 gain And the worst performing Nasdaq 100 component thus far
ALXN,ALXN:UW,BBG000G32HL2,#1 issue top traders want to fix in 2017 on our prop desk,2017-01-05 16:13:40 +0000,http://finance.yahoo.com/tumblr/blog-1-issue-top-traders-want-to-fix-in-2017-on-our-182805496.html,#1 issue top traders want to fix in 2017 on our prop desk
ALXN,ALXN:UW,BBG000G32HL2,Stocks Open Narrowly Mixed; CEB Surges On Gartner Buyout,2017-01-05 14:42:37 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-cut-narrow-losses-alexion-jumps-kohls-macys-dive/,Stocks Open Narrowly Mixed; CEB Surges On Gartner Buyout
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Stock Up on 10Q Filing; 2016 View Retained,2017-01-05 14:41:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ExIcNU4v8Qc/alexion-alxn-stock-up-on-10q-filing-2016-view-retained-cm729792,Alexion Pharmaceuticals Inc ALXN has finally announced the filing of its Form 10 Q with the Securities and Exchange Commission for the three quarters ended Sep 30 2016 Shares of the company gained approximately 5 on Jan 4 during the after hours trading session Shares of Alexion
ALXN,ALXN:UW,BBG000G32HL2,"Stocks to Watch: Macy's, Kohl's, CEB, Sonic, Alexion Pharmaceuticals",2017-01-05 14:35:07 +0000,http://blogs.wsj.com/moneybeat/2017/01/05/stocks-to-watch-macys-kohls-ceb-sonic-alexion-pharmaceuticals/?mod=yahoo_hs,"Stocks to Watch: Macy's, Kohl's, CEB, Sonic, Alexion Pharmaceuticals"
ALXN,ALXN:UW,BBG000G32HL2,Why Alexion Pharmaceuticals Is Overvalued,2017-01-05 13:59:00 +0000,http://www.forbes.com/sites/petercohan/2017/01/05/why-alexion-pharmaceuticals-is-overvalued/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Why Alexion Pharmaceuticals Is Overvalued
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a",2017-01-05 13:52:52 +0000,http://biz.yahoo.com/e/170105/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"
ALXN,ALXN:UW,BBG000G32HL2,How Trump-related uncertainty is bringing out the health-care stock bears,2017-01-05 13:29:15 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F9EE0888-D2BC-11E6-BCD6-E2A1A77CE9A2&siteid=yhoof2,How Trump-related uncertainty is bringing out the health-care stock bears
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Stock Up on 10Q Filing; 2016 View Retained,2017-01-05 13:10:01 +0000,http://finance.yahoo.com/news/alexion-alxn-stock-10q-filing-131001320.html,Alexion (ALXN) Stock Up on 10Q Filing; 2016 View Retained
ALXN,ALXN:UW,BBG000G32HL2,Alexion Moves Notably Higher After Reaffirming Guidance,2017-01-05 13:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EvMT5YPcae0/alexion-moves-notably-higher-after-reaffirming-guidance-20170105-00907,Alexion Moves Notably Higher After Reaffirming Guidance
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at the 35th Annual J.P. Morgan Healthcare Conference,2017-01-05 11:30:00 +0000,http://finance.yahoo.com/news/alexion-present-35th-annual-j-113000648.html,"[Business Wire] - Alexion Pharmaceuticals today announced that management will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 9, 2017 at 8:00 a.m., PT ."
ALXN,ALXN:UW,BBG000G32HL2,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017,2017-01-05 11:21:00 +0000,https://www.thestreet.com/story/13942459/1/what-biotech-investors-can-expect-from-the-j-p-morgan-healthcare-conference-2017.html?puc=yahoo&cm_ven=YAHOO,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. (ALXN) Is Up Sharply After Q3 10-Q Filing,2017-01-05 09:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A6UZXaoweTU/alexion-pharmaceuticals-inc-alxn-is-up-sharply-after-q3-10q-filing-20170105-00690,Alexion Pharmaceuticals Inc. (ALXN) Is Up Sharply After Q3 10-Q Filing
ALXN,ALXN:UW,BBG000G32HL2,PRESS DIGEST - Wall Street Journal - Jan 5,2017-01-05 05:10:27 +0000,http://finance.yahoo.com/news/press-digest-wall-street-journal-051027451.html,PRESS DIGEST - Wall Street Journal - Jan 5
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion Says Management Improperly Pressured Staff to Boost Sales,2017-01-05 02:16:07 +0000,http://www.wsj.com/articles/alexion-says-senior-management-improperly-pressured-staff-to-boost-sales-1483582564?mod=yahoo_hs,[$$] Alexion Says Management Improperly Pressured Staff to Boost Sales
ALXN,ALXN:UW,BBG000G32HL2,"Alexion says no need to revise earnings, shares rise",2017-01-05 00:07:13 +0000,http://finance.yahoo.com/news/alexion-says-no-revise-earnings-000713438.html,"[Reuters] - Alexion Pharmaceuticals Inc on Wednesday filed its delayed third-quarter 2016 financial report with U.S. regulators and said an investigation into allegations regarding sales practices found no need to restate previous financial results. Shares of Alexion, which rose 3.7 percent to close at $127.11 in regular trading, were up more than 6 percent after hours. The biotechnology company disclosed in November it was investigating allegations made by a former employee regarding sales practices involving its costly blood disorder drug Soliris."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Files Form 10-Q for Third Quarter 2016,2017-01-05 00:04:09 +0000,http://www.publicnow.com/view/E14244F562C6DBA5D5E45D71DF666D1CFEA86104,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) announced today that it has filed with the Securities and Exchange Commission its Form 10-Q for the third quarter ended September ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion shares add to gains after hours as quarterly report filed,2017-01-04 22:52:45 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D39CBAC1-1B85-4BB8-A90C-B5C4744BAC4E&siteid=yhoof2,Alexion shares add to gains after hours as quarterly report filed
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Files Form 10-Q for Third Quarter 2016,2017-01-04 22:21:00 +0000,http://finance.yahoo.com/news/alexion-pharmaceuticals-files-form-10-222100197.html,"[Business Wire] - Alexion Pharmaceuticals Inc. announced today that it has filed with the Securities and Exchange Commission its Form 10-Q for the third quarter ended September 30, 2016."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report",2017-01-04 22:19:17 +0000,http://biz.yahoo.com/e/170104/alxn10-q.html,"ALEXION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report"
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Alexion Pharmaceuticals, Inc. To Contact The Firm Before Lead Plaintiff Deadline",2017-01-04 20:34:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-203400049.html,"[PR Newswire] - NEW YORK, Jan. 4, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") (ALXN) of the January 17, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers. The lawsuit has been filed in the U.S. District Court for the District of Connecticut on behalf of all those who purchased Alexion securities between February 10, 2014 and December 9, 2016 (the ""Class Period""). The case, Boston Retirement System v. Alexion Pharmaceuticals Inc et al., No. 3:16-cv-02127 was filed on December 29, 2016."
ALXN,ALXN:UW,BBG000G32HL2,"Robbins Arroyo LLP: Alexion Pharmaceuticals, Inc. (ALXN) Misled Shareholders According to a Recently Filed Class Action",2017-01-04 18:17:00 +0000,http://finance.yahoo.com/news/robbins-arroyo-llp-alexion-pharmaceuticals-181700791.html,"[Business Wire] - Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Alexion Pharmaceuticals, Inc. in the U.S. District Court for the Southern District of New York."
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN): Will the Stock Continue to Suffer in 2017?,2017-01-04 15:42:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eJp2zghUXME/alexion-alxn-will-the-stock-continue-to-suffer-in-2017-cm729214,Alexion Pharmaceuticals Inc ALXN has had a bumpy ride throughout 2016 with shares of the company plunging 33 8 Alexion has largely underperformed the Zacks classified Medical Biomedical and Genetics industry which registered a decline of 24 during the year Setbacks
ALXN,ALXN:UW,BBG000G32HL2,Alexion’s Soliris Fails In Kidney Transplant Study,2017-01-04 15:41:00 +0000,http://www.investopedia.com/news/alexions-soliris-fails-kidney-transplant-trial-alxn/?partner=YahooSA,Alexion’s Soliris Fails In Kidney Transplant Study
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline - January 17, 2017",2017-01-04 15:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150300768.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 4, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation",2017-01-04 13:38:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Nr2bJB8Qk8/biotech-stock-roundup-inotek-plunges-on-pipeline-setback-kite-files-ind-for-study-initiation-cm729122,It was a relatively slow week for the biotech sector though companies like Inotek ITEK and OPKO OPK made it to the headlines due to pipeline setbacks Recap of the Week s Most Important Stories Inotek Shares Hit by Disappointing Data Inotek s shares plunged 71 3 on news that
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN): Will the Stock Continue to Suffer in 2017?,2017-01-04 13:34:01 +0000,http://finance.yahoo.com/news/alexion-alxn-stock-continue-suffer-133401272.html,Alexion (ALXN): Will the Stock Continue to Suffer in 2017?
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - (ALXN)",2017-01-04 03:00:00 +0000,http://finance.yahoo.com/news/alexion-shareholder-alert-former-louisiana-030000916.html,"[PR Newswire] - NEW ORLEANS, Jan. 3, 2017 /PRNewswire/ -- Kahn Swick & Foti, LLC (""KSF"") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until ..."
ALXN,ALXN:UW,BBG000G32HL2,"Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc.",2017-01-03 20:00:27 +0000,http://finance.yahoo.com/news/federman-sherwood-announces-filing-securities-200027492.html,"[Marketwired] - On December 29, 2016, a class action lawsuit was filed in the United States District Court for the District of Connecticut against Alexion Pharmaceuticals, Inc. . The complaint alleges violations of federal ..."
ALXN,ALXN:UW,BBG000G32HL2,"ALXN INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alexion Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 2017",2017-01-03 16:53:00 +0000,http://finance.yahoo.com/news/alxn-investor-alert-law-offices-165300062.html,"[PR Newswire] - NEW YORK, Jan. 3, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Alexion Pharmaceuticals, Inc. (ALXN) securities between February 10, 2014 and November 9, 2016. On November 4, 2016, Alexion cancelled an appearance at the Credit Suisse Healthcare Conference."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : January 2, 2017",2017-01-02 13:15:55 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-alxn-us-january-2-2017/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : January 2, 2017"
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ALXN",2017-01-02 13:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-130000402.html,"[GlobeNewswire] - NEW YORK, Jan. 02, 2017-- Pomerantz LLP announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. and certain of its officers. The class action, filed in United States ..."
ALXN,ALXN:UW,BBG000G32HL2,"Here's Your Last Chance to Sell Shake Shack, 4 More 'Toxic Stocks' in 2016",2017-01-01 20:40:00 +0000,https://www.thestreet.com/story/13938901/1/here-s-your-last-chance-to-sell-shake-shack-4-more-toxic-stocks-in-2016.html?puc=yahoo&cm_ven=YAHOO,"Here's Your Last Chance to Sell Shake Shack, 4 More 'Toxic Stocks' in 2016"
ALXN,ALXN:UW,BBG000G32HL2,Strensiq Boosted Alexion Pharmaceuticals’ Revenues in 2016,2016-12-30 20:06:08 +0000,http://marketrealist.com/2016/12/strong-strensiq-label-boosted-alexion-pharmaceuticals-revenues-2016/?utm_source=yahoo&utm_medium=feed,Strensiq Boosted Alexion Pharmaceuticals’ Revenues in 2016
ALXN,ALXN:UW,BBG000G32HL2,"Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Alexion Pharmaceuticals, Inc. and Certain of Its Senior Executives",2016-12-30 19:50:00 +0000,http://finance.yahoo.com/news/bernstein-litowitz-berger-grossmann-llp-195000969.html,"[PR Newswire] - NEW YORK, Dec. 30, 2016 /PRNewswire/ -- Bernstein Litowitz Berger & Grossmann LLP (""BLB&G"") today announced that it has filed a securities class action lawsuit on behalf of Boston Retirement ..."
ALXN,ALXN:UW,BBG000G32HL2,Will Soliris Drive Alexion Pharmaceuticals’ Revenues in 2017?,2016-12-30 18:35:38 +0000,http://marketrealist.com/2016/12/soliris-may-continue-drive-alexion-pharmaceuticals-revenues-2017/?utm_source=yahoo&utm_medium=feed,Will Soliris Drive Alexion Pharmaceuticals’ Revenues in 2017?
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Expects Strong Revenue Growth in 2016,2016-12-30 16:39:28 +0000,http://marketrealist.com/2016/12/alexion-pharmaceuticals-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Alexion Pharmaceuticals Expects Strong Revenue Growth in 2016
ALXN,ALXN:UW,BBG000G32HL2,Cystic Fibrosis Strategy: Will It Boost Vertex’s Future Revenues?,2016-12-30 12:37:54 +0000,http://marketrealist.com/2016/12/cystic-fibrosis-strategy-expected-boost-vertex-pharmaceuticals-revenues-future-years/?utm_source=yahoo&utm_medium=feed,Cystic Fibrosis Strategy: Will It Boost Vertex’s Future Revenues?
ALXN,ALXN:UW,BBG000G32HL2,Orkambi Is Still Strong Revenue Driver for Vertex Pharmaceuticals,2016-12-29 20:05:28 +0000,http://marketrealist.com/2016/12/orkambi-continues-strong-revenue-driver-vertex-pharmaceuticals-2016/?utm_source=yahoo&utm_medium=feed,Orkambi Is Still Strong Revenue Driver for Vertex Pharmaceuticals
ALXN,ALXN:UW,BBG000G32HL2,Vertex Pharmaceuticals Expects Strong Revenue Growth in 2016,2016-12-29 18:14:25 +0000,http://marketrealist.com/2016/12/vertex-pharmaceuticals-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Vertex Pharmaceuticals Expects Strong Revenue Growth in 2016
ALXN,ALXN:UW,BBG000G32HL2,"Safirstein Metcalf LLP Announces That A Class Action Lawsuit Has Been Filed Against Alexion Pharmaceuticals, Inc. - ALXN",2016-12-28 22:30:00 +0000,http://finance.yahoo.com/news/safirstein-metcalf-llp-announces-class-223000047.html,"[GlobeNewswire] - NEW YORK, Dec. 28, 2016-- Safirstein Metcalf LLP announces that a class action has been filed in the United States District Court for the Southern District of New York against Alexion Pharmaceuticals, ..."
ALXN,ALXN:UW,BBG000G32HL2,"The Zacks Analyst Blog Highlights: Alexion Pharmaceuticals, Celgene, Incyte, Eli Lilly, Regeneron Pharmaceuticals and Ophthotech",2016-12-28 17:02:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LHXNZZdyNGs/the-zacks-analyst-blog-highlights-alexion-pharmaceuticals-celgene-incyte-eli-lilly-regeneron-pharmaceuticals-and-ophthotech-cm726995,For Immediate Release Chicago IL December 28 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
ALXN,ALXN:UW,BBG000G32HL2,Why United Therapeutics Expects Strong Revenue Growth,2016-12-28 15:55:16 +0000,http://marketrealist.com/2016/12/united-therapeutics-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Why United Therapeutics Expects Strong Revenue Growth
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017",2016-12-28 15:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150300729.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 28, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alexion Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017",2016-12-27 17:19:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-171900669.html,"[Business Wire] - The following statement is being issued by Levi & Korsinsky, LLP:"
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: WDC, NVDA",2016-12-27 16:58:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/prXMVfgiQ3Q/nasdaq-100-movers-wdc-nvda-cm726464,In early trading on Tuesday shares of NVIDIA Corp NVDA topped the list of the day s best performing components of the Nasdaq 100 index trading up 4 1 And the worst performing Nasdaq 100 component thus far on the day is Western Digital WDC trading down 0 2 Western Digital
ALXN,ALXN:UW,BBG000G32HL2,"Forget Alexion (ALXN), Buy These 3 Biotech Stocks Instead",2016-12-27 16:02:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c7vFwp3s2r4/forget-alexion-alxn-buy-these-3-biotech-stocks-instead-cm726406,New Haven CT based Alexion Pharmaceuticals Inc ALXN has had a tough year with shares falling 33 3 year to date YTD The company which is known for its focus on developing treatments for rare disorders has underperformed the Zacks categorized Medical Biomed Genetics industry which
ALXN,ALXN:UW,BBG000G32HL2,SHAREHOLDER ALERT: Class Action Lawsuit Against Alexion Announced by Holzer & Holzer,2016-12-27 15:53:00 +0000,http://finance.yahoo.com/news/shareholder-alert-class-action-lawsuit-155300231.html,"[Business Wire] - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors in Alexion Pharmaceuticals, Inc. who purchased shares between February 10, 2014 and November 9, 2016."
ALXN,ALXN:UW,BBG000G32HL2,"Forget Alexion (ALXN), Buy These 3 Biotech Stocks Instead",2016-12-27 13:53:01 +0000,http://finance.yahoo.com/news/forget-alexion-alxn-buy-3-135301037.html,"Forget Alexion (ALXN), Buy These 3 Biotech Stocks Instead"
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - (ALXN)",2016-12-24 03:50:00 +0000,http://finance.yahoo.com/news/alexion-shareholder-alert-former-louisiana-035000535.html,"[Marketwired] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until January 17, 2017 to file lead plaintiff applications in a ..."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION (ALXN) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Alexion Pharmaceuticals, Inc.; Encourages all Investors to Contact the Firm for Information",2016-12-24 02:31:00 +0000,http://finance.yahoo.com/news/alexion-alxn-alert-johnson-weaver-023100809.html,"[PR Newswire] - SAN DIEGO, Dec. 23, 2016 /PRNewswire/ -- Johnson & Weaver, LLP announces that a class action complaint was filed on behalf of purchasers of Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN) securities during ..."
ALXN,ALXN:UW,BBG000G32HL2,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?,2016-12-23 11:36:39 +0000,http://www.fool.com/investing/2016/12/22/are-these-3-stocks-the-biggest-comeback-opportunit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion Stock May Be Worth $197 in Buyout,2016-12-23 11:14:00 +0000,http://www.barrons.com/articles/alexion-stock-may-be-worth-197-in-buyout-1482491691?mod=yahoobarrons&ru=yahoo,[$$] Alexion Stock May Be Worth $197 in Buyout
ALXN,ALXN:UW,BBG000G32HL2,"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. – ALXN",2016-12-22 22:29:03 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-222903161.html,"[GlobeNewswire] - NEW YORK, Dec. 22, 2016-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Alexion Pharmaceuticals, Inc. securities from February ..."
ALXN,ALXN:UW,BBG000G32HL2,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?,2016-12-22 17:01:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JqWGDEjmx7c/are-these-3-stocks-the-biggest-comeback-opportunities-of-2017-cm725176,Don t try to catch a falling knife That s good advice literally and figuratively when it comes to buying stocks You never know if a plunging stock will go down a lot more Three stocks that have certainly fallen this year are Alexion Pharmaceuticals NASDAQ ALXN
ALXN,ALXN:UW,BBG000G32HL2,Bad News Bashes Biotech Investors... Again,2016-12-22 15:51:44 +0000,http://www.fool.com/investing/2016/12/21/bad-news-bashes-biotech-investors-again.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Bad News Bashes Biotech Investors... Again
ALXN,ALXN:UW,BBG000G32HL2,How Alexion Pharmaceuticals Could Double in 2017,2016-12-22 15:42:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/22/how-alexion-pharmaceuticals-could-double-in-2017/?mod=yahoobarrons&ru=yahoo,How Alexion Pharmaceuticals Could Double in 2017
ALXN,ALXN:UW,BBG000G32HL2,Alexion Soliris Fails in Phase II/III Delayed Graft Function Study,2016-12-22 14:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OVD_91zg7co/alexion-soliris-fails-in-phase-iiiii-delayed-graft-function-study-cm724988,Alexion Pharmaceuticals Inc ALXN announced that Soliris has failed to meet the primary endpoint in a randomized parallel group double blind placebo controlled multi center phase II III study PROTECT We expect investors to react negatively to the news Alexion s year to date share
ALXN,ALXN:UW,BBG000G32HL2,Health Care Sector Impacted Markets on December 21,2016-12-22 14:04:19 +0000,http://marketrealist.com/2016/12/health-care-sector-weigh-markets-december-21/?utm_source=yahoo&utm_medium=feed,Health Care Sector Impacted Markets on December 21
ALXN,ALXN:UW,BBG000G32HL2,Alexion Soliris Fails in Phase II/III Delayed Graft Function Study,2016-12-22 13:03:01 +0000,http://finance.yahoo.com/news/alexion-soliris-fails-phase-ii-130301683.html,Alexion Soliris Fails in Phase II/III Delayed Graft Function Study
ALXN,ALXN:UW,BBG000G32HL2,"CALA Surges On BMY Deal, OVAS Hands Pink Slips, MACK Halts Breast Cancer Study",2016-12-21 23:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LivsjpkbrEE/cala-surges-on-bmy-deal-ovas-hands-pink-slips-mack-halts-breast-cancer-study-20161221-00953,"CALA Surges On BMY Deal, OVAS Hands Pink Slips, MACK Halts Breast Cancer Study"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Announces Top-Line Results from Phase 2/3 PROTECT Study of Eculizumab (Soliris®) for the Prevention of Delayed Graft Function (DGF) After Kidney Transplantation,2016-12-21 22:12:08 +0000,http://www.publicnow.com/view/B706AB21ECF9D4D95160575CF06D889C6BEAD18F,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today reported results from the PROTECT Study, a Phase 2/3 registration trial of eculizumab (Soliris) for the prevention ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Announces Phase Two Trial Failure, Falls Slightly After Hours",2016-12-21 21:39:00 +0000,https://www.thestreet.com/story/13934770/1/alexion-announces-phase-two-trial-failure-falls-slightly-after-hours.html?puc=yahoo&cm_ven=YAHOO,"Alexion Announces Phase Two Trial Failure, Falls Slightly After Hours"
ALXN,ALXN:UW,BBG000G32HL2,"Health Care Sector Update for 12/21/2016: ALXN,GILD,MRUS,INCY,MACK",2016-12-21 21:36:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yLz6DSRAPsI/health-care-sector-update-for-12212016-alxngildmrusincymack-cm724822,Top Health Care StocksTop Health Care Stocks JNJ 0 13 JNJ 0 13 PFE 1 34 PFE 1 34 MRK 0 13 MRK 0 13 ABT 1 62 ABT 1 62 AMGN 0 59 AMGN 0 59 Health care stocks weighed on the broader U S markets Wednesday with the NYSE Health Care Index retreating about 0 4 while shares of health
ALXN,ALXN:UW,BBG000G32HL2,Alexion Drug Doesn't Meet Primary Endpoint in Transplant-Related Study,2016-12-21 18:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9RUvjZTJHA8/alexion-drug-doesnt-meet-primary-endpoint-in-transplantrelated-study-20161221-00898,Alexion Drug Doesn't Meet Primary Endpoint in Transplant-Related Study
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-21 17:11:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-171100760.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 21, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Conatus Soars on Novartis Deal, Early FDA Nod for Clovis Drug",2016-12-21 17:02:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c_VJiHA4VFo/biotech-stock-roundup-conatus-soars-on-novartis-deal-early-fda-nod-for-clovis-drug-cm724634,Conatus CNAT is ending the year on a high note with the company signing a lucrative deal with Swiss pharma giant Novartis Investors applauded the deal sending the company s shares soaring 141 3 Meanwhile Gilead GILD was hit by a jury decision awarding 2 54 billion to Merck in a
ALXN,ALXN:UW,BBG000G32HL2,Bad News Bashes Biotech Investors... Again,2016-12-21 16:58:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m7fb_V-pvTY/bad-news-bashes-biotech-investors-again-cm724572,Push back on pricing trial failures and management misdeeds have bloodied biotech investors this year and unfortunately Alexion Pharmaceuticals NASDAQ ALXN and Ophthotech Corp NASDAQ OPHT have just delivered investors even more crushing news At Alexion
ALXN,ALXN:UW,BBG000G32HL2,Gilead Sciences: Buying Alexion Could Solve Both Their Problems,2016-12-21 15:36:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/21/gilead-sciences-buying-alexion-could-solve-both-their-problems/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: Buying Alexion Could Solve Both Their Problems
ALXN,ALXN:UW,BBG000G32HL2,"ALXN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alexion Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 2017",2016-12-21 15:25:00 +0000,http://finance.yahoo.com/news/alxn-shareholder-alert-law-offices-152500865.html,"[Business Wire] - The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Alexion Pharmaceuticals, Inc."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-12-20 22:46:00 +0000,http://finance.yahoo.com/news/shareholder-notice-lundin-law-pc-224600940.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / December 20, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alexion Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit – ALXN",2016-12-20 19:09:06 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-190906337.html,"[GlobeNewswire] - STEVENSON, Md., Dec. 20, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
ALXN,ALXN:UW,BBG000G32HL2,"Agree To Purchase Alexion Pharmaceuticals At $75, Earn 9.9% Using Options",2016-12-20 17:56:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9I-uqBQ8fRM/agree-to-purchase-alexion-pharmaceuticals-at-75-earn-99-using-options-cm724029,Investors eyeing a purchase of Alexion Pharmaceuticals Inc Symbol ALXN shares but tentative about paying the going market price of 115 50 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
ALXN,ALXN:UW,BBG000G32HL2,"Celgene Added To CS Focus List; ""The Best House In The Biotech Neighborhood""",2016-12-20 17:36:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/20/celgene-added-to-cs-focus-list-the-best-house-in-the-biotech-neighborhood/?mod=yahoobarrons&ru=yahoo,"Celgene Added To CS Focus List; ""The Best House In The Biotech Neighborhood"""
ALXN,ALXN:UW,BBG000G32HL2,"Biogen Looks Within for Next CEO, Raising Concerns Top Outside Talent Passed on Job",2016-12-19 22:25:00 +0000,https://www.thestreet.com/story/13931919/1/biogen-looks-within-for-next-ceo-raising-concerns-top-outside-talent-passed-on-job.html?puc=yahoo&cm_ven=YAHOO,"Biogen Looks Within for Next CEO, Raising Concerns Top Outside Talent Passed on Job"
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,457.44 up 20.28 points",2016-12-19 21:48:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YlAG3W4BwkA/market-close-report-nasdaq-composite-index-closes-at-545744-up-2028-points-cm723610,Monday s session closes with the NASDAQ Composite Index at 5 457 44 The total shares traded for the NASDAQ was over 1 72 billion Monday s session closes with the NASDAQ Composite Index at 5 457 44 The total shares traded for the NASDAQ was over 1 72 billion Advancers stocks led declining by 1
ALXN,ALXN:UW,BBG000G32HL2,Alexion Investors Want Answers,2016-12-19 19:58:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U8E5tqjP6Y4/alexion-investors-want-answers-cm723507,Perhaps in an attempt to get out in front of findings from an ongoing internal investigation into improper sales practices Alexion Pharmaceuticals NASDAQ ALXN board of directors has shown its CEO and CFO the door Is the board s retreat from these long term executives a signal
ALXN,ALXN:UW,BBG000G32HL2,Alexion Investors Want Answers,2016-12-19 18:25:06 +0000,http://www.fool.com/investing/2016/12/19/alexion-investors-want-answers.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Alexion Investors Want Answers
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy ETF Inflows: IBB, REGN, MYL, ALXN",2016-12-19 17:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CFRA5ugVjQI/noteworthy-etf-inflows-ibb-regn-myl-alxn-cm723399,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 1 1 billion dollar inflow that s a 16 1 increase week over week
ALXN,ALXN:UW,BBG000G32HL2,10 Biotech Stocks Surprises for 2017…And Not All of Them Are Bad,2016-12-19 17:40:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/19/10-biotech-stocks-surprises-for-2017-and-not-all-of-them-are-bad/?mod=yahoobarrons&ru=yahoo,10 Biotech Stocks Surprises for 2017…And Not All of Them Are Bad
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-17 13:04:00 +0000,http://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-130400479.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 17, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. – (ALXN)",2016-12-17 03:50:00 +0000,http://finance.yahoo.com/news/alexion-shareholder-alert-former-louisiana-035000696.html,"[GlobeNewswire] - NEW ORLEANS, Dec. 16, 2016-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until January 17, 2017 to file lead ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ALXN",2016-12-17 01:05:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010500660.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 16, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"Robbins Arroyo LLP Is Investigating the Officers and Directors of Alexion Pharmaceuticals, Inc. (ALXN) on Behalf of Shareholders",2016-12-17 00:16:00 +0000,http://finance.yahoo.com/news/robbins-arroyo-llp-investigating-officers-001600248.html,"[Business Wire] - Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Alexion Pharmaceuticals, Inc. breached their fiduciary duties to shareholders."
ALXN,ALXN:UW,BBG000G32HL2,"Dow Backs Away From 20,000; Oil Rises, Alexion Gets A Big Bounce",2016-12-16 21:23:58 +0000,http://www.investors.com/market-trend/stock-market-today/dow-backs-away-from-20000-oil-rises-alexion-gets-a-big-bounce/,"Dow Backs Away From 20,000; Oil Rises, Alexion Gets A Big Bounce"
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-12-16 18:12:00 +0000,http://finance.yahoo.com/news/investor-notice-lundin-law-pc-181200470.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / December 16, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"S&P 500 Movers: JWN, ALXN",2016-12-16 16:59:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NE5I1sW48R0/sp-500-movers-jwn-alxn-cm722547,In early trading on Friday shares of Alexion Pharmaceuticals ALXN topped the list of the day s best performing components of the S amp P 500 index trading up 3 2 Year to date Alexion Pharmaceuticals has lost about 36 9 of its value And the worst performing S amp P 500
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: NCLH, ALXN",2016-12-16 16:58:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/28jaKsnoS78/nasdaq-100-movers-nclh-alxn-cm722543,In early trading on Friday shares of Alexion Pharmaceuticals ALXN topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 2 Year to date Alexion Pharmaceuticals has lost about 36 8 of its value And the worst performing Nasdaq 100 component
ALXN,ALXN:UW,BBG000G32HL2,"ALXN INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Alexion Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 2017",2016-12-16 16:19:37 +0000,http://finance.yahoo.com/news/alxn-investor-alert-law-offices-161937141.html,"[GlobeNewswire] - NEW YORK, Dec. 16, 2016-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased ..."
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-15 20:26:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-202600764.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 15, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"ALXN LOSS ALERT: Rosen Law Firm Reminds Alexion Pharmaceuticals, Inc. Investors of Important Deadline in Class Action – ALXN",2016-12-15 17:55:00 +0000,http://finance.yahoo.com/news/alxn-loss-alert-rosen-law-175500485.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, reminds purchasers of Alexion Pharmaceuticals, Inc. securities from February 10, 2014 through November 9, 2016, inclusive of the important January 17, 2017 lead plaintiff deadline in the class action."
ALXN,ALXN:UW,BBG000G32HL2,We Did The Math PBE Can Go To $52,2016-12-15 14:58:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-qNiQn7hdF0/we-did-the-math-pbe-can-go-to-52-cm721898,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
ALXN,ALXN:UW,BBG000G32HL2,How you can bottom-feed for stocks left behind in the Trump rally,2016-12-15 10:21:17 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=88D5449A-C22C-11E6-9465-DAC2D347F235&siteid=yhoof2,How you can bottom-feed for stocks left behind in the Trump rally
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : December 14, 2016",2016-12-14 15:32:49 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-value-analysis-nasdaqalxn-december-14-2016/,"Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : December 14, 2016"
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Ophthotech Slumps on Fovista Results, Achaogen Skyrockets on Data",2016-12-14 13:59:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z3h1L1Yneak/biotech-stock-roundup-ophthotech-slumps-on-fovista-results-achaogen-skyrockets-on-data-cm721141,This week several companies presented data on pipeline candidates as well as approved products While companies like Achaogen AKAO soared on positive data others like Horizon HZNP and Ophthotech OPHT were hit by study results Meanwhile Alexion s ALXN shares were impacted by the
ALXN,ALXN:UW,BBG000G32HL2,Moderna's Mysterious Medicines,2016-12-14 11:56:00 +0000,http://www.forbes.com/sites/nathanvardi/2016/12/14/modernas-mysterious-medicines/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahoofeed&partner=yahoomag,Moderna's Mysterious Medicines
ALXN,ALXN:UW,BBG000G32HL2,The Biggest Loser: Alexion Pharmaceuticals Slumps 4.4%,2016-12-13 23:50:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/13/the-biggest-loser-alexion-pharmaceuticals-slumps-4-4/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Alexion Pharmaceuticals Slumps 4.4%
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,463.83.",2016-12-13 21:49:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2znFUKdSIfM/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-546383-cm720996,Tuesday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 5 463 83 up 51 29 for the day The index first reached the 5000 mark on 12 09 2016 The total shares traded for the NASDAQ was over 2 08 billion Tuesday s session closes with the NASDAQ
ALXN,ALXN:UW,BBG000G32HL2,"Missing Phrase May Give Clue To Alexion Shake-Up, Analyst Says",2016-12-13 21:21:00 +0000,http://www.investors.com/news/technology/eleven-words-alexion-ceo-cfo-departures-underscored-in-release/,"Missing Phrase May Give Clue To Alexion Shake-Up, Analyst Says"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion, Ophthotech Don’t Escape Tuesday’s 52-Week Low Club",2016-12-13 21:04:59 +0000,http://finance.yahoo.com/news/alexion-ophthotech-don-t-escape-210459300.html,"Alexion, Ophthotech Don’t Escape Tuesday’s 52-Week Low Club"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors",2016-12-13 19:29:00 +0000,http://finance.yahoo.com/news/alexion-pharmaceuticals-inc-shareholder-alert-192900789.html,"[Business Wire] - Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed in the United States District Court for the Southern District of New York against Alexion Pharmaceuticals, Inc."
ALXN,ALXN:UW,BBG000G32HL2,Is the Worst Yet to Come for Alexion Pharmaceuticals?,2016-12-13 18:57:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UmDohH-9E5c/is-the-worst-yet-to-come-for-alexion-pharmaceuticals-cm720877,It s usually not a good sign when a company s CEO suddenly departs It s definitely not a good sign when both the CEO and CFO leave at the same time That s what just happened for Alexion Pharmaceuticals NASDAQ ALXN with the company s stock falling nearly 14 in intra day
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-13 18:36:00 +0000,http://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-183600079.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 13, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,Is the Worst Yet to Come for Alexion Pharmaceuticals?,2016-12-13 17:33:44 +0000,http://www.fool.com/investing/2016/12/13/is-the-worst-yet-to-come-for-alexion-pharmaceutica.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is the Worst Yet to Come for Alexion Pharmaceuticals?
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ALXN, MYL",2016-12-13 16:57:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OXSN-E8oIis/nasdaq-100-movers-alxn-myl-cm720734,In early trading on Tuesday shares of Mylan MYL topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 1 Year to date Mylan has lost about 29 2 of its value And the worst performing Nasdaq 100 component thus far on the day is
ALXN,ALXN:UW,BBG000G32HL2,The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Alexion Technologies Corporation Investors and Encourages Investors to Contact the Firm,2016-12-13 16:26:00 +0000,http://finance.yahoo.com/news/law-offices-howard-g-smith-162600719.html,"[Business Wire] - Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Alexion Pharmaceuticals, Inc. securities between February 10, 2014 and November 9, 2016, inclusive ."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Slips to 52-Week Low as CEO, CFO Quit amid Probe",2016-12-13 16:00:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vNgEdxZ_HHc/alexion-slips-to-52-week-low-as-ceo-cfo-quit-amid-probe-cm720665,Alexion Pharmaceuticals Inc ALXN announced that its board of directors has appointed an interim Chief Executive Officer CEO and a new Chief Financial Officer CFO after the former CEO and CFO resigned unexpectedly during an internal investigation into the sales practices related to its
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals: Another Day, Another Drop",2016-12-13 16:00:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/13/alexion-pharmaceuticals-another-day-another-drop/?mod=yahoobarrons&ru=yahoo,"Alexion Pharmaceuticals: Another Day, Another Drop"
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017",2016-12-13 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000966.html,"[GlobeNewswire] - NEW YORK, Dec. 13, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. and certain of its ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Slips to 52-Week Low as CEO, CFO Quit amid Probe",2016-12-13 14:02:02 +0000,http://finance.yahoo.com/news/alexion-slips-52-week-low-140202256.html,"Alexion Slips to 52-Week Low as CEO, CFO Quit amid Probe"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : December 13, 2016",2016-12-13 12:46:43 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-alxn-us-december-13-2016/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : December 13, 2016"
ALXN,ALXN:UW,BBG000G32HL2,[$$] Changes but No Clarity at Alexion ​,2016-12-13 05:46:31 +0000,http://www.wsj.com/articles/changes-but-no-clarity-at-alexion-1481561076?ru=yahoo?mod=yahoo_itp,[$$] Changes but No Clarity at Alexion ​
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-12-13 01:13:00 +0000,http://finance.yahoo.com/news/investor-notice-lundin-law-pc-011300538.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / December 12, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,What Happened in the Stock Market Today,2016-12-12 23:56:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7Y1c7vGq0co/what-happened-in-the-stock-market-today-cm720408,Image source Getty Images Stocks posted a mixed start to the trading week with the Dow Jones Industrial Average DJINDICES DJI 160 rising slightly as the broader S amp P 500 SNPINDEX GSPC index ticked lower Today s stock
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. – (ALXN)",2016-12-12 22:57:00 +0000,http://finance.yahoo.com/news/alexion-shareholder-alert-former-louisiana-225700626.html,"[Business Wire] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until January 17, 2017 to file lead plaintiff applications in a securities class action lawsuit against Alexion Pharmaceuticals, Inc."
ALXN,ALXN:UW,BBG000G32HL2,What Happened in the Stock Market Today,2016-12-12 22:35:30 +0000,http://www.fool.com/investing/2016/12/12/what-happened-in-the-stock-market-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Happened in the Stock Market Today
ALXN,ALXN:UW,BBG000G32HL2,Monday's ETF with Unusual Volume: SPYG,2016-12-12 21:56:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N6XK6TTVNH0/mondays-etf-with-unusual-volume-spyg-cm720368,The SPDR S amp P 500 Growth ETF SPYG is seeing unusually high volume in afternoon trading Monday with over 592 000 shares traded versus three month average volume of about 35 000 Shares of SPYG were off about 0 2 on the day Components of that ETF with the highest volume on
ALXN,ALXN:UW,BBG000G32HL2,[$$] Chipotle shares jump on streamlined leadership plan,2016-12-12 21:55:35 +0000,"http://www.ft.com/cms/s/3b28bf7e-c088-11e6-9bca-2b93a6856354,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Investors sank their teeth into Chipotle on Monday, sending shares up more than 3 per cent after the fast-casual burrito chain announced a streamlined corporate leadership structure. Chipotle said it planned ..."
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,412.54 down -31.96 points",2016-12-12 21:48:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DrEkE9Lrr3A/market-close-report-nasdaq-composite-index-closes-at-541254-down-3196-points-cm720390,Monday s session closes with the NASDAQ Composite Index at 5 412 54 The total shares traded for the NASDAQ was over 2 billion Declining stocks led advancers by 2 22 to 1 ratio There were 903 advancers and 2007 decliners for the day On the NASDAQ Stock Exchange 258 stocks reached a 52 week
ALXN,ALXN:UW,BBG000G32HL2,"Health Care Sector Update for 12/12/2016: ALXN,AZN,HON,AKAO,OPHT",2016-12-12 21:36:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P5L3z_LKF7E/health-care-sector-update-for-12122016-alxnaznhonakaoopht-cm720383,Top Health Care StocksTop Health Care Stocks JNJ 2 73 JNJ 2 73 PFE 2 38 PFE 2 38 MRK 0 08 MRK 0 08 ABT 0 89 ABT 0 89 AMGN 1 69 AMGN 1 69 Health care stocks were extending their gains from late last week with the NYSE Health Care Index posting a 0 5 advance while shares of
ALXN,ALXN:UW,BBG000G32HL2,The Biggest Loser: Alexion Pharmaceuticals Tumbles 13%,2016-12-12 21:19:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/12/the-biggest-loser-alexion-pharmaceuticals-tumbles-13/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Alexion Pharmaceuticals Tumbles 13%
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Tanks After CEO, CFO Unexpectedly Resign Amid Sales Probe",2016-12-12 21:06:59 +0000,http://www.investors.com/news/technology/alexion-tanks-after-ceo-cfo-unexpectedly-resign-amid-sales-probe/,"Alexion Tanks After CEO, CFO Unexpectedly Resign Amid Sales Probe"
ALXN,ALXN:UW,BBG000G32HL2,"Ophthotech, Alexion Tumble into Monday’s 52-Week Low Club",2016-12-12 21:04:47 +0000,http://247wallst.com/investing/2016/12/12/ophthotech-alexion-tumble-into-mondays-52-week-low-club/,"Ophthotech, Alexion Tumble into Monday’s 52-Week Low Club"
ALXN,ALXN:UW,BBG000G32HL2,Mid-Afternoon Market Update: Achaogen Surges On Positive Phase 3 Results; Alexion Shares Slide,2016-12-12 20:41:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SNi569_Bl0o/mid-afternoon-market-update-achaogen-surges-on-positive-phase-3-results-alexion-shares-slide-cm720343,Toward the end of trading Monday the Dow traded up 0 07 percent to 19 771 48 while the NASDAQ declined 0 81 percent to 5 400 34 The S amp P also fell dropping 0 22 percent to 2 254 52 Leading and Lagging Sectors Monday afternoon energy shares gained by 0 84 percent
ALXN,ALXN:UW,BBG000G32HL2,Alexion CEO & CFO out,2016-12-12 19:17:00 +0000,http://finance.yahoo.com/video/alexion-ceo-cfo-191700950.html,Alexion CEO & CFO out
ALXN,ALXN:UW,BBG000G32HL2,Mid-Day Market Update: Crude Oil Up Over 3%; Ophthotech Shares Tumble After Failed Phase 3 Trial Of Fovista,2016-12-12 18:41:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UAYVr6NsNIg/mid-day-market-update-crude-oil-up-over-3-ophthotech-shares-tumble-after-failed-phase-3-trial-of-fovista-cm720293,Midway through trading Monday the Dow traded up 0 13 percent to 19 783 49 while the NASDAQ declined 0 66 percent to 5 408 68 The S amp P also fell dropping 0 15 percent to 2 256 25 Leading and Lagging Sectors On Monday energy shares gained by 1 1 percent Meanwhile top gainers
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-12-12 18:28:00 +0000,http://finance.yahoo.com/news/shareholder-notice-lundin-law-pc-182800885.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / December 12, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-12 18:25:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-182500376.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 12, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion's Information Blackout Isn't Working,2016-12-12 18:16:25 +0000,http://www.bloomberg.com/gadfly/articles/2016-12-12/alexion-ceo-cfo-departures-info-blackout-isn-t-working?cmpid=yhoo.headline,Alexion's Information Blackout Isn't Working
ALXN,ALXN:UW,BBG000G32HL2,Shakeup at Alexion Pharmaceuticals hits stock price,2016-12-12 17:59:04 +0000,http://uk.finance.yahoo.com/news/shakeup-alexion-pharmaceuticals-hits-stock-171448569.html,Shakeup at Alexion Pharmaceuticals hits stock price
ALXN,ALXN:UW,BBG000G32HL2,"Why Alexion Pharmaceuticals, Inc.'s Shareholders Lost $3 Billion Today",2016-12-12 17:58:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bLX8pke3Zzk/why-alexion-pharmaceuticals-incs-shareholders-lost-3-billion-today-cm720233,Image source Getty Images What happened After the company announced a surprise change to its senior management team shares of rare disease focused Alexion Pharmaceuticals NASDAQ ALXN fell by more than 13 in early morning trading on Monday The move erased more than
ALXN,ALXN:UW,BBG000G32HL2,Nasdaq Lags; Lockheed Falls On Trump F-35 Comment,2016-12-12 17:55:00 +0000,http://www.investors.com/market-trend/stock-market-today/nasdaq-lags-near-midday-lockheed-falls-on-trump-f-35-comment/,Nasdaq Lags; Lockheed Falls On Trump F-35 Comment
ALXN,ALXN:UW,BBG000G32HL2,"S&P 500 Movers: ALXN, REGN",2016-12-12 16:58:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OafTBBoQH1k/sp-500-movers-alxn-regn-cm720112,In early trading on Monday shares of Regeneron Pharmaceuticals REGN topped the list of the day s best performing components of the S amp P 500 index trading up 5 5 Year to date Regeneron Pharmaceuticals has lost about 27 6 of its value And the worst performing S amp P
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ALXN, REGN",2016-12-12 16:57:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LkQkj0G1c_E/nasdaq-100-movers-alxn-regn-cm720110,In early trading on Monday shares of Regeneron Pharmaceuticals REGN topped the list of the day s best performing components of the Nasdaq 100 index trading up 5 8 Year to date Regeneron Pharmaceuticals has lost about 27 4 of its value And the worst performing Nasdaq 100
ALXN,ALXN:UW,BBG000G32HL2,Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Alexion Technologies Corporation Investors and Encourages Investors to Contact the Firm,2016-12-12 16:47:00 +0000,http://finance.yahoo.com/news/glancy-prongay-murray-llp-announces-164700867.html,"[Business Wire] - Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors who purchased Alexion Pharmaceuticals, Inc. securities between February 10, 2014 and November 9, 2016, inclusive ."
ALXN,ALXN:UW,BBG000G32HL2,[$$] Changes but No Clarity at Alexion ​,2016-12-12 16:44:40 +0000,http://www.wsj.com/articles/changes-but-no-clarity-at-alexion-1481561076?mod=yahoo_hs,[$$] Changes but No Clarity at Alexion ​
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals: Where There's Smoke…,2016-12-12 16:37:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/12/alexion-pharmaceuticals-where-theres-smoke/?mod=yahoobarrons&ru=yahoo,Alexion Pharmaceuticals: Where There's Smoke…
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Shuffles the Deck With Recent Executive Changes,2016-12-12 16:15:22 +0000,http://finance.yahoo.com/news/alexion-pharmaceuticals-shuffles-deck-recent-161522572.html,Alexion Pharmaceuticals Shuffles the Deck With Recent Executive Changes
ALXN,ALXN:UW,BBG000G32HL2,Mid-Morning Market Update: Markets Open Mixed; Crude Oil Hits 17-Month High On OPEC Commitments,2016-12-12 16:06:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zwo3ZaD3nRc/mid-morning-market-update-markets-open-mixed-crude-oil-hits-17-month-high-on-opec-commitments-cm720176,Following the market opening Monday the Dow traded up 0 23 percent to 19 802 89 while the NASDAQ declined 0 36 percent to 5 424 98 The S amp P also rose gaining 0 07 percent to 2 261 00 Leading and Lagging Sectors Monday morning energy shares gained by 2 1 percent Meanwhile
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alexion Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 – ALXN",2016-12-12 16:06:27 +0000,http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-160627759.html,"[GlobeNewswire] - NEW YORK, Dec. 12, 2016-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Alexion Pharmaceuticals, Inc. ..."
ALXN,ALXN:UW,BBG000G32HL2,"Why Alexion Pharmaceuticals, Inc.'s Shareholders Lost $3 Billion Today",2016-12-12 16:06:18 +0000,http://www.fool.com/investing/2016/12/12/why-alexion-pharmacetuicals-incs-shareholders-lost.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Alexion Pharmaceuticals, Inc.'s Shareholders Lost $3 Billion Today"
ALXN,ALXN:UW,BBG000G32HL2,"After CEO Ouster, Interim Alexion Boss Says 'We Need To Move On'",2016-12-12 15:56:00 +0000,http://www.forbes.com/sites/matthewherper/2016/12/12/after-ceo-ouster-interim-alexion-boss-says-we-need-to-move-on/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"After CEO Ouster, Interim Alexion Boss Says 'We Need To Move On'"
ALXN,ALXN:UW,BBG000G32HL2,Oil Prices Surge as Non-OPEC Members Agree to Cut,2016-12-12 15:39:00 +0000,http://finance.yahoo.com/news/oil-prices-surge-non-opec-153900017.html,Oil Prices Surge as Non-OPEC Members Agree to Cut
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion Names New CEO and CFO,2016-12-12 15:08:45 +0000,http://www.wsj.com/articles/alexion-ceo-and-cfo-depart-1481548706?mod=yahoo_hs,[$$] Alexion Names New CEO and CFO
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Fires CEO, CFO in the Midst of Investigation on Improper Sales Practices",2016-12-12 14:50:00 +0000,http://www.thestreet.com/video/13921999/alexion-fires-ceo-cfo-in-the-midst-of-investigation-on-improper-sales-practices.html?puc=yahoov&cm_ven=YAHOOV,"Alexion Fires CEO, CFO in the Midst of Investigation on Improper Sales Practices"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma Rocked by Top Executive Firings Amid Drug Sales Investigation,2016-12-12 14:18:00 +0000,https://www.thestreet.com/story/13921914/1/alexion-pharma-rocked-by-top-executive-firings-amidst-drug-sales-investigation.html?puc=yahoo&cm_ven=YAHOO,Alexion Pharma Rocked by Top Executive Firings Amid Drug Sales Investigation
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers",2016-12-12 14:00:00 +0000,http://biz.yahoo.com/e/161212/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers"
ALXN,ALXN:UW,BBG000G32HL2,"Pre-Market Most Active for Dec 12, 2016 :  OPHT, CHK, SDRL, AKAO, BAC, PBR, WLL, ALXN, UGP, ORIG, TVIX, QQQ",2016-12-12 13:56:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4hrIJvRbCZY/pre-market-most-active-for-dec-12-2016-opht-chk-sdrl-akao-bac-pbr-wll-alxn-ugp-orig-tvix-qqq-cm719936,The NASDAQ 100 Pre Market Indicator is down 9 45 to 4 886 45 The total Pre Market volume is currently 9 855 189 shares traded The following are the most active stocks for the pre market session Ophthotech Corporation OPHT is 31 86 at 6 91 with 3 374 256
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals says CEO, CFO resign, shares slump",2016-12-12 13:41:00 +0000,http://finance.yahoo.com/news/alexion-pharmaceuticals-says-ceo-cfo-134100576.html,"Alexion Pharmaceuticals says CEO, CFO resign, shares slump"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals says CEO, CFO resigns",2016-12-12 12:57:02 +0000,http://finance.yahoo.com/news/alexion-pharmaceuticals-says-ceo-cfo-125702774.html,"Alexion Pharmaceuticals says CEO, CFO resigns"
ALXN,ALXN:UW,BBG000G32HL2,Alexion CEO and CFO leave company as accounting probe nears completion,2016-12-12 12:50:48 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=EC97F8FE-F9A1-4A86-9DF1-3A7DD2BFF5DE&siteid=yhoof2,Alexion CEO and CFO leave company as accounting probe nears completion
ALXN,ALXN:UW,BBG000G32HL2,Alexion’s Board of Directors Announces New Leadership Appointments,2016-12-12 12:29:00 +0000,http://finance.yahoo.com/news/alexion-board-directors-announces-leadership-122900754.html,"[Business Wire] - The Board of Directors of Alexion Pharmaceuticals, Inc. announced today that it has named David Brennan as Interim Chief Executive Officer, effective immediately. Mr. Brennan is the former Chief Executive Officer and Executive Director of AstraZeneca PLC and has been a member of the Alexion Board of Directors since July 2014."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Names New CEO and CFO -- 4th Update,2016-12-12 10:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oUS7q5_K1r0/alexion-names-new-ceo-and-cfo--4th-update-20161212-00555,Alexion Names New CEO and CFO -- 4th Update
ALXN,ALXN:UW,BBG000G32HL2,Alexion Names New CEO and CFO -- 3rd Update,2016-12-12 10:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5mnUFP2RHQM/alexion-names-new-ceo-and-cfo--3rd-update-20161212-00546,Alexion Names New CEO and CFO -- 3rd Update
ALXN,ALXN:UW,BBG000G32HL2,Alexion CEO and CFO Depart -- 2nd Update,2016-12-12 09:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sb5qZu_Z8ns/alexion-ceo-and-cfo-depart--2nd-update-20161212-00431,Alexion CEO and CFO Depart -- 2nd Update
ALXN,ALXN:UW,BBG000G32HL2,Alexion Names New CEO and CFO,2016-12-12 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OaIaf3jzLOQ/alexion-names-new-ceo-and-cfo-20161212-00556,Alexion Names New CEO and CFO
ALXN,ALXN:UW,BBG000G32HL2,Alexion CEO and CFO Depart,2016-12-12 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DJaQwCr6aE0/alexion-ceo-and-cfo-depart-20161212-00389,Alexion CEO and CFO Depart
ALXN,ALXN:UW,BBG000G32HL2,Alexion CEO and CFO Depart -- Update,2016-12-12 08:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FCs0B3gxGW4/alexion-ceo-and-cfo-depart--update-20161212-00396,Alexion CEO and CFO Depart -- Update
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma Names David Brennan As Interim CEO; David Anderson Appointed CFO,2016-12-12 07:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EWsg0cRGL3A/alexion-pharma-names-david-brennan-as-interim-ceo-david-anderson-appointed-cfo-20161212-00244,Alexion Pharma Names David Brennan As Interim CEO; David Anderson Appointed CFO
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-10 03:04:00 +0000,http://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-030400068.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 9, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ALXN",2016-12-10 01:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-011000295.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 9, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,ALXN Makes Bullish Cross Above Critical Moving Average,2016-12-09 22:56:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AoJYwZWovNk/alxn-makes-bullish-cross-above-critical-moving-average-cm719625,In trading on Friday shares of Alexion Pharmaceuticals Inc Symbol ALXN crossed above their 200 day moving average of 132 82 changing hands as high as 134 06 per share Alexion Pharmaceuticals Inc shares are currently trading up about 4 8 on the day The chart below shows the one
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-12-09 20:41:00 +0000,http://finance.yahoo.com/news/investor-notice-lundin-law-pc-204100807.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / December 9, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) & Lead Plaintiff Deadline - January 17, 2017",2016-12-09 15:38:00 +0000,http://finance.yahoo.com/news/investor-alert-bronstein-gewirtz-grossman-153800239.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 9, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,Why Stocks Move When Execs Cancel Presentation Appearances,2016-12-07 20:58:30 +0000,http://finance.yahoo.com/news/why-stocks-move-execs-cancel-205830009.html,Why Stocks Move When Execs Cancel Presentation Appearances
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-07 20:11:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-201100572.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 7, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Alexion Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm",2016-12-07 18:33:00 +0000,http://finance.yahoo.com/news/law-offices-howard-g-smith-183300141.html,"[Business Wire] - Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Alexion Pharmaceuticals, Inc. securities between February 10, 2014 and November 9, 2016, inclusive ."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 - ALXN",2016-12-07 16:20:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-162000325.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 7, 2016 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Alexion Pharmaceuticals, ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma To Present At The Citi Global Conference; Webcast At 11:00 AM ET,2016-12-07 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M5BxwLLCLGA/alexion-pharma-to-present-at-the-citi-global-conference-webcast-at-1100-am-et-20161207-00628,Alexion Pharma To Present At The Citi Global Conference; Webcast At 11:00 AM ET
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-12-06 20:25:00 +0000,http://finance.yahoo.com/news/shareholder-notice-lundin-law-pc-202500058.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / December 6, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) & Lead Plaintiff Deadline - January 17, 2017",2016-12-06 16:47:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-164700019.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 6, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-06 16:21:00 +0000,http://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-162100233.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 6, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017",2016-12-06 15:07:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150700247.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 6, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-12-05 21:35:00 +0000,http://finance.yahoo.com/news/investor-notice-lundin-law-pc-213500182.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / December 5, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) & Lead Plaintiff Deadline - January 17, 2017",2016-12-05 17:32:00 +0000,http://finance.yahoo.com/news/investor-alert-bronstein-gewirtz-grossman-173200627.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 5, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Presents Data from Ultra-Rare Blood Disorder Study,2016-12-05 14:05:02 +0000,http://finance.yahoo.com/news/alexion-presents-data-ultra-rare-140502739.html,Alexion Presents Data from Ultra-Rare Blood Disorder Study
ALXN,ALXN:UW,BBG000G32HL2,New Data from ALXN1210 Dose-Escalation Study Presented at ASH Show Rapid and Sustained Reductions in LDH in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH),2016-12-04 17:00:00 +0000,http://finance.yahoo.com/news/data-alxn1210-dose-escalation-study-170000673.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. announced today that new data from an ongoing Phase 1/2 dose-escalation study of ALXN1210 in patients with paroxysmal nocturnal hemoglobinuria showed rapid and sustained reductions in lactate dehydrogenase , a direct marker of hemolysis , in patients treated with once-monthly dosing."
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-12-03 02:48:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-024800340.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / December 2, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ALXN",2016-12-03 01:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010000104.html,"[GlobeNewswire] - NEW YORK, Dec. 02, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. and certain of its officers. The class action, filed in United States ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-12-01 20:11:00 +0000,http://finance.yahoo.com/news/shareholder-notice-lundin-law-pc-201100838.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / December 1, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"Is Alexion Pharmaceuticals, Inc. (ALXN) a Good Stock To Buy?",2016-12-01 19:03:49 +0000,http://www.insidermonkey.com/blog/is-alexion-pharmaceuticals-inc-alxn-a-good-stock-to-buy-2-490851/,"Is Alexion Pharmaceuticals, Inc. (ALXN) a Good Stock To Buy?"
ALXN,ALXN:UW,BBG000G32HL2,"Lifshitz & Miller Law Firm Announces Investigation of Alexion Pharmaceuticals, Inc., Blue Nile, Inc., Hill International, Inc., InfuSystem Holdings Inc., Rent-A-Center, Inc., Treehouse Foods, Inc. and Viking Investments Group, Inc.",2016-12-01 16:45:00 +0000,http://finance.yahoo.com/news/lifshitz-miller-law-firm-announces-164500760.html,"[PR Newswire] - NEW YORK, Dec.1, 2016 /PRNewswire/ -- Alexion Pharmaceuticals, Inc. (ALXN) Lifshitz & Miller announces investigation on behalf of ALXN investors concerning whether ALXN violated federal securities laws ..."
ALXN,ALXN:UW,BBG000G32HL2,"ETFs with exposure to Alexion Pharmaceuticals, Inc. : December 1, 2016",2016-12-01 15:46:52 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alexion-pharmaceuticals-inc-december-1-2016/,"ETFs with exposure to Alexion Pharmaceuticals, Inc. : December 1, 2016"
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-30 20:40:00 +0000,http://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-204000144.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / November 30, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 -- ALXN",2016-11-30 17:12:23 +0000,http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-171223376.html,"[Marketwired] - The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Alexion Pharmaceuticals, Inc. between February 10, 2014......"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : November 30, 2016",2016-11-30 12:13:05 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-alxn-us-november-30-2016/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : November 30, 2016"
ALXN,ALXN:UW,BBG000G32HL2,"U.S. Stocks Edge Higher, Led by Health-Care Gains",2016-11-30 05:10:38 +0000,http://www.wsj.com/articles/stocks-pressured-by-commodity-prices-1480408410?ru=yahoo?mod=yahoo_itp,"U.S. Stocks Edge Higher, Led by Health-Care Gains"
ALXN,ALXN:UW,BBG000G32HL2,"Why Thor Industries, Alexion Pharmaceuticals, and Berry Plastics Jumped Today",2016-11-29 23:54:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UDJ7_f68Q4Y/why-thor-industries-alexion-pharmaceuticals-and-berry-plastics-jumped-today-cm715414,Tuesday was a solid day for the stock market as major market benchmarks regained a bit of their lost ground from yesterday s session Within the stock market crosscurrents hit various sectors A drop in oil hurt many energy companies but strength in the healthcare industry helped
ALXN,ALXN:UW,BBG000G32HL2,"Why Thor Industries, Alexion Pharmaceuticals, and Berry Plastics Jumped Today",2016-11-29 22:19:05 +0000,http://www.fool.com/investing/2016/11/29/why-thor-industries-alexion-pharmaceuticals-and-be.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Thor Industries, Alexion Pharmaceuticals, and Berry Plastics Jumped Today"
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,379.92 up 11.11 points",2016-11-29 21:48:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sqs3dVptu4s/market-close-report-nasdaq-composite-index-closes-at-537992-up-1111-points-cm715368,Tuesday s session closes with the NASDAQ Composite Index at 5 379 92 The total shares traded for the NASDAQ was over 1 78 billion Declining stocks led advancers by 1 05 to 1 ratio There were 1395 advancers and 1459 decliners for the day On the NASDAQ Stock Exchange 74 stocks reached a 52
ALXN,ALXN:UW,BBG000G32HL2,The Hot Stock: Alexion Pharmaceuticals Jumps 5.2%,2016-11-29 21:15:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/29/the-hot-stock-alexion-pharmaceuticals-jumps-5-2/?mod=yahoobarrons&ru=yahoo,The Hot Stock: Alexion Pharmaceuticals Jumps 5.2%
ALXN,ALXN:UW,BBG000G32HL2,Mid-Day Market Update: U.S. Stocks Turn Higher; Nivalis Therapeutics Shares Tumble After Failed Drug Trial,2016-11-29 18:17:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5CzkObvrE_4/mid-day-market-update-us-stocks-turn-higher-nivalis-therapeutics-shares-tumble-after-failed-drug-trial-cm715265,Midway through trading Tuesday the Dow traded up 0 15 percent to 19 126 46 while the NASDAQ climbed 0 62 percent to 5 401 98 The S amp P also rose gaining 0 32 percent to 2 208 67 Leading and Lagging Sectors On Tuesday healthcare shares gained by 0 58 percent Meanwhile
ALXN,ALXN:UW,BBG000G32HL2,Healthcare Stocks Help Nasdaq Reach New Heights,2016-11-29 17:31:00 +0000,https://www.thestreet.com/story/13907958/1/healthcare-stocks-help-nasdaq-reach-new-heights.html?puc=yahoo&cm_ven=YAHOO,Healthcare Stocks Help Nasdaq Reach New Heights
ALXN,ALXN:UW,BBG000G32HL2,Stocks Subdued by Lower Commodities Prices,2016-11-29 16:31:50 +0000,http://www.wsj.com/articles/stocks-pressured-by-commodity-prices-1480408410?mod=yahoo_hs,Stocks Subdued by Lower Commodities Prices
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-11-29 15:57:00 +0000,http://finance.yahoo.com/news/investor-notice-lundin-law-pc-155700439.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / November 29, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017",2016-11-29 15:04:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150400868.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 29, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at the Citi 2016 Global Healthcare Conference,2016-11-29 15:00:00 +0000,http://finance.yahoo.com/news/alexion-present-citi-2016-global-150000406.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. today announced that management will present at the Citi 2016 Global Healthcare Conference on Wednesday, December 7, 2016 at 11:00 a.m., Eastern Time."
ALXN,ALXN:UW,BBG000G32HL2,"Lawsuit for Investors in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares announced by Shareholders Foundation",2016-11-29 14:45:00 +0000,http://finance.yahoo.com/news/lawsuit-investors-alexion-pharmaceuticals-inc-144500434.html,"[GlobeNewswire] - SAN DIEGO, Nov. 29, 2016-- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain purchasers of shares of Alexion Pharmaceuticals, Inc. over alleged Securities ..."
ALXN,ALXN:UW,BBG000G32HL2,"Analysts' Actions -- Goldman Sachs, Johnson & Johnson, Pfizer and More",2016-11-29 13:16:00 +0000,http://finance.yahoo.com/news/analysts-actions-goldman-sachs-johnson-131600699.html,"Analysts' Actions -- Goldman Sachs, Johnson & Johnson, Pfizer and More"
ALXN,ALXN:UW,BBG000G32HL2,Stocks Subdued by Lower Commodities Prices,2016-11-29 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CDfpL_imP_A/stocks-subdued-by-lower-commodities-prices-20161129-00225,Stocks Subdued by Lower Commodities Prices
ALXN,ALXN:UW,BBG000G32HL2,U.S. Stocks Edge Higher,2016-11-29 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q1JqbSj5Qc4/us-stocks-edge-higher-20161129-00864,U.S. Stocks Edge Higher
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-28 18:58:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-185800170.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / November 28, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Alexion Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadlin",2016-11-27 11:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-notifies-110000299.html,"[GlobeNewswire] - STEVENSON, Md., Nov. 27, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
ALXN,ALXN:UW,BBG000G32HL2,Should You Buy General Growth Properties Inc (GGP)?,2016-11-27 02:34:56 +0000,http://www.insidermonkey.com/blog/should-you-buy-general-growth-properties-inc-ggp-492725/,Should You Buy General Growth Properties Inc (GGP)?
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ALXN",2016-11-26 01:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010000474.html,"[PR Newswire] - NEW YORK, Nov. 25, 2016 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"")(NASDAQ: ALXN) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-08946, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Alexion between February 10, 2014 and November 9, 2016, both dates inclusive (the ""Class Period""), seeking to recover compensable damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ""Exchange Act"") and Rule 10b-5 promulgated thereunder. If you are a shareholder who purchased Alexion during the Class Period, you have until January 17, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-11-25 18:00:00 +0000,http://finance.yahoo.com/news/shareholder-notice-lundin-law-pc-180000940.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / November 25, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"ALXN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Alexion Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 2017",2016-11-25 15:15:00 +0000,http://finance.yahoo.com/news/alxn-shareholder-alert-law-offices-151500997.html,"[GlobeNewswire] - NEW YORK, Nov. 25, 2016-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017",2016-11-24 15:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150300268.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 24, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,3 Beaten-Down Biotech Stocks You Can Buy Right Now,2016-11-23 13:28:32 +0000,http://www.fool.com/investing/2016/11/22/3-beaten-down-biotech-stocks-you-can-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Beaten-Down Biotech Stocks You Can Buy Right Now
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola",2016-11-23 13:05:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eaUft2HOB78/biotech-stock-roundup-acorda-stops-ampyra-pswd-development-crl-for-spectrums-qapzola-cm713105,With elections over and third quarter earnings season drawing to a close focus is back on pipeline and regulatory updates This week Acorda ACOR announced that it won t be continuing with the development of Ampyra for post stroke walking difficulties PSWD Meanwhile Spectrum SPPI got
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-22 23:55:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-235500064.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / November 22, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") ..."
ALXN,ALXN:UW,BBG000G32HL2,"Robbins Arroyo LLP: Alexion Pharmaceuticals, Inc. (ALXN) Misled Shareholders According to a Recently Filed Class Action",2016-11-22 20:59:00 +0000,http://finance.yahoo.com/news/robbins-arroyo-llp-alexion-pharmaceuticals-205900910.html,"[Business Wire] - Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Alexion Pharmaceuticals, Inc. in the U.S. District Court for the Southern District of New York."
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-11-22 17:24:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-172400525.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / November 22, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,"Lockridge Grindal Nauen P.L.L.P. Announces Filing of a Securities Class Action Against Alexion Pharmaceuticals, Inc.",2016-11-22 16:33:57 +0000,http://finance.yahoo.com/news/lockridge-grindal-nauen-p-l-163357898.html,"[GlobeNewswire] - MINNEAPOLIS, Nov. 22, 2016-- Lockridge Grindal Nauen P.L.L.P. announces that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers ..."
ALXN,ALXN:UW,BBG000G32HL2,3 Beaten-Down Biotech Stocks You Can Buy Right Now,2016-11-22 15:20:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rIFJsAeThpA/3-beaten-down-biotech-stocks-you-can-buy-right-now-cm712563,Biotech stocks were experiencing a downright dismal year Then came the election surprise Now many biotech stocks are enjoying a big rebound That doesn t mean that there still aren t great buying opportunities though Here s why Alexion Pharmaceuticals NASDAQ ALXN
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-21 19:20:00 +0000,http://finance.yahoo.com/news/important-investor-alert-khang-khang-192000316.html,"[Business Wire] - Khang & Khang LLP announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. . Investors who purchased or otherwise acquired shares between February 10, 2014 and November 9, 2016 inclusive , are encouraged to contact the Firm in advance of the January 17, 2017 lead plaintiff motion deadline."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 – ALXN",2016-11-21 18:23:44 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-182344346.html,"[GlobeNewswire] - NEW YORK, Nov. 21, 2016-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Alexion Pharmaceuticals, Inc. ..."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-21 16:23:00 +0000,http://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-162300676.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017",2016-11-21 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000205.html,"[GlobeNewswire] - NEW YORK, Nov. 21, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. and certain of its ..."
ALXN,ALXN:UW,BBG000G32HL2,"BMO Sets Outperform Rating, $26 Target On Ra Pharmaceuticals",2016-11-21 14:16:48 +0000,http://finance.yahoo.com/news/bmo-sets-outperform-rating-26-141648863.html,"BMO Sets Outperform Rating, $26 Target On Ra Pharmaceuticals"
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-11-19 02:25:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-022500416.html,"[Business Wire] - Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws between February 10, 2014 and November 9, 2016 inclusive ."
ALXN,ALXN:UW,BBG000G32HL2,"Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Alexion Pharmaceuticals, Inc. (ALXN)",2016-11-19 01:00:00 +0000,http://finance.yahoo.com/news/gainey-mckenna-egleston-announces-class-010000145.html,"[GlobeNewswire] - NEW YORK, Nov. 18, 2016-- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. in the United States District Court for the Southern District ..."
ALXN,ALXN:UW,BBG000G32HL2,"Final Trade: JBLU, CME & more",2016-11-18 22:25:00 +0000,http://finance.yahoo.com/video/final-trade-jblu-cme-more-222500113.html,"Final Trade: JBLU, CME & more"
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-18 16:35:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-163500698.html,"[Business Wire] - Khang & Khang LLP announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. . Investors who purchased or otherwise acquired shares between February 10, 2014 and November 9, 2016 inclusive , are encouraged to contact the Firm in advance of the January 17, 2017 lead plaintiff motion deadline."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017",2016-11-18 15:20:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-152000732.html,"[PR Newswire] - NEW YORK, Nov. 18, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") (ALXN) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Alexion securities between February 10, 2014 and November 9, 2016, both dates inclusive (the ""Class Period""). Such investors are advised to join this case by visiting the firm's site: http://www.bgandg.com/alxn. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the ""Exchange Act"")."
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-18 02:32:00 +0000,http://finance.yahoo.com/news/investor-alert-goldberg-law-pc-023200034.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Alexion Pharmaceuticals, Inc. To Contact The Firm Before Lead Plaintiff Deadline",2016-11-18 01:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-010000483.html,"[GlobeNewswire] - NEW YORK, Nov. 17, 2016-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Alexion Pharmaceuticals, Inc. of the January 17, 2017. deadline to seek the role of lead plaintiff ..."
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm",2016-11-17 23:49:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-234900053.html,"[Business Wire] - Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws between February 10, 2014 and November 9, 2016 inclusive ."
ALXN,ALXN:UW,BBG000G32HL2,"EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. – ALXN",2016-11-17 23:04:00 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-230400873.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Alexion Pharmaceuticals, Inc. securities from February 10, 2014 through November 9, 2016, inclusive ."
ALXN,ALXN:UW,BBG000G32HL2,New Data from Global aHUS Registry Presented at ASN 2016 Show a Three-Fold Reduction in Post-Transplant Dialysis in Patients Initiating Soliris® (eculizumab) Treatment Prior to Transplant Compared to Initiating Treatment Post-Transplant,2016-11-17 22:40:09 +0000,http://www.publicnow.com/view/3339AC48A28E286718834EC691BCAF3998B48856,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced today that researchers presented new data from an analysis of patients enrolled in the Global atypical Hemolytic ..."
ALXN,ALXN:UW,BBG000G32HL2,New Data from Global aHUS Registry Presented at ASN 2016 Show a Three-Fold Reduction in Post-Transplant Dialysis in Patients Initiating Soliris® (eculizumab) Treatment Prior to Transplant Compared to Initiating Treatment Post-Transplant,2016-11-17 22:32:00 +0000,http://finance.yahoo.com/news/data-global-ahus-registry-presented-223200428.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. announced today that researchers presented new data from an analysis of patients enrolled in the Global atypical Hemolytic Uremic Syndrome Registry, demonstrating that initiation of Soliris® prior to kidney transplant reduces the risk of dialysis post-transplant in patients with aHUS."
ALXN,ALXN:UW,BBG000G32HL2,"Pomerantz Law Firm Announces the Filing of a Class Action against Alexion Pharmaceuticals, Inc. and Certain Officers – ALXN",2016-11-17 21:13:40 +0000,http://finance.yahoo.com/news/pomerantz-law-firm-announces-filing-211340974.html,"[GlobeNewswire] - NEW YORK, Nov. 17, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. and certain of its officers. The class action, filed in United States ..."
ALXN,ALXN:UW,BBG000G32HL2,"10 biotech companies ripe for a buyout, courtesy of Donald Trump",2016-11-17 14:28:16 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9AEFC198-ACC7-11E6-A769-02A54265C928&siteid=yhoof2,"10 biotech companies ripe for a buyout, courtesy of Donald Trump"
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or",2016-11-16 22:11:31 +0000,http://biz.yahoo.com/e/161116/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Receives NASDAQ Notification Related to the Late Filing of Form 10-Q,2016-11-16 22:00:00 +0000,http://finance.yahoo.com/news/alexion-receives-nasdaq-notification-related-220000355.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. today announced that it received a notification letter on November 15, 2016 from The NASDAQ Stock Market . The notification letter stated that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 , the Company is no longer in compliance with NASDAQ Marketplace Rule 5250 , which requires timely filing of periodic ..."
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Alexion Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm",2016-11-16 21:55:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-215500575.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / November 16, 2016 / Lundin Law PC , a shareholder rights firm, announces that it is investigating claims against Alexion Pharmaceuticals, Inc. (""Alexion"" or the ..."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Alexion Pharmaceuticals, Inc. To Contact The Firm",2016-11-16 19:30:00 +0000,http://finance.yahoo.com/news/alexion-notification-faruqi-faruqi-llp-193000255.html,"[PR Newswire] - NEW YORK, Nov. 16, 2016 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Alexion Pharmaceuticals, Inc. (""Alexion"" or ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion's Valuation Could Be Getting Pummeled Unnecessarily,2016-11-15 21:23:36 +0000,http://finance.yahoo.com/news/alexions-valuation-could-getting-pummeled-212336151.html,Alexion's Valuation Could Be Getting Pummeled Unnecessarily
ALXN,ALXN:UW,BBG000G32HL2,Shkreli's Very Bullish Call On Alexion Following Recent Downside: 'Double From Here',2016-11-15 19:29:32 +0000,http://finance.yahoo.com/news/shkrelis-very-bullish-call-alexion-192932260.html,Shkreli's Very Bullish Call On Alexion Following Recent Downside: 'Double From Here'
ALXN,ALXN:UW,BBG000G32HL2,"IBB, REGN, ALXN, VRTX: ETF Inflow Alert",2016-11-15 17:29:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Syp8GhNKWDU/ibb-regn-alxn-vrtx-etf-inflow-alert-cm709519,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 1 5 billion dollar inflow that s a 21 4 increase week over week
ALXN,ALXN:UW,BBG000G32HL2,"Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks",2016-11-14 18:21:11 +0000,http://www.insidermonkey.com/blog/incyte-corporation-incy-seattle-genetics-inc-sgen-two-more-top-healthcare-hedge-fund-loves-these-stocks-485619/,"Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks"
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Offers Long-Term Phase III Data on Kanuma,2016-11-14 15:31:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mH4caIoHea4/alexion-alxn-offers-long-term-phase-iii-data-on-kanuma-cm708551,Alexion Pharmaceuticals Inc ALXN revealed new long term data from an ongoing open label extension of the pivotal phase III ARISE study on Kanuma sebelipase alfa in children and adults with lysosomal acid lipase deficiency LAL D Data was presented at the annual meeting of the
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Offers Long-Term Phase III Data on Kanuma,2016-11-14 13:35:01 +0000,http://finance.yahoo.com/news/alexion-alxn-offers-long-term-133501635.html,Alexion (ALXN) Offers Long-Term Phase III Data on Kanuma
ALXN,ALXN:UW,BBG000G32HL2,[$$] Biotech Company Bloodied by Sales Investigation,2016-11-14 05:52:12 +0000,http://www.wsj.com/articles/biotech-company-bloodied-by-sales-investigation-1478795929?ru=yahoo?mod=yahoo_itp,[$$] Biotech Company Bloodied by Sales Investigation
ALXN,ALXN:UW,BBG000G32HL2,The Biggest Loser: Alexion Pharmaceuticals Tumbles 10%,2016-11-11 21:56:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/11/the-biggest-loser-alexion-pharmaceuticals-tumbles-10/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Alexion Pharmaceuticals Tumbles 10%
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,237.11 up 28.31 points",2016-11-11 21:49:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pXK4Xx9G3CE/market-close-report-nasdaq-composite-index-closes-at-523711-up-2831-points-cm708160,Friday s session closes with the NASDAQ Composite Index at 5 237 11 The total shares traded for the NASDAQ was over 2 23 billion Friday s session closes with the NASDAQ Composite Index at 5 237 11 The total shares traded for the NASDAQ was over 2 23 billion Advancers stocks led declining by 2
ALXN,ALXN:UW,BBG000G32HL2,"EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-11 18:10:00 +0000,http://finance.yahoo.com/news/equity-alert-khang-khang-llp-181000454.html,"[Business Wire] - Khang & Khang LLP announces that it is investigating claims against Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alexion Pharmaceuticals, Inc. - ALXN",2016-11-11 17:09:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-170900442.html,"[PR Newswire] - NEW YORK, Nov. 11, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alexion Pharmaceuticals, Inc. (""Alexion"" or the ""Company"") (NASDAQ: ALXN) (ISIN: ..."
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ALXN, NVDA",2016-11-11 16:28:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O1gFSp7Lpqs/nasdaq-100-movers-alxn-nvda-cm707853,In early trading on Friday shares of NVIDIA NVDA topped the list of the day s best performing components of the Nasdaq 100 index trading up 24 1 Year to date NVIDIA registers a 155 1 gain And the worst performing Nasdaq 100 component thus far on the day is Alexion
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Alexion Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm",2016-11-11 16:25:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-162500409.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)",2016-11-11 15:07:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150700025.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 11, 2016 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alexion Pharmaceuticals, Inc. (""Alexion"" or the ..."
ALXN,ALXN:UW,BBG000G32HL2,Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep,2016-11-11 14:35:07 +0000,http://247wallst.com/healthcare-business/2016/11/11/top-biotech-and-health-care-stocks-set-to-run-on-huge-republican-sweep/,Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep
ALXN,ALXN:UW,BBG000G32HL2,New Long-Term Data Presented at AASLD Show Reduction in Liver Fibrosis and Cirrhosis in a Cohort of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) Treated with Kanuma® (sebelipase alfa),2016-11-11 13:00:00 +0000,http://finance.yahoo.com/news/long-term-data-presented-aasld-130000212.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. announced today that researchers presented new longer-term data from an ongoing, open-label extension of the pivotal Phase 3 ARISE trial of Kanuma® in children and adults with lysosomal acid lipase deficiency , a genetic and progressive ultra-rare metabolic disease."
ALXN,ALXN:UW,BBG000G32HL2,Alexion faces a downside position,2016-11-11 11:47:06 +0000,http://finance.yahoo.com/news/alexion-faces-downside-position-114706190.html,Alexion faces a downside position
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Alexion Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm",2016-11-11 00:47:00 +0000,http://finance.yahoo.com/news/investor-alert-goldberg-law-pc-004700078.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws."
ALXN,ALXN:UW,BBG000G32HL2,"Bragar Eagel & Squire, P.C. Is Investigating Alexion Pharmaceuticals, Inc. (ALXN) on Behalf of Stockholders and Encourages Investors to Contact the Firm",2016-11-10 22:39:00 +0000,http://finance.yahoo.com/news/bragar-eagel-squire-p-c-223900568.html,"[Business Wire] - Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Alexion Pharmaceuticals, Inc. concerning whether the board has breached its fiduciary duties to shareholders."
ALXN,ALXN:UW,BBG000G32HL2,JPMorgan Believes Its Positive Long-Term Thesis On Alexion Remains Intact,2016-11-10 20:35:27 +0000,http://finance.yahoo.com/news/jpmorgan-believes-positive-long-term-203527210.html,JPMorgan Believes Its Positive Long-Term Thesis On Alexion Remains Intact
ALXN,ALXN:UW,BBG000G32HL2,"INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm",2016-11-10 20:23:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-202300278.html,"[Business Wire] - Khang & Khang LLP announces that it is investigating claims against Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws."
ALXN,ALXN:UW,BBG000G32HL2,"Harwood Feffer LLP Announces Investigation of Alexion Pharmaceuticals, Inc.",2016-11-10 20:14:00 +0000,http://finance.yahoo.com/news/harwood-feffer-llp-announces-investigation-201400494.html,"[PR Newswire] - NEW YORK, Nov. 10, 2016 /PRNewswire/ -- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential claims against the board of directors of Alexion Pharmaceuticals, Inc. (""Alexion"" or the ..."
ALXN,ALXN:UW,BBG000G32HL2,"Despite Alexion's Internal Investigation, Goldman Standing Behind Its Buy Rating",2016-11-10 19:08:21 +0000,http://finance.yahoo.com/news/despite-alexions-internal-investigation-goldman-190821273.html,"Despite Alexion's Internal Investigation, Goldman Standing Behind Its Buy Rating"
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)",2016-11-10 17:56:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-175600007.html,"[PR Newswire] - NEW YORK, Nov. 10, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alexion Pharmaceuticals, Inc. (""Alexion"" ..."
ALXN,ALXN:UW,BBG000G32HL2,[$$] Biotech Company Bloodied by Sales Investigation,2016-11-10 16:38:53 +0000,http://www.wsj.com/articles/biotech-company-bloodied-by-sales-investigation-1478795929?mod=yahoo_hs,[$$] Biotech Company Bloodied by Sales Investigation
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Management On Internal Investigation: So Far, So Good",2016-11-10 16:04:32 +0000,http://finance.yahoo.com/news/alexion-management-internal-investigation-far-160432580.html,"Alexion Management On Internal Investigation: So Far, So Good"
ALXN,ALXN:UW,BBG000G32HL2,"IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Alexion Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm",2016-11-10 16:03:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-160300637.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Alexion Pharmaceuticals, Inc.-- ALXN",2016-11-10 14:43:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-144300369.html,"[Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws by certain officers and directors."
ALXN,ALXN:UW,BBG000G32HL2,"SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Alexion Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm",2016-11-10 02:01:00 +0000,http://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-020100294.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Alexion Pharmaceuticals, Inc. concerning possible violations of federal securities laws."
ALXN,ALXN:UW,BBG000G32HL2,"Glancy Prongay & Murray LLP Commences Investigation on Behalf of Alexion Pharmaceuticals, Inc. Investors",2016-11-09 23:49:00 +0000,http://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-234900262.html,"[Business Wire] - Glancy Prongay & Murray LLP announces an investigation on behalf of Alexion Pharmaceuticals, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws."
ALXN,ALXN:UW,BBG000G32HL2,"After-hours buzz: TWTR, TASR, SHAK & more",2016-11-09 22:49:41 +0000,http://www.cnbc.com/id/104094206?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104094206,"After-hours buzz: TWTR, TASR, SHAK & more"
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion Pharmaceuticals Investigating Drug's Sales Practices,2016-11-09 22:41:50 +0000,http://www.wsj.com/articles/alexion-pharmaceuticals-investigating-drugs-sales-practices-1478728722?mod=yahoo_hs,[$$] Alexion Pharmaceuticals Investigating Drug's Sales Practices
ALXN,ALXN:UW,BBG000G32HL2,Alexion Investigating Allegations About Its Sales Practices,2016-11-09 21:58:27 +0000,http://www.investors.com/news/technology/alexion-investigating-allegations-about-its-sales-practices/,Alexion Investigating Allegations About Its Sales Practices
ALXN,ALXN:UW,BBG000G32HL2,Alexion says investigating Soliris sales practices,2016-11-09 21:56:49 +0000,http://finance.yahoo.com/news/alexion-says-investigating-soliris-sales-215649960.html,[Reuters] - Alexion Pharmaceuticals Inc said on Wednesday it was conducting an investigation into allegations made by a former employee regarding sales practices of blood disorder drug Soliris. The company said it ...
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharma shares halted, company to delay quarterly results",2016-11-09 21:56:04 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=8D9E4DFB-15D6-4245-A04B-940825F25930&siteid=yhoof2,"Alexion Pharma shares halted, company to delay quarterly results"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Drug Sale Practices Target of Internal Investigation,2016-11-09 21:47:00 +0000,https://www.thestreet.com/story/13887406/1/alexion-drug-sale-practices-target-of-internal-investigation.html?puc=yahoo&cm_ven=YAHOO,Alexion Drug Sale Practices Target of Internal Investigation
ALXN,ALXN:UW,BBG000G32HL2,Alexion Provides Update on Form 10-Q Filing,2016-11-09 21:41:21 +0000,http://www.publicnow.com/view/8BB80D3E56DDD45C7C49E283FC00F0AEBF95C29E,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a Form 12b-25 Notification of Late ..."
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-11-09 21:38:49 +0000,http://biz.yahoo.com/e/161109/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ALXN,ALXN:UW,BBG000G32HL2,What Do Analysts Say about Regeneron after 3Q16 Earnings?,2016-11-09 19:04:05 +0000,http://marketrealist.com/2016/11/what-do-analysts-say-about-regeneron-after-3q16-earnings/?utm_source=yahoo&utm_medium=feed,What Do Analysts Say about Regeneron after 3Q16 Earnings?
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Investigating Drug''s Sales Practices -- Update,2016-11-09 17:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sHJq1WZg8Xk/alexion-pharmaceuticals-investigating-drugs-sales-practices--update-20161109-01469,Alexion Pharmaceuticals Investigating Drug''s Sales Practices -- Update
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Investigating Drug's Sales Practices,2016-11-09 17:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uHJ7lmzWWrU/alexion-pharmaceuticals-investigating-drugs-sales-practices-20161109-01462,Alexion Pharmaceuticals Investigating Drug's Sales Practices
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Investigating Drug''s Sales Practices,2016-11-09 17:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tv-4ajTWMLs/alexion-pharmaceuticals-investigating-drugs-sales-practices-20161109-01395,Alexion Pharmaceuticals Investigating Drug''s Sales Practices
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Trading Halted; Expected To Resume At 5:00 PM ET,2016-11-09 16:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z6W-3AatbDg/alexion-pharmaceuticals-trading-halted-expected-to-resume-at-500-pm-et-20161109-01328,Alexion Pharmaceuticals Trading Halted; Expected To Resume At 5:00 PM ET
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed",2016-11-09 13:55:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o62MSuZGffg/biotech-stock-roundup-ionis-soars-on-spinraza-data-regenerons-q3-results-mixed-cm706221,With third quarter earnings season winding down the only major biotech company to report results over the last five trading days was Regeneron REGN While some small and mid sized biotechs are yet to report results focus is back on pipeline and regulatory updates Recap of the Week s
ALXN,ALXN:UW,BBG000G32HL2,Biotech ETFs Slumping on Q3 Results,2016-11-09 00:07:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IFQ3FMbTTLY/biotech-etfs-slumping-on-q3-results-cm706018,The biotech sector has faced rough trading since the beginning of 2016 continuing the volatile trend from the second half of 2015 Media and political focus on the high prices of drugs and increasing competition have made things difficult for the sector Democratic presidential candidate
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for November 8th,2016-11-08 20:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MHsBK2REvLA/new-strong-sell-stocks-for-november-8th-cm705547,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today Alamo Group Inc ALG designs manufactures and sells agricultural equipment and infrastructure maintenance equipment for governmental and industrial use The Zacks Consensus Estimate for its current year earnings has
ALXN,ALXN:UW,BBG000G32HL2,Biotech ETFs Slumping on Q3 Results,2016-11-08 20:26:08 +0000,http://finance.yahoo.com/news/biotech-etfs-slumping-q3-results-202608322.html,Biotech ETFs Slumping on Q3 Results
ALXN,ALXN:UW,BBG000G32HL2,Gilead Sciences: 5 Reasons to Buy Alexion…and 4 Reasons It Shouldn't,2016-11-08 20:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/08/gilead-sciences-5-reasons-to-buy-alexion-and-4-reasons-it-shouldnt/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: 5 Reasons to Buy Alexion…and 4 Reasons It Shouldn't
ALXN,ALXN:UW,BBG000G32HL2,The companies that could be the biggest winners from a Trump or Clinton victory,2016-11-08 15:03:54 +0000,http://finance.yahoo.com/news/companies-could-biggest-winners-either-150354781.html,The companies that could be the biggest winners from a Trump or Clinton victory
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for November 8th,2016-11-08 14:21:02 +0000,http://finance.yahoo.com/news/strong-sell-stocks-november-8th-142102126.html,New Strong Sell Stocks for November 8th
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : November 8, 2016",2016-11-08 13:29:54 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-alxn-us-november-8-2016/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : November 8, 2016"
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,166.17 up 119.80 points",2016-11-07 21:48:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6hMmV4vj1c8/market-close-report-nasdaq-composite-index-closes-at-516617-up-11980-points-cm705266,Monday s session closes with the NASDAQ Composite Index at 5 166 17 The total shares traded for the NASDAQ was over 1 94 billion Monday s session closes with the NASDAQ Composite Index at 5 166 17 The total shares traded for the NASDAQ was over 1 94 billion Advancers stocks led declining by 3
ALXN,ALXN:UW,BBG000G32HL2,SPY ETF Tests A Key Level As Every S&P Sector Posts A Weekly Loss,2016-11-07 19:07:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FGKLw43I_T4/spy-etf-tests-a-key-level-as-every-sp-sector-posts-a-weekly-loss-cm704132,Down down and down That was the ETF market story this week as election uncertainties jangled investors nerves Voters head to the polls Tuesday to elect the next president of the United States SPDR S amp P 500 SPY wobbled 160 on the stock market today 160
ALXN,ALXN:UW,BBG000G32HL2,"S&P 500 Movers: NEM, SYY",2016-11-07 17:13:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OPW03qUGhPw/sp-500-movers-nem-syy-cm704966,In early trading on Monday shares of Sysco SYY topped the list of the day s best performing components of the S amp P 500 index trading up 10 2 Year to date Sysco registers a 29 2 gain And the worst performing S amp P 500 component thus far on the day is Newmont Mining
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: LVNTA, BIIB",2016-11-07 17:12:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iufIMiTe5BU/nasdaq-100-movers-lvnta-biib-cm704962,In early trading on Monday shares of Biogen BIIB topped the list of the day s best performing components of the Nasdaq 100 index trading up 5 9 Year to date Biogen has lost about 4 3 of its value And the worst performing Nasdaq 100 component thus far on the day is Liberty
ALXN,ALXN:UW,BBG000G32HL2,"Gilead Sciences: No M&A, No Pipeline?",2016-11-07 15:50:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/07/gilead-sciences-no-ma-no-pipeline/?mod=yahoobarrons&ru=yahoo,"Gilead Sciences: No M&A, No Pipeline?"
ALXN,ALXN:UW,BBG000G32HL2,SPY ETF Tests A Key Level As Every S&P Sector Posts A Weekly Loss,2016-11-04 21:40:52 +0000,http://www.investors.com/etfs-and-funds/etfs/biotech-etf-surges-as-stock-market-wobbles-after-three-down-days/,SPY ETF Tests A Key Level As Every S&P Sector Posts A Weekly Loss
ALXN,ALXN:UW,BBG000G32HL2,Friday's ETF with Unusual Volume: BBH,2016-11-04 18:49:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WoOGlq7FBns/fridays-etf-with-unusual-volume-bbh-cm704304,The Biotech ETF BBH is seeing unusually high volume in afternoon trading Friday with over 219 000 shares traded versus three month average volume of about 71 000 Shares of BBH were up about 1 5 on the day Components of that ETF with the highest volume on Friday were
ALXN,ALXN:UW,BBG000G32HL2,"Noteworthy Friday Option Activity: OFG, ALXN, SCTY",2016-11-04 17:08:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WbL8YYX5dQ4/noteworthy-friday-option-activity-ofg-alxn-scty-cm704208,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in OFG Bancorp Symbol OFG where a total of 4 416 contracts have traded so far representing approximately 441 600 underlying shares That amounts to about 237 1 of OFG s average
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Soars, Then Falls Amid Takeover Rumors",2016-11-04 17:03:00 +0000,https://www.thestreet.com/story/13881782/1/alexion-soars-then-falls-amid-takeover-rumors.html?puc=yahoo&cm_ven=YAHOO,"Alexion Soars, Then Falls Amid Takeover Rumors"
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: SYMC, ALXN",2016-11-04 16:23:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K8YQYw8hd5M/nasdaq-100-movers-symc-alxn-cm704149,In early trading on Friday shares of Alexion Pharmaceuticals ALXN topped the list of the day s best performing components of the Nasdaq 100 index trading up 10 2 Year to date Alexion Pharmaceuticals has lost about 26 3 of its value And the worst performing Nasdaq 100
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals: Is Something Afoot?,2016-11-04 16:03:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/04/alexion-pharmaceuticals-is-something-afoot/?mod=yahoobarrons&ru=yahoo,Alexion Pharmaceuticals: Is Something Afoot?
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. (ALXN) Has Jumped To A 5-Month High,2016-11-04 09:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4TirQi7f_2M/alexion-pharmaceuticals-inc-alxn-has-jumped-to-a-5month-high-20161104-00829,Alexion Pharmaceuticals Inc. (ALXN) Has Jumped To A 5-Month High
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Amgen Down on Enbrel Sales, Regeneron's Sarilumab Faces Delay",2016-11-03 14:09:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IvrO7ewrYvE/biotech-stock-roundup-amgen-down-on-enbrel-sales-regenerons-sarilumab-faces-delay-cm703242,Third quarter earnings season is in full flow with several major biotech companies including Gilead GILD and Amgen AMGN reporting results Meanwhile companies like TESARO TSRO and Regeneron REGN provided regulatory updates while TESARO submitted a regulatory application for its
ALXN,ALXN:UW,BBG000G32HL2,Researchers to Present New Phase 1/2 Data on ALXN1210 in Patients with PNH at ASH 2016 Annual Meeting,2016-11-03 13:25:00 +0000,http://finance.yahoo.com/news/researchers-present-phase-1-2-132500858.html,"[Business Wire] - Alexion Pharmaceuticals, Inc. today announced that researchers will present new interim data from a Phase 1/2 dose-escalation study of ALXN1210, the Company’s investigational, highly innovative longer-acting anti-C5 antibody, in patients with paroxysmal nocturnal hemoglobinuria ."
ALXN,ALXN:UW,BBG000G32HL2,Alexion’s Upward Revision of Its 2016 Revenue Guidance,2016-11-03 12:04:29 +0000,http://marketrealist.com/2016/10/alexions-upward-revision-of-its-2016-revenue-guidance/?utm_source=yahoo&utm_medium=feed,Alexion’s Upward Revision of Its 2016 Revenue Guidance
ALXN,ALXN:UW,BBG000G32HL2,"Top Research Reports for Celgene, Ford & Dow Chemical",2016-11-02 16:55:04 +0000,http://finance.yahoo.com/news/top-research-reports-celgene-ford-165504468.html,"Top Research Reports for Celgene, Ford & Dow Chemical"
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for November 2nd,2016-11-02 15:10:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_U-xAUzPX0w/new-strong-sell-stocks-for-november-2nd-cm702536,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today 160 160 160 Alexion Pharmaceuticals Inc ALXN develops pharmaceutical products for the treatment of heart disease and inflammation diseases of the immune system and cancer in humans The Zacks Consensus
ALXN,ALXN:UW,BBG000G32HL2,How Is Kanuma Progressing Globally?,2016-11-02 15:04:40 +0000,http://marketrealist.com/2016/10/how-is-kanuma-progressing-globally/?utm_source=yahoo&utm_medium=feed,How Is Kanuma Progressing Globally?
ALXN,ALXN:UW,BBG000G32HL2,Strensiq: A Potential Driver for Alexion,2016-11-02 14:05:12 +0000,http://marketrealist.com/2016/10/strensiq-a-potential-driver-for-alexion/?utm_source=yahoo&utm_medium=feed,Strensiq: A Potential Driver for Alexion
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for November 2nd,2016-11-02 13:41:01 +0000,http://finance.yahoo.com/news/strong-sell-stocks-november-2nd-134101813.html,New Strong Sell Stocks for November 2nd
ALXN,ALXN:UW,BBG000G32HL2,An Update on Phase 3 Studies for Soliris,2016-11-02 12:05:45 +0000,http://marketrealist.com/2016/10/an-update-on-phase-3-studies-for-soliris/?utm_source=yahoo&utm_medium=feed,An Update on Phase 3 Studies for Soliris
ALXN,ALXN:UW,BBG000G32HL2,Alexion’s Soliris Is Still Going Strong,2016-11-01 15:06:01 +0000,http://marketrealist.com/2016/10/alexions-soliris-is-still-going-strong/?utm_source=yahoo&utm_medium=feed,Alexion’s Soliris Is Still Going Strong
ALXN,ALXN:UW,BBG000G32HL2,Analyzing Alexion’s 3Q16 Performance,2016-11-01 14:06:36 +0000,http://marketrealist.com/2016/10/analyzing-alexions-3q16-performance/?utm_source=yahoo&utm_medium=feed,Analyzing Alexion’s 3Q16 Performance
ALXN,ALXN:UW,BBG000G32HL2,"Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More",2016-11-01 13:15:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rxmVtmQScKM/drug-stocks-to-watch-for-earnings-on-nov-2-agn-zts-more-cm701594,The Q3 earnings season moves into the second half of the reporting cycle with results from 291 S amp P 500 members as of Oct 28 accounting for 58 2 of the index s total market capitalization according to the Earnings Preview report While total earnings for these 291 index members were
ALXN,ALXN:UW,BBG000G32HL2,Alexion Exceeded Revenue Expectations in 3Q16,2016-11-01 12:07:24 +0000,http://marketrealist.com/2016/10/alexion-exceeded-revenue-expectations-in-3q16/?utm_source=yahoo&utm_medium=feed,Alexion Exceeded Revenue Expectations in 3Q16
ALXN,ALXN:UW,BBG000G32HL2,[$$] Alexion Pharma Fairly Valued Despite Strong Q3,2016-11-01 10:05:00 +0000,http://www.barrons.com/articles/alexion-pharma-fairly-valued-despite-strong-q3-1477994708?mod=yahoobarrons&ru=yahoo,[$$] Alexion Pharma Fairly Valued Despite Strong Q3
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,189.14 down -.96 points",2016-10-31 20:48:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KG_jP-RFKZI/market-close-report-nasdaq-composite-index-closes-at-518914-down-96-points-cm701392,Monday s session closes with the NASDAQ Composite Index at 5 189 14 The total shares traded for the NASDAQ was over 1 64 billion Declining stocks led advancers by 1 02 to 1 ratio There were 1423 advancers and 1451 decliners for the day On the NASDAQ Stock Exchange 23 stocks reached a 52
ALXN,ALXN:UW,BBG000G32HL2,"3 Big Stock Charts: ConocoPhillips (COP), Western Digital Corp (WDC) and Alexion Pharmaceuticals, Inc. (ALXN)",2016-10-31 17:15:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_eJh6zEpPyo/3-big-stock-charts-conocophillips-cop-western-digital-corp-wdc-and-alexion-pharmaceuticals-inc-alxn-cm701155,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips As we ve pointed out time and time again the earnings season can take away as quickly as it gives which is why ConocoPhillips NYSE COP Western Digital Corp NASDAQ WDC and
ALXN,ALXN:UW,BBG000G32HL2,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : October 31, 2016",2016-10-31 17:14:34 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alexion-pharmaceuticals-inc-october-31-2016/,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : October 31, 2016"
ALXN,ALXN:UW,BBG000G32HL2,Genetic Stocks to Watch for Earnings on Nov 1: GILD & More,2016-10-31 14:16:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a8RySugHg7M/genetic-stocks-to-watch-for-earnings-on-nov-1-gild-more-cm700965,As Q3 earnings season gains momentum approximately 291 S amp P 500 members representing 58 2 of the index s total market capitalization have already reported quarterly results as of Oct 28 While total earnings for these 291 index members were up 2 2 year over year revenues inched
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : October 28, 2016",2016-10-28 13:41:32 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-alxn-us-october-28-2016/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : October 28, 2016"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016",2016-10-28 13:33:27 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-alxn-us-earnings-analysis-q3-2016-by-the-numbers-october-28-2016/,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016"
ALXN,ALXN:UW,BBG000G32HL2,Edited Transcript of ALXN earnings conference call or presentation 27-Oct-16 2:00pm GMT,2016-10-28 04:54:43 +0000,http://finance.yahoo.com/news/edited-transcript-alxn-earnings-conference-045443291.html,Edited Transcript of ALXN earnings conference call or presentation 27-Oct-16 2:00pm GMT
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Q3 Earnings Lag, Revenues Tops; Lifts View",2016-10-27 21:43:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3wXufHWsTJ0/alexion-alxn-q3-earnings-lag-revenues-tops-lifts-view-cm699808,Alexion Pharmaceuticals Inc s ALXN third quarter 2016 earnings including stock based compensation expense of 1 03 cents per share missed the Zacks Consensus Estimate of 1 04 Revenues on the other hand soared 20 1 year over year to 799 million The impact of currency headwind
ALXN,ALXN:UW,BBG000G32HL2,"Bristol-Myers, Celgene Stocks Rocket After Sweeping Q3 Expectations",2016-10-27 20:56:03 +0000,http://www.investors.com/news/technology/bristol-myers-celgene-stocks-rocket-after-sweeping-q3-expectations/,"Bristol-Myers, Celgene Stocks Rocket After Sweeping Q3 Expectations"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Surges on Heavy Trade,2016-10-27 20:53:00 +0000,https://www.thestreet.com/story/13871140/1/alexion-pharmaceuticals-surges-on-heavy-trade.html?puc=yahoo&cm_ven=YAHOO,Alexion Pharmaceuticals Surges on Heavy Trade
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,215.97 down -34.30 points",2016-10-27 20:49:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9l72wznLLMo/market-close-report-nasdaq-composite-index-closes-at-521597-down-3430-points-cm699850,Thursday s session closes with the NASDAQ Composite Index at 5 215 97 The total shares traded for the NASDAQ was over 1 88 billion Declining stocks led advancers by 1 99 to 1 ratio There were 945 advancers and 1881 decliners for the day On the NASDAQ Stock Exchange 22 stocks reached a 52
ALXN,ALXN:UW,BBG000G32HL2,Alexion Crushes Q3 Expectations; Stock Bounds On Drug Trial Plans,2016-10-27 20:19:18 +0000,http://www.investors.com/news/technology/alexion-crushes-q3-expectations-stock-bounds-on-drug-trial-plans/,Alexion Crushes Q3 Expectations; Stock Bounds On Drug Trial Plans
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Q3 Earnings Lag, Revenues Tops; Lifts View",2016-10-27 19:44:07 +0000,http://finance.yahoo.com/news/alexion-alxn-q3-earnings-lag-194407907.html,"Alexion (ALXN) Q3 Earnings Lag, Revenues Tops; Lifts View"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals (ALXN) Stock Soars on Q3 Beat, Outlook",2016-10-27 18:03:00 +0000,https://www.thestreet.com/story/13870546/1/alexion-pharmaceuticals-alxn-stock-soars-on-q3-beat-outlook.html?puc=yahoo&cm_ven=YAHOO,"Alexion Pharmaceuticals (ALXN) Stock Soars on Q3 Beat, Outlook"
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ORLY, WDC",2016-10-27 15:42:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NQxZp5xpDvc/nasdaq-100-movers-orly-wdc-cm699344,In early trading on Thursday shares of Western Digital WDC topped the list of the day s best performing components of the Nasdaq 100 index trading up 8 8 Year to date Western Digital registers a 2 4 gain And the worst performing Nasdaq 100 component thus far on the day is O
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Misses on Q2 Earnings, Beats Revenues",2016-10-27 14:45:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j1SdAe7BgrE/alexion-alxn-misses-on-q2-earnings-beats-revenues-cm699209,Alexion Pharmaceuticals Inc ALXN focuses on the development and commercialization of life transforming drugs for treating patients suffering from ultra rare disorders Soliris approved for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome is the key product of this
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a",2016-10-27 13:27:34 +0000,http://biz.yahoo.com/e/161027/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion (ALXN) Misses on Q2 Earnings, Beats Revenues",2016-10-27 13:08:01 +0000,http://finance.yahoo.com/news/alexion-alxn-misses-q2-earnings-130801154.html,"Alexion (ALXN) Misses on Q2 Earnings, Beats Revenues"
ALXN,ALXN:UW,BBG000G32HL2,Q3 2016 Alexion Pharmaceuticals Inc Earnings Release - Before Market Open,2016-10-27 11:07:05 +0000,http://biz.yahoo.com/research/earncal/20161027.html?t=alxn,Q3 2016 Alexion Pharmaceuticals Inc Earnings Release - Before Market Open
ALXN,ALXN:UW,BBG000G32HL2,Alexion beats Street 3Q forecasts,2016-10-27 10:40:47 +0000,http://sg.finance.yahoo.com/news/alexion-beats-street-3q-forecasts-104047344.html,Alexion beats Street 3Q forecasts
ALXN,ALXN:UW,BBG000G32HL2,Alexion Initiates Simultaneous Registration Trials of ALXN1210 for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS),2016-10-27 10:36:05 +0000,http://www.publicnow.com/view/D43DD8FFAE5129CF1D36FADE345B945E83609ED0,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the initiation of two Phase 3 trials of ALXN1210, a highly innovative, longer-acting anti-C5 antibody that ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Reports Third Quarter 2016 Results,2016-10-27 10:36:02 +0000,http://www.publicnow.com/view/3B8E1F206A0816D5B7C00190B94F5B08164466A8,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the third quarter of 2016. Total revenues grew to $799 million, a 20 percent increase, ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Q3 16 Earnings Conference Call At 10:00 AM ET,2016-10-27 09:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hgq2Qxsi4os/alexion-pharmaceuticals-q3-16-earnings-conference-call-at-1000-am-et-20161027-00909,Alexion Pharmaceuticals Q3 16 Earnings Conference Call At 10:00 AM ET
ALXN,ALXN:UW,BBG000G32HL2,Alexion Raises Revenue Outlook,2016-10-27 08:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cVGeo1KaPQ0/alexion-raises-revenue-outlook-20161027-00765,Alexion Raises Revenue Outlook
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma Updates FY16 Guidance - Quick Facts,2016-10-27 06:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eByvPdYM-ZQ/alexion-pharma-updates-fy16-guidance--quick-facts-20161027-00300,Alexion Pharma Updates FY16 Guidance - Quick Facts
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. Profit Climbs 13% In Q3,2016-10-27 06:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oPCyzqQQmaY/alexion-pharmaceuticals-inc-profit-climbs-13-in-q3-20161027-00277,Alexion Pharmaceuticals Inc. Profit Climbs 13% In Q3
ALXN,ALXN:UW,BBG000G32HL2,"Drug Stock Q3 Earnings Roster for Oct 27: AMGN, BMY & More",2016-10-26 13:50:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oh1yETFMaVw/drug-stock-q3-earnings-roster-for-oct-27-amgn-bmy-more-cm698462,The Q3 earnings season has so far seen encouraging reports with 116 S amp P 500 companies having already released results as of Oct 21 Of the total 80 2 surpassed earnings estimates while 62 9 trumped revenue expectations The Q3 earnings cycle is on track to be the first quarter to
ALXN,ALXN:UW,BBG000G32HL2,"Drug Stock Q3 Earnings Roster for Oct 27: AMGN, BMY & More",2016-10-26 12:45:12 +0000,http://finance.yahoo.com/news/drug-stock-q3-earnings-roster-124512439.html,"Drug Stock Q3 Earnings Roster for Oct 27: AMGN, BMY & More"
ALXN,ALXN:UW,BBG000G32HL2,iShares Nasdaq Biotechnology ETF Experiences Big Outflow,2016-10-24 16:23:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kkJxe-sEMuo/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-cm697146,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 414 3 million dollar outflow that s a 5 5 decrease week over week
ALXN,ALXN:UW,BBG000G32HL2,Alexion Graft-Versus-Host Disease Gets ODD (ALXN),2016-10-20 18:02:00 +0000,http://www.investopedia.com/news/alexions-alxn1007-earns-orphan-drug-status-alxn/?partner=YahooSA,Alexion Graft-Versus-Host Disease Gets ODD (ALXN)
ALXN,ALXN:UW,BBG000G32HL2,Alexion Graft-Versus-Host Disease Drug Wins Orphan Status,2016-10-20 17:27:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b4VrFi1OLFQ/alexion-graft-versus-host-disease-drug-wins-orphan-status-cm696084,Alexion Pharmaceuticals Inc ALXN announced that the FDA has granted orphan drug designation ODD to its pipeline candidate ALXN1007 for the treatment of acute graft versus host disease GVHD The FDA through its Office of Orphan Products Development grants this status to candidates
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Q3 Earnings: Can the Stock Pull a Surprise?,2016-10-20 15:29:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vElM-CBd3Pg/alexion-alxn-q3-earnings-can-the-stock-pull-a-surprise-cm695938,Alexion Pharmaceuticals Inc ALXN is scheduled to report third quarter 2016 results on Oct 27 before the opening bell The company s track record has been mixed Over the last four quarters the company has beaten estimates on two occasions Overall Alexion has posted an average
ALXN,ALXN:UW,BBG000G32HL2,Strensiq and Kanuma: Potential Revenue Drivers for Alexion,2016-10-20 15:04:54 +0000,http://marketrealist.com/2016/10/strensiq-and-kanuma-potential-revenue-drivers-for-alexion/?utm_source=yahoo&utm_medium=feed,Strensiq and Kanuma: Potential Revenue Drivers for Alexion
ALXN,ALXN:UW,BBG000G32HL2,Alexion Graft-Versus-Host Disease Drug Wins Orphan Status,2016-10-20 14:53:02 +0000,http://finance.yahoo.com/news/alexion-graft-versus-host-disease-145302069.html,Alexion Graft-Versus-Host Disease Drug Wins Orphan Status
ALXN,ALXN:UW,BBG000G32HL2,Which Factors Might Lead to Stagnant Growth for Soliris in 3Q16?,2016-10-20 14:06:29 +0000,http://marketrealist.com/2016/10/which-factors-might-lead-to-stagnant-growth-for-soliris-in-3q16/?utm_source=yahoo&utm_medium=feed,Which Factors Might Lead to Stagnant Growth for Soliris in 3Q16?
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Q3 Earnings: Can the Stock Pull a Surprise?,2016-10-20 13:53:01 +0000,http://finance.yahoo.com/news/alexion-alxn-q3-earnings-stock-135301871.html,Alexion (ALXN) Q3 Earnings: Can the Stock Pull a Surprise?
ALXN,ALXN:UW,BBG000G32HL2,What Are the Drivers behind the Success of Soliris?,2016-10-20 12:06:20 +0000,http://marketrealist.com/2016/10/what-are-the-drivers-behind-the-success-of-soliris/?utm_source=yahoo&utm_medium=feed,What Are the Drivers behind the Success of Soliris?
ALXN,ALXN:UW,BBG000G32HL2,"CERU Gains Big On Nanoparticle Deal, LLY Gets FDA Nod, BABY Makes Big Strides",2016-10-20 01:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yBWOilte3bA/ceru-gains-big-on-nanoparticle-deal-lly-gets-fda-nod-baby-makes-big-strides-20161020-00031,"CERU Gains Big On Nanoparticle Deal, LLY Gets FDA Nod, BABY Makes Big Strides"
ALXN,ALXN:UW,BBG000G32HL2,Will Alexion Beat Investor Expectations in Its 3Q16 Earnings?,2016-10-19 22:04:21 +0000,http://marketrealist.com/2016/10/will-alexion-beat-investor-expectations-in-its-3q16-earnings/?utm_source=yahoo&utm_medium=feed,Will Alexion Beat Investor Expectations in Its 3Q16 Earnings?
ALXN,ALXN:UW,BBG000G32HL2,FDA Grants Orphan Drug Designation to ALXN1007 for the Treatment of Patients with Graft-Versus-Host Disease (GVHD),2016-10-19 20:58:05 +0000,http://www.publicnow.com/view/5B48AB3CF635F45DC63989B53557CB81E6AF027D,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to ALXN1007, a ..."
ALXN,ALXN:UW,BBG000G32HL2,How Much Return Could Alexion Offer over the Next 12 months?,2016-10-19 19:55:01 +0000,http://marketrealist.com/2016/10/how-much-return-could-alexion-offer-over-the-next-12-months/?utm_source=yahoo&utm_medium=feed,How Much Return Could Alexion Offer over the Next 12 months?
ALXN,ALXN:UW,BBG000G32HL2,Vertex Not the Only Pharmaceutical to See Its Share Price Fall,2016-10-18 17:04:14 +0000,http://marketrealist.com/2016/10/vertex-not-the-only-pharmaceutical-to-see-its-share-price-fall/?utm_source=yahoo&utm_medium=feed,Vertex Not the Only Pharmaceutical to See Its Share Price Fall
ALXN,ALXN:UW,BBG000G32HL2,Weighing Vertex Pharmaceuticals’ Attributes before It Reports,2016-10-18 15:12:16 +0000,http://marketrealist.com/2016/10/weighing-vertex-pharmaceuticals-attributes-before-it-reports/?utm_source=yahoo&utm_medium=feed,Weighing Vertex Pharmaceuticals’ Attributes before It Reports
ALXN,ALXN:UW,BBG000G32HL2,The Math Shows QUS Can Go To $69,2016-10-13 19:42:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GUh4N6aNCsk/the-math-shows-qus-can-go-to-69-cm692920,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: WDC, ULTA",2016-10-13 15:42:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ejAXpJLUIAg/nasdaq-100-movers-wdc-ulta-cm692821,In early trading on Thursday shares of Ulta Salon Cosmetics amp Fragrance ULTA topped the list of the day s best performing components of the Nasdaq 100 index trading up 6 1 Year to date Ulta Salon Cosmetics amp Fragrance registers a 37 0 gain And the worst performing
ALXN,ALXN:UW,BBG000G32HL2,Alexion Presents New Long-Term Phase III Data on Kanuma,2016-10-11 15:21:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RBoWQ9DXcKI/alexion-presents-new-long-term-phase-iii-data-on-kanuma-cm691774,Alexion Pharmaceuticals Inc ALXN announced that new long term data from an ongoing open label extension of the pivotal phase III ARISE study on Kanuma in children and adults suffering from lysosomal acid lipase deficiency LAL D were presented at the World Congress of
ALXN,ALXN:UW,BBG000G32HL2,Alexion Presents New Long-Term Phase III Data on Kanuma,2016-10-11 13:30:01 +0000,http://finance.yahoo.com/news/alexion-presents-long-term-phase-133001338.html,Alexion Presents New Long-Term Phase III Data on Kanuma
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals to Report Third Quarter 2016 Results on Thursday, October 27, 2016",2016-10-10 14:13:03 +0000,http://www.publicnow.com/view/668FBA4635658B04714E30F6CB272F2A95A582AA,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the third quarter ended September 30, 2016 on Thursday, ..."
ALXN,ALXN:UW,BBG000G32HL2,Health Care Sector Update for 10/07/2016: CELG,2016-10-07 13:44:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b8iNJ2VzjHc/health-care-sector-update-for-10072016-celg-cm690232,Top Health care stocks Top Health care stocks JNJ 0 2 JNJ 0 2 PFE 0 2 PFE 0 2 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mainly higher in pre market trade Friday Health care shares were mainly higher in pre market trade Friday In health
ALXN,ALXN:UW,BBG000G32HL2,New Long-Term Data Presented at WCPGHAN 2016 Show Rapid and Sustained Improvements in Important Markers of Liver Injury and Lipid Abnormalities in Children and Adults with Lysosomal Acid Lipase Deficiency (LAL-D) Treated with Kanuma® (sebel,2016-10-06 21:49:01 +0000,http://www.publicnow.com/view/7D56273CD004BB9757601CB67EC74EFB143586B7,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced today that researchers presented new long-term data from an ongoing, open-label extension of the pivotal Phase ..."
ALXN,ALXN:UW,BBG000G32HL2,3 Growth Stocks to Buy in October,2016-10-05 00:42:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zxY_8hW8Ml8/3-growth-stocks-to-buy-in-october-cm688865,Image source Getty images With the markets trading near all time highs it s getting harder and harder to find growth stocks that are trading 160 at an attractive price However our Foolish contributors are always up for a challenge so we asked three of them to scour the markets
ALXN,ALXN:UW,BBG000G32HL2,3 Growth Stocks to Buy in October,2016-10-04 22:42:27 +0000,http://www.fool.com/investing/2016/10/04/3-growth-stocks-to-buy-in-october.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Growth Stocks to Buy in October
ALXN,ALXN:UW,BBG000G32HL2,Cambridge-based Ra Pharmaceuticals files plans for $86M IPO,2016-10-03 10:40:11 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/10/cambridge-based-ra-pharmaceuticals-files-plans-for.html?ana=yahoo,Cambridge-based Ra Pharmaceuticals files plans for $86M IPO
ALXN,ALXN:UW,BBG000G32HL2,What Do Analysts Say about Regeneron’s Upside Potential?,2016-09-30 14:05:05 +0000,http://marketrealist.com/2016/09/what-do-analysts-say-about-regenerons-upside-potential/?utm_source=yahoo&utm_medium=feed,What Do Analysts Say about Regeneron’s Upside Potential?
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data",2016-09-28 14:24:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZF4F-ZpA4AE/biotech-stock-roundup-amgens-kyprolis-disappoints-array-up-on-cancer-data-cm685947,Several biotech companies came out with clinical data and regulatory updates this week While Amgen AMGN provided mixed updates companies like Array ARRY Kite KITE and GW Pharma GWPH reported positive data on key pipeline candidates 160 Recap of the Week s Most Important
ALXN,ALXN:UW,BBG000G32HL2,What’s the Upward Return Potential for BioMarin?,2016-09-28 14:04:58 +0000,http://marketrealist.com/2016/09/whats-the-upward-return-potential-for-biomarin/?utm_source=yahoo&utm_medium=feed,What’s the Upward Return Potential for BioMarin?
ALXN,ALXN:UW,BBG000G32HL2,What’s the Word on Street for Vertex?,2016-09-28 14:04:36 +0000,http://marketrealist.com/2016/09/whats-the-word-on-street-for-vertex/?utm_source=yahoo&utm_medium=feed,What’s the Word on Street for Vertex?
ALXN,ALXN:UW,BBG000G32HL2,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : September 28, 2016",2016-09-28 13:37:57 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alexion-pharmaceuticals-inc-september-28-2016/,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : September 28, 2016"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : September 26, 2016",2016-09-26 12:51:14 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-alxn-us-september-26-2016/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : September 26, 2016"
ALXN,ALXN:UW,BBG000G32HL2,[$$] Biotech Is Cheaper Than Big Pharma,2016-09-24 05:00:00 +0000,http://www.barrons.com/articles/biotech-is-cheaper-than-big-pharma-1474693211?mod=yahoobarrons&ru=yahoo,[$$] Biotech Is Cheaper Than Big Pharma
ALXN,ALXN:UW,BBG000G32HL2,Alexion Gets U.K. Approval for High-Cost Drug (ALXN),2016-09-24 00:20:00 +0000,http://www.investopedia.com/news/alexion-gets-uk-approval-highcost-drug-alxn/?partner=YahooSA,Alexion Gets U.K. Approval for High-Cost Drug (ALXN)
ALXN,ALXN:UW,BBG000G32HL2,"Market Close Report: NASDAQ Composite index closes at 5,305.75 down -33.77 points",2016-09-23 20:49:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_JZB3sBiu1E/market-close-report-nasdaq-composite-index-closes-at-530575-down-3377-points-cm684069,Friday s session closes with the NASDAQ Composite Index at 5 305 75 The total shares traded for the NASDAQ was over 1 72 billion Declining stocks led advancers by 1 65 to 1 ratio There were 1084 advancers and 1791 decliners for the day On the NASDAQ Stock Exchange 40 stocks reached a 52
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: ALXN, BMRN",2016-09-23 16:22:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mUMPezSm8nU/nasdaq-100-movers-alxn-bmrn-cm683814,In early trading on Friday shares of BioMarin Pharmaceutical BMRN topped the list of the day s best performing components of the Nasdaq 100 index trading up 1 7 Year to date BioMarin Pharmaceutical has lost about 5 4 of its value And the worst performing Nasdaq 100 component
ALXN,ALXN:UW,BBG000G32HL2,Alexion Employees Volunteer Together in Company’s First Global Day of Service,2016-09-23 10:42:05 +0000,http://www.publicnow.com/view/EE78B06C29532BB0A49484F0B3AC799C288043E3,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that more than 1,500 employees around the world are volunteering in their respective communities as part of ..."
ALXN,ALXN:UW,BBG000G32HL2,[$$] Biotech Is Cheaper Than Big Pharma: What to Buy,2016-09-23 10:17:00 +0000,http://www.barrons.com/articles/biotech-is-cheaper-than-big-pharma-what-to-buy-1474625841?mod=yahoobarrons&ru=yahoo,[$$] Biotech Is Cheaper Than Big Pharma: What to Buy
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E",2016-09-22 21:18:14 +0000,http://biz.yahoo.com/e/160922/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals: Two Steps Forward, One Step Back",2016-09-22 15:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/22/alexion-pharmaceuticals-two-steps-forward-one-step-back/?mod=yahoobarrons&ru=yahoo,"Alexion Pharmaceuticals: Two Steps Forward, One Step Back"
ALXN,ALXN:UW,BBG000G32HL2,UK okays Alexion drug costing up to $2 mln but wants price cut,2016-09-22 12:23:38 +0000,http://uk.finance.yahoo.com/news/uk-okays-alexion-drug-costing-122338697.html,UK okays Alexion drug costing up to $2 mln but wants price cut
ALXN,ALXN:UW,BBG000G32HL2,Why Horizon Trades at a Discount Compared to Its Peers,2016-09-22 12:04:28 +0000,http://marketrealist.com/2016/09/why-horizon-trades-at-a-discount-compared-to-its-peers/?utm_source=yahoo&utm_medium=feed,Why Horizon Trades at a Discount Compared to Its Peers
ALXN,ALXN:UW,BBG000G32HL2,How Analysts See Horizon Compared to Its Peers,2016-09-21 15:05:03 +0000,http://marketrealist.com/2016/09/how-analysts-see-horizon-compared-to-its-peers/?utm_source=yahoo&utm_medium=feed,How Analysts See Horizon Compared to Its Peers
ALXN,ALXN:UW,BBG000G32HL2,"Commit To Buy Alexion Pharmaceuticals At $85, Earn 6.7% Using Options",2016-09-20 17:22:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_I3ecCpH7ao/commit-to-buy-alexion-pharmaceuticals-at-85-earn-67-using-options-cm682148,Investors eyeing a purchase of Alexion Pharmaceuticals Inc Symbol ALXN stock but tentative about paying the going market price of 131 04 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
ALXN,ALXN:UW,BBG000G32HL2,S&P 500 Analyst Moves: ALXN,2016-09-20 17:21:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uyBsa8htRNQ/sp-500-analyst-moves-alxn-cm682100,The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S amp P 500 index Alexion Pharmaceuticals ALXN is now the 117 analyst pick moving up by 2 spots This rank is formed by averaging the analyst opinions for each component
ALXN,ALXN:UW,BBG000G32HL2,"Why Sarepta Approval is Good News for BioMarin, Alexion",2016-09-20 15:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/20/why-sarepta-approval-is-good-news-for-biomarin-alexion/?mod=yahoobarrons&ru=yahoo,"Why Sarepta Approval is Good News for BioMarin, Alexion"
ALXN,ALXN:UW,BBG000G32HL2,Biotech bright spots,2016-09-15 21:42:00 +0000,http://finance.yahoo.com/video/biotech-bright-spots-214200999.html,Biotech bright spots
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma (ALXN) Stock Gets 'Underperform' Rating at FBR Capital,2016-09-15 20:02:00 +0000,https://www.thestreet.com/story/13742000/1/alexion-pharma-alxn-stock-gets-underperform-rating-at-fbr-capital.html?puc=yahoo&cm_ven=YAHOO,Alexion Pharma (ALXN) Stock Gets 'Underperform' Rating at FBR Capital
ALXN,ALXN:UW,BBG000G32HL2,Alexion’s ‘Uncommon Strength’ Campaign Offers a Win-Win (ALXN),2016-09-15 00:10:00 +0000,http://www.investopedia.com/news/alexions-uncommon-strength-campaign-offers-winwin-alxn/?partner=YahooSA,Alexion’s ‘Uncommon Strength’ Campaign Offers a Win-Win (ALXN)
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : September 14, 2016",2016-09-14 16:29:09 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-value-analysis-nasdaqalxn-september-14-2016/,"Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : September 14, 2016"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Launches Uncommon Strength Campaign to Unite and Celebrate the Courage and Resilience of People Living with Rare Diseases,2016-09-13 20:38:07 +0000,http://www.publicnow.com/view/455516C028525BC3704E3CFBC0A433499B49165A,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the launch of Uncommon Strength, a global campaign to raise awareness of rare diseases through the celebration ..."
ALXN,ALXN:UW,BBG000G32HL2,Don’t Get Caught with These Stocks this Week According to Forcerank,2016-09-13 13:16:32 +0000,http://finance.yahoo.com/tumblr/blog-dont-get-caught-with-these-stocks-this-week-131637052.html,Don’t Get Caught with These Stocks this Week According to Forcerank
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : September 13, 2016",2016-09-13 12:22:15 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-alxn-us-september-13-2016/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : September 13, 2016"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals To Participate In Morgan Stanley Conference At 9:10 AM,2016-09-13 08:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_3QP6CCDnlQ/alexion-pharmaceuticals-to-participate-in-morgan-stanley-conference-at-910-am-20160913-00432,Alexion Pharmaceuticals To Participate In Morgan Stanley Conference At 9:10 AM
ALXN,ALXN:UW,BBG000G32HL2,Look Under The Hood: IVV Has 11% Upside,2016-09-12 14:31:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tuk31qifyPI/look-under-the-hood-ivv-has-11-upside-cm677843,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: TSCO, WBA",2016-09-08 16:18:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-XyzLA1zBUo/nasdaq-100-movers-tsco-wba-cm676299,In early trading on Thursday shares of Walgreens Boots Alliance WBA topped the list of the day s best performing components of the Nasdaq 100 index trading up 1 5 Year to date Walgreens Boots Alliance has lost about 1 2 of its value And the worst performing Nasdaq 100
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: CoLucid Soars on Migraine Data, Dynavax Drug FDA Panel Meeting Cancelled",2016-09-07 15:21:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oik0MnvC884/biotech-stock-roundup-colucid-soars-on-migraine-data-dynavax-drug-fda-panel-meeting-cancelled-cm675560,It was a relatively slow week for the biotech sector though companies like CoLucid CLCD and Dynavax DVAX came out with important pipeline updates Recap of the Week s Most Important Stories CoLucid Hits 52 Week High on Positive Migraine Data CoLucid s shares shot up 123 6
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at Upcoming Investor Conferences,2016-09-06 14:09:04 +0000,http://www.publicnow.com/view/8DF13987057082270EF71B8BF6BBF31FE08EEE02,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that management will present at two upcoming investor conferences: Morgan Stanley Global Healthcare Conference ..."
ALXN,ALXN:UW,BBG000G32HL2,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : September 2, 2016",2016-09-02 13:40:26 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alexion-pharmaceuticals-inc-september-2-2016/,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : September 2, 2016"
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Gilead in Patent Infringement Lawsuit, Enbrel Biosimilar Approved",2016-09-01 18:13:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f-_RJiNJl0c/biotech-stock-roundup-gilead-in-patent-infringement-lawsuit-enbrel-biosimilar-approved-cm673518,The overall healthcare sector was under pressure over the last week with focus going back to the pricing policies of pharma and biotech companies Meanwhile biosimilars are picking up pace with the FDA approving Sandoz s biosimilar version of Amgen s AMGN multi billion dollar drug Enbrel
ALXN,ALXN:UW,BBG000G32HL2,Biotech Stocks: Look At Those Takeover Premiums!,2016-09-01 17:53:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/01/biotech-stocks-look-at-those-takeover-premiums/?mod=yahoobarrons&ru=yahoo,Biotech Stocks: Look At Those Takeover Premiums!
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : September 1, 2016",2016-09-01 12:17:20 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-alxn-us-september-1-2016/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : September 1, 2016"
ALXN,ALXN:UW,BBG000G32HL2,5 Growth Stocks to Buy in September,2016-08-31 19:05:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y7uGgi1gxTA/5-growth-stocks-to-buy-in-september-cm672860,"Image source  Getty Images.  History has shown that investors who consistently put small amounts of money to work in good growth stocks will do quite well over time. Of course, not every company that"
ALXN,ALXN:UW,BBG000G32HL2,5 Growth Stocks to Buy in September,2016-08-31 16:50:28 +0000,http://www.fool.com/investing/2016/08/31/5-growth-stocks-to-buy-in-september.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Growth Stocks to Buy in September
ALXN,ALXN:UW,BBG000G32HL2,Alexion's GVHD Candidate Gets Orphan Drug Status in the EU,2016-08-30 16:14:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JgeYE2fFF48/alexions-gvhd-candidate-gets-orphan-drug-status-in-the-eu-cm672284,"Alexion Pharmaceuticals, Inc.ALXN announced that the European Commission has granted orphan drug designation to ALXN1007 for the treatment of graft versus host disease (GVHD).  We note that ALXN1007 is an anti inflammatory monoclonal antibody targeting complement"
ALXN,ALXN:UW,BBG000G32HL2,Alexion's GVHD Candidate Gets Orphan Drug Status in the EU,2016-08-30 14:04:02 +0000,http://finance.yahoo.com/news/alexions-gvhd-candidate-gets-orphan-140402237.html,Alexion's GVHD Candidate Gets Orphan Drug Status in the EU
ALXN,ALXN:UW,BBG000G32HL2,European Commission Grants Orphan Drug Designation to ALXN1007 for the Treatment of Patients with Graft-Versus-Host Disease (GVHD),2016-08-29 20:53:07 +0000,http://www.publicnow.com/view/D523B6D6368B4141C1F5FE984F468AE1F1506360,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the European Commission has granted orphan drug designation (ODD) to ALXN1007, a novel anti-inflammatory ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals' Rebound To Continue -Vetr Crowd,2016-08-26 19:38:26 +0000,http://finance.yahoo.com/news/alexion-pharmaceuticals-rebound-continue-vetr-193826248.html,Alexion Pharmaceuticals' Rebound To Continue -Vetr Crowd
ALXN,ALXN:UW,BBG000G32HL2,What Do Analysts Think about BioMarin’s Return Potential?,2016-08-26 15:06:30 +0000,http://marketrealist.com/2016/08/analysts-think-biomarins-return-potential/?utm_source=yahoo&utm_medium=feed,What Do Analysts Think about BioMarin’s Return Potential?
ALXN,ALXN:UW,BBG000G32HL2,How Much Did BioMarin’s Lead Drug Vimizim Earn in 1H16?,2016-08-26 12:04:55 +0000,http://marketrealist.com/2016/08/much-biomarins-lead-drug-vimizim-earn-1h16/?utm_source=yahoo&utm_medium=feed,How Much Did BioMarin’s Lead Drug Vimizim Earn in 1H16?
ALXN,ALXN:UW,BBG000G32HL2,"Tesla Tops Forbes' 2016 List of Most Innovative Companies (TSLA, CRM)",2016-08-26 01:35:00 +0000,http://www.investopedia.com/news/tesla-tops-forbes-2016-list-most-innovative-companies-tsla-crm/?partner=YahooSA,"Tesla Tops Forbes' 2016 List of Most Innovative Companies (TSLA, CRM)"
ALXN,ALXN:UW,BBG000G32HL2,Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?,2016-08-25 13:04:31 +0000,http://marketrealist.com/2016/08/teva-pharmaceutical-expected-strengthen-specialty-pipeline-3q16/?utm_source=yahoo&utm_medium=feed,Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review",2016-08-24 20:46:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ia7VRSpmnw/biotech-stock-roundup-medivation-to-pfizer-clovis-priority-review-cm669752,The big news this week in the biotech sector was Pfizer's announcement that it will acquire cancer focused Medivation MDVN for $14 billion. This announcement has revived acquisition chatter in the sector with much speculation regarding which
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for August 22nd,2016-08-22 15:49:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nzqCJ2l65Gs/new-strong-sell-stocks-for-august-22nd-cm668454,"Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today   •     Alexion Pharmaceuticals, Inc.ALXN develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system"
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for August 22nd,2016-08-22 15:48:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ynPP3NLa3eA/new-strong-sell-stocks-for-august-22nd-cm668437,"Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today   •     Alexion Pharmaceuticals, Inc.ALXN develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system"
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for August 22nd,2016-08-22 13:27:01 +0000,http://finance.yahoo.com/news/strong-sell-stocks-august-22nd-132701898.html,New Strong Sell Stocks for August 22nd
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stocks: Trouble Ahead, Trouble Behind?",2016-08-19 16:39:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/19/biotech-stocks-trouble-ahead-trouble-behind/?mod=yahoobarrons&ru=yahoo,"Biotech Stocks: Trouble Ahead, Trouble Behind?"
ALXN,ALXN:UW,BBG000G32HL2,Horizon’s Orphan Drug Business Faces These Opportunities,2016-08-19 15:04:43 +0000,http://marketrealist.com/2016/08/horizons-orphan-drug-business-faces-these-opportunities/?utm_source=yahoo&utm_medium=feed,Horizon’s Orphan Drug Business Faces These Opportunities
ALXN,ALXN:UW,BBG000G32HL2,Spiros Segalas on Alexion Pharmaceuticals,2016-08-18 22:29:21 +0000,http://finance.yahoo.com/news/spiros-segalas-alexion-pharmaceuticals-222921560.html,Spiros Segalas on Alexion Pharmaceuticals
ALXN,ALXN:UW,BBG000G32HL2,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : August 18, 2016",2016-08-18 22:07:00 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alexion-pharmaceuticals-inc-august-18-2016/,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : August 18, 2016"
ALXN,ALXN:UW,BBG000G32HL2,What Are the Opportunities for Horizon in 2016?,2016-08-18 15:10:16 +0000,http://marketrealist.com/2016/08/what-are-the-opportunities-for-horizon-in-2016/?utm_source=yahoo&utm_medium=feed,What Are the Opportunities for Horizon in 2016?
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for August 15th,2016-08-15 13:34:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W8cjP_KofzU/new-strong-sell-stocks-for-august-15th-cm665179,"Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today •     Abaxis IncABAX develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid"
ALXN,ALXN:UW,BBG000G32HL2,"Alnylam Pharmaceuticals, Inc. Cranks Out the Data",2016-08-12 21:34:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mejcINpFEJc/alnylam-pharmaceuticals-inc-cranks-out-the-data-cm664913,Image source  Getty Images.  There isn't much to say about Alnylam Pharmaceuticals '(NASDAQ  ALNY) second quarter earnings    or lack thereof    but it certainly was a data
ALXN,ALXN:UW,BBG000G32HL2,How to Play a Nasdaq Breakout,2016-08-12 12:53:00 +0000,http://finance.yahoo.com/video/play-nasdaq-breakout-125300808.html,How to Play a Nasdaq Breakout
ALXN,ALXN:UW,BBG000G32HL2,The Implied Analyst 12-Month Target For QQXT,2016-08-11 13:52:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/psXk1Uo49Qg/the-implied-analyst-12-month-target-for-qqxt-cm663920,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
ALXN,ALXN:UW,BBG000G32HL2,Are High Composite Ratings An Automatic 'Buy' Signal? No. Here's Why,2016-08-10 16:41:38 +0000,http://www.investors.com/how-to-invest/investors-corner/294578/,Are High Composite Ratings An Automatic 'Buy' Signal? No. Here's Why
ALXN,ALXN:UW,BBG000G32HL2,AstraZeneca bets another $140 million on Moderna's 'messenger' drugs,2016-08-10 14:43:26 +0000,http://sg.finance.yahoo.com/news/astrazeneca-bets-another-140-million-144326868.html,AstraZeneca bets another $140 million on Moderna's 'messenger' drugs
ALXN,ALXN:UW,BBG000G32HL2,Biotech Stocks: Blame Gilead?,2016-08-09 14:49:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/09/biotech-stocks-blame-gilead/?mod=yahoobarrons&ru=yahoo,Biotech Stocks: Blame Gilead?
ALXN,ALXN:UW,BBG000G32HL2,What Do Analysts Recommend for Regeneron after 2Q16 Earnings?,2016-08-09 13:08:47 +0000,http://marketrealist.com/2016/08/what-do-analysts-recommend-for-regeneron-after-2q16-earnings/?utm_source=yahoo&utm_medium=feed,What Do Analysts Recommend for Regeneron after 2Q16 Earnings?
ALXN,ALXN:UW,BBG000G32HL2,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Other Events",2016-08-08 20:41:16 +0000,http://biz.yahoo.com/e/160808/alxn8-k.html,"ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Other Events"
ALXN,ALXN:UW,BBG000G32HL2,What Are Analysts Recommending for Shire?,2016-08-08 13:05:05 +0000,http://marketrealist.com/2016/08/analysts-recommending-shire/?utm_source=yahoo&utm_medium=feed,What Are Analysts Recommending for Shire?
ALXN,ALXN:UW,BBG000G32HL2,An Update on Shire’s Upcoming Milestones,2016-08-05 15:07:58 +0000,http://marketrealist.com/2016/08/update-shires-upcoming-milestones/?utm_source=yahoo&utm_medium=feed,An Update on Shire’s Upcoming Milestones
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for August 5th,2016-08-05 12:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mq84a6PVnqM/new-strong-sell-stocks-for-august-5th-cm660952,"Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today •     Abaxis IncABAX develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid"
ALXN,ALXN:UW,BBG000G32HL2,New Strong Sell Stocks for August 5th,2016-08-05 11:22:11 +0000,http://finance.yahoo.com/news/strong-sell-stocks-august-5th-112211413.html,New Strong Sell Stocks for August 5th
ALXN,ALXN:UW,BBG000G32HL2,What’s behind Shire’s 2Q16 Earnings Surprise?,2016-08-04 20:48:34 +0000,http://marketrealist.com/2016/08/whats-behind-shires-2q16-earnings-surprise/?utm_source=yahoo&utm_medium=feed,What’s behind Shire’s 2Q16 Earnings Surprise?
ALXN,ALXN:UW,BBG000G32HL2,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : August 4, 2016",2016-08-04 18:37:25 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-alexion-pharmaceuticals-inc-august-4-2016/,"ETF’s with exposure to Alexion Pharmaceuticals, Inc. : August 4, 2016"
ALXN,ALXN:UW,BBG000G32HL2,4 Top Growth Stocks Priced at a Bargain This Summer,2016-08-04 14:55:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CKm9_Wpny_w/4-top-growth-stocks-priced-at-a-bargain-this-summer-cm660291,"Image source  Getty Images.  This year didn't exactly begin on the right foot. The three major U.S. indexes wound up tumbling between 8% and 10% during the first two weeks of 2016, marking"
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016",2016-08-03 15:34:05 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-alxn-us-earnings-analysis-q2-2016-by-the-numbers-august-3-2016/,"Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016"
ALXN,ALXN:UW,BBG000G32HL2,Update on Analyst Recommendations for Alexion,2016-08-03 13:04:49 +0000,http://marketrealist.com/2016/07/update-analyst-recommendations-alexion/?utm_source=yahoo&utm_medium=feed,Update on Analyst Recommendations for Alexion
ALXN,ALXN:UW,BBG000G32HL2,Biogen Is a Takeover Target but Don't Ignore the Risks,2016-08-03 11:01:00 +0000,https://www.thestreet.com/story/13662498/1/biogen-is-a-takeover-target-but-don-t-ignore-the-risks.html?puc=yahoo&cm_ven=YAHOO,Biogen Is a Takeover Target but Don't Ignore the Risks
ALXN,ALXN:UW,BBG000G32HL2,Analyst Recommendations for Vertex Pharmaceuticals after 2Q16 Earnings,2016-08-02 15:05:11 +0000,http://marketrealist.com/2016/07/analyst-recommendations-vertex-pharmaceuticals-2q16-earnings/?utm_source=yahoo&utm_medium=feed,Analyst Recommendations for Vertex Pharmaceuticals after 2Q16 Earnings
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : August 2, 2016",2016-08-02 13:59:19 +0000,http://www.capitalcube.com/blog/index.php/alexion-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-alxn-us-august-2-2016/,"Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ALXN-US : August 2, 2016"
ALXN,ALXN:UW,BBG000G32HL2,Is BioMarin Set to Become Profitable in 2017?,2016-08-02 13:08:06 +0000,http://marketrealist.com/2016/07/biomarin-set-become-profitable-2017/?utm_source=yahoo&utm_medium=feed,Is BioMarin Set to Become Profitable in 2017?
ALXN,ALXN:UW,BBG000G32HL2,How Significant Is Alexion’s Opportunity with Soliris?,2016-08-02 13:05:49 +0000,http://marketrealist.com/2016/07/significant-opportunity-soliris/?utm_source=yahoo&utm_medium=feed,How Significant Is Alexion’s Opportunity with Soliris?
ALXN,ALXN:UW,BBG000G32HL2,How Vertex Is Strategizing to Continue Its Growth,2016-08-02 13:05:36 +0000,http://marketrealist.com/2016/07/vertex-strategizing-continue-growth/?utm_source=yahoo&utm_medium=feed,How Vertex Is Strategizing to Continue Its Growth
ALXN,ALXN:UW,BBG000G32HL2,What's Driving The Biotech Stock Rally? And Will It Last?,2016-08-01 21:05:07 +0000,http://www.investors.com/news/technology/whats-driving-the-biotech-stock-rally-and-will-it-last/,What's Driving The Biotech Stock Rally? And Will It Last?
ALXN,ALXN:UW,BBG000G32HL2,"S&P 500 Movers: RIG, BIIB",2016-08-01 15:55:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TnkKUXtbKD4/sp-500-movers-rig-biib-cm658030,"In early trading on Monday, shares of Biogen ( BIIB ) topped the list of the day's best performing components of the S&P 500 index, trading up 5.4%. Year to date, Biogen has lost about 0.2% of its value."
ALXN,ALXN:UW,BBG000G32HL2,"Nasdaq 100 Movers: CTXS, BIIB",2016-08-01 15:55:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NO--VxWXkT4/nasdaq-100-movers-ctxs-biib-cm658023,"In early trading on Monday, shares of Biogen ( BIIB ) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.5%. Year to date, Biogen has lost about 0.1% of its value."
ALXN,ALXN:UW,BBG000G32HL2,Strong Growth for Soliris in 2Q16,2016-08-01 15:08:20 +0000,http://marketrealist.com/2016/07/strong-growth-soliris-2q16/?utm_source=yahoo&utm_medium=feed,Strong Growth for Soliris in 2Q16
ALXN,ALXN:UW,BBG000G32HL2,How Much Did Kalydeco Add to Vertex’s Top Line?,2016-08-01 15:07:37 +0000,http://marketrealist.com/2016/07/much-kalydeco-add-vertexs-top-line/?utm_source=yahoo&utm_medium=feed,How Much Did Kalydeco Add to Vertex’s Top Line?
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Tops Q2 Earnings and Revenues (Revised),2016-07-28 17:26:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LLStgCDdmJ0/alexion-alxn-tops-q2-earnings-and-revenues-revised-cm656576,"Alexion Pharmaceuticals, Inc. 's ALXN second quarter 2016 earnings (including stock based compensation expense) of 93 cents per share surpassed the Zacks Consensus Estimate of 91 cents. Earnings were, however, lower than the year ago figure of $1.13. Alexion's"
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Beats on Q2 Earnings and Revenues,2016-07-28 13:28:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TPckYGGQGBs/alexion-alxn-beats-on-q2-earnings-and-revenues-cm656375,"Alexion Pharmaceuticals, Inc.ALXN focuses on the development and commercialization of life transforming drugs for treating patients suffering from ultra rare disorders. Soliris approved for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome is the key product of this New"
ALXN,ALXN:UW,BBG000G32HL2,Alexion misses 2Q profit forecasts,2016-07-28 12:17:26 +0000,http://sg.finance.yahoo.com/news/alexion-misses-2q-profit-forecasts-112041359.html,Alexion misses 2Q profit forecasts
ALXN,ALXN:UW,BBG000G32HL2,Alexion Reports Second Quarter 2016 Results,2016-07-28 10:38:07 +0000,http://www.publicnow.com/view/536ED341020C4BFCFBE2BBCF67F18936C067FCA9,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the second quarter of 2016. Total revenues grew to $753 million, an 18 percent increase, ..."
ALXN,ALXN:UW,BBG000G32HL2,U.S. Hot Stocks: Hot Stocks to Watch,2016-07-28 09:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0rtxEsVfnRE/us-hot-stocks-hot-stocks-to-watch-20160728-01028,U.S. Hot Stocks: Hot Stocks to Watch
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Q2 16 Earnings Conference Call At 10:00 AM ET,2016-07-28 09:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lgUK6xSIhs0/alexion-pharmaceuticals-q2-16-earnings-conference-call-at-1000-am-et-20160728-00973,Alexion Pharmaceuticals Q2 16 Earnings Conference Call At 10:00 AM ET
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Q2 16 Earnings Conference Call At 10:00 AM ET,2016-07-28 09:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_J2kFKvjMek/alexion-pharmaceuticals-q2-16-earnings-conference-call-at-1000-am-et-20160728-00971,Alexion Pharmaceuticals Q2 16 Earnings Conference Call At 10:00 AM ET
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Cuts Profit Guidance,2016-07-28 07:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T3-zK6IC_40/alexion-pharmaceuticals-cuts-profit-guidance-20160728-00586,Alexion Pharmaceuticals Cuts Profit Guidance
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharma Q2 Profit Declines, Cuts FY16 Adj. EPS Outlook",2016-07-28 07:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CGKVTaYcLZI/alexion-pharma-q2-profit-declines-cuts-fy16-adj-eps-outlook-20160728-00462,"Alexion Pharma Q2 Profit Declines, Cuts FY16 Adj. EPS Outlook"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. Q2 Earnings Retreat 4%,2016-07-28 06:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vXlDDA45RpI/alexion-pharmaceuticals-inc-q2-earnings-retreat-4-20160728-00316,Alexion Pharmaceuticals Inc. Q2 Earnings Retreat 4%
ALXN,ALXN:UW,BBG000G32HL2,"Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure",2016-07-27 21:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SHmIJ6MBYHA/biotech-stock-roundup-biogen-q2-results-impress-gilead-hcv-franchise-under-pressure-cm655979,"Earnings season for the biotech sector has kicked off with two big biotech names, Biogen BIIB and Gilead GILD reporting second quarter results. Meanwhile, companies like AbbVie ABBV and Amgen AMGN provided updates on their pipeline efforts.Recap of the"
ALXN,ALXN:UW,BBG000G32HL2,"Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More",2016-07-27 16:32:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gZS3Z5R8hAY/watch-for-drug-stocks-earnings-on-jul-28-bmy-celg-more-cm655762,"With the Q2 earnings season shifting into top gear this week, the earnings picture has not been as dismal as was expected of the 130 S&P 500 companies that have reported so far (Jul 25), 70.8% surpassed earnings estimates"
ALXN,ALXN:UW,BBG000G32HL2,Alexion (ALXN) Q2 Earnings: Stock Likely to Disappoint,2016-07-26 19:28:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UiQyW0IQ8Q8/alexion-alxn-q2-earnings-stock-likely-to-disappoint-cm654801,"Alexion Pharmaceuticals, Inc.ALXN is scheduled to report second quarter 2016 results on Jul 28, before the opening bell. The company's track record has been far from encouraging. Over the last four reported quarters, the company posted an average negative"
ALXN,ALXN:UW,BBG000G32HL2,I Just Bought These 4 Fast-Growing Biotech Stocks,2016-07-23 12:07:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uzorTLE_6As/i-just-bought-these-4-fast-growing-biotech-stocks-cm653701,"Image source  Getty Images.  The S&P 500 is currently trading near its all time high, but that doesn't mean there aren't bargains on the market today. That's especially true when you consider that"
ALXN,ALXN:UW,BBG000G32HL2,"Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly",2016-07-21 22:10:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EKbGyIp9Cpk/sorry-you-cant-buy-this-hot-biotech-at-least-not-directly-cm652964,"Image source  Getty Images.  You're excused if you've never heard of Moderna Therapeutics. The company is still private, so unless you've got enough money to invest in a venture capital fund, you're out"
ALXN,ALXN:UW,BBG000G32HL2,Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why,2016-07-19 22:12:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cEsc7zCrmzY/earnings-estimates-for-these-3-biotech-giants-should-be-heading-lower-heres-why-cm651615,Image source  Getty Images.  Investors have been taken for quite the wild ride in 2016. Stocks opened the year with the worst two week start in recorded history and followed it with the
ALXN,ALXN:UW,BBG000G32HL2,Alexion Reports Positive SBC-103 Phase 1/2 Data - Quick Facts,2016-07-17 23:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KMqlvvAfzYo/alexion-reports-positive-sbc103-phase-12-data--quick-facts-20160717-00060,Alexion Reports Positive SBC-103 Phase 1/2 Data - Quick Facts
ALXN,ALXN:UW,BBG000G32HL2,Alexion Presents New SBC-103 (rhNAGLU enzyme) Phase 1/2 Data on Brain MRI and Neurocognitive Assessments in Patients with Mucopolysaccharidosis IIIB (MPS IIIB),2016-07-14 13:28:06 +0000,http://www.publicnow.com/view/54222682E1DF60BBC18E62E54D9A4F2B12DF6E9E,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced today that researchers presented new data from an ongoing open-label, Phase 1/2 trial of intravenous (IV) SBC-103 ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals to Report Second Quarter 2016 Results on Thursday, July 28, 2016",2016-07-11 14:13:07 +0000,http://www.publicnow.com/view/2ACEF098347D64CBC8B1B173B7638F1A9367B85E,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the second quarter ended June 30, 2016 on Thursday, ..."
ALXN,ALXN:UW,BBG000G32HL2,New Data from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis (gMG) Presented at ICNMD Annual Congress,2016-07-07 12:41:06 +0000,http://www.publicnow.com/view/9051342E1F3C761D36E953FEE88B276EC46798D3,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that researchers presented new results from the REGAIN study, a global, placebo-controlled Phase 3 registration ..."
ALXN,ALXN:UW,BBG000G32HL2,Ventas Signs $1.5 Billion Life Sciences-Focused Deal,2016-07-05 18:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XjKuehxytEk/ventas-signs-15-billion-life-sciencesfocused-deal-20160705-01027,Ventas Signs $1.5 Billion Life Sciences-Focused Deal
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma. To Present At William Blair Conference; Webcast At 2:30 PM ET,2016-06-14 13:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/57O1f6kVmZ0/alexion-pharma-to-present-at-william-blair-conference-webcast-at-230-pm-et-20160614-00799,Alexion Pharma. To Present At William Blair Conference; Webcast At 2:30 PM ET
ALXN,ALXN:UW,BBG000G32HL2,Late-Breaking Data Presented at EHA: All Patients with PNH Treated with Once-Monthly Dosing of ALXN1210 in Phase 1/2 Study Exhibit Rapid and Sustained Reductions in LDH,2016-06-10 06:49:03 +0000,http://www.publicnow.com/view/3E61E942974ACAB49D8F0D7CD2FC32F25F8AC5FB,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that interim data were presented from a Phase 1/2 study of ALXN1210, an investigational, highly innovative ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion: ALXN1210 Shows Rapid, Sustained Reductions In LDH - Quick Facts",2016-06-10 03:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xIPEE9eBY3Q/alexion-alxn1210-shows-rapid-sustained-reductions-in-ldh--quick-facts-20160610-00064,"Alexion: ALXN1210 Shows Rapid, Sustained Reductions In LDH - Quick Facts"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma. To Present At Goldman Sachs Conference; Webcast At 11:40 AM ET,2016-06-08 10:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/It-oZmHBg4c/alexion-pharma-to-present-at-goldman-sachs-conference-webcast-at-1140-am-et-20160608-00625,Alexion Pharma. To Present At Goldman Sachs Conference; Webcast At 11:40 AM ET
ALXN,ALXN:UW,BBG000G32HL2,Biogen Shares Down as Multiple Sclerosis Therapy Misses Study Goals,2016-06-07 09:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sVT3m3cGevo/biogen-shares-down-as-multiple-sclerosis-therapy-misses-study-goals-20160607-00667,Biogen Shares Down as Multiple Sclerosis Therapy Misses Study Goals
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharmaceuticals Inc. (ALXN) Is Sinking On Phase 3 Study News,2016-06-07 09:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HKX0fOjQSqg/alexion-pharmaceuticals-inc-alxn-is-sinking-on-phase-3-study-news-20160607-00662,Alexion Pharmaceuticals Inc. (ALXN) Is Sinking On Phase 3 Study News
ALXN,ALXN:UW,BBG000G32HL2,"ADMP Snubbed Again, OCUL, DNAI Skid On Trial Data, AGN Gets FDA Nod. SRPT Abuzz",2016-06-07 01:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0lid86hsxY/admp-snubbed-again-ocul-dnai-skid-on-trial-data-agn-gets-fda-nod-srpt-abuzz-20160607-00028,"ADMP Snubbed Again, OCUL, DNAI Skid On Trial Data, AGN Gets FDA Nod. SRPT Abuzz"
ALXN,ALXN:UW,BBG000G32HL2,Alexion Announces Topline Results from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis (gMG),2016-06-06 20:28:05 +0000,http://www.publicnow.com/view/57C7AFDEB978EAFA1F1C29F812C456B0902CC2CD,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced topline results from the REGAIN study, a Phase 3 registration trial of eculizumab (Soliris) in patients with ..."
ALXN,ALXN:UW,BBG000G32HL2,European Commission Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH),2016-06-01 20:25:09 +0000,http://www.publicnow.com/view/5512A485CAD58EE176CA594CCD405FC27FBC29B2,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the European Commission has granted orphan drug designation (ODD) to ALXN1210, a highly innovative, longer-acting ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at Upcoming Investor Conferences,2016-05-31 14:12:01 +0000,http://www.publicnow.com/view/BCDEF8E671680A1CCD4915385C889D5554B78993,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that management will present at two upcoming investor conferences: Goldman Sachs 37 Annual Healthcare Conference ..."
ALXN,ALXN:UW,BBG000G32HL2,Researchers to Present Late-Breaking Data on ALXN1210 in Patients with PNH at EHA Annual Congress,2016-05-19 11:02:04 +0000,http://www.publicnow.com/view/B0914E24D85887594ACF8816E3CF587F1E9BC916,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers will present late-breaking data from a Phase 1/2 dose-escalating study of ALXN1210, the Company's ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at the Bank of America Merrill Lynch 2016 Health Care Conference,2016-05-04 14:20:01 +0000,http://www.publicnow.com/view/A77F46DBB34BC9AF2D5BAEB818ABFB65A5563776,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that management will present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas ..."
ALXN,ALXN:UW,BBG000G32HL2,Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation,2016-04-28 17:04:50 +0000,http://sg.finance.yahoo.com/news/frances-sanofi-makes-9-3-063121129.html,Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
ALXN,ALXN:UW,BBG000G32HL2,Sanofi launches $9.3 bln fight for U.S. cancer firm Medivation,2016-04-28 17:03:33 +0000,http://uk.finance.yahoo.com/news/sanofi-bids-9-3-bln-065659524.html,Sanofi launches $9.3 bln fight for U.S. cancer firm Medivation
ALXN,ALXN:UW,BBG000G32HL2,Alexion misses Street 1Q forecasts,2016-04-28 10:47:33 +0000,http://sg.finance.yahoo.com/news/alexion-misses-street-1q-forecasts-104733125.html,Alexion misses Street 1Q forecasts
ALXN,ALXN:UW,BBG000G32HL2,Alexion Reports First Quarter 2016 Results,2016-04-28 10:40:15 +0000,http://www.publicnow.com/view/1372AC2467169DAD73FD4DF7AC64DEF563093239,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the first quarter of 2016. Total revenues grew to $701 million, a 17 percent increase, ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals to Report First Quarter 2016 Results on Thursday, April 28, 2016",2016-04-12 14:19:15 +0000,http://www.publicnow.com/view/BF57308E5EF12D4B29DA8749D27C93B97988828E,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2016 on Thursday, ..."
ALXN,ALXN:UW,BBG000G32HL2,"Data Presented at ENDO 2016 Show Sustained Improvements in Survival Rates, Bone Healing, Respiratory Support and Physical Function in Children with Hypophosphatasia (HPP) Receiving Long-Term Treatment with Strensiq® (asfotase alfa)",2016-04-04 10:45:22 +0000,http://www.publicnow.com/view/30B3A3D0F2EE2D90AF15DDA45ACEB1C9E388ABDA,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that researchers presented new data showing children with perinatal- and infantile-onset hypophosphatasia ..."
ALXN,ALXN:UW,BBG000G32HL2,Kanuma® (sebelipase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Lysosomal Acid Lipase Deficiency (LAL-D),2016-03-28 10:58:23 +0000,http://www.publicnow.com/view/6EB90E5A97FD86571EDDE28897E28B210E47C362,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Kanuma (sebelipase alfa) for the treatment ..."
ALXN,ALXN:UW,BBG000G32HL2,"UK cost agency queries value of $700,000-a-year Alexion drug",2016-02-18 08:28:09 +0000,http://uk.finance.yahoo.com/news/uk-cost-agency-queries-value-082809246.html,"UK cost agency queries value of $700,000-a-year Alexion drug"
ALXN,ALXN:UW,BBG000G32HL2,Alexion beats 4Q profit forecasts,2016-02-03 11:53:41 +0000,http://sg.finance.yahoo.com/news/alexion-beats-4q-profit-forecasts-115341532.html,Alexion beats 4Q profit forecasts
ALXN,ALXN:UW,BBG000G32HL2,"Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2015 Results on Wednesday, February 3, 2016",2016-01-20 15:35:05 +0000,http://www.noodls.com/view/BB4E4EDA4ABF95C460A2F4374AA5231AD9983E9E,"[at noodls] - NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Present at the 34th Annual J.P. Morgan Healthcare Conference,2016-01-04 15:38:04 +0000,http://www.noodls.com/view/45451EB3B301BF5E4150540B7827BCB4F09A87B6,"[at noodls] - CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at the 34 Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion Highlights Innovative Rare Disease Portfolio at Investor Day Meeting,2015-12-10 22:23:07 +0000,http://www.noodls.com/view/44E1DC0A744EE9637A6800CAE98DA5CC07DBBD4F,"[at noodls] - CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the Company highlighted significant progress in its early- and late-stage rare disease portfolio and provided ..."
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Highlight Innovative Rare Disease Portfolio at Investor Day Meeting,2015-12-10 11:56:28 +0000,http://www.noodls.com/view/E3FD4FCC018E1E2C628128CEE483059A67F89D86,"[at noodls] - CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the Company will highlight significant progress in its early- and late-stage rare disease portfolio and ..."
ALXN,ALXN:UW,BBG000G32HL2,FDA Approves Kanuma™ (sebelipase alfa) for the Treatment of Patients with Lysosomal Acid Lipase Deficiency (LAL-D),2015-12-08 17:29:06 +0000,http://www.noodls.com/view/1195AF8D7F582292807CBB98858C8D114D527B1B,"[at noodls] - CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that the U.S. Food and Drug Administration (FDA) has approved Kanuma™ (sebelipase alfa) for the treatment ..."
ALXN,ALXN:UW,BBG000G32HL2,"Alexion's $550,000 bone drug too expensive for Britain",2015-12-03 00:00:02 +0000,http://uk.finance.yahoo.com/news/alexions-550-000-bone-drug-000002957.html,"Alexion's $550,000 bone drug too expensive for Britain"
ALXN,ALXN:UW,BBG000G32HL2,Alexion to Highlight Robust Rare Disease Pipeline at Investor Day,2015-11-19 15:13:12 +0000,http://www.noodls.com/view/F4FC9E0C43A663A0044CC9FADC3FAA0E4B307628,"[at noodls] - CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) today announced that the Company will host an Investor Day on Thursday, December 10, 2015 from 12:00 p.m. to 5:00 p.m. Eastern ..."
ALXN,ALXN:UW,BBG000G32HL2,"Germany, U.S. in hot pursuit of ""messenger"" drug molecules",2015-11-12 10:33:54 +0000,http://uk.finance.yahoo.com/news/germany-u-hot-pursuit-messenger-103354548.html,"Germany, U.S. in hot pursuit of ""messenger"" drug molecules"
ALXN,ALXN:UW,BBG000G32HL2,Alexion reports 3Q loss,2015-10-29 10:41:30 +0000,http://sg.finance.yahoo.com/news/alexion-reports-3q-loss-104130261.html,Alexion reports 3Q loss
ALXN,ALXN:UW,BBG000G32HL2,Alexion gets EU approval for drug acquired in Synageva deal,2015-09-01 20:03:10 +0000,http://uk.finance.yahoo.com/news/alexion-gets-eu-approval-drug-200310844.html,Alexion gets EU approval for drug acquired in Synageva deal
ALXN,ALXN:UW,BBG000G32HL2,Alexion tops Street 2Q forecasts,2015-07-30 10:42:58 +0000,http://sg.finance.yahoo.com/news/alexion-tops-street-2q-forecasts-104258014.html,Alexion tops Street 2Q forecasts
ALXN,ALXN:UW,BBG000G32HL2,Alexion to bolster rare disease offering with $8.4 billion deal,2015-05-06 21:48:18 +0000,http://sg.finance.yahoo.com/news/alexion-pharma-buy-synageva-biopharma-142612108.html,Alexion to bolster rare disease offering with $8.4 billion deal
ALXN,ALXN:UW,BBG000G32HL2,"US stocks drop on jobs data, Yellen's warning on values",2015-05-06 20:40:20 +0000,http://uk.finance.yahoo.com/news/us-stocks-drop-jobs-data-204020102.html,"US stocks drop on jobs data, Yellen's warning on values"
ALXN,ALXN:UW,BBG000G32HL2,Deals of the day- Mergers and acquisitions,2015-05-06 20:02:34 +0000,http://sg.finance.yahoo.com/news/deals-day-mergers-acquisitions-135229570.html,Deals of the day- Mergers and acquisitions
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma to pay $8.4 billion for Synageva BioPharma,2015-05-06 15:48:48 +0000,http://sg.finance.yahoo.com/news/alexion-pharma-pay-8-4-115414307.html,Alexion Pharma to pay $8.4 billion for Synageva BioPharma
ALXN,ALXN:UW,BBG000G32HL2,US stocks drop in volatile trade on weak jobs data,2015-05-06 15:01:50 +0000,http://uk.finance.yahoo.com/news/us-stocks-drop-volatile-trade-150150652.html,US stocks drop in volatile trade on weak jobs data
ALXN,ALXN:UW,BBG000G32HL2,Alexion to buy Synageva BioPharma in $8.4 billion deal,2015-05-06 15:01:02 +0000,http://uk.finance.yahoo.com/news/alexion-buy-synageva-biopharma-8-150102402.html,Alexion to buy Synageva BioPharma in $8.4 billion deal
ALXN,ALXN:UW,BBG000G32HL2,US stocks rise on big biopharma merger,2015-05-06 14:00:18 +0000,http://uk.finance.yahoo.com/news/us-stocks-rise-big-biopharma-140018119.html,US stocks rise on big biopharma merger
ALXN,ALXN:UW,BBG000G32HL2,Alexion misses 1Q profit forecasts,2015-04-23 10:46:01 +0000,http://sg.finance.yahoo.com/news/alexion-misses-1q-profit-forecasts-104601572.html,Alexion misses 1Q profit forecasts
ALXN,ALXN:UW,BBG000G32HL2,Alexion beats Street 4Q forecasts,2015-01-29 11:51:50 +0000,http://sg.finance.yahoo.com/news/alexion-beats-street-4q-forecasts-115150430.html,Alexion beats Street 4Q forecasts
ALXN,ALXN:UW,BBG000G32HL2,Alexion Pharma co-founder Squinto to retire,2014-11-10 15:45:08 +0000,http://sg.finance.yahoo.com/news/alexion-pharma-co-founder-squinto-154508081--finance.html,Alexion Pharma co-founder Squinto to retire
ALXN,ALXN:UW,BBG000G32HL2,Alexion tops Street 3Q forecasts,2014-10-23 10:40:05 +0000,http://sg.finance.yahoo.com/news/alexion-tops-street-3q-forecasts-104005256--finance.html,Alexion tops Street 3Q forecasts
ALXN,ALXN:UW,BBG000G32HL2,"US STOCKS-Wall St rallies, S&P back above 14-day moving average",2014-09-24 20:20:58 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-rallies-202058624.html,"US STOCKS-Wall St rallies, S&P back above 14-day moving average"
